[
  {
    "serial": 1,
    "genericName": "Atropine Sulphate",
    "doseList": [
      {
        "route": "mouth",
        "description": "0.25-2 mg daily in single or divided doses. Dosage should be gradually increased to the max as tolerated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "0.25-2 mg S/C or I/M. Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 2,
    "genericName": "Belladonna alkaloid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 t.s.f 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 t.sf. 3 times daily ½ hour before or between meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 3,
    "genericName": "Dicycloverine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "10 to 20mg 3 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "description": "Over 6 months of age- 5 to 10mg 3 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 4,
    "genericName": "HyoscineButylbromide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "20 mg 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs. 10mg 3 times daily. Under 6 years not recommended",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0,
          "max": 6
        },
        "description": "6-12 yrs. 10mg 3 times daily. Under 6 years not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "indication": "in acute pain or spasm",
        "description": "20mg I/M. or I/V Inj. (in acute pain or spasm), Repeated after 30 minutes if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "Repeated after 30 minutes if necessary."
          }
        ]
      }
    ]
  },
  {
    "serial": 5,
    "genericName": "Propantheline",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "15mg 3 times daily before meals and 2 Tablet at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before"
            },
            "extraDose": {
              "when": "night",
              "amount": {
                "min": 2,
                "max": 2
              }
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Up to 2mg/kg body-wt daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Up to 2mg/kg body-wt daily in divided doses."
          }
        ]
      }
    ]
  },
  {
    "serial": 6,
    "genericName": "Drotaverine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-2 Tablet Once. Can be repeated 2-3 times daily if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Can be repeated 2-3 times daily if necessary."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "1-2 amp. S/C or I/M Can be repeated 2-3 times daily if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ampule",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Can be repeated 2-3 times daily if necessary."
          }
        ]
      }
    ]
  },
  {
    "serial": 7,
    "genericName": "Mebeverine",
    "doseList": [
      {
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "description": "135mg (1 Tablet or 15ml of liquid Preparation) 3 times daily. Preferable half an hour before meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 135,
              "max": 135
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 8,
    "genericName": "Oxyphenonium bromide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-2 Tablet Several times daily, if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "Several times daily, if necessary."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "Over 6yrs, ½ to 1 Tablet 1-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 9,
    "genericName": "Tiemoninium",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2 to 6 Tablets (100-300mg) daily in divided doses as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 300
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "5mg by slow S/C or I/M Injection 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 10,
    "genericName": "Domperidone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Acute Nausea and Vomitiong (including drug induced)",
        "description": "Acute Nausea and Vomitiong (including drug induced), 10-20mg every 4-8 hours daily orally 15-30 minutes before a mealI.Maximum period of treatment is 12 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 8
            },
            "connectionToMeal": {
              "when": "before",
              "minute": {
                "min": 15,
                "max": 30
              }
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Functional dyspepsia",
        "description": "10-20mg 3 times daily orally before foods & at night. Maximum period of treatment is 12 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before"
            },
            "extraDose": {
              "when": "night"
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Nausea and Vomiting (following cytotoxic or radiotherapy only",
        "description": "Nausea and Vomiting (following cytotoxic or radiotherapy only)  0.2-0.4mg/kg every 4-8 hours daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.2,
              "max": 0.4
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Functional dyspepsia",
        "description": "Functional dyspepsia- Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 11,
    "genericName": "Metoclopramide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 15,
          "max": 20
        },
        "description": "15 to 20 years: 5-10mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 20
        },
        "description": "20 years and over: 10mg. 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1year :1mg twice daily; 1-3 yrs:1mg 2 or 3 times daily; 3-5 yrs.:  2mg 2 or 3 times daily; 3-5 yrs:2mg 2 or 3 times daily; 4-14 yrs. 2.5mg 3 times daily, all orally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "description": "Under 1year :1mg twice daily; 1-3 yrs:1mg 2 or 3 times daily; 3-5 yrs.:  2mg 2 or 3 times daily; 3-5 yrs:2mg 2 or 3 times daily; 4-14 yrs. 2.5mg 3 times daily, all orally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 5
        },
        "description": "Under 1year :1mg twice daily; 1-3 yrs:1mg 2 or 3 times daily; 3-5 yrs.:  2mg 2 or 3 times daily; 3-5 yrs:2mg 2 or 3 times daily; 4-14 yrs. 2.5mg 3 times daily, all orally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 14
        },
        "description": "Under 1year :1mg twice daily; 1-3 yrs:1mg 2 or 3 times daily; 3-5 yrs.:  2mg 2 or 3 times daily; 3-5 yrs:2mg 2 or 3 times daily; 4-14 yrs. 2.5mg 3 times daily, all orally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "I.M or I.V maximum dose for all ages:  0.5mg/kg body-wt./day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 12,
    "genericName": "Cimetidine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Duodenal & Benign Gastric Ulcer",
        "description": "400mg, 2 times daily with breakfast & at bed time or 800 mg at bedtime for minimum 4 weeks. Then 400mg. once or twice daily as maintenance dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "breakfast": true,
              "bedtime": true
            },
            "notes": "2 times daily with breakfast & at bed time"
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Reflux oEsophagitis",
        "description": "400mg 4 times a day after meals",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after"
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Reflux oEsophagitis",
        "description": "200mg I.M. or slow I.(100-150mg/hour) 4 to 6 hourly, max dose 2mg. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "timesDaily": {
              "max": 2
            },
            "notes": "200mg I.M. or slow I.(100-150mg/hour) 4 to 6 hourly"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child:not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 13,
    "genericName": "Famotidine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Benign Gastric and Duodenal ulceration",
        "description": "40mg at night for 4-8 weeks; Maintenance, 20 mgat night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Reflux oEsophagitis",
        "description": "20-40mg twice daily for 6-12 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Zollinger-Ellison Syndrome",
        "description": "20 mg every 6 hours (May require higher dose if previously received another H2- antagonist)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "notes": "May require higher dose if previously received another H2- antagonist"
          }
        ]
      }
    ]
  },
  {
    "serial": 14,
    "genericName": "Ranitidine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Benign Gastric and Duodenal ulcer",
        "description": "150mg (1 tab or 2 tsf) b.i.d in the morning and at bed time; or 300mg at bed time for 4 weeks; Maintenance therapy, 150mg at bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "doseTime": {
              "morning": true,
              "bedtime": true
            },
            "notes": "150mg (1 tab or 2 tsf) b.i.d"
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 8
        },
        "description": "Under 8 yrs. Not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8
        },
        "description": "over 8 yrs. Upto 150mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "50mg I.M or by slow I.V Injection or Infusion, Repeated 6 to 8 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "50mg I.M or by slow I.V Injection or Infusion"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child- not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": ".Infusion",
        "description": "25mg (or 50ml)/hour for 2 hours; May be repeated every 6-8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "duration": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "25mg (or 50ml)/hour for 2 hours"
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Prophylaxis of stress ulceration",
        "description": "Initially slow I.Infusion of 50mg over 2 hour. Maintenance then continuous Infusion of 125-250mg/kg /hour.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "duration": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "notes": "Initially slow I.Infusion of 50mg over 2 hour"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "notes": "Maintenance then continuous Infusion of 125-250mg/kg /hour."
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "severely impaired renal function",
        "description": "in patients with severely impaired renal function if CreatinineCleatrance less than 50ml/min, the recommended dosage is 50mg every 18-24 hours. If the patient’s condition requires, the frequency of dosing may be increased to every 12 hours or even further with caution.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "CreatinineCleatrance less than 50ml/min",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 18,
              "max": 24
            },
            "notes": "f the patient’s condition requires, the frequency of dosing may be increased to every 12 hours or even further with caution."
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "description": "Child- not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 15,
    "genericName": "Roxatidne",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "150 mg once daily in the evening or 75mg twice daily for 4-6 weeks. Maintenance therapy: 75mg daily in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 16,
    "genericName": "Misoprostol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "800mcg daily, in 2-4 divided doses with breakfast or main meals and at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 800,
              "max": 800
            },
            "doseTime": {
              "breakfast": true,
              "bedtime": true
            },
            "alternateDoseTime": {
              "mainMeals": true,
              "bedtime": true
            },
            "notes": "800mcg daily, in 2-4 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "nduction of labor",
        "description": "100mcg taken orally",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "nduction of labor",
        "secondaryIndication": "f cervical ripening or active labor does not occur",
        "description": "f cervical ripening or active labor does not occur, repeated dose of 100-200 mcg of oral misoprostol is given every 4 hourly until labor is established ( as evidenced by a Bishop score of 7 or more).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "repeated dose of 100-200 mcg of oral misoprostol is given every 4 hourly until labor is established"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Use of misoprostol in Children below the age of 18 years have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 17,
    "genericName": "Omeprazole",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Benign Gastric and Duodenal ulcers (including those complicating NSAID therapy)",
        "description": "Benign Gastric and Duodenal ulcers (including those complicating NSAID therapy) 20mg daily for 4 weeks in Duodenal ulceration or 8 weeks in Gastric ulceration; In severe cases doses increase to 40mg daily; Long-term use not recommended",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "condition": "in Duodenal ulceration",
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "notes": "in severe cases doses increase to 40mg daily, and Long-term use not recommended"
          },
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "condition": "in Gastric ulceration",
            "treatmentPeriod": {
              "unit": "week",
              "min": 8,
              "max": 8
            },
            "notes": "in severe cases doses increase to 40mg daily, and Long-term use not recommended"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Zollinger-Ellison Syndrome",
        "description": "Initially 60mg once daily; Usual ranger 20-120 mg daily( above 80mg in 2 divided doses).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 120
            },
            "notes": "above 80mg in 2 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Reflux oEsophagitis",
        "description": "20mg daily for 4 weeks, followed by a further 4-8 weeks if not fully healed; 40mg daily has been given for 8 weeks in reflux oEsophagitis refractory to other treatment; may be continued at 20 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "condition": "f not fully healed",
              "unit": "week",
              "min": 4,
              "max": 8
            }
          },
          {
            "type": "alternate",
            "condition": "in reflux oEsophagitis refractory",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child-: not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 18,
    "genericName": "esomeprazole",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Gastroesophageal reflux disease (GERD)",
        "description": "Symptomatic gastroesophageal reflux-20mg once daily for 4 weeks; if symptoms do not resolve completely after 4 weeks, as additional 4 weeks of treatment my be considered. Healing of Erosive Esophagitis-20mg or 40mg once daily for 4 to weeks; patients who do not heal after 8 weeks; patients who do not heal after 8 weeks, an additional 4-8 weeks treatment may be consideredI.Maintenance of healing of Erosive Esophagitis- 20mg once daily for up to hot beyond six months.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Symptomatic gastroesophageal reflux",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "symptoms do not resolve completely after 4 weeks",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "condition": "Healing of Erosive Esophagitis",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternateFollowup",
            "condition": "patients who do not heal after 8 weeks",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "condition": "Maintenance of healing of Erosive Esophagitis",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Triple therapy for H. PylarEradication",
        "description": "Esomeprazole 40 mg once daily for 10 days with Amoxicillin 1 gm twice daily for 10 days & Clarithromycin 500 mg twice daily for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "additionalItemOne": {
              "genericName": "Amoxicillin",
              "unit": "gm",
              "amount": {
                "min": 1,
                "max": 1
              },
              "timesDaily": {
                "min": 2,
                "max": 2
              },
              "treatmentPeriod": {
                "unit": "day",
                "min": 10,
                "max": 10
              }
            },
            "additionalItemTwo": {
              "genericName": "Clarithromycin",
              "unit": "mg",
              "amount": {
                "min": 500,
                "max": 500
              },
              "timesDaily": {
                "min": 2,
                "max": 2
              },
              "treatmentPeriod": {
                "unit": "day",
                "min": 10,
                "max": 10
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 19,
    "genericName": "Lansoprazole",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Benign Gastric ulcer",
        "description": "Benign Gastric ulcer- 30mg daily in the morning for 8 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 8,
              "max": 8
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Duodenal ulcer",
        "description": "Benign Gastric ulcer- 30mg daily in the morning for 8 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "NSAID associated Duodenal or Gastric ulcer",
        "description": "15mg to 30mg once daily for 4 weeks, followed by a further 4 weeks if not healed completely. Zollinger-Ellison Syndrome (and other hypersecretory conditions).initially 60mg once daily adjusted according to response; Daily doses of 120mg or more is given in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f not healed completely",
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "condition": "Zollinger-Ellison Syndrome (and other hypersecretory conditions).",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "condition": "f not healed completely",
            "unit": "mg",
            "amount": {
              "min": 120
            },
            "notes": "Daily doses of 120mg or more is given in two divided doses."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Gastro-oesophageal reflux disease",
        "description": "30mg daily in the morning for 4 weeks, followed by a further 4 weeks if not fully healed; Maintenance therapy may be required, 15-30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f not healed completely",
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "condition": "f not fully healed",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Acid-related dyspepsia",
        "description": "Acid-related dyspepsia- 15mg to 30mg daily in the morning for 2-4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 20,
    "genericName": "Pantoprazole",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral dose is 40mg once daily, preferably in the morning with or without food. The duration of therapy is ranging from2-8 weeks",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 8
            },
            "notes": "preferably in the morning with or without food."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "in Duodenal ulcers",
        "description": "Pantoprazole 40mg once daily given for 2-4 weeks;If generally heals within 2 weeks",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "notes": "f generally heals within 2 weeks"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "in Gastric ulcers",
        "description": "Pantoprazole 40mg once daily given for 4-8 weeks; it also heals within 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 8
            },
            "notes": "t also heals within 4 weeks."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in resistant ulcers",
        "description": "40 mg once daily given for 8 weeks",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in ulcers induced by NSAIDs",
        "description": "in ulcers induced by NSAIDs, 40mg once daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Eradication of Helicobacter Pylori",
        "description": "Eradication of Helicobacter Pylori- pantoprazole 40mg twice daily in triple therapy’ in combination with appropriate antibiotic for one week achieved eradication rates of 90-100%",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "in triple therapy’ in combination with appropriate antibiotic for one week achieved eradication rates of 90-100%"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Zollinger-Ellison Syndrome",
        "description": "Zollinger-Ellison Syndrome- Pantoprazole 160mg (40mg x 4 Tablets) per day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 160,
              "max": 160
            },
            "notes": "160mg (40mg x 4 Tablets) per day"
          }
        ]
      }
    ]
  },
  {
    "serial": 21,
    "genericName": "Rabeprazole",
    "doseList": [
      {
        "route": "mouth",
        "description": "20mg daily for 4 to 8 weeks. Patients who have not healed after 8 weeks of treatment, an additional 8 weeks course may be considered.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "condition": "Patients who have not healed after 8 weeks of treatment",
            "treatmentPeriod": {
              "unit": "week",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Esophageal Reflux Diseases (GERD)",
        "description": "Esophageal Reflux Diseases (GERD);The recommended dose is 20mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Healing of Duodenal ulcers",
        "description": "Healing of Duodenal ulcers:the recommended dose is 20mg daily in the morning for 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 22,
    "genericName": "Sucralfate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Usually 1-2 Tablet 4 times daily before meals for minimum 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "connectionToMeal": {
              "when": "before"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 23,
    "genericName": "Triple Therapy",
    "doseList": [
      {
        "route": "mouth",
        "description": "Each ‘Triple therapy’ kit twice daily for 7-14 days or as per the physician’s advice.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 24,
    "genericName": "Helicon Kit General",
    "doseList": [
      {
        "route": "mouth",
        "description": "Each Helicon kit twice daily for 7-14 days or as per the physician’s advice.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 25,
    "genericName": "Neo kit beximco",
    "doseList": [
      {
        "route": "mouth",
        "description": "Each Neo kit twice daily for 7-14 days or as per the physician’s advice.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 26,
    "genericName": "Pylopac Beximeo",
    "doseList": [
      {
        "route": "mouth",
        "description": "One pylopac (2 Tablets & 1 Capsule in one blister strip) twice daily (12 hourly) for 7 days or as per the physician’s advice.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "polypac",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "notes": "One pylopac (2 Tablets & 1 Capsule in one blister strip)"
          }
        ]
      }
    ]
  },
  {
    "serial": 27,
    "genericName": "Pylotrip Square",
    "doseList": [
      {
        "route": "mouth",
        "description": "Each Pylotrip strip twice daily for 7-14 days or as per the physician’s advice.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Pylotrip strip",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 28,
    "genericName": "spaghula Husk",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-2 tsf in water twice or thrice daily with meals or just after meals.In Diarrhoea water should be minimum.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with or after"
            },
            "notes": "1-2 tsf in water and In Diarrhoea water should be minimum"
          }
        ]
      }
    ]
  },
  {
    "serial": 29,
    "genericName": "Loperamide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Acute Diarrhoea",
        "description": "Acute Diarrhoea, initially 2 caps.Then 1 at each loose stool, (usually 3-4 daily)I.Maximum 8 daily. ",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Caps",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "1 at each loose stool, (usually 3-4 daily)"
          },
          {
            "type": "maintenance",
            "unit": "caps",
            "amount": {
              "min": 3,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Chronic Diarrhoea",
        "description": "Acute Diarrhoea, initially 2 caps.Then 1 at each loose stool, (usually 3-4 daily). Maximum 8 daily. ",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Caps",
            "amount": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "description": "Under 4 year, not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 8
        },
        "description": "4-8 yrs.:½ of 1 Capsule; Both four time daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9,
          "max": 12
        },
        "description": "9-12 yrs:1 Capsule. Both four time daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 30,
    "genericName": "Mesalazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "acute attack",
        "description": "6 Tablets daily in divided doses;maintenance 3-6 Tablets daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child, not Recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 31,
    "genericName": "Sulphasalazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2-4 times daily;maintenance, 4 Tablet Daily in divided doses",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- Initially 1 tab. Daily for one week increasing by one each week to maximum 6 daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "ncreasing by one each week to maximum 6"
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Under 2 years not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Over 2 years 40-60mg/kg daily; Maintenance 20-30 mg/kg. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 60
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 32,
    "genericName": "Tegaserod",
    "doseList": [
      {
        "route": "mouth",
        "description": "6 mg orally twice daily prior to meal. NO dosage adjustment is required in elderly patients",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6,
              "max": 6
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "before"
            },
            "notes": "NO dosage adjustment is required in elderly patients"
          }
        ]
      }
    ]
  },
  {
    "serial": 33,
    "genericName": "spaghula Husk",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2 tsf (10ml) in water once or twice daily with meals",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "notes": "2 tsf (10ml) in water"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child:  half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 34,
    "genericName": "Methyl Cellulose",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Constipation",
        "description": "2-4 Tablet Twice daily with at least 300ml of water/ liquid",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "temName": "water/liquid",
              "unit": "ml",
              "amount": {
                "min": 300
              }
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Colostomy, ileostomy & Diarrhoea",
        "description": "2-4 Tablet 2-3 times daily with minimum liquid. Liquid should be avoided for 30 mins. Before & after each dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "additionalItem": {
              "temName": "liquid"
            },
            "notes": "Liquid should be avoided for 30 mins. Before & after each dose."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Diverticuler disease & ulcerative colitis",
        "description": "2-4 Tablet Twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Obesity",
        "description": "Obesity-2-3 Tablet",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 35,
    "genericName": "Bisacodyl",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-2 Tablet After meal usually at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after"
            },
            "doseTime": {
              "night": true
            },
            "notes": "After meal usually at night"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 yrs. 1 tab At night",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "description": "over 10 yrs same as Adult. Avoid taking with milk and antacids",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after"
            },
            "doseTime": {
              "night": true
            },
            "notes": "After meal usually at night;Avoid taking with milk and antacids."
          }
        ]
      }
    ]
  },
  {
    "serial": 36,
    "genericName": "Sennoside",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2-4 Tablet At bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Under 2 years, not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "description": "2-6 yrs 1/4th tabs;Both ages take in the morning",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "over 6 yrs. ½ tabs Adult dose. Both ages take in the morning.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 37,
    "genericName": "Lactulose",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Constipation",
        "description": "Initially 15ml twice daily then gradually reduced according to patient’s needs",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 15,
              "max": 15
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "then gradually reduced according to patient’s needs"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year 2.5ml;all twice daily, gradually reduced",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1-5 years 5ml; all twice daily, gradually reduced",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years 10ml, all twice daily, gradually reduced",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Hepatic Encephalopathy",
        "description": "Hepatic Encephalopathy- 30-50ml 3 times daily,subsequently adjusted to produce 2-3 saft stools daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 30,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "subsequently adjusted to produce 2-3 saft stools daily"
          }
        ]
      }
    ]
  },
  {
    "serial": 38,
    "genericName": "Lactitol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "The initial daily dosage should be 20gm, to be taken in a single dose with morning or evening meal. This dose can be reduced to 10gm/day when desired effect has been obtained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 20,
              "max": 20
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "notes": "This dose can be reduced to 10gm/day when desired effect has been obtained."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 6
        },
        "description": "1-6 years old,2.5-5gm per day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2.5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years old,5-10 gm per day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12,
          "max": 16
        },
        "description": "12-16 years old,10-20gm per day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 39,
    "genericName": "Polyethylene glycol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "17gm of powder per day (or as directed by the physician) in a glass of water, juice, coke, coffee or tea (approx. 240ml). Polyethylene glycol achieves its best results when used between 1 and 2 weeks",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 17,
              "max": 17
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "in a glass of water, juice, coke, coffee or tea (approx. 240ml)."
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 40,
    "genericName": "Liquid paraffin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2 tsf (10ml)at night and morning or after meals",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true,
              "morning": true
            },
            "alternateDoseTime": {
              "afterMeals": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child:half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true,
              "morning": true
            },
            "alternateDoseTime": {
              "afterMeals": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 41,
    "genericName": "Ultracarbon",
    "doseList": [
      {
        "route": "Mouth",
        "description": "1-2 Tablets to be taken several time daily, disintegrated in water stirred before drinking. In severe cases, a large number of Tablets should be taken (4-6-8 or more once).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "disintegrated in water stirred before drinking."
          }
        ]
      }
    ]
  },
  {
    "serial": 42,
    "genericName": "Diosmin + Hesperidin",
    "doseList": [
      {
        "route": "Mouth",
        "indication": "Acute Hemarrhoidal attacks",
        "description": "3 Tablets twice daily for 4 days, Then 2 Tablets twice daily for 3 days and if required 1 Tablet twice daily as maintenance dosage.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "indication": "Chorine Hemorrhoide",
        "description": "1 Tablet twice daily initially for 7 days; duration may be increased depending on severity. Tablet should be taken at meal times.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "connectionToMeal": {
              "when": "at meal time"
            },
            "notes": "duration may be increased depending on severity"
          }
        ]
      }
    ]
  },
  {
    "serial": 43,
    "genericName": "Betamethasone + Phenylephrine + Lignocaine",
    "doseList": [
      {
        "route": "Mouth",
        "description": "Apply locally 2 or 3 times daily initially, using  the applicator if internal administration is required. When inflammation is subsiding once daily application is sufficient in most cases.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "using  the applicator if internal administration is required."
          },
          {
            "type": "maintenance",
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 44,
    "genericName": "Hydrocortisone + Aesculin + Cinchocaine + Framycetion/ Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult and Child",
        "description": "application of ointment on the painful or pruritic area by using finger, at morning and night and after defecation.Suppository: Use one suppository in the morning and one in the evening and after each stool.",
        "subDoseList": [
          {
            "type": "primary",
            "doseTime": {
              "morning": true,
              "night": true,
              "afterDefection": true
            },
            "notes": "Suppository: Use one suppository in the morning and one in the evening and after each stool."
          }
        ]
      }
    ]
  },
  {
    "serial": 45,
    "genericName": "Pancreatin",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "description": "2 gm of pancreatic BP daily in divided doses according to the patients need.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Up to 1 yr. 500 to 750 mg with each feed",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 750
            },
            "connectionToMeal": {
              "when": "with each feed"
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "description": "1-12 yrs. 0.75-1gm with  (or just before) meals",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.75,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with (or just before) meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 46,
    "genericName": "Ursodeoxycholic acid",
    "doseList": [
      {
        "route": "Mouth",
        "indication": "Dissolution of gallstones",
        "description": "8-12mg/kg daily as a single dose at bedtime or in two divided doses for up to 2 years; Treatment is continued for 3-4 months after stones dissolved",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 12
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "year",
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "condition": "after stones dissolved",
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "indication": "Primary Billiary Cirrhosis",
        "description": "10-15mg/kg daily in 2-4 divided doses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 47,
    "genericName": "Amiodarone",
    "doseList": [
      {
        "description": "200mg 3 times daily for 12 week.Reduced to 200mg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "weel",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "maintenance",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 48,
    "genericName": "Disopyramide",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "description": "400mg daily in 4 divided doses i.e 100 mg 6 hourly, Then 150 mg 6 hourly,",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Adjusting to maintenance",
        "description": "400-800mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 800
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Adjusting to maintenance",
        "description": "f clearance rate is 40-30 ml/min, Give 100mg 8 hourly,",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "clearance rate is 40-30 ml/min",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Adjusting to maintenance",
        "description": "f 30-15 ml/min, 100 mg 12 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "clearance rate is 30-15 ml/min",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Adjusting to maintenance",
        "description": "f>15ml/min,100mg in f24 hours",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "clearance rate is >15ml/min",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 49,
    "genericName": "Lignocaine",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "description": "50-100 mg I.followed by continuous I.Infusion of usually 0.2% soln. (i.e. by diluting 2% soln. with. 5% dextrose soln.) at 2-4 mg/minimum rate.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "notes": "followed by continuous I.Infusion of usually 0.2% soln."
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 50,
    "genericName": "Sotalol",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "description": "80mg daily in single or 2 divided doses.After ECG monitoring and measurement or corrected QT interval, arrhythmias, dose is increased gradually at intervals of 2-3 days to usual dose of 160-320mg daily in 2 divided doses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            },
            "notes": "After ECG monitoring and measurement or corrected QT interval, arrhythmias, dose is increased gradually at intervals of 2-3 days to usual dose of 160-320mg daily in 2 divided doses"
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Higher doses of 480-640mg daily for life",
        "description": "f creatinine clearance is 60ml/min, recommended dose is 160mg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f creatinine clearance is 60ml/min",
            "unit": "mg",
            "amount": {
              "min": 160,
              "max": 160
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Higher doses of 480-640mg daily for life",
        "description": "f creatinine clearance between 40 and 60ml/min, the dose is 160mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f creatinine clearance between 40 and 60ml/min",
            "unit": "mg",
            "amount": {
              "min": 160,
              "max": 160
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 51,
    "genericName": "Digoxin",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Slow digitalization",
        "description": "Slow digitalization, 0.25-0.75mg daily; Maintenance 0.25-0.5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.75
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.5
            }
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "indication": "Rapid digitalization",
        "description": "Rapid digitalization, 0.75-1.5mg followed by 0.25mg. 6 hourly until ventricular rate 70-80/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.75,
              "max": 1.5
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "notes": "6 hourly until ventricular rate 70-80/minimum"
          }
        ]
      },
      {
        "route": "Mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 years, digitalization 10-20 mcg/kg body-wt. 6 hourly; Maintenance, Usually 10-20 mcg/kg body-wt. Daily in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "notes": "digitalization 10-20 mcg/kg body-wt. 6 hourly"
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 52,
    "genericName": "Clonidine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertensive argencies",
        "description": "Hypertensive argencies, 0.1mg twice daily to manage the hypertensive crisis than tailing off the therapy;",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.1,
              "max": 0.1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Resistant Hypertension",
        "description": "Resistant Hypertension, 0.1mg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.1,
              "max": 0.1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Atrial Fibrillation",
        "description": "Atrial Fibrillation,0.075mg once or twice daily alone or with digoxin",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.075,
              "max": 0.075
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "alone or with digoxin"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Attention Deficit Hyperactivity Disorder (ADHD)",
        "description": "For the treatment of attention deficit hyperactivity disorder (ADHD), 5mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Autism",
        "description": "Autism,0.15mg to 0.2mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.15,
              "max": 0.2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Tourette’Syndrome",
        "description": "Tourette’Syndrome, 150-200mcg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 150,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "For growth retardation",
        "description": "For growth retardation, 37.5-150mcg/m2 day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/m2",
            "amount": {
              "min": 37.5,
              "max": 150
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Menopausal Hot Flash",
        "description": "Menopausal hot flash, 0.1mg to 0.4mg daily for up to 2 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.1,
              "max": 0.4
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 53,
    "genericName": "Methyldopa",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially, 250 mg 2 or 3 times daily increased to maximum 3gm daily adjust at two day intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "adjust at two day intervals"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Initially 10mg/kg body-wt. daily in 2-4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 54,
    "genericName": "Propranolol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Hypertension,initially 80mg twice daily increasing if necessary at weekly intervals to 160-320 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 160,
              "max": 320
            },
            "notes": "f necessary at weekly intervals"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Anxiety",
        "description": "Anxiety, 40mg 2-3 times daily increasing if necessary at weekly interval upto 120-140mg/ day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 140
            },
            "notes": "f necessary at weekly intervals"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Phaeochromocytoma",
        "description": "Phaeochromocytoma, 60mg daily with an alpha-blocker for 3 days preoperatively or 30mg daily in inoperable case.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "preoperatively",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "additionalItem": {
              "genericName": "alpha-blocker"
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternate",
            "condition": "noperable case",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Palpitations, sweating, tremor etc.",
        "description": "Palpitations, sweating, tremor etc. 40mg 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "0.25-0.5mg/kg body-wt 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "1 mg over 1 minimum preceded by atropine sulph. 1-2mg; If necessary, repeat at 2minimumIntervals; max 10 mg (5mg in anaesthesia).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "genericName": "atropine sulph.",
              "unit": "mg",
              "amount": {
                "min": 1,
                "max": 2
              }
            },
            "notes": "f necessary, repeat at 2min"
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Prophylaxis after infarction",
        "description": "40mg 4 times daily for 2-3 days then 80mg thrice daily, beginning 5-21 days after infarction.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "beginning 5-21 days after Infarction"
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Migraine prophylaxis",
        "description": "Migraine prophylaxis- initially 40mg 2-3 times daily; maintenance 80-160mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 160
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 55,
    "genericName": "Atenolol",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Hypertension",
        "description": "Hypertension, 50 mg daily (higher doses no longer considered necessary).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Angina",
        "description": "Angina, 100mg daily in 1 or 2 doses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "notes": "in 1 or 2 doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Arrhythmias",
        "description": "Arrhythmias, 50-100 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Arrhythmias",
        "description": "Arrhythmias, 1.5 mg at a rate of 1mg/min repeated at 5-minute intervals to a maximum of 10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "preoperatively",
            "unit": "mg",
            "amount": {
              "min": 1.5,
              "max": 10
            },
            "notes": "at a rate of 1mg/min repeated at 5-minute intervals"
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Adult",
        "indication": "Arrhythmias",
        "description": "Arrhythmias, 150mcg/kg over 20 minutes,Repeated every 12 hours if required. Early intervention within 12 hours of infarction, 5-10 mg by slow I.V Injection,Then by  50mg after 15 minutes,50mg after 12 hours, then 100mg daily.Note: Excessive bradycardia can be countered with intravenous Injection of atropine sulphate 0.6-2.4mg in divided doses of 0.6mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 56,
    "genericName": "Carvedilol",
    "doseList": [
      {
        "route": "mouth",
        "indication": "in Hypertension",
        "description": "Treatment should be started with 12.5mg once daily,Then increased to 25mg daily after 2 days.The dose may further be increased to maximum 50mg daily in single or divided doses, at intervals of at least 2 weeks, if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "notes": "daily in single or divided doses, at intervals of at least 2 weeks, if necessary"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Angina",
        "description": "in angina-initially 12.5mg twice daily, Then increased to 25mg twice daily after 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "after 2 days"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in heart failure",
        "description": "in heart failure- 3.125mg twice daily with food; dose may be increased at intervals of at least 2 weeks at 6.25mg twice daily, then to 12.5mg twice daily, Then to 25mg twice daily. Patients less than 85kg body-weight, maximum 25mg twice daily and in patients over 85kg, maximum 50mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3.125,
              "max": 3.125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 6.25,
              "max": 6.25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "condition": "Patients less than 85kg body-weight",
            "unit": "mg",
            "amount": {
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "condition": "patients over 85kg",
            "unit": "mg",
            "amount": {
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 57,
    "genericName": "Celiprolol",
    "doseList": [
      {
        "indication": "Hypertension",
        "description": "The recommended initial dose is 200mg once daily.The dose may be increased to 400mg once daily if necessary at 2 to 4 week intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "The dose may be increased if necessary at 2 to 4 week intervals."
          }
        ]
      },
      {
        "indication": "Angina Pectoris",
        "description": "the usual dose is 200mg once daily;Dosage may be increased to 400mg or 600mg once daily after 2 to 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Dosage may be increased after 2 to 4 weeks."
          }
        ]
      }
    ]
  },
  {
    "serial": 58,
    "genericName": "Metoprolol",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Hypertension",
        "description": "Initially 100mg daily, Maintenance 100-200mg daily in 1-2 doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Angina",
        "description": "Angina, 50-100 mg 2-3 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Arrhythmias",
        "description": "usually 50mg 2-3 times daily;Up to 300mg daily in divided doses if necessary",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Migraine Prophylaxis",
        "description": "Migraine prophylaxis, 100-200mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Arrhythmias",
        "description": "Arrhythmias, up to 5mg at a rate 1-2 mg/minute, repeated after 5 minutes if necessary, Total doses 10-15mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "in surgery",
        "description": "in surgery, 2-4mg by slow I.V Injection at induction or to control arrhythmias developing during anaeshesia; 2mg doses may be repeated to a maximum of 10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 59,
    "genericName": "Prazosin",
    "doseList": [
      {
        "route": "Mouth",
        "ageGroup": "Adult",
        "description": "0.5mg on first evening, then 0.5mg 2-3 time daily for 3-7 days Followed by 1 mg 2 or 3 times daily for 3-7 days; Thereafter, increase gradually as required. Maximum 20 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 60,
    "genericName": "Terazosin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Hypertension, initial dose- 1mg at bedtime (compliance with bedtime dose important); Dose can be increased or doubled after 7 days if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "notes": "Dose can be increased or doubled after 7 days if necessary;"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "more than 20mg daily rarely improves efficacy."
          }
        ]
      }
    ]
  },
  {
    "serial": 61,
    "genericName": "Captopril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Mild to moderate Hypertension",
        "description": "Initially 12.5mg twice daily with a thiazide diuretic. Maintenance: 25 mg twice daily increasing gradually at 2-4 weeks interval if necessary to maximum 50mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "genericName": "thiazide diuretic"
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "ncreasing gradually at 2-4 weeks interval if neterval if necessary"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Severe Hypertension",
        "description": "25 mg twice daily increasing if necessary to 50mg three time daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "ncreasing if necessary"
          }
        ]
      }
    ]
  },
  {
    "serial": 62,
    "genericName": "Cilazapril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Essential Hypertension",
        "description": "Initially 1 mg once daily; If used in those receiving a diuretic, in elderly, or in Renal Impairment, initially 500mcg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "genericName": "thiazide diuretic"
            }
          },
          {
            "type": "alternate",
            "condition": "f used in those receiving a diuretic, in elderly, or inRenal Impairment",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in renovascular Hypertension, Liver cirrhosis",
        "description": "Initially 250-500mcg once daily; usual maintenance dose 1-2.5mg once daily; Maximum 5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Maximum 5mg daily"
          }
        ]
      }
    ]
  },
  {
    "serial": 63,
    "genericName": "Enalapril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Initially 5mg once daily; If used in addition to diuretic, in elderly patients or in Renal Impairment, initially 2.5mg daily; Usual maintenance dose 10-20 mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "f used in addition to diuretic, in elderly patients or in Renal Impairment",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Heart failure",
        "description": "Initially 2.5mg daily under close medical supervision; Usual maintenance 20mg daily in1-2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "notes": "under close medical supervision"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 64,
    "genericName": "Fosinopril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Initially 10mg daily, increased if necessary after 4 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "notes": "Increased if necessary after 4 week"
          }
        ]
      },
      {
        "indication": "Heart failure (adjunct)",
        "description": "Initially 10mg daily under close medical supervision; If initial dose is well tolerated, may be increased to up to 40mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "notes": "under close medical supervision"
          },
          {
            "type": "primaryFollowup",
            "condition": "f initial dose is well tolerated",
            "unit": "mg",
            "amount": {
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 65,
    "genericName": "Lisinopril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially, 2.5mg once daily increasing gradually over 2-4weeks to maintenance of 10-20mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "notes": "ncreasing gradually"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 66,
    "genericName": "Perindopril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "4mg once a day in the morning, If necessary, the dose may be increased to 8mg after 1 month of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "f necessary, the dose may be increased to 8mg after 1 month of treatment"
          }
        ]
      }
    ]
  },
  {
    "serial": 67,
    "genericName": "Ramipril",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Hypertension-Or the management of Hypertension Adult not receiving a diuretic, the usual initial dose is 1.25-2.5 mg once daily.The usual maintenance dosage in Adults is 2.5-20mg daily given as a single dose or in 2 divided doses daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Adult not receiving a diuretic",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 20
            },
            "notes": "daily given as a single dose or in 2 divided doses daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage in Renal Impairment",
        "description": "The recommended initial dose is 1.25mg once daily.The doses may be increased to 1.25mg twice daily and up to a maximum dose of 2.5mg twice daily depending upon clinical response and tolerability.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Adult not receiving a diuretic",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 68,
    "genericName": "Candesartan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Blood pressure response is dose related over the range of 2 mg to 32mg.Candesartan can be administered once or twice daily with total daily dosage ranging from 8 mg to 32mg. Most of the antihypertensive effect is present within 2 weeks, and maximal blood pressure reduction is generally obtained within 4 to 6 weeks of treatment with Candesartan.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": null,
              "max": null
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 69,
    "genericName": "rbesartan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "The usual initial and maintenance dose of Irbesartan is 150mg once daily.It may be administered with or without food.Patients requiring further reduction in blood pressure, dose may be increased to 300mg once daily.If Blood pressure is not adequately controlled with irbesartan alone, a diuretic (e.g hydrochlorothiazide 12.5 mg daily)Or Another antihypertensive drug (e.g beta-adrenergic blocking agent, long-acting calcium channel blocking agent) may be added.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": null,
              "max": null
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 70,
    "genericName": "Losartan potassium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "The usual starting dose is 50mg once daily; But, in patients with possible depletion of intravascular volume (e.g patients treated with diuretics), patients with a history of Hepatic or Renal Impairment & in case of very elderly patients (over 75 years ) should be started with 25 mg once daily.It can be administered once or twice daily with total daily doses ranging from 25mg to increasing upto 100mg afterseveral weeks, if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in patients with possible depletion of intravascular volume",
            "unit": "mg",
            "amount": {
              "min": 25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "condition": "in patients with possible depletion of intravascular volume",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 71,
    "genericName": "Telmisartan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The usual starting dose of Telmisartan is 40mg once daily.The dose may be increased up to 80 mg if required.Telmisartan Tablet canbe administered with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "The dose may be increased up to 80 mg if required"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Safety and effectiveness in peadiatric patients has not been established..",
        "subDoseList": []
      }
    ]
  },
  {
    "serial": 72,
    "genericName": "Valsartan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The Recommended dose is 80mg once daily,In patients whose blood pressure is not adequately controlled, the daily dose may be increased to 160mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in patients whose blood pressure is not adequately controlled",
            "unit": "mg",
            "amount": {
              "max": 160
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Safety and effectiveness in peadiatric patients has not been established..",
        "subDoseList": []
      }
    ]
  },
  {
    "serial": 73,
    "genericName": "Sodium nitroprusside",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "nfusion should be started at and very low rate of 3mcg/kg/minimumThe maximum recommended Infusion rate is 10mcg/kg/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/min",
            "amount": {
              "min": 0.3,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 74,
    "genericName": "Thiazides",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Diuresis",
        "description": "50-100mg once or twice daily or intermittently.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "once or twice daily or intermittently"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Initially 50-100mg daily as a single or divided doses, maximum 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 200
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Under 6 month upto:3.5mg/kg body-wt. daily.All in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3.5,
              "max": 3.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 2
        },
        "description": "6 months to 2 years:12.5-37.5mg daily.All in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 37.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 12
        },
        "description": "2-12 yrs.:37.5-100mg daily.All in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 37.5,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 75,
    "genericName": "ndapamide",
    "doseList": [
      {
        "description": "2.5mg Tablet (or 1.5mg SR Tablet) daily in single dose, preferable in the morning.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 76,
    "genericName": "Frusemide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 20-80 mg once or twice daily, then adjusted according to the response.  By I.M or slow I.V Injection 20-40mg; By I.V. Infusion, in oliguria 0.25-1gm at a rate not exceeding 4mg/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 80
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "condition": "By I.M or slow I.V Injection",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            }
          },
          {
            "type": "alternate",
            "condition": "By I.V. Infusion, in oliguria",
            "unit": "gm",
            "amount": {
              "min": 0.25,
              "max": 1
            },
            "notes": "a rate not exceeding 4mg/minimum"
          }
        ]
      }
    ]
  },
  {
    "serial": 77,
    "genericName": "Torasemide",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Edema",
        "description": "usual oral dose is 5mg once daily,preferable in the morning.If necessary, the dose can be increased stepwise up to 20mg once daily.The usual maximum dose is 40mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "The usual maximum dose is 40mg once daily."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Essential Hypertension",
        "description": "an oral low dose of 2.5mg once daily is recommended,if necessary, the dose can be increased to 5mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 78,
    "genericName": "Spironolactone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Congestive Heart Failure",
        "description": "100mg daily, increasing if necessary to 400mg daily;Maintenance 75-200mg daily.Hypertension, 50-100mg daily increasing if necessary at two weekly intervals upto 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 400
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "50-100mg daily increasing if necessary at two weekly intervals upto 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 200
            },
            "notes": "at two weekly intervals"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Initially 3mg/kg body-wt. daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 79,
    "genericName": "Spironolactone+Frusemide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1 to 4 Tablets daily according to the patients response or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 4
            },
            "notes": "1 to 4 Tablets daily according to the patients response or as directed by the physician."
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 80,
    "genericName": "Thiazide + Amiloride",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-2 Tablet Daily in single or divided doses, Increasing if necessary to maximum 4 Tablet",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "Tablet",
            "amount": {
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 81,
    "genericName": "Thiazide + Triamterine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 1 tab. Twice daily after meals, reducing to usually 1 daily or 2 on alternate days. Maximum 4 daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternatePrimaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "on alternate days"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "Hypertension, initially 1 daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 82,
    "genericName": "Acetazolamide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 250-375mg once daily in the morning or on alternate days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 375
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "in the morning or on alternate days."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Premenstrual tension",
        "description": "125-375 mg as a single daily dose beginning 5-10 days before menstruation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 375
            },
            "notes": "a single daily dose beginning 5-10 days before menstruation."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Glaucoma",
        "description": "Initially 500mg, subsequent doses 250mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "notes": "every 6 hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 83,
    "genericName": "Mannitol",
    "doseList": [
      {
        "route": ".V Infusion",
        "description": "50-200gm over 24 hours, may be Preceded by a test dose of 200mg/liter by slow I.V Injection. Maximum 1000ml (liter) per day or as directed by physician",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 50,
              "max": 200
            },
            "notes": "Preceded by a test dose of 200mg/liter by slow I.V InjectionI.Maximum 1000ml (liter) per day as directed by physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 86,
    "genericName": "ndapamide + Perindopril",
    "doseList": [
      {
        "route": "mouth",
        "description": "One Tablet daily (strength as advised by the physician), preferable to be taken in the morning and before a meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "connectionToMeal": {
              "when": "before a meal"
            },
            "notes": "strength as advised by the physician"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "description": "normal dosage. One Tablet daily (strength as advised by the physician), preferable to be taken in the morning and before a meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "connectionToMeal": {
              "when": "before a meal"
            },
            "notes": "strength as advised by the physician"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Renal failure",
        "description": "Creatinine clearance (CrCl)>30ml/min: No dosage modification. (CrCl) >30ml/min: Treatment contraindicated.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Creatinine clearance (CrCl)>30ml/min",
            "notes": "No dosage modification"
          },
          {
            "type": "primary",
            "condition": "Creatinine clearance (CrCl)>30ml/min",
            "notes": "Treatment contraindicated"
          }
        ]
      }
    ]
  },
  {
    "serial": 87,
    "genericName": "Candesartan + Hydrochlorothiazide",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 4mg (2mg in Hepatic and Renal Impairment ) once daily adjusted according to response.Usual maintenance dose is 8mg once daily;Maximum 32mg once daily.Doses larger than 32mg do not appear to have a greater blood pressure lowering effect.Hydrochlorothiazide is effective in doses of 12.5 to 50mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "2mg in Hepatic and Renal Impairment; adjusted according to response"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Maximum 32mg once daily.Doses larger than 32mg do not appear to have a greater blood pressure lowering effect.Hydrochlorothiazide is effective in doses of 12.5 to 50mg once daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 91,
    "genericName": "Glyceryl trinitrate",
    "doseList": [
      {
        "route": "mouth",
        "ageRange": "Adult",
        "description": "2.6-6.4mg as sustained release Tablets, 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.6,
              "max": 6.4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "description": "10-200mcg/min",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/min",
            "amount": {
              "min": 10,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "spray",
        "indication": "Treatment or prophylaxis of angina",
        "description": "Treatment or prophylaxis of angina, spray 1-2 dose under tongue & then close mouth.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "under tongue & then close mouth."
          }
        ]
      }
    ]
  },
  {
    "serial": 92,
    "genericName": "sosorbide dinitrate",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Prophylaxis Angina",
        "description": "Prophylaxis Angina 30-120 mg daily in 3 or 4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 120
            },
            "notes": "daily in 3 or 4 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Left ventricular failure",
        "description": "Left ventricular failure, 40-160mg upto 240mg daily if required, in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 160
            },
            "notes": "upto 240mg daily if required, in divided doses."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Acute attack",
        "description": "Acute attack, 5-10 mg sublingually.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Acute attack",
        "description": "2-10mg/hour, higher doses upto 20mg/hour may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/hour",
            "amount": {
              "min": 2,
              "max": 10
            },
            "notes": "higher doses upto 20mg/hour may be required"
          }
        ]
      }
    ]
  },
  {
    "serial": 93,
    "genericName": "Mannitol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 20mg 2-3 times daily or 40mg twice daily (10mg twice daily in those who have not previously received nitrate);Up to 120mg daily in divided doses if required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "(10mg twice daily in those who have not previously received nitrate);Up to 120mg daily in divided doses if required."
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "(10mg twice daily in those who have not previously received nitrate);Up to 120mg daily in divided doses if required."
          }
        ]
      }
    ]
  },
  {
    "serial": 94,
    "genericName": "Amlodipine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Hypertension",
        "description": "5mg once daily. Amlodipine may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Maximum dose is 10mg once daily"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Elderly patients with Hepatic insufficiance",
        "description": "Elderly patients with Hepatic insufficiance may be started with 2.5mg once daily.Amlodipine may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Angina",
        "description": "5-10mg once daily. Most patients require 10mg. Amlodipine may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Most patients require 10mg."
          }
        ]
      }
    ]
  },
  {
    "serial": 95,
    "genericName": "Diltazem",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Angina",
        "description": "Angina, 60mg 3 times daily (elderly initially twice daily);Increased if necessary to 360mg daily (maximum 480mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "Increased if necessary to 360mg daily"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "indication": "Angina",
        "description": "Angina, 60mg 3 times daily (elderly initially twice daily);Increased if necessary to 360mg daily (maximum 480mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Increased if necessary to maximum 480mg daily"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "SR (sustained relicense) preparations",
        "description": "SR (sustained relicense) preparations- initially 90mg twice daily (elderly and in Hepatic and Renal Impairment, dose form not appropriate for initial dose titration);Increased if necessary to 120mg or 180mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 90
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Increased if necessary to 120mg or 180mg twice daily."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "indication": "SR (sustained release) preparations and in Hepatic and Renal Impairment",
        "description": "elderly and in Hepatic and Renal Impairment, dose form not appropriate for initial dose titration",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "elderly and in Hepatic and Renal Impairment, dose form not appropriate for initial dose titration"
          }
        ]
      }
    ]
  },
  {
    "serial": 96,
    "genericName": "Lercanidipine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "10mg orally once daily at least 15 minutes before meals;The dose may be increased to 20mg depending on the individual patient’s response.It may take about 2 weeks before the maximal antihypensive effect is apparent.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before meals",
              "minute": 15
            },
            "notes": "The dose may be increased to 20mg depending on the individual patient’s response."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Use in Children under the age of 18years is not currently recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "indication": "Use in renal or Hepatic dysfunction",
        "description": "20mg daily must be approached with caution..",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "must be approached with caution."
          }
        ]
      }
    ]
  },
  {
    "serial": 97,
    "genericName": "Nifedipine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5-20mg 3 times daily with or after meals. If immediate effect required, bite capsule & allow liquid to retain in the mouth.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 20
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with or after meals"
            },
            "notes": "f immediate effect required, bite capsule & allow liquid to retain in the mouth."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 98,
    "genericName": "Verapamil",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Supravantricular arrhythmias",
        "description": "40-120mg t.d.s.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 120
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Angina",
        "description": "80-120 mg t.d.s. daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 120
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Hypertension",
        "description": "240-480mg daily in 2-3 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 240,
              "max": 480
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "Hypertension",
        "description": "By slow I.V Injection:Over 2 minutes 5-10mg (preferable with W.C.G monitoring);In paroxysmal tachyarrhythmias a further 5mg after 5-10 minutes if required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "in paroxysmal tachyarrhythmias",
            "notes": "in paroxysmal tachyarrhythmias a further 5mg after 5-10 minutes if required."
          }
        ]
      }
    ]
  },
  {
    "serial": 99,
    "genericName": "Nicorandil",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 10mg twice daily (if susceptible to headache 5mg twice daily)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "f susceptible to headache",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 100,
    "genericName": "Trimetazidine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "20mg table preparations",
        "description": "20mg table preparations:1 Tablet 3 times daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "35mg Tablet preparations",
        "description": "35mg Tablet preparations:1 Tablet at mealtimes in the morning and evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "at mealtimes"
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 101,
    "genericName": "Almitrine + Raubasine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1 Tablet once or twice daily (one in the morning & one in the evening).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 102,
    "genericName": "Bencyclane",
    "doseList": [
      {
        "route": "mouth",
        "description": "100mg (1 tab) orally 3 times daily after meal (as in int. claudicating) In serious cases, dose can be increased to 200mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            }
          },
          {
            "type": "alternate",
            "condition": "in serious cases",
            "unit": "mg",
            "amount": {
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 103,
    "genericName": "Vinpocetine",
    "doseList": [
      {
        "route": "mouth",
        "description": "Initially 1-2 Tablet 3 times daily; Maintenance, 1 tab. 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 104,
    "genericName": "Cilostazol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "The recommended dosage is 100mg orally twice daily, taken at least half an hour beore or two hours after breakfast and dinner. A dose of 50mg b.i.d should be considered during coadministration of inhibitors of CYP3A4 (e.g oreprazole).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "taken at least half an hour beore or two hours after breakfast and dinner."
          },
          {
            "type": "alternate",
            "condition": "during coadministration of inhibitors of CYP3A4 (e.g oreprazole).",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Peadiatric use: The safety and effectiveness of cilostazol in peadiatric patients have not been establishe.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 105,
    "genericName": "Oxpentifylline",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "200mg 3 times daily (during the first week); The dose should be lowered to 100mg 3 times daily in the case of excessive blood pressure reduction, as well as in longterm treatment. In slow release form 400mg tab. 2-3 times daily may be given. All dosage usually after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            },
            "notes": "during the first week."
          },
          {
            "type": "primaryFollowup",
            "condition": "in the case of excessive blood pressure reduction, as well as in longterm treatment.",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            }
          },
          {
            "type": "alternatePrimaryFollowup",
            "condition": "in slow release form 400mg tab.",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 106,
    "genericName": "Levocarnitine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "300mg 2 or 3 times daily. Depending on clinical response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "nfant & Children",
        "description": "50-100 mg/kg/day in divided doses, with a maximum of 3mg/day.Dosage should begin at 50mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "50-100 mg/kg/day in divided doses, with a maximum of 3mg/day.Dosage should begin at 50mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 108,
    "genericName": "Dopamine",
    "doseList": [
      {
        "route": "By I.Infusion",
        "description": "By I.V. Infusion, 2-5 mcg/kg/minimum initially.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/min",
            "amount": {
              "min": 2,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 109,
    "genericName": "Venotonic",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Venous insufficiency",
        "description": "The Tablets should be taken at meal times 2 Tablets daily, one at midday and one in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "midday": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Acute Haemorrhoidal attack",
        "description": "a 4 day course of 6 Tablets daily, followed by 4 Tablets daily over the next 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            },
            "notes": "over the next 3 days"
          }
        ]
      }
    ]
  },
  {
    "serial": 110,
    "genericName": "Heparin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "For deep vein thrombosis Loading dose of 5000 units (10,000 units in severe pulmonary embolism) followed by continuous Infusion of 1000-2000 units/hour, Or By subcutaneous Injection: 15,000 units every 12 hourly under laboratory monitoring",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 5000,
              "max": 5000
            },
            "notes": "10,000 units in severe pulmonary embolism"
          },
          {
            "type": "primaryFollowup",
            "unit": "unit/hour",
            "amount": {
              "min": 1000,
              "max": 2000
            }
          },
          {
            "type": "alternate",
            "condition": "By subcutaneous Injection",
            "unit": "unit",
            "amount": {
              "min": 15000,
              "max": 15000
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "notes": "under laboratory monitoring"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Prophylaxis of deep vein thrombosis",
        "description": "5000 units 2 hour before surgery then every 8-12 hours until patient is ambulant.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 5000,
              "max": 5000
            },
            "notes": "2 hour before surgery"
          },
          {
            "type": "primaryFollowup",
            "condition": "until patient is ambulant",
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in pregnancy",
        "description": "in pregnancy, 10,000 units every12 hourly (with monitoring).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 10000,
              "max": 10000
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "notes": "with monitoring"
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "description": "Lower loading dose, then 15-25 units/kg/hour by I.Infusion Or 250 units/kg every 12 hours by s/c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Lower loading dose"
          },
          {
            "type": "primaryFollowup",
            "unit": "units/kg/hour",
            "amount": {
              "min": 15,
              "max": 25
            }
          },
          {
            "type": "alternate",
            "condition": "by s/c Injection",
            "unit": "units/kg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "s.c Injection",
        "ageGroup": "Child",
        "indication": "Prophylaxis in general surgery",
        "description": "By s/c Injection 5000 units 2 hours before surgery, then every 8-12 hours for 7 days or until patient is ambulant (monitoring not needed).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 5000,
              "max": 5000
            },
            "notes": "2 hours before surgery"
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "During pregnancy",
        "description": "During pregnancy (with monitoring), 5000-10,000 units every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 5000,
              "max": 10000
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "notes": "with monitoring"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Prevention of mural thrombosis",
        "description": "Heparin is considered effective when given by sc Injection of 12,500 units every 12 hours for at least 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 12500,
              "max": 12500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 111,
    "genericName": "Enoxaparin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "moderate risk",
        "description": "Moderate risk, 20mg 1-2 hours before surgery then 20mg every 24 hours for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "1-2 hours before surgery "
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "high risk",
        "description": "High risk, 40mg 12 hours before surgery. Then 40mg every 24 hours for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "notes": "12 hours before surgery "
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in general surgery",
        "description": "in general surgery, the first Injection should be given 2 hours before the surgical procedure.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "in general surgery, the first Injection should be given 2 hours before the surgical procedure"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in orthopaedic surgery",
        "description": "in orthopaedic surgery, the first Injection is to be given 12 hours preoperatively.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "in orthopaedic surgery, the first Injection is to be given 12 hours preoperatively"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Enoxaparin therapy",
        "description": "Enoxaparin therapy is usually prescribed for an average period of 7 to 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Treatment of established deep vein thrombosis",
        "description": "Treatment of established deep vein thrombosis: a dose of 1mg/kg should be given s.c every 12 hours. The duration of treatment should not exceed a period of 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Enoxaparin in not recommended in Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 112,
    "genericName": "Dalteparin",
    "doseList": [
      {
        "route": "Injection",
        "indication": "moderate risk",
        "description": "Moderate risk, 2500 units 1-2 hours before surgery, Then 2500 units every 24 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "notes": "1-2 hours before surgery "
          },
          {
            "type": "primaryFollowup",
            "unit": "unit",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "high risk",
        "description": "High risk, 2500units 1-2 hours before surgery,Then 2500 units 12 hours later, Then 5000 units every 24 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "notes": "1-2 hours before surgery "
          },
          {
            "type": "primaryFollowup",
            "unit": "unit",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "notes": "12 hours later"
          },
          {
            "type": "maintenance",
            "unit": "unit",
            "amount": {
              "min": 5000,
              "max": 5000
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "s.c Injection",
        "indication": "Treatment of deep-vein thrombosis",
        "description": "Treatment of deep-vein thrombosis, By s.c Injection, 200 units/kg as a single daily dose (max 18,000 units daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit/kg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "notes": "max 18,000 units daily"
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Patients with increased risk of haemorrhage",
        "description": "Patients with increased risk of haemorrhage, 100 units/kg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 113,
    "genericName": "Warfarin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "The baseline prothrombin time should be determined before the initial dose of warfanin is given, whenever is possible.The usual Adult induction dose of warfarin is 10mg daily for 2 days. The subsequent maintenance dose must depend upon the prothrombin time/INR and is usually 3-9mg daily and should be taken at the same time each day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "notes": "The baseline prothrombin time should be determined before the initial dose of warfanin is given, whenever is possible."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 9
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "notes": "The subsequent maintenance dose must depend upon the prothrombin time/INR"
          }
        ]
      }
    ]
  },
  {
    "serial": 114,
    "genericName": "Aspirin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Myocardial infarction",
        "description": "Myocardial infarction: 75mg Tablet 1 to 2 daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Following Coronary Artery By-Pass(CABG) Surgery",
        "description": "75mg Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Children- not to be given to Children under 12 yers, unless the expected benefits outweigh the possible risks.",
        "subDoseList": [],
        "notRecommended": true,
        "notes": "unless the expected benefits outweigh the possible risks."
      }
    ]
  },
  {
    "serial": 115,
    "genericName": "Clopidogrel",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "75mg once daily with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 116,
    "genericName": "Dipyridamole",
    "doseList": [
      {
        "indication": "thromboembolism",
        "description": "300-600 mg daily in 3-4 divided doses before food for thromboembolism.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 600
            },
            "connectionToMeal": {
              "when": "before"
            }
          }
        ]
      },
      {
        "indication": "Angina ",
        "description": "Angina 50mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 117,
    "genericName": "Clopidogrel + Aspirin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "75mg once daily with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "(75mg +75mg) is one Tablet"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Peadiatric use: not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 118,
    "genericName": "Streptokinase",
    "doseList": [
      {
        "route": "ntravenous Infusion",
        "description": "250,000 units over 30 minutes,Then 100,000 units every hour for up to 24-72 hours according to condition.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 250000,
              "max": 250000
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "unit",
            "amount": {
              "min": 100000,
              "max": 100000
            },
            "notes": "every hour for up to 24-72 hours according to condition."
          }
        ]
      },
      {
        "route": "ntravenous Infusion",
        "indication": "Myocardial infarction",
        "description": "Myocardial infarction, 1500,000 units over 60 minutes followed by aspirin 150mg daily by mouth for at least 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 1500000,
              "max": 1500000
            },
            "duration": {
              "unit": "minute",
              "min": 60,
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "treatmentPeriod": {
              "unit": "week",
              "min": 4
            },
            "notes": "followed by aspirin 150mg daily by mouth for at least 4 weeks."
          }
        ]
      }
    ]
  },
  {
    "serial": 119,
    "genericName": "Adrenochrome Monosemicarbazone",
    "doseList": [
      {
        "route": "I.M Injection",
        "indication": "for medical haemorrhage",
        "description": "75mg once daily with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "amp",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 120,
    "genericName": "Aminocaproic acid",
    "doseList": [
      {
        "route": "Injection",
        "indication": "for medical haemorrhage",
        "description": "4-5 gm initially I.(or orally) followed by 1.25 gm/ hour unitl bleeding is controlled. The total dose should not exceed 30gm in 24 hours.The average dose is 8-16 gm a day & is to be given as 1-2 amps. 6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 4,
              "max": 5
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "unitl bleeding is controlled",
            "unit": "gm/hour",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "notes": "The total dose should not exceed 30gm in 24 hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 121,
    "genericName": "Phytomenadione",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult: 10-20 mg, max 40 mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "notes": "max 40 mg in 24 hours"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "neonate",
        "description": "Child-neonates, 1 mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3
        },
        "description": "over 3 months, 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "10-20mg I.M or slow I.V., maximum 40mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "notes": "max 40 mg in 24 hours"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neonate",
        "description": "Neonates, 1 mg I.M.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3
        },
        "description": "over 3 months, 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 122,
    "genericName": "Tranexamic acid",
    "doseList": [
      {
        "description": "1-1.5gm 2-4 times daily. By slow intravenous Injection, 0.5-1gm 3 time daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.5
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "condition": "By slow intravenous Injection",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 123,
    "genericName": "Ezetimibe",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "The Recommended dose of ezetimibe is 10mg once daily.It can be administered with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with or without food"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Treatment with ezetimibe in Children(<10yeras)is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Treatment with ezetimibe in Children(<10yeras)is not recommended."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Ezetimibe monotherapy",
        "description": "Ezetimibe administered alone, is indicated as adjust therapy to diet for the reduction of elevated total-C, LDL-C, and Apo-B in patients with primary (heterozygous familial and non-familial) hypercholesterolemia.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Ezetimibe administered alone, is indicated as adjust therapy to diet for the reduction of elevated total-C, LDL-C, and Apo-B in patients with primary (heterozygous familial and non-familial) hypercholesterolemia."
          }
        ]
      }
    ]
  },
  {
    "serial": 124,
    "genericName": "Fenofibrate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "treatment of primary hyperlipidemia",
        "description": "Fenofibrate 200mg one capsule once daily or 67mg 3 capsules daily in divided doses is recommended as the dose for the treatment of primary hyperlipidemia.Absorption of fenofibrate is increased by approximately 35% when administered with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with food"
            },
            "notes": "200mg one capsule"
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 67,
              "max": 67
            },
            "notes": "3 capsules daily in divided doses is recommended"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "67mg 1 capsule/20kg body-weight daily.Absorption of fenofibrate is increased by approximately 35% when administered with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 67,
              "max": 67
            },
            "notes": "1 capsule/20kg body-weight daily"
          }
        ]
      }
    ]
  },
  {
    "serial": 125,
    "genericName": "Gemfibrozil",
    "doseList": [
      {
        "description": "1.2mg daily. Usually in 2 divided doses; range 0.9-1.5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.2,
              "max": 1.2
            },
            "notes": "Usually in 2 divided doses; range 0.9-1.5mg daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 126,
    "genericName": "Atorvastatin",
    "doseList": [
      {
        "route": "mouth",
        "description": "50-200gm over 24 hours, Preceded by a test dose of 200mg/liter by slow I.V InjectionI.Maximum 1000ml (liter) per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 80
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "as a single daily dose, and can be taken at any time of the day"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Primary hypercholesterolaemia and combined hyperlipidaemia",
        "description": "Primary hypercholesterolaemia and combined hyperlipidaemia, usually 10mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Familial hypercholesterolaemia",
        "description": "Familial hypercholesterolaemia, initially 10mg daily, increased at intervals of 4 weeks to 40mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "at intervals of 4 weeks"
          }
        ]
      }
    ]
  },
  {
    "serial": 127,
    "genericName": "Fluvastatin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "The recommended starting dose is 40mg (one 40mg capsule) once daily in the evening. In mild cases 20mg may be adequate. At very high cholesterol levels, the dosage may be increased to 80mg daily (one 40mg capsule twice daily or one 80mg XL Tablet once daily in the evening).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            }
          },
          {
            "type": "alternate",
            "condition": "in mild cases",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "alternate",
            "condition": "At very high cholesterol levels",
            "unit": "mg",
            "amount": {
              "max": 80
            },
            "notes": "one 40mg capsule twice daily or one 80mg XL Tablet once daily in the evening"
          }
        ]
      }
    ]
  },
  {
    "serial": 128,
    "genericName": "Lovastatin",
    "doseList": [
      {
        "route": "mouth",
        "description": "Usual recommended starting dose is 20mg once a day given with the evening meal; (dose range may be 10mg to maximum80mg/day in single or 2 divided doses).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "doseTime": {
              "evening": true
            },
            "notes": "dose range may be 10mg to maximum80mg/day in single or 2 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in Renal Insufficiency",
        "description": "in Renal Insufficiency (creatinine clearance< 30ml/min)dosage increase above 20mg/day should be carefully considered & if deemed necessary, implemented cautiously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "creatinine clearance< 30ml/min",
            "notes": "dosage increase above 20mg/day should be carefully considered & if deemed necessary, implemented cautiously."
          }
        ]
      }
    ]
  },
  {
    "serial": 129,
    "genericName": "Rosuvastatin",
    "doseList": [
      {
        "route": "mouth",
        "description": "The usual recommended starting dose of Rosuvastatin is 10mg once daily.After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly"
          }
        ]
      },
      {
        "route": "mouth",
        "description": "nitiation of therapy with 5mg once daily may be considered for patients requiring less aggressive LDL-C reductions or who have predisposing factors for myopathy.After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients requiring less aggressive LDL-C reductions or who have predisposing factors for myopathy",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly"
          }
        ]
      },
      {
        "route": "mouth",
        "description": "For patients with marked hypercholesterolemia (LDL-C>190mg/dl) and aggressive lipid targets, a 20mg starting dose may be considered.After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "For patients with marked hypercholesterolemia (LDL-C>190mg/dl) and aggressive lipid targets",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly"
          }
        ]
      },
      {
        "route": "mouth",
        "description": "A 40mg dose of Rosuvastatin should be reserved for those patients who have not achieved goal LDL-C at 20mg.After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients who have not achieved goal LDL-C at 20mg",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "notes": "After initiation and /or upon titration of Rosuvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Homozygous Hypercholesterolemia (Familial)",
        "description": "The recommended starting dose of Rosuvastatin is 20mg once daily.The maximum recommended daily dose is 40mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 40
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Dosage in patients with renal insufficiency",
        "description": "No modification of dosage is necessary for patients with mild to moderate Renal Insufficiency.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients with mild to moderate Renal Insufficiency",
            "notes": "No modification of dosage is necessary for patients with mild to moderate Renal Insufficiency."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Dosage in patients with renal insufficiency",
        "description": "For patients with severe Renal Impairment (cLcr <30ml/min 1.73m2) not on hemodailysis, dosing of Rosuvastatin should be started at 5mg once daily and not to exceed 10mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "For patients with severe Renal Impairment (cLcr <30ml/min 1.73m2) not on hemodailysis",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Peadiatric patients:The safety and effectiveness in peadiatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 130,
    "genericName": "Simvastatin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Hypercholesterolaemia",
        "description": "Initially 10mg once daily at night; Dose range 10-40mg/day. (A marked response to Simvastatin is seen within two weeks and the maximum therapeutic response occurs within four to six weeks.)Adjustment of dosage, if required, should be made at intervals  of not less than four weeks, depending on the patient’s individual response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true
            },
            "range": {
              "unit": "mg/day",
              "min": 10,
              "max": 40
            },
            "notes": "A marked response to Simvastatin is seen within two weeks and the maximum therapeutic response occurs within four to six weeks.Adjustment of dosage, if required, should be made at intervals  of not less than four weeks, depending on the patient’s individual response."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Hypercholesterolaemia",
        "description": "f LDL-cholesterol level falls below 1.94 mmol/l or total serum cholesterol level falls below 3.6 mmol/l, consider-ation should be given to reduce the dose of Simvastatin.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f LDL-cholesterol level falls below 1.94 mmol/l or total serum cholesterol level falls below 3.6 mmol/l",
            "notes": "consider-ation should be given to reduce the dose of Simvastatin"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Hypercholesterolaemia",
        "description": "CHD - initially 20mg/day once daily at night. (Adjustment of dosage, if required, should be made as specified above for Hypercholesterolaemia",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "CHD",
            "unit": "mg/day",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true
            },
            "notes": "Adjustment of dosage, if required, should be made as specified above for Hypercholesterolaemia"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Hypercholesterolaemia",
        "description": "Concomitant therapy with immunosuppressives maximum 10mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Concomitant therapy with immunosuppressives",
            "unit": "mg/day",
            "amount": {
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 131,
    "genericName": "nositol Nicotinate",
    "doseList": [
      {
        "route": "mouth",
        "indication": "lipid-lowering and improving conditions related to peripheral vascular insufficiency",
        "description": "Recommended dosage for lipid-lowering and improving conditions related to peripheral vascular insufficiency ranges from 1500mg to 4 Gm daily in 2 to 3 divided dosages.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1500,
              "max": 4000
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 132,
    "genericName": "Salbutamol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "2 to 4 mg or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Under 2 yrs.:Not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "description": "2-6 yrs.:1-2mg. Both 3 or 4 times daily. Or,0.1 mg/kg/dose, 3 or 4 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "unit": "mg/kg/dose",
            "amount": {
              "min": 0.1,
              "max": 0.1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12yrs:2 mg. Both 3 or 4 times daily. Or,0.1 mg/kg/dose, 3 or 4 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "unit": "mg/kg/dose",
            "amount": {
              "min": 0.1,
              "max": 0.1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "Initially 5 mcg/min, adjusted according to response & heart-tate usually in range 3-20 mcg/min, or more if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/min",
            "amount": {
              "min": 5,
              "max": 5
            },
            "range": {
              "unit": "mcg/min",
              "min": 3,
              "max": 20
            },
            "notes": "adjusted according to response & heart-tate usually in range 3-20 mcg/min, or more if necessary"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Adult",
        "indication": "For the relief of acute bronchospasm and for managing intermittent episodes of asthma",
        "description": "For the relief of acute bronchospasm and for managing intermittent episodes of asthma,1or 2 puffs (100 or 200mcg) as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Adult",
        "indication": "for chronic maintenance therapy",
        "description": "for chronic maintenance therapy,puffs 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Adult",
        "indication": "for prevention of exercise induced bronchospasm",
        "description": "for prevention of exercise induced bronchospasm, 2 puffs before exertion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "before exertion"
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Prophylaxis, 2 puffs 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Child",
        "indication": "for relief of acute bronchospasm, management of episodic asthma and for prevention of exercise induced bronchospasm",
        "description": "for relief of acute bronchospasm, management of episodic asthma and for prevention of exercise induced bronchospasm, 1 puff.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Child",
        "indication": "for routine maintenance and prophylaxis",
        "description": "for routine maintenance and prophylaxis, 1 puff 3 or 4 times daily.increasing if necessary to 2 puffs 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if necessary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "elderly",
        "indication": "For the relief of acute bronchospasm and for managing intermittent episodes of asthma",
        "description": "the dose is the same as that for Adult.For the relief of acute bronchospasm and for managing intermittent episodes of asthma,1or 2 puffs (100 or 200mcg) as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "elderly",
        "indication": "for chronic maintenance therapy",
        "description": "the dose is the same as that for Adult.For chronic maintenance therapy,puffs 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "elderly",
        "indication": "for prevention of exercise induced bronchospasm",
        "description": "the dose is the same as that for Adult. For prevention of exercise induced bronchospasm, 2 puffs before exertion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "before exertion"
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "elderly",
        "indication": "Prophylaxis",
        "description": "the dose is the same as that for Adult. Prophylaxis, 2 puffs 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "nhalation of dry powder",
        "ageGroup": "Adult",
        "description": "200-400 mcg; for persistent symptoms up to 3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "nhalation of dry powder",
        "ageGroup": "Child",
        "description": "200 mcg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "nhalation of dry powder",
        "indication": "Prophylaxis in exercise-induced bronchospasm",
        "description": "Prophylaxis in exercise-induced bronchospasm 400mcg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": "nhalation of dry powder",
        "indication": "Prophylaxis in exercise-induced bronchospasm",
        "ageGroup": "Child",
        "description": "200 mcg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "nhalation of nebulised solution",
        "ageGroup": "Adult",
        "indication": "Chronie bronchospasm unresponsive to conventional therapy and severe acute asthma",
        "description": "Chronie bronchospasm unresponsive to conventional therapy and severe acute asthma, Adult and Child over 18 month 2.5mg, repeated up to 4 times daily; May be increased to 5mg if necessary, but medical assessment should be considered since alternative therapy may be indicated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "but medical assessment should be considered since alternative therapy may be indicated"
          }
        ]
      },
      {
        "route": "nhalation of nebulised solution",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 18
        },
        "indication": "Chronie bronchospasm unresponsive to conventional therapy and severe acute asthma",
        "description": "Chronie bronchospasm unresponsive to conventional therapy and severe acute asthma, Adult and Child over 18 month 2.5mg, repeated up to 4 times daily; May be increased to 5mg if necessary, but medical assessment should be considered since alternative therapy may be indicated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "but medical assessment should be considered since alternative therapy may be indicated"
          }
        ]
      },
      {
        "route": "nhalation of nebulised solution",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 18
        },
        "indication": "Chronie bronchospasm unresponsive to conventional therapy and severe acute asthma",
        "description": "Child under 18 months, clinical efficacy uncertain (transient hypoxaemia may occur,consider supplemental oxygen).",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 133,
    "genericName": "Formoterol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "One cozycap (12mcg) should be administered by cozyhaler once or twice daily. The dose can be administered in the morning and /or at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "cozycap",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "The dose can be administered in the morning and /or at night."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "The use of formoterol in Children below 12 years yet not been documented.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "elderly",
        "description": "NO adjustment of dose should be required in the elderly, or in patients with renal or Hepatic impairment at the recommended normal doses.One cozycap (12mcg) should be administered by cozyhaler once or twice daily. The dose can be administered in the morning and /or at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "cozycap",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "The dose can be administered in the morning and /or at night."
          }
        ]
      },
      {
        "indication": "patients with renal or Hepatic impairment",
        "description": "NO adjustment of dose should be required in the elderly, or in patients with renal or Hepatic impairment at the recommended normal doses.One cozycap (12mcg) should be administered by cozyhaler once or twice daily. The dose can be administered in the morning and /or at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "cozycap",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "The dose can be administered in the morning and /or at night."
          }
        ]
      },
      {
        "indication": "Prophylaxis in exercise-induced as time",
        "description": "Prophylaxis in exercise-induced as time: 12-24 mcg 15-30 minutes prior to physical exertion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 12,
              "max": 24
            },
            "notes": "15-30 minutes prior to physical exertion."
          }
        ]
      }
    ]
  },
  {
    "serial": 134,
    "genericName": "Salmeterol",
    "doseList": [
      {
        "route": "nhalation",
        "ageGroup": "Adult",
        "condition": "Metered dose inhalation (25mcg/puff of dose)",
        "description": "By inhalation, 50mcg (2 puffs) twice daily; up to 100 mcg (4 puffs) twice daily in more severe airways obstruction.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "in more severe airways obstruction",
            "unit": "puff",
            "amount": {
              "max": null
            },
            "volume": {
              "unit": "mcg",
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "nhalation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "condition": "Metered dose inhalation (25mcg/puff of dose)",
        "description": "Under 4 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "nhalation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4
        },
        "condition": "Metered dose inhalation (25mcg/puff of dose)",
        "description": "over 4 years, 50mcg (2 puffs) twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "nhalation",
        "ageGroup": "Adult",
        "condition": "Dry powder inhalation (50mcg/puff or dose)",
        "description": "50mcg (1 puff) twice daily.Up to 100mcg (2 puffs)twice daily in more severe airways obstruction",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "in more severe airways obstruction.",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "nhalation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4
        },
        "condition": "Dry powder inhalation (50mcg/puff or dose)",
        "description": "Under 4 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "nhalation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4
        },
        "condition": "Dry powder inhalation (50mcg/puff or dose)",
        "description": "over 4 years, 50mcg (1 puff) twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 135,
    "genericName": "Terbutline",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Use in bronchospasm",
        "description": "During the first 1-2 weeks 2.5 mg 3 times daily is recommended.The dose may then be increased to 5 mg 3 times daily to achieve adequate bronchodilatation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "to achieve adequate bronchodilatation.",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Use in bronchospasm",
        "description": "dosage as for Adults. During the first 1-2 weeks 2.5 mg 3 times daily is recommended.The dose may then be increased to 5 mg3 times daily to achieve adequate bronchodilatation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "to achieve adequate bronchodilatation.",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 15
        },
        "indication": "Use in bronchospasm",
        "description": "Children 7 to 15 years- The usual starting dose is 2.5mg 2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "in some patients.",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 136,
    "genericName": "Tulobuterol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult, A convenient starting dose for Adults and Children of 12 years and over, is 1 mg twice daily. After 7-10 days of treatment, the dose should be increased to 2 mg twice daily to achieve greater effect.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult, A convenient starting dose for Adults and Children of 12 years and over, is 1 mg twice daily. After 7-10 days of treatment, the dose should be increased to 2 mg twice daily to achieve greater effect.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 10
        },
        "description": "6-10 years:0.5-1mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "description": "Over 10 years 1-2 mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 6
        },
        "description": "Who are supposed to take syrup- 1-6 years, ¼- ½  tsf twice daily.The above recommended dosage may have to be modified depending upon the patient response.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Who are supposed to take syrup",
            "unit": "t.s.f",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Who are supposed to take syrup- 6-12 years, ½-1 tsf twice daily.The above recommended dosage may have to be modified depending upon the patient response.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Who are supposed to take syrup",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 137,
    "genericName": "Bambuterol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "20mg once daily at bedtime is effective if the patient has been previously tolerated with b2–agonists stimulants.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f the patient has been previously tolerated with b2–agonists stimulants",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Other patients, initially 10mg once daily at bedtime, increased if necessary after 1-2 weeks to 20mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f the patient has been previously tolerated with b2–agonists stimulants",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "dose adjustment is not required. 20mg once daily at bedtime is effective if the patient has been previously tolerated with b2 –agonists stimulants.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f the patient has been previously tolerated with b2–agonists stimulants",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "dose adjustment is not required. Other patients, initially 10mg once daily at bedtime, increased if necessary after 1-2 weeks to 20mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "f the patient has been previously tolerated with b2 –agonists stimulants",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "in significant hepatic dysfunction",
        "description": "in significant hepatic dysfunction, not recommended because of unpredictable conversion to terbutaline.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 138,
    "genericName": "Adrenaline",
    "doseList": [
      {
        "route": "Injection",
        "indication": "Bronchospasm",
        "description": "Bronchospasm, as a single dose by s.c.or I.M or by oral inhalation of nebulised solution, 200-500mcg. (1-2 puffs) upto 3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Acute anaphylaxis",
        "description": "Acute anaphylaxis, by s.c.or I.M Injection,0.5-1mg..",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 139,
    "genericName": "Ephedrine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "15-60mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 60
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Child: upto 1 yr.7.5 mg;All 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1-5 yrs, 15mg;All 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs. 30mg;All 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 140,
    "genericName": "pratropium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "For inhalation only",
        "description": "the usual dose is 1-2 puffs 3 or 4 times daily. Single dose up to 80mg (4 puffs of 20mcg/puff or 2 puffs of 40mcg/puff) may be required to obtain maximum benefit during early treatment.Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 puffs (20mcg/puff) or 6 puffs(40mcg/puff) in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "Single dose up to 80mg (4 puffs of 20mcg/puff or 2 puffs of 40mcg/puff) may be required to obtain maximum benefit during early treatment.Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 puffs (20mcg/puff) or 6 puffs(40mcg/puff) in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "condition": "For inhalation only",
        "description": "6 to 12 years- usually 1-2 puffs (20mcg/puff) 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg/puff",
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "condition": "For inhalation only",
        "description": "Below 6 years-the usual dose is 1 puff (20mcg) 3 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 141,
    "genericName": "Tiotropium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "for the maintenance treatment of bronchospasm associated with COPD",
        "description": "The recommended dosage of tiotropium bromide is the inhalation of 2 puffs once daily for the maintenance treatment of bronchospasm associated with COPD. No adjustment of tiotropium dosage in geriatric patients is warranted.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "No adjustment of tiotropium dosage in geriatric patients is warranted."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "The safety and effectiveness of tiotropium in peadiatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 142,
    "genericName": "Aminophylline",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 100-200mg 2-3 times daily for one week, then maintenance 200-600mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 600
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "Over 1 year 12mg/kg body-wt. twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "125-250mg by slow (over 10-15 mins) I.V Injection, Usually given in 5% dextrose in aqua or normal saline (Rapid Injection may result in cardiac arrest).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "duration": {
              "unit": "minute",
              "min": 10,
              "max": 15
            },
            "notes": "Usually given in 5% dextrose in aqua or normal saline. (Rapid Injection may result in cardiac arrest)."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "2-3mg/kg 2-3 times daily by very slow I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Usually given in 5% dextrose in aqua or normal saline. (Rapid Injection may result in cardiac arrest)."
          }
        ]
      },
      {
        "route": "rectal suppositories",
        "ageGroup": "Adult",
        "description": "360mg once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 360,
              "max": 360
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "rectal suppositories",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Once or twice daily, upto 1 yr:12.5-25mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 25
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "rectal suppositories",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Once or twice daily, 1-5 yrs.:50-100mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "rectal suppositories",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Once or twice daily, 6-12 yrs.:100-200mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 143,
    "genericName": "Theophylline Sodium Glycinate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "125-250mg 3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "description": "Child:2-6 years:62.5mg,3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 12
        },
        "description": "1-5 yrs, 15mg;All 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 125
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 144,
    "genericName": "Theophylline anhydrous",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Over 50kg-  250-300mg (1 tab.) twice daily in the morning & evening.Adults with low body weight & adolescents, half the Adult dose (1/2 tab.)2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          },
          {
            "type": "alternate",
            "condition": "Adults with low body weight & adolescents",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "10-15 mg/kg given in 2 divided doses at 12 hours intervals. It is better taken after meals with a little water. It is suitable for longterm administration.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 15
            },
            "notes": "given in 2 divided doses at 12 hours intervals. It is better taken after meals with a little water."
          }
        ]
      }
    ]
  },
  {
    "serial": 145,
    "genericName": "Salbutamol + Ipratropium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The dose of this combined inhalation aerosol is 2 puffs 4 times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "The dose of this combined inhalation aerosol is 2 puffs 4 times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "The dose of this combined inhalation aerosol is 2 puffs 4 times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Children (below 12 years): Not Recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 146,
    "genericName": "Sodium Cromoglycate",
    "doseList": [
      {
        "route": "aerosol inhalation",
        "ageGroup": "Adult",
        "description": "10mg (or 2 puffs)4 times daily initially at regular intervals in spinhaler, increasing in severe cases or during periods  of risk to 6-8 times daily. Before exercise, additional doses may be taken. Maintenance, 5 mg (1 puff) 4 time daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "ncreasing in severe cases or during periods  of risk to 6-8 times daily. Before exercise, additional doses may be taken.Therapy should be continuous."
          },
          {
            "type": "maintenance",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "aerosol inhalation",
        "ageGroup": "Child",
        "description": "10mg (or 2 puffs)4 times daily initially at regular intervals in spinhaler, increasing in severe cases or during periods  of risk to 6-8 times daily. Before exercise, additional doses may be takenI.Maintenance, 5 mg (1 puff) 4 time daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "ncreasing in severe cases or during periods  of risk to 6-8 times daily. Before exercise, additional doses may be taken.Therapy should be continuous."
          },
          {
            "type": "maintenance",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "nhalation of nebulised solution",
        "ageGroup": "Adult",
        "description": "20mg 4 time daily, increased in severe cases to 6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Increased in severe cases to 6 times daily.."
          }
        ]
      },
      {
        "route": "nhalation of nebulised solution",
        "ageGroup": "Child",
        "description": "20mg 4 time daily, increased in severe cases to 6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Increased in severe cases to 6 times daily.."
          }
        ]
      }
    ]
  },
  {
    "serial": 147,
    "genericName": "Nedocromil sodium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "in initial and maintenance therapy 4mg (2 puffs) twice daily;If necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "f necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary."
          },
          {
            "type": "maintenance",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "in initial and maintenance therapy 4mg (2 puffs) twice daily;If necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "f necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary."
          },
          {
            "type": "maintenance",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "in initial and maintenance therapy 4mg (2 puffs) twice daily;If necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "f necessary may be increased to 4 times daily;When control achieved may be possible to reduce to 2 times daily. Regular use is necessary."
          },
          {
            "type": "maintenance",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Children below 6 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 148,
    "genericName": "Ketotifen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 mg twice daily with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Under 2 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Over 2 yrs. 1 mg twice daily with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 149,
    "genericName": "Montelukast",
    "doseList": [
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 15
        },
        "description": "Adult (15 years & over) 10mg daily to be taken in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 14
        },
        "description": "6-14 years- 5mg daily to be taken in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "2-5 years- 4mg daily to be taken in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Paediatric patients younger than 2 years of age- not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 150,
    "genericName": "Zafirlukast",
    "doseList": [
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult & Children over 12 years of age-20mg twice daily;It should be taken at least 1 hour before or 2 hours after meals, or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after",
              "hour": {
                "min": 1,
                "max": 2
              }
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 152,
    "genericName": "Ascon inhaler (MDI) acme",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 puffs (250mcg puff) twice daily Or 1 puff (250mcg) four times daily;If necessary may be increased to 500mcg 3-4 times daily. Or,200mcg (100mcg/puff) 3-4 times daily;In more severe cases initially 600-800mcg may be given daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternatePrimaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "in more severe cases initially 600-800mcg may be given daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: 1 or 2 puffs (100mcg/puff)2-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg/puff",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 153,
    "genericName": "Beclod inhaler (DPI) acme",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200mcg twice daily or 100mcg 3-4 times daily; In moresever cases initially 600-800 mcg may be given daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "condition": "in moresever cases",
            "unit": "mcg",
            "amount": {
              "min": 600,
              "max": 800
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "50-100 mcg 2-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 154,
    "genericName": "Becloforte inhaler (MDI)GlaxoSmithKline",
    "doseList": [
      {
        "route": "aerosol inhaler",
        "description": "By an aerosol inhaler 500mcg (2 puffs)twice daily or 250mcg (1 puff) 4 times daily;If necessary may be increased to 500mcg 3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "500mcg (2 puffs)"
          },
          {
            "type": "alternate",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "250mcg (1 puff)"
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 155,
    "genericName": "Beclomin inhaler (MDI) Square",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 puffs (250mcg/puff)twice daily or 1 puff (250mcg four times daily; If necessary may be increased to 500mcg 3-4 times daily. Or, 200 mcg (100mcg/puff)twice daily or 100mcg (1 puff) 3-4 times daly; in more severe cases initially 600-800 mcg may be given daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "2 puffs (250mcg/puff)"
          },
          {
            "type": "alternate",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "1 puff (250mcg) "
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternatePrimaryFollowup",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "200 mcg (100mcg/puff)"
          },
          {
            "type": "alternatePrimaryFollowup",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "100mcg (1 puff)"
          },
          {
            "type": "alternatePrimaryFollowup",
            "condition": "in more severe cases",
            "unit": "mcg",
            "amount": {
              "min": 600,
              "max": 800
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or2 puffs (100mcg/puff) 2-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "1 or2 puffs (100mcg/puff)"
          }
        ]
      }
    ]
  },
  {
    "serial": 156,
    "genericName": "Becotide Inhaler (MDI) GlaxoSmithKline",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "(100mcg/puff)3 or 4 times daily or 3-4 puffs twice daily.Severe cases, Initially 12-16 puffs daily, reducing according to response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/puff",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "Severe cases, Initially 12-16 puffs daily, reducing according to response."
          },
          {
            "type": "alternate",
            "unit": "puff",
            "amount": {
              "min": 3,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or to pufs (50mcg/puff)2-4 times daly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg/puff",
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 157,
    "genericName": "Cycloson Inhalar (DPI)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200mcg twice daily or 100 mcg 3-4 times daily; in more severe cases initially 600-800mcg may be given daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases",
            "unit": "mcg",
            "amount": {
              "min": 600,
              "max": 800
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "50-100mcg 2-4 times daily. Rinsing the mouth after inhalation is  advised.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Rinsing the mouth after inhalation is  advised"
          }
        ]
      }
    ]
  },
  {
    "serial": 158,
    "genericName": "Decomit inhaler (MDI) Beximco",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 puffs (250mcg/puff) twice daily or 1 puff (250mcg) four times daily;If necessary may be increased to 500mcg 3-4 times daily. Or 200mcg (100mcg/puff) twice daily or 100mcg (1 puff)3-4 times daily;In more severe cases initially 600-800mcg may be givendaily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg/puff",
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "f necessary may be increased to 500mcg 3-4 times daily.In more severe cases initially 600-800mcg may be givendaily."
          },
          {
            "type": "alternate",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or 2 puffs (100mcg/puff) 2-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "puff",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg/puff",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 159,
    "genericName": "Budesonide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Patient treated previously with bronchodilators alone- recommended starting dose is 200-400 mcg twice daily; Highest recommended dose is 400mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with bronchodilators alone",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 400mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Patient treated previously with inhaled corticosteroids- recommended starting dose is 200-400 mcg twice daily;Highest recommended dose is 800mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with inhaled corticosteroids",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 800mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Patient treated previously with inhaled corticosteroids- Recommended starting dose is 400-400mcg twice daily; Highest recommended dose is 800mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with inhaled corticosteroids",
            "unit": "mcg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 800mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "description": "Patient treated previously with bronchodilators alone- recommended starting dose is 200-400 mcg twice daily; Highest recommended dose is 400mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with bronchodilators alone",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 400mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "description": "Patient treated previously with inhaled corticosteroids- recommended starting dose is 200-400 mcg twice daily;Highest recommended dose is 800mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with inhaled corticosteroids",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 800mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "description": "Patient treated previously with inhaled corticosteroids- Recommended starting dose is 400-400mcg twice daily; Highest recommended dose is 800mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with inhaled corticosteroids",
            "unit": "mcg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 800mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "description": "Patient treated previously with bronchodilators alone- Recommended starting dose is 200 mcg twice daly;Highest recommended dose is 400mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with bronchodilators alone",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 400mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "description": "Patient treated previously with inhaled corticosteroide- recommended starting dose is 200mcg twice daily;Highest recommended dose is 400mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patient treated previously with inhaled corticosteroide",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest recommended dose is 400mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "description": "in patients with mild to moderate asthma who are well-controlled on inhaled corticosteroids, dosing with the drug 200mcg or 400 mcg may be consided.This can be administered once daily either in the morning or in the evening. Rinsing the mouth after each inhalation is advised.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in patients with mild to moderate asthma who are well-controlled on inhaled corticosteroids",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "alternateDoseTime": {
              "evening": true
            },
            "notes": "Rinsing the mouth after each inhalation is advised"
          }
        ]
      }
    ]
  },
  {
    "serial": 160,
    "genericName": "Fluticasone propionate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Bronchodilators along",
        "description": "Starting dose 100mcg twice daily.Highest dose 500mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 500mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "nhaled corticosteroids",
        "description": "starting dose 100-250mcg twice daily, Highest dose 500mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 500mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Oral corticosteroids",
        "description": "starting dose 1000mcg twice daily,Highest dose 1000mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 1000mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Bronchodilators along",
        "description": "Starting dose 100mcg twice daily.Highest dose 500mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 500mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "nhaled corticosteroids",
        "description": "starting dose 100-250mcg twice daily, Highest dose 500mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 500mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Oral corticosteroids",
        "description": "starting dose 1000mcg twice daily,Highest dose 1000mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 1000mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 11
        },
        "indication": "Bronchodilators along",
        "description": "starting dose 50mcg twice daily,Highest dose 100mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 100mcg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 11
        },
        "indication": "nhaled corticosteroids",
        "description": "Starting dose 50mcg twice daily, Highest dose 100mcg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Highest dose 100mcg twice daily"
          }
        ]
      }
    ]
  },
  {
    "serial": 161,
    "genericName": "Triamcinolone Acetonide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The usual dosage is 2 inhalations (approximately 200mcg) given 3 to 4 times a day.The maximal daily intake should not exceed 16 inhalations (1600mcg) in Adults.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "The maximal daily intake should not exceed 16 inhalations (1600mcg) in Adults"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "patients with more asthma",
        "description": "Higher initial doses (12 to 16 inhalations per day) may be advisable in patients with more asthma, the dosage then being adjusted down-ward according to the response of the patient",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 12,
              "max": 16
            },
            "notes": "the dosage then being adjusted down-ward according to the response of the patient."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "The usual dosage is 1 or 2 inhalations (100mcg or 200mcg) given 3 to 4 times a day according to the response of the patient.The maximal daily intake should not exceed 2 inhalations (1200mcg in Children of 6-12 years.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "The maximal daily intake should not exceed 2 inhalations (1200mcg in Children of 6-12 years."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "nsufficiaent clinical date exist with respect to the administration of triamcinolone oral inhaler in Children below the age of 6 years.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 162,
    "genericName": "Axinat-F inhaler (MDI) acme",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 inhalation of Axinat-F containing fluticasone 125 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in moderate to severe asthma",
            "unit": "nhalation",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "2 inhalation of Axinat-F containing fluticasone 125 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in moderate to severe asthma",
            "unit": "nhalation",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "description": "Axinat-F 125 and Axinat-f 250 is not applicable in cases of Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 163,
    "genericName": "Salflu inhaler (DPI) acme",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in mild to moderate asthma",
        "description": "1inhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe asthma twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in moderate to severe asthma",
        "description": "1inhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe asthma twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in mild to moderate asthma",
        "description": "1inhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe asthma twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in moderate to severe asthma",
        "description": "1inhaler containing fluticasone 100mcg in mild to moderate and 250mcg in moderate to severe asthma twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "description": "1 inhalation of Salful inhaler containing flugicasone 100mcg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 164,
    "genericName": "Ticamet Cozycap (DPI) Square",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in mild to moderate asthma",
        "description": "1 inhalation of  Ticamet cozyhaler containing fluticasone 100mcg in mild to moderate and 250 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in moderate to severe asthma",
        "description": "1 inhalatio of  Ticamet cozyhaler containing fluticasone 100mcg in mild to moderate and 250 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in mild to moderate asthma",
        "description": "1 inhalation of  Ticamet cozyhaler containing fluticasone 100mcg in mild to moderate and 250 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in moderate to severe asthma",
        "description": "1 inhalatio of  Ticamet cozyhaler containing fluticasone 100mcg in mild to moderate and 250 mcg in moderate to severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "description": "1 inhalation of Ticamet cozyhaler containing fluticasone 100 mcg twice daily.The dose can be reduced to 1 inhalation once daily  if control maintained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg",
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f control maintained",
            "unit": "nhalation",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 165,
    "genericName": "Ticamet Inhaler (MDI) Square",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in moderate to severe asthma",
        "description": "2 inhalations of Ticamet 125 (containing fluticasone 125mcg) in moderate to severe and Ticamet 250 (containing fluticasone 250 mcg) in severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in severe asthma twice daily",
        "description": "2 inhalations of Ticamet 125 (containing fluticasone 125mcg) in moderate to severe and Ticamet 250 (containing fluticasone 250 mcg) in severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in moderate to severe asthma",
        "description": "2 inhalations of Ticamet 125 (containing fluticasone 125mcg) in moderate to severe and Ticamet 250 (containing fluticasone 250 mcg) in severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nhalation",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mcg",
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "in severe asthma twice daily",
        "description": "2 inhalations of Ticamet 125 (containing fluticasone 125mcg) in moderate to severe and Ticamet 250 (containing fluticasone 250 mcg) in severe asthma twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "description": "Children 4-12 years:Ticamet inhaler not available for this group of patients.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 166,
    "genericName": "Dextromethorphan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5ml (1 tsf) 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "5ml (1 tsf)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1-5 years,:1/4th Adult dose.",
        "subDoseList": []
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years,: ½ Adult dose..",
        "subDoseList": []
      }
    ]
  },
  {
    "serial": 167,
    "genericName": "Dextromethorpilan +Pseudoephedrine + Guaiphenesin",
    "doseList": [
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "5ml (1 tsf) 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years 1 tsf 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "2-5 years ½ tsf 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 168,
    "genericName": "Ambroxol",
    "doseList": [
      {
        "ageRange": {
          "unit": "month",
          "min": 0,
          "max": 6
        },
        "condition": "Peadiatric drops",
        "description": "0-6 months old- 0.5ml 2 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "condition": "Peadiatric drops",
        "description": "6-12 months old 1ml 2 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "condition": "Peadiatric drops",
        "description": "1-2 years old- 1.25ml 2 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "condition": "Syrup preparation",
        "description": "2-5 years old- 2.5ml (1/2 tsf)2-3 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "condition": "Syrup preparation",
        "description": "5-10 years old- 5ml (1 tsf) 2-3 timesa day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "condition": "Syrup preparation",
        "description": "10 years old & Adults 10ml (2 tsf) 3 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Syrup preparation",
        "description": "10 years old & Adults 10ml (2 tsf) 3 times a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Tablet preparation (30mg)",
        "description": "Adults and Children over 10 years- 1 Tablet (30mg) 3 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "condition": "Tablet preparation (30mg)",
        "description": "Adults and Children over 10 years- 1 Tablet (30mg) 3 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Capsule preparation (72mg SR)",
        "description": "Adult & Children over 12 years- 1 Capsule once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "condition": "Capsule preparation (72mg SR)",
        "description": "Adult & Children over 12 years- 1 Capsule once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 169,
    "genericName": "Bromhexine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended daily dose is 8-16mg (10-20ml) 3-4 times.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 16
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "8-16mg (10-20ml)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "description": "Suggested dosage for Children aged 5-10 years, 4mg (5ml) 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "4mg (5ml)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "2-5 years ½ tsf 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "4mg (5ml)"
          }
        ]
      }
    ]
  },
  {
    "serial": 170,
    "genericName": "Carbocisteine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Dosage is based upon an initial dose of 2250mg daily in divided doses (750mg 3 times daily),Reduced to 1500mg daily in divided doses ((375mg 4 times daily), When a satisfactory response has been obtained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "an initial dose of 2250mg daily in divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 375,
              "max": 375
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Reduced to 1500mg daily in divided doses When a satisfactory response has been obtained."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Dosage is based upon an initial dose of 2250mg daily in divided doses (750mg 3 times daily),Reduced to 1500mg daily in divided doses ((375mg 4 times daily), When a satisfactory response has been obtained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "an initial dose of 2250mg daily in divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 375,
              "max": 375
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Reduced to 1500mg daily in divided doses When a satisfactory response has been obtained."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "Normal daily dose is 20mg/kg body weight in divided doses.2-5 years:62.5-125mg 4 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 125
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Normal daily dose is 20mg/kg body weight in divided doses.6-12 years:250mg 3 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "nfants: Dosage in infants has not been established",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 171,
    "genericName": "Potassium Guaiacol",
    "doseList": [
      {
        "description": "1-2 tsf 2-4 times daily is the usual dosage.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 172,
    "genericName": "Adrenaline: Injection",
    "doseList": [
      {
        "description": "1 amp. (1ml) to be injected s.c, I.M, I.or direct intracardiac Injection. May be repeated,if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "amp",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "1 amp. (1ml)"
          }
        ]
      }
    ]
  },
  {
    "serial": 173,
    "genericName": "Aminophylline: Injection",
    "doseList": [
      {
        "description": "250-500mg given over 10-15 mins.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "notes": "over 10-15 mins"
          }
        ]
      }
    ]
  },
  {
    "serial": 174,
    "genericName": "Nikethamide Inj. Jayson",
    "doseList": [
      {
        "description": "250-500mg given over 10-15 mins.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 2,
              "max": 10
            },
            "notes": "every 20 to 30 mins. If necessary"
          }
        ]
      }
    ]
  },
  {
    "serial": 175,
    "genericName": "Naloxone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.4-2mg by I.V., I.M, or s.c inj-every 2-3 minimum as required or by I.Infusion to a maximum of 10mg if respiratory function does not improve.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "by I.V., I.M, or s.c Injection",
            "unit": "mg",
            "amount": {
              "min": 0.4,
              "max": 2
            },
            "repeated": {
              "unit": "minute",
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primary",
            "condition": "by I.Infusion",
            "unit": "mg",
            "amount": {
              "max": 10
            },
            "repeated": {
              "unit": "minute",
              "min": 2,
              "max": 3
            },
            "notes": "f respiratory function does not improve."
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Adult",
        "description": "Elderly, 15 mg at bed time & Others, 15-30mg at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "elderly",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 176,
    "genericName": "Benzoin Tincture",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Add one teaspoonful to a pint of hot, (not boiling), water and inhale the vapour.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "hot, (not boiling), water",
              "quantity": "a pint"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "The use of strong aromatic decongestants is not advised for infants under the age of 3 months.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 177,
    "genericName": "Menthol & Eucalyptus oil",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Add one teaspoonful to a pint of hot, (not boiling), water and inhale the vapour.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "hot, (not boiling), water",
              "quantity": "a pint"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "The use of strong aromatic decongestants is not advised for infants under the age of 3 months.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 178,
    "genericName": "Flurazepam",
    "doseList": [
      {
        "ageGroup": "elderly",
        "description": "Elderly, 15 mg at bed time & Others, 15-30mg at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "elderly",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Elderly, 15 mg at bed time & Others, 15-30mg at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not Recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 179,
    "genericName": "Midazolam",
    "doseList": [
      {
        "route": "mouth",
        "description": "7.5-15mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in elderly & debilitated patient",
        "description": "in elderly & debilitated patient the recommended dose is 7.5mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "patient with impaired liver & kidney function",
        "description": "This dose is also applied patient with impaired liver & kidney function.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "description": "For premedication of Adult 15mg of midazolam should be given orail 30-60 minutes before the operation unless the parenteral route is preferred.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "connectionToSurgery": {
              "when": "before",
              "minute": {
                "min": 30,
                "max": 60
              }
            },
            "notes": "unless the parenteral route is preferred."
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "patient with impaired liver & kidney function",
        "description": "Over 30 seconds, 2 mg (elderly 1-1.5 mg)followed after 2 minutes by increments of 0.5-1mg if sedation not adequate;Usual range 2.5-7.5mg (about 70mcg/kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 180,
    "genericName": "Nitrazepam",
    "doseList": [
      {
        "ageGroup": "elderly",
        "description": "Adult:Elderly, 2.5-5 mg at bed time; Others, 5-10mg at bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Adult:Elderly, 2.5-5 mg at bed time; Others, 5-10mg at bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Others",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not Recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 181,
    "genericName": "Zaleplon",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose of zaleplon for most non-elderly Adults is 10mg.For certain low weight individuals, 5mg may be a sufficient dose.Although the risk of certain adverse events associated with the use of zaleplon appears to be dose dependent, the 20mg dose has been shown to be adequately toterated and may be considered for the occasional patient who does not benefit for a trial of lower dose.Doses above 20mg are not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primary",
            "condition": "For certain low weight individuals",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "Although the risk of certain adverse events associated with the use of zaleplon appears to be dose dependent, the 20mg dose has been shown to be adequately toterated and may be considered for the occasional patient who does not benefit for a trial of lower dose.Doses above 20mg are not recommended."
          }
        ]
      }
    ]
  },
  {
    "serial": 182,
    "genericName": "Phenobarbitone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "15-30mg 2 or 3 times daily. Mx. 600mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Mx. 600mg in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Up to 1 years,:15-30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "description": "1-12 years,:30-60mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 60
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 183,
    "genericName": "Chloral Hydrate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "nsomnia",
        "description": "nsomnia, 500mg-1 mg taken with water 15-30 mins. before bedtime or 1-2 hours before surgery. Maximum 2 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 1
            },
            "additionalItem": {
              "temName": "water"
            },
            "connectionToBedtime": {
              "when": "before",
              "minute": {
                "min": 15,
                "max": 30
              }
            },
            "connectionToSurgery": {
              "when": "before",
              "hour": {
                "min": 1,
                "max": 2
              }
            },
            "notes": "Maximum 2 gm daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Sedation",
        "description": "Sedation, 250mg 3 times daily with water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalItem": {
              "temName": "water"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "30-50mg/kg upto a maximum single dose of 1 gm.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 50
            },
            "notes": "upto a maximum single dose of 1 gm."
          }
        ]
      }
    ]
  },
  {
    "serial": 184,
    "genericName": "Melatonin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3mg (1 Tablet) orally approximately 30 to 60 minutes before bed.Dose may be increased if needed after three nights.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "connectionToBedtime": {
              "when": "before",
              "minute": {
                "min": 30,
                "max": 60
              }
            },
            "notes": "Dose may be increased if needed after three nights."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Night shift workers",
        "description": "Night shift workers- 3 to 6mg (1-2 Tablets) at the desired bed time after the night shift.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 6
            },
            "notes": "at the desired bed time after the night shift."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "t is not for use in Children or teenagers (below 18 years).",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 185,
    "genericName": "Promethazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "10-20mg 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "25-50mg. by deep I.M. or slow I.inj-after dilution.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 0.5
        },
        "description": "Under 6 months, not recommended; If two doses in 24 hours are required use lower amount stated",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "description": "6 months-1 years,:5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1 -5 years,:15mg; If two doses in 24 hours are required use lower amount stated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Over 5 years,10-25mg; If two doses in 24 hours are required use lower amount stated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Under 5 years not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Over 5yrs. 6.25-12.50mg by deep I.M. Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6.25,
              "max": 12.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 186,
    "genericName": "Zopiclone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "7.5 mg at bedtime increased to 15mg in severe Insomnia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "alternate",
            "condition": "in severe Insomnia",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly, initially 3.75mg at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3.75,
              "max": 3.75
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 187,
    "genericName": "Diazepam",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Anxiety",
        "description": "Anxiety, 2mg 3 times daily, Increased in severe anxiety to 15-30mg. daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primary",
            "condition": "in severe anxiety",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child, 1-5mg. daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "nsomnia",
        "description": "nsomnia, 5-30mg. at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 30
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "For severe anxiety, control of acute panic attack and acute alcoholic withdrawal",
        "description": "For severe anxiety, control of acute panic attack and acute alcoholic withdrawal, 10mg (at a rate of not more then 5 mg/minimum) repeat in necessary 4 hourly. In epilepsy-see under anticonvulsant drugs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "suppository",
        "indication": "when oral route not appropriate",
        "description": "By rectum as suppositories, when oral route not appropriate, apply 10mg suppository 1 to 3 times daily..",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 188,
    "genericName": "Alprazolam",
    "doseList": [
      {
        "indication": "anxiety",
        "description": "0.25-05 mg 3 times daily (maximum dose 4 mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "maximum dose 4 mg daily"
          }
        ]
      },
      {
        "indication": "panic disorder of agoraphobia",
        "description": "0.5mg 3 times daily after meals for 2 days and then the dose may be increased by adding 0.5mg to 1 mg of the existing dose every 2-3 days until 2 mg thrice daily is given; Usual dose 3-6 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after"
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "notes": "by adding 0.5mg to 1 mg of the existing dose every 2-3 days until 2 mg thrice daily is given;Usual dose 3-6 mg daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 189,
    "genericName": "Bromazepam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3-18mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 18
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly (or debilitated) half Adult dose; maximum(in exceptional circumstances in hospital patients) 60mg daily in divided dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.5,
              "max": 9
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primary",
            "condition": "in exceptional circumstances in hospital patients",
            "unit": "mg",
            "amount": {
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 190,
    "genericName": "Clobazam",
    "doseList": [
      {
        "ageGroup": "elderly",
        "description": "Elderly: 20mg.Both daily in divided doses or as a single dose at night. Maximum 60mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "doseTime": {
              "night": true
            },
            "notes": "Maximum 60mg daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Others, 20-30mg.Both daily in divided doses or as a single dose at nightI.Maximum 60mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Others",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 3
        },
        "description": "Child: Under 3 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 12
        },
        "description": "3-12 years, upto half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 191,
    "genericName": "Lorazepam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The usual range of dosage is 2-7 mg/day given in divided doses;The largest dose being taken before bedtime, But the largest dosage may vary from 1 to 10mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 2,
              "max": 7
            },
            "doseTime": {
              "condition": "The largest dose",
              "when": "before",
              "bedtime": true
            },
            "notes": "But the largest dosage may vary from 1 to 10mg/day."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "anxiety",
        "description": "For anxiety, most patients require an initial dose of 2-3mg/day given b.i.d. or t.i.d.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "elderly or debilitated patients",
        "description": "For elderly or debilitated patients, an initial dosage of 1-2mg/day in divided doses is recommended, to be adjusted as needed and tolerated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "to be adjusted as needed and tolerated."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "nsomnia",
        "description": "For Insomnia 1-2mg before bedtime and as premedicant 1-2mg the night before surgery and 1 to 2 hour before surgery.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "when": "before",
              "bedtime": true
            },
            "additionalDose": {
              "when": "the night before surgery",
              "unit": "mg",
              "amount": {
                "min": 1,
                "max": 2
              }
            },
            "connectionToSurgery": {
              "when": "before",
              "hour": {
                "min": 1,
                "max": 2
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 13
        },
        "indication": "anxiety",
        "description": "Lorazepem is not recommended in anxiety states in Children but may be used as premedicant before surgery at a dose of 0.05mg/kg in Children aged 5 to 13 years.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 13
        },
        "indication": "premedicant before surgery",
        "description": "Lorazepem is not recommended in anxiety states in Children but may be used as premedicant before surgery at a dose of 0.05mg/kg in Children aged 5 to 13 years.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.05,
              "max": 0.05
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 192,
    "genericName": "Chlorpromazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 25mg 3 times daily increasing if necessary by 25mg dailyI.Maintenance, usually 75-300mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "ncreasing if necessary by 25mg daily."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 300
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Upto 5 year 5-10mg 3 times daily;",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "5-12 yrs. Third to half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8.33,
              "max": 12.5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "25-50mg I.M. as a single dose or repeated if necessary 6 to 8 hourly. Follow as soon as possible by oral therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "I.M.",
            "amount": {
              "min": 25,
              "max": 50
            },
            "notes": "a single dose or repeated if necessary 6 to 8 hourly."
          }
        ]
      }
    ]
  },
  {
    "serial": 193,
    "genericName": "Thioridazine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "30-100mg daily, increasing to 600mg daily in divided doses according to response, for upto 4 weeks. Usual maintenance does 100-200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 4
            },
            "notes": ", increasing to 600mg daily in divided doses according to response"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Under 5 yrs.:1mg/kg body–wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "5-12yrs.:¼ to ½ Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7.5,
              "max": 50
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 194,
    "genericName": "Trifluoperazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Psychoses",
        "description": "Initially 10mg daily in single or divided doses increasing after 7 days to 15mg daily.If required increase further by 5mg at 3 day intervals, then reduce to maintenance dose 10mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "f required increase further by 5mg at 3 day intervals"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Anxiety (Psychoneuroses)",
        "description": "Anxiety (Psychoneuroses)- 2 to 6mg daily in divided or single doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "indication": "Psychoses",
        "description": "under 12 yrs. Upto 5mg in divided doses , then adjust according to the response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 5
            }
          },
          {
            "type": "maintenance",
            "notes": "adjust according to the response"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 3
        },
        "indication": "Anxiety",
        "description": "under 3 yrs, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 5
        },
        "indication": "Anxiety",
        "description": "3-5 yrs. 1 mg daily in divided doses (as syrup.).",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "as syrup",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Anxiety",
        "description": "6-12 yrs. Upto 4 mg daily (as syp.) in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "as syp.",
            "unit": "mg",
            "amount": {
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "1-3mg daily by I.M. inj-maximum 6 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "1mg/20kg body-wt daily by I.M. inj in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/20kg",
            "amount": {
              "min": 1,
              "max": null
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 195,
    "genericName": "Clozapine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "12.5 mg once or twice on first day then 25-50mg on second day, then slowly increased (if well tolerated) in steps of 25-50mg over 14-21 days to 300mg daily in divided doses (larger dose at night, up to 200mg daily may be he taken as a single dose at bed time); If necessary may be further increased in steps of 50-100mg once (peperable) or twice weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on first day"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on second day"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on second day"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Usual antipsychotic dose",
        "description": "Usual antipsychotic dose 200-450mg daily (maximum 900mg daily);Subsequent adjustment to usual maintenance of 150-300mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 450
            },
            "notes": "maximum 900mg daily."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 300
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 196,
    "genericName": "Flupenthixol",
    "doseList": [
      {
        "route": "Injection",
        "description": "Initially use test does 20mg; Then 100-200mg by deep I.M Injection (better gluteal muscle) after 5 to 10 day; Repeat usually every 2 to 4 weeks maximum 4oomg weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "repeated": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "notes": "Repeat usually every 2 to 4 weeks maximum 4oomg weekly."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "oral",
        "ageGroup": "Adult",
        "indication": "Flupenthixol",
        "description": "Flupenthixol:Adult, 3-9 mg twice daily; maximum 18mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 9
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "maximum 18mg daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 197,
    "genericName": "Flupenthixol + Melitracin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Usually 2 Tablets daily divided in morning and evening doses. In severe cases, morning  dose may be increased to 2 Tablets.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "notes": "in severe cases, morning  dose may be increased to 2 Tablets."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly, 1 Tablet in the morning; maintenance, usually 1 Tablet in the morning.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 198,
    "genericName": "Zuclopenthixol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 20-30mg daily in divided dosesI.Maintenance, 20-50mg daily;Maximum 150mg daily if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 50
            },
            "notes": "Maximum 150mg daily if necessary"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 199,
    "genericName": "Haloperidol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Psychoses",
        "description": "Initially 0.5-5mg 2 or 3 times daily, increasing gradually as required maximum 200mg. daily when control is achieved reduce to maintenance dose (5-10mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "gradually as required",
            "unit": "mg",
            "amount": {
              "max": 200
            }
          },
          {
            "type": "maintenance",
            "condition": "when control is achieved",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Anxiety",
        "description": "0.5mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "0.05mg/kg body-wt. daily in 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.05,
              "max": 0.05
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "psychoses",
        "description": "Initially 20-30mg I.M, then 5 mg 1 to 8 hourly as required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "as dose by mouth. 0.05mg/kg body-wt. daily in 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.05,
              "max": 0.05
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 200,
    "genericName": "Aripiprazole",
    "doseList": [
      {
        "indication": "Schizophrenia",
        "description": "Usual recommended starting and target dose for aripiprazole is 10mg to 15mg/day administered on a oncea-day schedule without regard to meals.Aripiprazole has been shown to be effective in a dose range of 10mg to 30mg/day. Maximum dosage increase should not be made before 2 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 30
            },
            "notes": "Maximum dosage increase should not be made before 2 weeks."
          }
        ]
      },
      {
        "indication": "Acute manic & mixed episodes associated with bipolor disorder",
        "description": "Usual recommended starting dose is 30mg given once a day.Dose may be deceased to 15mg based on assessment of tolerability.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "condition": "based on assessment of tolerability.",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 201,
    "genericName": "Olanzapine",
    "doseList": [
      {
        "description": "10mg once daily regardless of meal. Daily dosage may subsequently be adjusted on the basis of individual clinical status within the range of 5-20mg once daily.Doses of 15mg or more daily should be given only after appropriate clinical reassessment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "on the basis of individual clinical status",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Doses of 15mg or more daily should be given only after appropriate clinical reassessment."
          }
        ],
        "notes": "Metabolism rate of Olanzapine is slower in female, elderly (over 65 years of age) & non-smokers. So, a lower initial & a more gradual dose schedule should be considered."
      },
      {
        "indication": "Patients with Renal Impairment",
        "description": "starting dose are 5 mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Patient with Hepatic impairment",
        "description": "Patient with Hepatic impairment- starting dose is 5mg once daily & only increased with caution.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "only increased with caution."
          }
        ]
      }
    ]
  },
  {
    "serial": 202,
    "genericName": "Quetiapine",
    "doseList": [
      {
        "indication": "Bipolar mania",
        "secondaryIndication": "As monotherapy or as adjunct therapy with other anti-psychotic drugs",
        "description": "1st day-50mg twice daily; 2nd day-100mg twice daily; 3rd day- 150mg twice daily; 4th day- 200mg twice daily; 5th day 300mg twice daily; 6th day 400mg twice daily. Data indicates that the majority of patients responded between 400mg to 800mg/day. Safety of doses above 800mg/day  has not been evaluated in clinical trials.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "1st day",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd day",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "3rd day",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "4th day",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "5th day",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "6th day",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": null
            }
          }
        ],
        "notes": "Data indicates that the majority of patients responded between 400mg to 800mg/day. Safety of doses above 800mg/day  has not been evaluated in clinical trials."
      },
      {
        "indication": "Schizophrenia",
        "description": "Usual dose: Quetiapine should generally be administered with an initial dose of 25mg twice daily, with increments of 25-50mg twice daily or thrice daily on the second and third day, as tolerated, to a target dose range of 300mg to 400mg daily by the 4th day, given twice daily or thrice daily. Further dosage adjustment- if indicated, should generally occur at intervals of not less than 2 days, as steady-state for quetiapine would not be achieved for approximately 1-2 days in the typical patient. When dosage adjustments are necessary, dose increments/decrements of 25-50mg twice daily are recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "1st day",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd day and 3rd day",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "4th day",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "Further dosage adjustment- if indicated, should generally occur at intervals of not less than 2 days, as steady-state for quetiapine would not be achieved for approximately 1-2 days in the typical patient."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 203,
    "genericName": "Resperidone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Start with 2mg daily in single or two divided doses; May be increased to 4mg/day on the second day. Most patients benefit from doses of 4-6mg/day, but an optimal response maybe obtained at lower doses. Above 10mg/day may increase extrapyramidal symptoms risk, consider risks vs benefits. Maximum dose 16mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd day",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/day",
            "amount": {
              "max": 16
            }
          }
        ],
        "notes": "Most patients benefit from doses of 4-6mg/day, but an optimal response maybe obtained at lower doses. Above 10mg/day may increase extrapyramidal symptoms risk, consider risks vs benefits."
      },
      {
        "ageGroup": "Adult",
        "indication": "Elderly, renal & liver disease",
        "description": "Start with 0.5mg b.d; adjust by 0.5mg twice daily to 1-2mg thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/day",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Behavioural disturbances in patients with dementia",
        "description": "Start with 0.25mg b.d; adjust by 0.25mg b.d every other day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "notes": "adjust by 0.25mg b.d every other day"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Optimum",
        "description": "0.5mg b.d; some may benefit from 1mg b.d.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "notes": "some may benefit from 1mg b.d."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 204,
    "genericName": "Ziprasidone",
    "doseList": [
      {
        "route": "mouth",
        "description": "Ziprasidone should be administered at an initial dose of 20mg twice daily with food. In some patients, daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80m gtwice daily; Or, As directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with food"
            }
          },
          {
            "type": "alternate",
            "condition": "in some patients on the basis of individual clinical status",
            "unit": "mg",
            "amount": {
              "max": 80
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 205,
    "genericName": "Lithium carbonate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Acute mania",
        "description": "0.25-2mg daily in divided doses, adjust the dose by daily blood tests to maintain a serum lithium level in range 0.6-1.2 mmol/L.Sample taken 12 hours after last dose for 5 to 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "adjust the dose by daily blood tests to maintain a serum lithium level in range 0.6-1.2 mmol/L",
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            },
            "notes": "Sample taken 12 hours after last dose"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Prophylaxis, 0.25-1.2mg daily in divided doses, adjust the dose to minatiain a serum level in range 0.5-1 mmol/L for first 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 1.2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "adjust the dose to minatiain a serum level in range 0.5-1 mmol/L",
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly, usually 0.5-1gm/day given individed doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm/day",
            "amount": {
              "min": 0.5,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not recommentde.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 206,
    "genericName": "Amitriptyline",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 75mg (elderly 10-50mg) daily in divided doses or as a single dose at night, increasing if required to maximum 200mg daily. Usual maintenance, 50-100mg at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "doseTime": {
              "night": true
            },
            "notes": "daily in divided doses or as a single dose at night"
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if required",
            "unit": "mg",
            "amount": {
              "max": 200
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Initially 75mg (elderly 10-50mg) daily in divided doses or as a single dose at night, increasing if required to maximum 200mg daily. Usual maintenance, 50-100mg at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 50
            },
            "doseTime": {
              "night": true
            },
            "notes": "daily in divided doses or as a single dose at night"
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if required",
            "unit": "mg",
            "amount": {
              "max": 200
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 10
        },
        "indication": "Nocturnal enuresis",
        "description": "Nocturnal enuresis-Child:7-10 years 10-20mg, 11-16 years 25-50mg at night for maximum 3 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 11,
          "max": 16
        },
        "indication": "Nocturnal enuresis",
        "description": "Nocturnal enuresis-Child:7-10 years 10-20mg, 11-16 years 25-50mg at night for maximum 3 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By I.M. or I.V Injection 20-30mg 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 207,
    "genericName": "Clomipramine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "25mg 3 times daily for 3 days, increasing to 50mg 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "description": "Elderly, initially 10mg at night increasing to 10-25mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "(use syrup) Under 6 yrs. Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 7
        },
        "description": "6-7 yrs. 25mg.All bedtime for 6-8 wks. Then gradually withdraw therapy",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8,
          "max": 11
        },
        "description": "8-11 yrs. 25-50mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 11
        },
        "description": "Over 11 years 50-75mg.All bedtime for 6-8 wks. Then gradually withdraw therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 75
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 208,
    "genericName": "Maprotiline",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 25-75mg. daily in one dose (usually at night)  or 3 divided doses, adjusting after 1-2 weeks as necessary. Maximum 150mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 75
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "daily in one dose (usually at night)"
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 75
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "3 divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 150
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "description": "Initially 30mg at night or 10mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommentded.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 209,
    "genericName": "Nortriptyline",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "20-40mg daily in divided doses increasing if necessary to 100mg daily. Usual maintenance.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if necessary",
            "unit": "mg",
            "amount": {
              "max": 100
            }
          },
          {
            "type": "maintenance",
            "notes": "Usual maintenance"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly: Initially 10mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "indication": "Enuresis",
        "description": "Enuresis, under 6 year recommended",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Enuresis, under 6 year recommended"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "indication": "Enuresis",
        "description": "Over 6 years 10-35mg 30mins. Before bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 35
            },
            "connectionToBedtime": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 210,
    "genericName": "Mianserin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 30-40mg (30mg in old age) daily in divided doses or as a single dose at bedtime, increased gradually as necessary;Usual dose range 30-90mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 40
            },
            "notes": "(30mg in old age) daily in divided doses or as a single dose at bedtime"
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased gradually as necessary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 90
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 211,
    "genericName": "Citalopram",
    "doseList": [
      {
        "indication": "Depressive illness",
        "description": "20mg daily as a single dose in the morning or evening; Increased if necessary to maximum 60mg daily (elderly, maximum 40mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "doseTime": {
              "morning": true
            },
            "alternateDoseTime": {
              "evening": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "max": 60
            },
            "notes": "elderly, maximum 40mg daily"
          }
        ]
      },
      {
        "indication": "Panic disorder",
        "description": "Initially 10mg daily, increased to 20mg after 7 days; Usual dose 20-30mg daily; maximum 60mg daily (elderly, maximum 40mg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "notes": "maximum 60mg daily (elderly, maximum 40mg daily)"
          }
        ]
      }
    ]
  },
  {
    "serial": 212,
    "genericName": "Escitalopram",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The initial dose of escitalopram oxalate is 10mg once daily. (A fixed dose trial of escitalopram oxalate demonstrated the effectiveness of both 10mg and 20mg of escitalopram, but failed to demonstrate a greater benefit of 20mg over 10mg). If the dose is increased to 20mg, this should occur after a minimum of one week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "(A fixed dose trial of escitalopram oxalate demonstrated the effectiveness of both 10mg and 20mg of escitalopram, but failed to demonstrate a greater benefit of 20mg over 10mg)."
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "f the dose is increased to 20mg, this should occur after a minimum of one week."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "A single oral dose of 10mg/day is the recommended dose for most elderly patients. No significant differences in safety or effectiveness between the elderly group (age 65 and over) and the younger subjects ware observed, but greater sensitivity of some elderly individuals could not be ruled out.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Safety and effectiveness in Children below the age of 18 years have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 213,
    "genericName": "Duloxetine",
    "doseList": [
      {
        "indication": "Major depressive disorder (MDD)",
        "description": "20-30mg twice daily or 60mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Diabetic peripheral neuropathy",
        "description": "A total dose of 60mg given once a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Safety and efficacy in peadiatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 214,
    "genericName": "Fluoxetine",
    "doseList": [
      {
        "indication": "Depressive illness",
        "description": "20mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Depressive illness",
        "description": "Child,not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "Bulimia nervosa",
        "description": "60mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Bulimia nervosa",
        "description": "Child,not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "Obsessive-compulsive disorder",
        "description": "Initially 20mg daily, dose increase may be considered if no response after several weeks, but there may be increased potential for side-effects; maximum 60mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "dose increase may be considered if no response after several weeks, but there may be increased potential for side-effects"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Obsessive-compulsive disorder",
        "description": "Child,not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 215,
    "genericName": "Fluvoxamine",
    "doseList": [
      {
        "indication": "Obsessive compulsive disorded",
        "description": "Initially 50mg in the evening for 3-4 days, increasing if necessary to 300mg daily (over 150mg in divided doses).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "doseTime": {
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if necessary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "notes": "over 150mg in divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8
        },
        "indication": "Obsessive compulsive disorded",
        "description": "Over 8 years, initially 25mg daily, increased if necessary in steps of 25mg every 3-4 days to maximum 200mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if necessary",
            "unit": "mg",
            "amount": {
              "max": 200
            },
            "notes": "in steps of 25mg every 3-4 days to maximum 200mg daily in divided doses."
          }
        ]
      },
      {
        "indication": "Depression",
        "description": "Initially 50-100mg daily in the evening, increased if necessary to 300mg daily (over 150mg in divided doses). Usual maintenance dose 100mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "doseTime": {
              "evening": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "ncreasing if necessary",
            "unit": "mg",
            "amount": {
              "max": 300
            },
            "notes": "over 150mg in divided doses."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Depression",
        "description": "Child- Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 216,
    "genericName": "Paroxetine",
    "doseList": [
      {
        "indication": "Major depressive disorder",
        "description": "Usual initial dose is paroxetine 20mg as a single daily dose with or without food, preferable in the morning. Some patients not responding to 20mg dose may benefit from dose increases in 10mg/day increments up to a maximum of 50mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "connectionToMeal": {
              "when": "with or without"
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "alternate",
            "condition": "Some patients not responding to 20mg dose",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 50
            },
            "connectionToMeal": {
              "when": "with or without"
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "indication": "Obsessive compulsive disorder (OCD)",
        "description": "Patients should be started on 20mg/day and the dose can be increased weekly in 10mg/ day increments.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "the dose can be increased weekly in 10mg/ day increments."
          }
        ]
      },
      {
        "indication": "Panic disorder",
        "description": "Usual initial dose is paroxetine 20mg as a single daily dose with or without food, preferable in the morning.The target dose in the treatment of panic disorder is 40mg/day. Dose change should occur in 10mg/day increments at intervals of at least 1 week.The maximum dosage should not exceed 60mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "connectionToMeal": {
              "when": "with or without"
            },
            "doseTime": {
              "morning": true
            },
            "notes": "The target dose in the treatment of panic disorder is 40mg/day."
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 60
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "Dose change should occur in 10mg/day increments."
          }
        ]
      },
      {
        "indication": "Generalized anxiety disorder (Gad)",
        "description": "The Recommended starting dosage and the established effective dosage is 20mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "indication": "Post-traumatic stress disorder (PTSD)",
        "description": "The Recommended starting dosage and the established effective dosage is 20mg/day.Dose changes, if indicated, should occur in 10mg/day increments at intervals of at least 1 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 10
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "Dose changes, if indicated, should occur in 10mg/day increments at intervals of at least 1 week."
          }
        ]
      }
    ]
  },
  {
    "serial": 217,
    "genericName": "Sertraline",
    "doseList": [
      {
        "indication": "Depression",
        "description": "Initially 50mg daily, increased if necessary by 50mg over several weeks to maximum 200mg daily; Then redced to usual maintenance dose 50mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 200
            },
            "notes": "by 50mg over several weeks to maximum 200mg daily"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "indication": "Obsessive- Compulsive disorder",
        "description": "Initially 50mg daily, increased if necessary by 50mg over several weeks; usual dose range 50-200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 200
            },
            "notes": "Increased if necessary by 50mg over several weeks"
          }
        ]
      },
      {
        "indication": "Panic disorder",
        "description": "25mg once daily; After one week the dose should be increased to 50mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 218,
    "genericName": "Bupropion",
    "doseList": [
      {
        "indication": "Depression",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "doseTime": {
              "morning": true
            },
            "notes": "Treatment should begin at 150mg/day given as a single daily dose."
          },
          {
            "type": "primaryFollowup",
            "condition": "f the 150mg initial dose is adequately tolerated",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "Interval": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "an increase to the 300mg/day target dose, may be made as early as early as fourth day of therapy."
          },
          {
            "type": "maintenance",
            "condition": "for patients in whom no clinical improvement is noted after several weeks of treatment at 300mg/day.",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "an increase to the 300mg/day target dose, may be made as early as early as fourth day of therapy."
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Child & Adolescent under 18years: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 219,
    "genericName": "Flupenthixol + Melitracin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Usually 2 Tablets daily divided in morning and evening doses. In severe cases, morning dose may be inceased to 2 Tablets.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "notes": "in severe cases, morning dose may be inceased to 2 Tablets"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly, 1 Tablet in the morning; maintenance, usually 1 Tablet in the morning.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 220,
    "genericName": "Mirtazapine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 15mg daily at bedtime. The effective daily dose is usually between 15 and 45mg as a single or 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "doseTime": {
              "bedtime": true
            },
            "notes": "The effective daily dose is usually between 15 and 45mg as a single or 2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 221,
    "genericName": "Venlafaxine",
    "doseList": [
      {
        "indication": "Depression",
        "description": "Initially 75mg (1 Tablet) in 2 divided doses, and can be increased if necessary after several weeks to 150mg daily in 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "notes": "in 2 divided doses"
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary after several weeks",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "notes": "in 2 divided doses"
          }
        ]
      },
      {
        "indication": "Severely depressed or hospitalized patients",
        "description": "Initially 150mg daily in 2 divided doses, and can be increased if necessary in steps of up to 75mg every 2-3 days to maximum 375mg daily then gradually reduced.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "notes": "in 2 divided doses"
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary in steps of up to 75mg every 2-3 days",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 375
            },
            "notes": "be increased if necessary in steps of up to 75mg every 2-3 days to maximum 375mg daily then gradually reduced."
          }
        ]
      },
      {
        "indication": "Generalised anxiety disorder",
        "description": "Generalised anxiety disorder- 75mg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "notes": "as a single dose"
          }
        ]
      }
    ]
  },
  {
    "serial": 222,
    "genericName": "Fluphenazine + Nortriptyline",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 Tablet (Fluphenazine hydrochlor. 0.5mg + Nortriptyline hydrochlor. 10mg per Tablet.) 2 to 3 times daily for maximum 3 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 3
            },
            "notes": "1 Tablet (Fluphenazine hydrochlor. 0.5mg + Nortriptyline hydrochlor. 10mg per Tablet.)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 223,
    "genericName": "Cinnarizine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Nausea",
        "description": "Nausea, 15-30mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Vestiblar disorder",
        "description": "Vestiblar disorder, 25-30 mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Motion sickness",
        "description": "Motion sickness, 30mg 2 hours before, then 15mg 8 hourly during journey.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "notes": "2 hours before"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "during journey"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Under 5 yrs. Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "indication": "Nausea",
        "description": "5-12 yrs. Half Adult dose (Nausea, 15-30mg 3 times daily.)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 15
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "indication": "Vestiblar disorder",
        "description": "5-12 yrs. Half Adult dose (Vestiblar disorder, 25-30 mg 3 times daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 15
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "indication": "Motion sickness",
        "description": "5-12 yrs. Half Adult dose (Motion sickness, 30mg 2 hours before, then 15mg 8 hourly during journey.)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "2 hours before"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "during journey"
          }
        ]
      }
    ]
  },
  {
    "serial": 224,
    "genericName": "Meclizine",
    "doseList": [
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Nausea and vomiting",
        "description": "25-50mg daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physician."
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Motion sickness",
        "description": "Take an initial dose of 25-50mg, 1 hour prior to travel; may repeat the dose every 24 hours for the duration of the journey.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "notes": "1 hour prior to travel,may repeat the dose every 24 hours for the duration of the journey."
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Radiation sickness",
        "description": "50mg administered 2-12 hours prior to radiation treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "notes": "2-12 hours prior to radiation treatment."
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Vertigo",
        "description": "25-100mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Emergency contraception",
        "description": "25-50mg, 1 hour before first ECP dose; repeat if needed in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "repeated": {
              "condition": "f needed",
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "notes": "1 hour before first ECP dose"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "The safety and efficacy for use in Children less than 12 years of age have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 225,
    "genericName": "Promethazine Theoclate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "25-75mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 75
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "For severe nausea & vomiting in pregnance",
        "description": "For severe nausea & vomiting in pregnance, 25mg at bedtime, increased if necessary to a maximum of 100mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 100
            },
            "doseTime": {
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "description": "Child: 5-10 years. 12.5-37.5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 37.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 226,
    "genericName": "Promethazine HCI",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "25-50mg daily in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "daily, upto 1 year 5-10mg; 1-5 yrs.:10-15mg;6-12 yrs.:15-25mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "daily, upto 1 year 5-10mg; 1-5 yrs.:10-15mg;6-12 yrs.:15-25mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "daily, upto 1 year 5-10mg; 1-5 yrs.:10-15mg;6-12 yrs.:15-25mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Deep I.M Injection, half oral dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 25
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 227,
    "genericName": "Prochlorperazine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Mainor mental disturbances",
        "description": "5-20mg daily in divided doses increasing to maximum 40mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 40
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Schiziphrenia",
        "description": "75-100mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Nausea & vomiting",
        "description": "Initially 20mg then 10mg after 2 hours if required. Vertigo-15mg daily in divided (3) doses, max 30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "after 2 hours if neqd.",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Vertigo",
        "description": "15mg daily in divided (3) doses, max 30mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "in divided (3) doses, max 30mg daily"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "condition": "use syrup",
        "description": "1-5yrs. 2.5mg twice daily; 6-12yrs. 5mg 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "condition": "use syrup",
        "description": "1-5yrs. 2.5mg twice daily; 6-12yrs. 5mg 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "condition": "use syrup",
        "description": "12.5mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "condition": "use syrup",
        "description": "Child, use syrup.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "use syrup."
          }
        ]
      }
    ]
  },
  {
    "serial": 228,
    "genericName": "Menaril",
    "doseList": [
      {
        "description": "nitial dose is 8mg to 16mg 3 times daily taken preferable with meals;Maintenance dosage up to 48mg daily have been recommended for Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 16
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "preferable with meals"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 48
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- Betahistine is not recommended for Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 229,
    "genericName": "Merislon",
    "doseList": [
      {
        "description": "nitial dose is 6mg to 12 mg 3 times daily taken preferable after meals..",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6,
              "max": 12
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "preferable after meals."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- Betahistine is not recommended for Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 230,
    "genericName": "Chlorpromazine HCI",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "25-50mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "upto 5 yrs. 5-10mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "5-12 yrs. ¾ to ½ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By inj: By s.c or I.M Injection 12.5 -50mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 231,
    "genericName": "Metoclopramide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 15,
          "max": 20
        },
        "description": "15 to 20 years 5-10mg; other, 10mg. both 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "15 to 20 years 5-10mg; other, 10mg. both 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 yrs, 1 mg twice daily; 1-3yrs.:1mg 2 or 3 times daily;3-5 yrs:2mg 2 or 3 times; 5-14 yrs:2.5-5mg 3 times daily. All orally, I.M or I.Usual maximum doses, all ages 0.5mg/kg body-wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Usual maximum doses, all ages 0.5mg/kg body-wt. daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "description": "Under 1 yrs, 1 mg twice daily; 1-3yrs.:1mg 2 or 3 times daily;3-5 yrs:2mg 2 or 3 times; 5-14 yrs:2.5-5mg 3 times daily. All orally, I.M or I.Usual maximum doses, all ages 0.5mg/kg body-wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Usual maximum doses, all ages 0.5mg/kg body-wt. daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 5
        },
        "description": "Under 1 yrs, 1 mg twice daily; 1-3yrs.:1mg 2 or 3 times daily;3-5 yrs:2mg 2 or 3 times; 5-14 yrs:2.5-5mg 3 times daily. All orally, I.M or I.Usual maximum doses, all ages 0.5mg/kg body-wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Usual maximum doses, all ages 0.5mg/kg body-wt. daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 14
        },
        "description": "Under 1 yrs, 1 mg twice daily; 1-3yrs.:1mg 2 or 3 times daily;3-5 yrs:2mg 2 or 3 times; 5-14 yrs:2.5-5mg 3 times daily. All orally, I.M or I.Usual maximum doses, all ages 0.5mg/kg body-wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "Usual maximum doses, all ages 0.5mg/kg body-wt. daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 232,
    "genericName": "Granisetron",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "the recommended dosage is 10mcg/kg administered I.within 30 minutes before initiation of chemotherapy, and only on the day (s) chemotherapy is given; Injection may be administered I.either undiluted over 30 seconds. or diluted in 100 ml and infused over 5 min",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "notes": "the recommended dosage is administered I.within 30 minutes before initiation of chemotherapy, and only on the day (s) chemotherapy is given; Injection may be administered I.either undiluted over 30 seconds. or diluted in 100 ml and infused over 5 min"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 16
        },
        "description": "Paediatric patients- The recommended dose in paediatric patients 2- 16years of age is 10mcg/kg; Uses of this drug under 2 years of age have not been studied.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Paediatric patients- The recommended dose in paediatric patients 2- 16years of age is 10mcg/kg; Uses of this drug under 2 years of age have not been studied.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Prevention & treatment of postoperative nausea & vomiting",
        "description": "The recommended dosage for prevention of postoperative nausea and vomiting is, a single dose of 1mg (1ml) of Injection should be diluted to 5ml and administered as a slow I.V Injection (over 30 seconds).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "Injection should be diluted to 5ml and administered as a slow I.V Injection (over 30 seconds)"
          }
        ]
      },
      {
        "condition": "Tablet preparation",
        "indication": "Emetogenic chemotherapy",
        "description": "The recommended Adult dose of oral granisetron is 2 mg once daily or 1ml twice daily.In the 2mg once daily regimen, two  1mg Tablets are given up to one hour before chemotherapy; in the 1mg twice-daily regimen, the first 1mg Tablet is given up to one hour before chemotherapy, and the second Tablet 12 hours after the first; either regimen is administered only on the day(s) chemotherapy is given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ],
        "notes": "in the 2mg once daily regimen, two  1mg Tablets are given up to one hour before chemotherapy; in the 1mg twice-daily regimen, the first 1mg Tablet is given up to one hour before chemotherapy, and the second Tablet 12 hours after the first; either regimen is administered only on the day(s) chemotherapy is given."
      },
      {
        "ageGroup": "Adult",
        "indication": "Radiation",
        "description": "The recommended Adult dosage of oral granisetron is 2mg once daily; two 1mg Tablets are taken withing one hour of irradiation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "two 1mg Tablets are taken withing one hour of irradiation."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "the prevention of radiation induced nausea and vomiting in paediatric patients.",
        "description": "Paediatric use- There is no experience with oral granisetron in the prevention of radiation induced nausea and vomiting in paediatric patients.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 233,
    "genericName": "Ondansetron",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "A. In case of moderately emetogenic chemotherapy",
        "description": "8mg orally 1 to 2 hours before treatment, then followed by 8mg every 12 hours for up to 5 days (or up to 1 to 2 days after completion of chemotherapy).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "1 to 2 hours before treatment"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "or up to 1 to 2 days after completion of chemotherapy"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 11
        },
        "indication": "A. In case of moderately emetogenic chemotherapy",
        "description": "The dosage is 4mg given 8 or 12 hours 2 or 3 times a day for up to 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Severely (highly) emetogenic chemotherapy",
        "description": "the recommended Adult oral dosage is 24mg (3 times) to be administered 30minutes before the start of single-day highly emoetoenic chemotherapy, including cisplatin>50mg/m^2. Then followed by 8mg orally every 12 hours for up to 5 days. For gerisatric patients same as the general population.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 24,
              "max": 24
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "to be administered 30minutes before the start of single-day highly emoetoenic chemotherapy, including cisplatin>50mg/m^2."
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ],
        "notes": "For geriatric patients same as the general population"
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 11
        },
        "indication": "Severely (highly)emeto genic chemotherapy",
        "description": "The dosage is 4 mg given 8 or 12 hoursly 2 or 3 times a day for up to 5 day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Radiatherapy induced nausea and vomiting",
        "description": "The recommended oral dosage is one 8mg Tablet given 3 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Radiatherapy induced nausea and vomiting",
        "secondaryIndication": "For total body irradiation",
        "description": "For total body irradiation, one 8mg Tablet should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "administered 1 to 2 hours before each fraction of radiotherapy administered each day"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Radiatherapy induced nausea and vomiting",
        "secondaryIndication": "For single high-dose fraction radiotherapy to the abdomen",
        "description": "For single high-dose fraction radiotherapy to the abdomen, one 8mg Tablet should be administered 1 to 2 days after completion of radiotherapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "administered 1 to 2 days after completing of radiotherapy."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "C. Radiatherapy induced nausea and vomiting",
        "secondaryIndication": "For daily fractionated radiotherapy to the abdomen",
        "description": "For daily fractionated radiotherapy to the abdomen, one 8mg Tablet should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "administered 1 to 2 hours before radiotherapy"
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "with subsequent doses every 8 hours after the first dose for each day radiotherapy is given."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Prevention of postoperative nausea and vomitiong",
        "description": "16mg orally 1 hour before anaesthesia or 8mg 1 hour before anaesthesia followed by 8mg at intervals of 8 hours for 2 further doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 16,
              "max": 16
            },
            "notes": "1 hour before anaesthesia"
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "1 hour before anaesthesia"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "at intervals of 8 hours for 2 further doses."
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Moderately emetogenic chemotherapy or radiotherapy",
        "description": "by I.M or slow I.V Injection 8mg immediately before treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "mmediately before treatment"
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Severe emetogenic chemotherapy",
        "description": "by I.M or slow I.V Injection 8mg immediately before treatment, when necessary followed by 8mg at intervals of 2-4 hours for further 2 doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "mmediately before treatment"
          },
          {
            "type": "primaryFollowup",
            "condition": "when necessary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "at intervals of 2-4 hours for further 2 doses"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "By slow I.V Injection 5mg/m^2 immediately before chemotherapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "mmediately before chemotherapy"
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "C. Prevention and treatmet of postoperative nausea and vomiting",
        "description": "By I.M or slow I.V Injection 4 mg at induction of anaesthesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "notes": "at induction of anaesthesia."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "indication": "Prevention and treatmet of postoperative nausea and vomiting",
        "description": "By slow I.V Injection, 100mcg/kg (maximum 4mg before, during or after induction of anaesthesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "notes": "maximum 4mg before, during or after induction of anaesthesia."
          }
        ]
      }
    ]
  },
  {
    "serial": 234,
    "genericName": "Carbamazepine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 100-200mg once or twice daily increasing slowly to optimum dosage, Usually 800mg to 1.2mg daily. Maximum 1.6mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 1.2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "Maximum 1.6mg daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Upto 1 years:100-200mg; 1-5 years:200-400mg;5-10 years: 400-600mg;10-15 years:600mg-1mg. All daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Upto 1 years:100-200mg; 1-5 years:200-400mg;5-10 years: 400-600mg;10-15 years:600mg-1mg. All daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10,
          "max": 15
        },
        "description": "Upto 1 years:100-200mg; 1-5 years:200-400mg;5-10 years: 400-600mg;10-15 years:600mg-1mg. All daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 235,
    "genericName": "Clobazam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Anxiety",
        "description": "Anxiety, 20-30mg daily in divided doses; Maximum 60mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "notes": "Maximum 60mg daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Epilepsy",
        "description": "Epilepsy, 20-30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 3
        },
        "description": "Child: Under 3 yrs. Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 12
        },
        "indication": "Anxiety",
        "description": "3-12 yrs, upto half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            },
            "notes": "Maximum 30mg daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 12
        },
        "indication": "Epilepsy",
        "description": "3-12 yrs, upto half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 236,
    "genericName": "Clonazepam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1mg (elderly, 500mcg), initially at night for 4 nights, increased over 2-4 weeks to a usual maintenance dose of 4-8mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            },
            "notes": "elderly, 500mcg"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 8
            },
            "notes": "Increased over 2-4 weeks"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "up to 1 year 250mcg increased as above to 0.5-1mg",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1-5 years 250mcg increased to 1-2mg",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "5-12 years 500mcg increased to 3-6mg",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 237,
    "genericName": "Diazepam",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "10-20mg I.M or I.at a rate of 2-5mg/30 sec. Repeated after 30-60mins. If necessary. Then upto 3mg/kg body-wt. by.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "minute",
              "min": 30,
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child: 0.2-0.3mg/kg",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.2,
              "max": 0.3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 238,
    "genericName": "Lamotrigine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Monotherapy",
        "description": "Initially 25mg daily for 14 days then 50mg daily for further 14 days;Usual maintenance as monotherapy, 100-200mg daily in 1-2 divided doses (up to 500mg daily has been required).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "notes": "daily in 1-2 divided doses (up to 500mg daily has been required)"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Monotherapy",
        "description": "Elderly not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Adult",
        "indication": "Adjunctive therapy with valproate",
        "description": "Initially 25mg every other day for 14 days then 25mg daily for further 14days; Usual maintenance as monotherapy, 100-200mg daily in 1-2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "notes": "daily in 1-2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Adjunctive therapy with valproate",
        "description": "Elderly not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Adult",
        "indication": "Adjunctive therapy without valproate",
        "description": "Initially 50mg daily for 14 days then 50mg twice daily for further 14days; ; Usual maintenance as monotherapy, 200-400mg daily in 1-2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "notes": "daily in 1-2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Adjunctive therapy without valproate",
        "description": "Elderly not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 12
        },
        "indication": "Adjunctive therapy with valproate",
        "description": "2-12 years, adjunctive therapy with valproate, initially 200mcg/kg daily for 14 days then 500mcg/kg daily for further 14 days (those weighing less than 25kg may receive 5mg on alternate days for first 14 days); Usual maintenance with valproate 1-5mg/kg daily in 1-2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mcg/kg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "alternatePrimaryFollowup",
            "condition": "those weighing less than 25kg",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 5
            },
            "notes": "daily in 1-2 divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 239,
    "genericName": "Oxcarbazepine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "600-2400mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 600,
              "max": 2400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "min": 2
        },
        "description": "2 years of age and above 8-46mg/kg/day.Administration in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 8,
              "max": 46
            },
            "notes": "Administration in two divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 240,
    "genericName": "Phenobarbitone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "60-180mg at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 180
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "5-8mg/kg daily (febrile convulsion, 2-4mg/kg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 8
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "febrile convulsion",
        "description": "5-8mg/kg daily (febrile convulsion, 2-4mg/kg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 4
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "50-200mg as a single dose, repeat after 6 hours if necessary, maximum 600mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 200
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 600
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "By I.M or I.V Injection, upto 1 year 30-60mg; 1-5 years 90mg; 6-12 years 120mg, or 3-5mg/kg intramuscularly.(For I.administration, dilute Injection 1 in 10 with water before administration).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 60
            },
            "doseTime": {
              "night": true
            },
            "notes": "For I.administration, dilute Injection 1 in 10 with water before administration"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "By I.M or I.V Injection, upto 1 year 30-60mg; 1-5 years 90mg; 6-12 years 120mg, or 3-5mg/kg intramuscularly.(For I.administration, dilute Injection 1 in 10 with water before administration).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 90
            },
            "doseTime": {
              "night": true
            },
            "notes": "For I.administration, dilute Injection 1 in 10 with water before administration"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "By I.M or I.V Injection, upto 1 year 30-60mg; 1-5 years 90mg; 6-12 years 120mg, or 3-5mg/kg intramuscularly.(For I.administration, dilute Injection 1 in 10 with water before administration).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "doseTime": {
              "night": true
            },
            "notes": "For I.administration, dilute Injection 1 in 10 with water before administration"
          },
          {
            "type": "alternate",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 241,
    "genericName": "Phenytoin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200mg daily increased to 400mg daily (maximum 600mg/day) in divided doses (2-4 times) according to patients response or 3-4 mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "according to patients response",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "maximum 600mg/day"
          },
          {
            "type": "alternatePrimaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Upto 1 year 25mg, 1-5 years 25-50 mg increasing to 75mg. 6-12 years 50-100mg increasing to 150mg. All twice daily, Or 5-8mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Upto 1 year 25mg, 1-5 years 25-50 mg increasing to 75mg. 6-12 years 50-100mg increasing to 150mg. All twice daily, Or 5-8mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Upto 1 year 25mg, 1-5 years 25-50 mg increasing to 75mg. 6-12 years 50-100mg increasing to 150mg. All twice daily, Or 5-8mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 242,
    "genericName": "Sodium valproate / Valproic acid",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially, 600mg daily given in 2 divided doses, preferably after food, increasing by 200mg/day at 3-day intervals to a maximum of 2.5 gm daily in divided doses, usual maintenance 1-2 gm daily (20-30mg/kg daily).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "connectionToMeal": {
              "when": "after"
            },
            "notes": "given in 2 divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "Interval": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "notes": "to a maximum of 2.5mg daily in divided doses"
          },
          {
            "type": "maintenance",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "20-30mg/kg daily"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "up to 20 kg",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primary",
            "condition": "Over 20kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "notes": "daily in divided doses increased until control (usually in range of 20-30mg/kg daily)"
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "max": 35
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 243,
    "genericName": "Gabapentin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Neuralgia",
        "description": "The effective dose of gabapentin is 300-1800mg daily in three divided doses; Maximum dose is 3600mg daily in 3 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 1800
            },
            "notes": "daily in three divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 3600
            },
            "notes": "daily in three divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Seizure",
        "description": "The effective dose of gabapantin is 900-1800mg daily in three divided doses.The starting dose is 300mg three times a day.Doses of 3600mg/day have also been administered to a small number of patients for a relatively short duration, and have bee found well tolerated. The maximum time between doses should not exceed 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 900,
              "max": 1800
            },
            "notes": "daily in three divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ],
        "notes": "Doses of 3600mg/day have also been administered to a small number of patients for a relatively short duration, and have bee found well tolerated. The maximum time between doses should not exceed 12 hours."
      },
      {
        "route": "mouth",
        "indication": "in sleep disorder or mood disorder",
        "description": "900mg daily in divided doses found effective.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 900,
              "max": 900
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Safety and effectiveness in peadiatric patients  below the age of 12 years have not been established.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "indication": "in case of Renal Impairment gabapentin doses must be reduced",
        "secondaryIndication": "Creatinine clearance >60ml/min",
        "description": "Creatinine clearance >60ml/min; maximum Dose 1200mg daily orally in 3 divided doses.Gabapentin can be taken oral with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1200,
              "max": 1200
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "daily orally in 3 divided doses."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in case of Renal Impairment gabapentin doses must be reduced",
        "secondaryIndication": "Creatinine clearance 30-60ml/min",
        "description": "Creatinine clearance 30-60ml/min; maximum Dose 600mg daily orally in 2 divided doses.Gabapentin can be taken oral with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "daily orally in 2 divided doses."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in case of Renal Impairment gabapentin doses must be reduced",
        "secondaryIndication": "Creatinine clearance 15-30mlI.Min",
        "description": "Creatinine clearance 15-30mlI.Min: maximum Dose 300mg daily orally in single dose.Gabapentin can be taken oral with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "daily orally in single dose."
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in case of Renal Impairment gabapentin doses must be reduced",
        "secondaryIndication": "Creatinine clearance<15ml/min",
        "description": "Creatinine clearance<15ml/min: maximum Dose 150mg daily orally in single dose or 300mg every alternate day.Gabapentin can be taken oral with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "connectionToMeal": {
              "when": "with or without food"
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "notes": "every alternate day"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in case of Renal Impairment gabapentin doses must be reduced",
        "secondaryIndication": "For patients on hemodailysis",
        "description": "For patients on hemodailysis: maximum 300mg dose only after each dailysis session.Gabapentin can be taken oral with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "only after each dailysis session."
          }
        ]
      }
    ]
  },
  {
    "serial": 244,
    "genericName": "Topiramate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Titration should begin at 25mg nightly for 1 week. The doses should then be increased at 1-or 2-week intervals by increments of 25mg or 50mg/day, administered in two divided doses. The recommended initial target dose range for topiramate monotherepy in Adults is 100mg to 200mg/day and the maximum recommended daily dose is 500mg. Same patients with refractory forms of epilepsy have tolerated topiramate monotherepy at doses of 1000mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "ncrementRate": {
              "unit": "mg/day",
              "min": 25,
              "max": 50
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "The doses should then be increased at 1-or 2-week intervals by increments of 25mg or 50mg/day, administered in two divided doses"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 500
            },
            "notes": "Some patients with refractory forms of epilepsy have tolerated topiramate monotherepy at doses of 1000mg/day."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Treatment of Children (2 years and above) should begin at 1mg to 3mg/kg nightly for the first week. The dosage should then be increased at 1- or 2 week intervals by increments of 1mg to 3mg/kg/day, administered in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 3
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "ncrementRate": {
              "unit": "mg/kg/day",
              "min": 25,
              "max": 50
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "The dosage should then be increased at 1- or 2 week intervals by increments of 1mg to 3mg/kg/day, administered in two divided doses."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Adjunctive therapy",
        "description": "Titration should begin at 25mg nightly for 1 week. Subsequently, at weekly or biweekly intervals, the dose should be increased by 25mg/day and given in two divided doses.The usual total daily dose of topiramate as adjunctive therapy is 200mg to 400mg/day in two divided doses.Individual patients have received dosages as high as 1600mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "ncrementRate": {
              "unit": "mg/day",
              "min": 25,
              "max": 25
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "Subsequently, at weekly or biweekly intervals, the dose should be increased by 25mg/day and given in two divided doses.The usual total daily dose of topiramate as adjunctive therapy is 200mg to 400mg/day in two divided doses."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 1600
            },
            "notes": "Same patients with refractory forms of epilepsy have tolerated topiramate monotherepy at doses of 1000mg/day."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Adjunctive therapy",
        "description": "The recommended total daily dose of topiramate as adjunctive therapy for seizures in Children is approximately 5mg ot 9mg/kg/day in 2 divided doses. Titration should begin at 15mg to 25mg (or less based on a range of 1mg to 3mg/kg/day) nightly for the first week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 5,
              "max": 9
            },
            "notes": "in 2 divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 25
            },
            "ncrementRate": {
              "unit": "mg/kg/day",
              "min": 1,
              "max": 3
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "Subsequently, at weekly or biweekly intervals, the dose should be increased by 25mg/day and given in two divided doses.The usual total daily dose of topiramate as adjunctive therapy is 200mg to 400mg/day in two divided doses."
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 1600
            },
            "notes": "Same patients with refractory forms of epilepsy have tolerated topiramate monotherepy at doses of 1000mg/day."
          }
        ]
      }
    ]
  },
  {
    "serial": 245,
    "genericName": "Levodopa",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 250mg daily in divided doses (two)after meals, increasing by 125mg every 3 or 4 days or weekly intervals.Until optimum response obtained, maintenance usually 2.5-8mg daily.The total daily dose being given in 4 or 5 divided doses after food.As the patient ages, the maintenance dose may need to be reduced.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "connectionToMeal": {
              "when": "after meals"
            },
            "notes": "in divided doses (two)"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "Interval": {
              "unit": "day",
              "min": 3,
              "max": 7
            },
            "notes": "ncreasing by 125mg every 3 or 4 days or weekly intervals.Until optimum response obtained"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 8
            },
            "notes": "As the patient ages, the maintenance dose may need to be reduced."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 246,
    "genericName": "Co-careldopa (levodopa + carbidopa)",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Patients not receiving levodopa",
        "condition": "co-careldopa 110 (levodopa 100mg + carbidopa 10mg)Tablet",
        "description": "Dosage of co-careldopa 110 (levodopa 100mg + carbidopa 10mg)Tablet:Patients not receiving levodopa, initially 1 Tablet 3 times daily increasing in small increments to maximum 8 Tablets daily.Usual maintenance dose is 2 1/2 Tablets 3 or 4 times daily after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "the patients already receiving plain levodopa",
        "condition": "co-careldopa 275(levodopa 250mg + carbidopa 25mg)Tablet",
        "description": "Dosage of co-careldopa 275(levodopa 250mg + carbidopa 25mg)Tablet: This preparationis for the patients already receiving plain levodopa.First discontinue levodopa atleast 12 hours before starting the therapy with this combination. The dose should be approximately 25% of the previous daily dosage of levodopa. When daily levodopa intake is greater than 1500mg, start with this com-careldopa 275 one Tablet 3-4 times daily after food.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "First discontinue levodopa atleast 12 hours before starting the therapy with this combination. The dose should be approximately 25% of the previous daily dosage of levodopa."
          },
          {
            "type": "primaryFollowup",
            "condition": "When daily levodopa intake is greater than 1500mg",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 247,
    "genericName": "Bromocriptine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Parkinsonism",
        "description": "First week, 1-1.25mg at night,Second week, 2-2.5mg at night,Third week, 2.5mg twice daily,Then 3 times daily increasing by 2.5mg every 3-14 days according to response to a usual range of 10-40mg daily; taken with food.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First week",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.25
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Second week",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2.5
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Third week",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "condition": "Third week",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 40
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with food"
            },
            "notes": "daily increasing by 2.5mg every 3-14 days according to response"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prevention/suppression of lactation for medical reasons",
        "description": "Prevention/suppression of lactation for medical reasons, 2.5 mg on 1 st day (prevention)  or daily for 2-3 days (suppression); then 2.5mg twice daily for 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 3
            },
            "notes": "2.5 mg on 1 st day (prevention)  or daily for 2-3 days (suppression)"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Hypogonadism/galactorrhoea/infertility",
        "description": "Initially 1-1.25mg at bedtime, increased gradually; usual dose 7.5mg daily in divided doses, increased if necessary to a maximum of 30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "nfertility without hyperprolactinaemia",
        "description": "Usual dose in infertility without hyperprolactinaemia, 2.5 mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Cyclinal benign breast disease and cyclical menstrual disorders (particularly breast pain)",
        "description": "Cyclinal benign breast disease and cyclical menstrual disorders (particularly breast pain), 1-1.25mg at bed time, increased gradually; usual dose 2.5mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Acromegaly",
        "description": "Initially 1-1.25mg at bedtime increase gradually to 5mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prolactinoma",
        "description": "Initially 1-1.25mg at bed time; increased gradually to 5mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1.25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 248,
    "genericName": "Entacapone",
    "doseList": [
      {
        "description": "200mg with each levodopa/ dopadecarboxylase inhibitor doseI.Maximum recommended daily dose is 2000mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "notes": "with each levodopa/ dopadecarboxylase inhibitor dose"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 2000
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 249,
    "genericName": "Selegline",
    "doseList": [
      {
        "description": "10mg in the morning, or 5mg at breakfast and midday.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "doseTime": {
              "breakfast": true,
              "midday": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 250,
    "genericName": "Procyclidine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 2.5-5mg 3 times daily increasing at intervals of 2 or 3 days by 2.5-5mg daily; usual maximum 30mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "Interval": {
              "unit": "day",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Parenteral dose",
        "description": "10-20mg daily by I.M or I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Acute dystonia",
        "description": "By I.M Injection, 5-10mg repeated if necessary after 20 minutes; maximum 20mg daily; by I.V Injection 5mg (usually effective within 5 minutes); an occasional patient may need 10mg or more and may require up to half an hour to obtain relief.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "By I.M Injection",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "notes": "repeated if necessary after 20 minutes; maximum 20mg daily"
          },
          {
            "type": "primary",
            "condition": "by I.V Injection",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "notes": "an occasional patient may need 10mg or more and may require up to half an hour to obtain relief."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 251,
    "genericName": "Haloperidol",
    "doseList": [
      {
        "route": "mouth",
        "description": "0.5-1.5mg 3 times daily adjusted according to the response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Gilles de la Tourette Syndrome",
        "description": "10mg daily or more may occasionally be necessary in Gilles de la Tourette Syndrome.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Gilles de la Tourette Syndrome",
        "description": "Child, Gilles de la Tourette Syndrome up to 10mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 252,
    "genericName": "Piracetam",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Usual dose is 800mg 3 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "in myoclonic seizures",
        "description": "in myoclonic seizures, a dose of 7.2mg daily, incrasing by 4.8mg per day every 3 to 4 days up to maximum of 20mg daily, given in 2 or 3 divided doses..",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.2,
              "max": 7.2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 20
            },
            "ncrementRate": {
              "unit": "mg/day",
              "min": 4.8,
              "max": 4.8
            },
            "Interval": {
              "unit": "day",
              "min": 3,
              "max": 4
            },
            "notes": "ncrasing by 4.8mg per day every 3 to 4 days up to maximum of 20mg daily, given in 2 or 3 divided doses."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "50mg/kg of body weight in 3 divided doses. ",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "notes": "in 3 divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 253,
    "genericName": "Orlistat",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "120mg with each main meal; If a meal is missed or contains no fat, the dose of orlistat may be omitted for that meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "notes": "f a meal is missed or contains no fat, the dose of orlistat may be omitted for that meal"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Children,Below the age of 18 years not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 254,
    "genericName": "Sibutramine",
    "doseList": [
      {
        "route": "mouth",
        "description": "The recommended starting dose is 10mg once daily with or without food. If there is inadequate weight loss, the dose may be increased after 4 weeks to a total for 15mg once daily. The 5mg dose should be reserved for patients who do ot tolerate 10mg dose. Analysis of numerous variables has indicated that 60% of patients who lose at least 4 lbs in the first 4 weeks of treatment with a given dose of sibutramine in combination with a reduced-calorie diet lose at least 5% of their initial body weight by the end of 6 months to 1 years of treatment on that dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "notes": "The 5mg dose should be reserved for patients who do not tolerate 10mg dose."
          },
          {
            "type": "primaryFollowup",
            "condition": "f there is inadequate weight loss",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "f there is inadequate weight loss, the dose may be increased after 4 weeks"
          }
        ],
        "notes": "Analysis of numerous variables has indicated that 60% of patients who lose at least 4 lbs in the first 4 weeks of treatment with a given dose of sibutramine in combination with a reduced-calorie diet lose at least 5% of their initial body weight by the end of 6 months to 1 years of treatment on that dose."
      }
    ]
  },
  {
    "serial": 255,
    "genericName": "Donepezil",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5mg once daily orally at bed time, for at least one month, in order ot allow te earliest clinical response to treatment to be assessed and to allow steady-state concentrations of donepezil hydrochloride to be achieved. Following a one-month clinical assessment of treatment, the dose can be increased to 10mg/day (oncea-day dosing). Since food does not affect the rate or extent or absorption of donepezil, it can be administered with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 1
            },
            "connectionToMeal": {
              "when": "with or without food"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 256,
    "genericName": "Rivastigmine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f well tolerated",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 4.5,
              "max": 6
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 257,
    "genericName": "Naltrexone",
    "doseList": [
      {
        "route": "mouth",
        "condition": "A patient is candidate for treatment  with naltrexone if-  The patient is willing to take a medicine, iThe patient is opioid free for 7 to 10 days.  The patient does not have severe or active liver or kidney problem, The patient is not allergic to naltrexone and no other contraindications are present.",
        "indication": "in opiodid dependence",
        "description": "in opiodid dependence, treatment should be initiated carefully with an initial dose of 25mg of naltrexone; if no withdrawal signs occur, the patient may be started with 50mg a day thereafter.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f no withdrawal signs occur",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "condition": "A patient is candidate for treatment  with naltrexone if-  The patient is willing to take a medicine, iThe patient is opioid free for 7 to 10 days.  The patient does not have severe or active liver or kidney problem, The patient is not allergic to naltrexone and no other contraindications are present.",
        "indication": "in alcoholism",
        "description": "in alcoholism, A dose of 50mg once daily (up to 12 weeks) is recommended for most patients.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "condition": "A patient is candidate for treatment  with naltrexone if-  The patient is willing to take a medicine, iThe patient is opioid free for 7 to 10 days.  The patient does not have severe or active liver or kidney problem, The patient is not allergic to naltrexone and no other contraindications are present.",
        "indication": "Alternative dosing schedules",
        "description": "Alternative dosing schedules: Once the patient has been started on naltrexone, 50mg every other day, or  150mg every third day.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "every other day",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "every third day",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 258,
    "genericName": "nsulin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "The average insulin requirement is between 0.5 to 1 i.u per kg body wt. per day. Duration: Soluble or short acting insulin approx. 7-8 hours; intermediate acting, Approx. 18-24 hours; long acting approx . 24-36 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "duration": {
              "condition1": {
                "condition": "Soluble or short acting insulin approx",
                "unit": "hour",
                "min": 7,
                "max": 8
              },
              "condition2": {
                "condition": "Intermediate acting",
                "unit": "hour",
                "min": 18,
                "max": 24
              },
              "condition3": {
                "condition": "long acting approx ",
                "unit": "hour",
                "min": 24,
                "max": 36
              }
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "The average insulin requirement is between 0.5 to 1 i.u per kg body wt. per day. Duration: Soluble or short acting insulin approx. 7-8 hours; intermediate acting, Approx. 18-24 hours; long acting approx . 24-36 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "duration": {
              "condition1": {
                "condition": "Soluble or short acting insulin approx",
                "unit": "hour",
                "min": 7,
                "max": 8
              },
              "condition2": {
                "condition": "Intermediate acting",
                "unit": "hour",
                "min": 18,
                "max": 24
              },
              "condition3": {
                "condition": "long acting approx ",
                "unit": "hour",
                "min": 24,
                "max": 36
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 259,
    "genericName": "Glibenclamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 5mg daily as single dose at breakfast, increasing if necessary by 2.5-5mg at weekly intervals to maximum 15mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "doseTime": {
              "breakfast": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "notes": "at weekly intervals to maximum 15mg daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 260,
    "genericName": "Gliclazide",
    "doseList": [
      {
        "condition": "Dosage of 80mg plain Tablet",
        "description": "Initially 40-80mg daily, adjusted according to response; up to 160mg as a single dose with breakfast; Higher dose should be given in divide doses; 320mg may e given daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 80
            },
            "notes": "adjusted according to response"
          },
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 160
            },
            "doseTime": {
              "breakfast": true
            },
            "notes": "as a single dose"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 320
            },
            "notes": "Higher dose should be given in divide doses"
          }
        ]
      },
      {
        "condition": "Dosage of 30mg MR (modified release) Tablet CR (Controlled release)capsule",
        "description": "The usual daily dosage is 1 to 4 MR Tablets or CR capsules per day as a single dose. It is recommended that the drug should be taken at breakfast time. Every administration of Tablets/capsules must be followed by a meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet or capsule",
            "amount": {
              "min": 1,
              "max": 4
            },
            "doseTime": {
              "breakfast": true
            },
            "notes": "Every administration of Tablets/capsules must be followed by a meal."
          }
        ]
      }
    ]
  },
  {
    "serial": 261,
    "genericName": "Glimepiride",
    "doseList": [
      {
        "route": "mouth",
        "description": "The user dose is 1 mg once daily. If necessary, the daily dose can be increased. Any increase should be based on reqular blood suger monitoring. And gradual, i.e at intervals of one to two weeks, and carried out stepwise as follows-1mg-2mg-3mg-4mg. In patients with well controlled diabetes, the usual dose range is 1 to 4 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "f necessary, the daily dose can be increased. Any increase should be based on reqular blood suger monitoring. And gradual, i.e at intervals of one to two weeks, and carried out stepwise as follows-1mg-2mg-3mg-4mg."
          },
          {
            "type": "primary",
            "condition": "in patients with well controlled diabetes",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 262,
    "genericName": "Glipizide",
    "doseList": [
      {
        "route": "mouth",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "notes": "maximum 40mg daily; Upto 15mg may be given as a single dose before breakfast; High doses divided."
          }
        ]
      }
    ]
  },
  {
    "serial": 263,
    "genericName": "Metformin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Initially 500mg twice daily or 850mg daily with meals increasing gradually if necessary to maximum 3 gm daily. Reduce to maintenance, usually 500mg thrice or 850mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 850,
              "max": 850
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "gm",
            "amount": {
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternateMaintenance",
            "unit": "mg",
            "amount": {
              "min": 850,
              "max": 850
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: Not applieabe.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "indication": "Dosage of LA, XR preparations",
        "description": "The usual starting diose of LA or XR 500mg (metformin hydrochloride-long acting or extended release)  is one Tablet once daily with the evening meal. Dosage can be increased with a rate of 500mg weekly, Up to a maximum of 2000mg once daily with the evening meal. If glycemic control is not achieved LA or XR 2000mg once daily, a trial or LA or XR 1000mg twice daily should be considered.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            },
            "connectionToMeal": {
              "when": "with evening meal"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 2000
            },
            "ncrementRate": {
              "unit": "mg/week",
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            },
            "connectionToMeal": {
              "when": "with evening meal"
            }
          },
          {
            "type": "alternate",
            "condition": "f glycemic control is not achieved LA or XR 2000mg once daily",
            "unit": "mg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 264,
    "genericName": "Acarbose",
    "doseList": [
      {
        "condition": "Starting dosage",
        "description": "25mg 3 times daily with meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          }
        ]
      },
      {
        "condition": "Usual dosage",
        "description": "50-100mg 3 times daily or as the number of meals, depending on the patient’s weight and tolerance of side-effects. Same patients may benefit from gradual dose adaptation by initiating treatment at 50mg twice day for 1 or 2 weeks followed by 50mg three times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "3 times daily or as the number of meals, depending on the patient’s weight and tolerance of side-effects."
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternateFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 265,
    "genericName": "Nateglinide",
    "doseList": [
      {
        "description": "The usual dose is 120mg before main meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 120,
              "max": 120
            },
            "connectionToMeal": {
              "when": "before main meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 266,
    "genericName": "Pioglitazone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "At first, the dose is 15 or 30mg once daily; It may be increased later up to 45mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 45
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Dose must be determined by the physician.",
        "subDoseList": [
          {
            "notes": "Dose must be determined by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 267,
    "genericName": "Repaglinide",
    "doseList": [
      {
        "description": "Initially, 0.5mg to 1 mg within 30minutes before main meals, adjusted according to response at intervals of 1-2 weeks; Up to 4mg may be given as a single dose, maximum 16mg daily. Patients who skip a meal (or add an extra meal) should be instructed to skip (or add) a dose for that meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before main meals",
              "minute": 30
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "adjusted according to response at intervals of 1-2 weeks"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 16
            },
            "notes": "Patients who skip a meal (or add an extra meal) should be instructed to skip (or add) a dose for that meal."
          }
        ]
      }
    ]
  },
  {
    "serial": 268,
    "genericName": "Glipizide + Metformin",
    "doseList": [
      {
        "indication": "nitial therapy",
        "description": "The recommended starting dose of combination is 2.5mg/250mg once daily with meal. In clinical trials of this combination as initial therapy there was no experience with total daily doses greater then 10mg/2000mg per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 250
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "notes": "in clinical trials of this combination as initial therapy there was no experience with total daily doses greater then 10mg/2000mg per day."
          }
        ]
      },
      {
        "indication": "Second line therapy",
        "description": "The recommended starting dose of this combination is 2.5mg/500mg or 5mg/500mg twice daily with the morning and evening meals. The daily dose should be titrated in increments of no more than 5mg/500mg up to the minimum effective dose to achieve adequate control of blood glucose or to a maximum dose of 20mg/2000mg per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "connectionToMeal": {
              "when": "with meal"
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "connectionToMeal": {
              "when": "with meal"
            }
          }
        ],
        "notes": "The daily dose should be titrated in increments of no more than 5mg/500mg up to the minimum effective dose to achieve adequate control of blood glucose or to a maximum dose of 20mg/2000mg per day."
      }
    ]
  },
  {
    "serial": 269,
    "genericName": "Thyroxine/levothyroxine",
    "doseList": [
      {
        "indication": "in Adult patients without cardiac problems",
        "description": "Initially Adult oral dose is 50-100mcg daily, preferable in the fasting state, adjusted in steps of 50mcg every 3-4 week until normal metabolism maintained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "notes": "preferable in the fasting state"
          },
          {
            "type": "primaryFollowup",
            "ncrementRate": {
              "unit": "mcg",
              "min": 50,
              "max": 50
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "notes": "adjusted in steps of 50mcg every 3-4 week until normal metabolism maintained"
          }
        ]
      },
      {
        "indication": "in the elderly and in patients with cardiac problems",
        "description": "Initially 25mcg daily or 50mcg on alternate days adjusted in steps of 25mcg every 4 weeks until euthyroid.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "notes": "on alternate days"
          },
          {
            "type": "alternate",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "notes": "on alternate days"
          },
          {
            "type": "primaryFollowup",
            "ncrementRate": {
              "unit": "mcg",
              "min": 25,
              "max": 25
            },
            "Interval": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "notes": "until euthyroid."
          }
        ]
      },
      {
        "indication": "Maintenance therapy",
        "description": "The usual maintenance dose to relieve hypothyroidism is 100-200mcg daily, which can be administered as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "notes": "which can be administered as a single dose"
          }
        ]
      },
      {
        "ageGroup": "Child and neonate",
        "ageRange": {
          "unit": "month",
          "min": 0,
          "max": 6
        },
        "description": "At age 0-6mon,:8-10mcg/kg/day; 6-12 mon,:6-8mcg/kg/day; 1-5 yrs:5-6mcg/kg/day; 6-12 yrs,:4-5mcg; 12 years and over 2 mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/day",
            "amount": {
              "min": 8,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child and neonate",
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "description": "At age 0-6 month,:8-10mcg/kg/day; 6-12 month,:6-8mcg/kg/day; 1-5 yrs:5-6mcg/kg/day; 6-12 yrs,:4-5mcg; 12 years and over 2 mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/day",
            "amount": {
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child and neonate",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "At age 0-6 month,:8-10mcg/kg/day; 6-12 month,:6-8mcg/kg/day; 1-5 yrs:5-6mcg/kg/day; 6-12 yrs,:4-5mcg; 12 years and over 2 mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/day",
            "amount": {
              "min": 5,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child and neonate",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "At age 0-6 month,:8-10mcg/kg/day; 6-12 month,:6-8mcg/kg/day; 1-5 yrs:5-6mcg/kg/day; 6-12 yrs,:4-5mcg; 12 years and over 2 mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/day",
            "amount": {
              "min": 4,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child and neonate",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "At age 0-6 month,:8-10mcg/kg/day; 6-12 month,:6-8mcg/kg/day; 1-5 yrs:5-6mcg/kg/day; 6-12 yrs,:4-5mcg; 12 years and over 2 mcg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/day",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 270,
    "genericName": "odised oil",
    "doseList": [
      {
        "ageGroup": "infant",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "for the prevention and treatment of IDD for 1 years protection",
        "description": "1 capsule (200mg)a year.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "year",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "indication": "for the prevention and treatment of IDD for 1 years protection",
        "description": "2capsules (200mg x 2) every years or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "year",
              "min": 1,
              "max": 1
            },
            "notes": "(200mg x 2) every years or as directed by the physician."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "for the prevention and treatment of IDD for 1 years protection",
        "condition": "Adults, pregnant women & nursing mothers",
        "description": "2 capsules (200mg x 2) every years or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg",
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "year",
              "min": 1,
              "max": 1
            },
            "notes": "(200mg x 2) every years or as directed by the physician."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "ageRange": {
          "unit": "year",
          "min": 45
        },
        "indication": "for the prevention and treatment of IDD for 1 years protection",
        "description": "Reduced dose should be given to patients over 45 years with nodular goiters.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Reduced dose should be given to patients over 45 years with nodular goiters."
          }
        ]
      }
    ]
  },
  {
    "serial": 271,
    "genericName": "Lugols iodine soln",
    "doseList": [
      {
        "description": "0.1-0.3ml 3 times daily (well diluted with milk or water) for about 2 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.1,
              "max": 0.3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "notes": "well diluted with milk or water"
          }
        ]
      }
    ]
  },
  {
    "serial": 272,
    "genericName": "Potassium iodide",
    "doseList": [
      {
        "description": "30-60mg daily for about 2 wks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 60
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 273,
    "genericName": "Betamethasone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Rheumatoid arthritis & other rheumatic conditions",
        "description": "Rheumatoid arthritis & other rheumatic conditions initially 1-2.5mg daily, maintenance  0.5-1.5 mg daily, maintenance 0.5-1.5mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2.5
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "acute Rheumatic Fever",
        "description": "acute Rheumatic Fever 6-8mg daily, maintenance minimum effective dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "notes": "minimum effective dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "condition": "Effective dose",
        "indication": "asthmatic attack",
        "description": "asthmatic attack, initially 3.5-4.5mg, maintenance, minimum effective dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3.5,
              "max": 4.5
            }
          },
          {
            "type": "maintenance",
            "notes": "minimum effective dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "condition": "Effective dose",
        "indication": "chronic Refractory asthma",
        "description": "chronic. Refractory asthma 3.5mg daily, Maintenance 0.5-2.5mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3.5,
              "max": 3.5
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 2.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "condition": "Effective dose",
        "indication": "Allergic dermatosis",
        "description": "Allergic dermatosis, 2.5-4.5mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 4.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "condition": "Effective dose",
        "indication": "nflammatory occular conditions",
        "description": "nflammatory occular conditions, 2.5-4.5mg daily, maintenance minimum effective dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 4.5
            }
          },
          {
            "type": "maintenance",
            "notes": "minimum effective dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 years, Not recommended; 1-7 years,¼ to ½ Adult dose; 7-12 years ½ to ¾ Adult dose.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 7
        },
        "description": "Under 1 years, Not recommended; 1-7 years,¼ to ½ Adult dose; 7-12 years ½ to ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "¼ to ½ Adult dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 12
        },
        "description": "Under 1 years, Not recommended; 1-7 years,¼ to ½ Adult dose; 7-12 years ½ to ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "½ to ¾ Adult dose"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "specially in shock, adrenal crisis & acute conditions",
        "description": "By Injection: (specially in shock, adrenal crisis & acute conditions) Adult- 4-20mg I.repeated 3 or 4 times daily if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 20
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "specially in shock, adrenal crisis & acute conditions",
        "description": "Child- upto 1 year:1 mg; 1-5yrs,:2 mg; 6-12 yrs,:4mg. All by I.inj.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "specially in shock, adrenal crisis & acute conditions",
        "description": "Child- upto 1 year:1 mg; 1-5yrs,:2 mg; 6-12 yrs,:4mg. All by I.inj.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "specially in shock, adrenal crisis & acute conditions",
        "description": "Child- upto 1 year:1 mg; 1-5yrs,:2 mg; 6-12 yrs,:4mg. All by I.inj.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 274,
    "genericName": "Dexamethasone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1.5-3mg daily in divided doses, reducing by 0.25 or 0.5mg every 3 or 4 days to maintenance 0.5-1.5mg. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.5,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1.5
            },
            "notes": "reducing by 0.25 or 0.5mg every 3 or 4 days"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Cerebral oedema",
        "description": "Cerebral oedema,Initially 4-8mg daily then 10-20mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 years, Not recommended, 1-7 yrs,:1/5 to 2/3 Adult dose; 7-12 yrs,:1/2 to ¾ Adult dose, Or 0.010-0.04mg/kg body-wt.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 7
        },
        "description": "Under 1 years, Not recommended, 1-7 yrs,:1/5 to 2/3 Adult dose; 7-12 yrs,:1/2 to ¾ Adult dose, Or 0.010-0.04mg/kg body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "1/5 to 2/3 Adult dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 12
        },
        "description": "Under 1 years, Not recommended, 1-7 yrs,:1/5 to 2/3 Adult dose; 7-12 yrs,:1/2 to ¾ Adult dose, Or 0.010-0.04mg/kg body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "1/2 to ¾ Adult dose"
          },
          {
            "type": "alternative",
            "unit": "mg/kg body-wt",
            "amount": {
              "min": 0.010,
              "max": 0.04
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Acute condition, such as shock, severe allergic reactions, fuliminating infections, Hepatic coma and cerebral oedema",
        "description": "Acute condition, such as shock, severe allergic reactions, fuliminating infections, Hepatic coma and cerebral oedema, 8-40mg by slow I.V Injection or infuction.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg body-wt",
            "amount": {
              "min": 8,
              "max": 40
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "ntra- Articular",
        "description": "ntra- Articular, 2-4mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg body-wt",
            "amount": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "about acute conditions",
        "description": "(about acute conditions) 0.25-0.5mg/kg body-wt. daily by slow I.V Injection or Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg body-wt",
            "amount": {
              "min": 0.25,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 275,
    "genericName": "Prednisolone",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "10-20mg daily in divided (2-3) doses reducing by 2.5 or 5mg every 3  or 4 days to maintenance 5-12mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "notes": "in divided (2-3) doses"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 12
            },
            "notes": "reducing by 2.5 or 5mg every 3  or 4 days"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year,:Not recommended; 1-7 yrs :1/4 to half Adult dose; 7-12yrs:1/2 to ¾ Adult dose.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 7
        },
        "description": "Under 1 year,:Not recommended; 1-7 yrs :1/4 to half Adult dose; 7-12yrs:1/2 to ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "1/4 to half Adult dose"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 12
        },
        "description": "Under 1 year,:Not recommended; 1-7 yrs :1/4 to half Adult dose; 7-12yrs:1/2 to ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "1/2 to ¾ Adult dose"
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "as sodium phosphate",
        "description": "By I.V or I.M Injection, upto 100mg (as sodium phosphate). Parenteral route usually used in acute conditions. After remission of acute symptoms, continue for a few day orally as mentioned above.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 100
            }
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "Prednisolone acetate",
        "description": "By I.M. Injection, Prednisolone acetate 25-100mg. Parenteral route usually used in acute conditions. After remission of acute symptoms, continue for a few day orally as mentioned above.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 276,
    "genericName": "Methyl prednisolone",
    "doseList": [
      {
        "route": "Injection",
        "indication": "Rheumatoid arthritis & osteoarthritis",
        "description": "Rheumatoid arthritis & osteoarthritis:The Dosage depends upon the size of the joint and severity of the conditions; maximum dose may be up to 120mg. Injection may be repeated if needed at an interval of 1 to 5 or more weeks depending upon the degree of relief obtained from initial dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 120
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Dermatological conditions",
        "description": "Dermatological conditions-40-120mg (1-3ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 120
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Allergic conditions",
        "description": "Allergic conditions- 80-120mg (2-3ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 120
            },
            "volume": {
              "unit": "ml",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Collagen diseases",
        "description": "Collagen diseases- 40-120mg (1-3ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 120
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 3
            },
            "repeated": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Adrenogenital Syndrome",
        "description": "Adrenogenital Syndrome-  40mg (1ml) every 2 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 277,
    "genericName": "Hydrocortisone",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Shock",
        "description": "Shock, 100-500mg I.repeated as necessary every 2-6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Status asthmaticus",
        "description": "Status asthmaticus, 500mg. I.stat, may be repeated 4-6 hours later or followed by an infusion of 500mg. every 4 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "or followed by an infusion of 500mg. every 4 hours"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Acute adrenal crisis",
        "description": "Acute adrenal crisis, 250mg. I.then approximately 250mg. every 12 hours interval by I.infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Ulcerative colitis",
        "description": "Ulcerative colitis, 100mg. dissolved in 120ml saline and administered as rectal drip.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "additionalItem": {
              "temName": "saline",
              "quantity": {
                "unit": "ml",
                "min": 120,
                "max": 120
              }
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Ulcerative colitis",
        "description": "Usual doses are 6-10mg/kg body wt. But 50mg/kg body-wt. may be required if life threatening states. The dose should not fall below 25mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 6,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "f life threatening states",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "notes": "The dose should not fall below 25mg daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 278,
    "genericName": "Triamcinolone",
    "doseList": [
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "For Children from 6 to 12 years, initial dose is 40mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "nitial systemic dose for Adults and Children over 12 years dose is 40 to 80 to 100mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "nitial systemic dose for Adults and Children over 12 years dose is 40 to 80 to 100mg. for local areas, dose for Adults is upto 10mg for smaller and 40mg for larger areas.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 100
            }
          },
          {
            "type": "primary",
            "condition": "for smaller areas",
            "unit": "mg",
            "amount": {
              "max": 10
            }
          },
          {
            "type": "primary",
            "condition": "for larger areas",
            "unit": "mg",
            "amount": {
              "max": 40
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 279,
    "genericName": "Conjugated oestrogens",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Menopausal",
        "description": "Menopausal, usually 0.625mg or 1.25mg daily for 21 days starting on 5th day of menstruation then repeat after 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.625,
              "max": 0.625
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "starting on 5th day of menstruation then repeat after 7 days."
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "starting on 5th day of menstruation then repeat after 7 days."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Postmenopausal osteoporosis",
        "description": "Postmenopausal osteoporosis, cyclically 0.625mg or 1.25mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.625,
              "max": 0.625
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 1.25
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Functional amenorrhoea",
        "description": "Functional amenorrhoea, 0.625 or 1.25mg daily for 21 days. For the last 7 days progesterone therapy should be added.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.625,
              "max": 0.625
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "For the last 7 days progesterone therapy should be added."
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "For the last 7 days progesterone therapy should be added."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child: Not applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 280,
    "genericName": "Conjugated oestrogen inj",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "by slow I.V Injection 25mg. repeat after 6-12 hours if required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 281,
    "genericName": "Conjugated oestrogen vaginal cream",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 mg daily topically or intravaginally using calibrated applicator for 3 weeks followed by 1 week rest.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 282,
    "genericName": "Norethisterone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5mg 3 times daily for starting 3 days before expected onset of menstruation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "starting 3 days before expected onset of menstruation."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dysmenorrhoea",
        "description": "5mg 3 times daily for 20 days starting on 5th day of menstruation, then 8 Tablet-free days. Maintain treatment for 3 or 4 cycles.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 20,
              "max": 20
            },
            "notes": "starting on 5th day of menstruation, then 8 Tablet-free days."
          },
          {
            "type": "maintenance",
            "notes": "Maintain treatment for 3 or 4 cycles."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Menorrhagia and pre- menstrual Syndrome",
        "description": "5mg. 2 or 3 times daily for day 19-26 of cycle.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "for day 19-26 of cycle"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not Applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 283,
    "genericName": "Andriol",
    "doseList": [
      {
        "description": "Initially 120-160mg daily for 2-3 weeks is adequate, followed by a maintenance dosage of 40-120mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 160
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 120
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 284,
    "genericName": "Andriol testocaps",
    "doseList": [
      {
        "description": "Initially 120-160mg daily for 2-3 weeks is adequate, followed by a maintenance dosage of 40-120mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 160
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 120
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 285,
    "genericName": "Testesterone (inj.)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "By deep I.M Injection 1ml every 3 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "week",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not Applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 286,
    "genericName": "Testesterone (inj.)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "By deep I.M Injection 1ml every 3 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "week",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not Applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 287,
    "genericName": "Y-45 gel",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended starting dose of Y-45 gel is 5mg applied once daily (preferably in the morning) to clean, dry, intact skin of shoulders, upper arms and abdomen. Serum testosterone levels should be measured approximately 14 days after initiation of therapy to ensure proper dosing. Y-45 gel must not be appliced to the genitals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "Serum testosterone levels should be measured approximately 14 days after initiation of therapy to ensure proper dosing. Y-45 gel must not be appliced to the genitals."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Y-45 gel has not been clinically evaluated in males under 18 years of age.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 288,
    "genericName": "Nandrolone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "25-50mg I.M every three weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "repeated": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "notes": "every three weeks."
          }
        ]
      },
      {
        "route": "I.M. Injection",
        "ageGroup": "Adult",
        "indication": "Anaemia of chronic renal failure",
        "description": "Anaemia of chronic renal failure, 100-200mg weekly by deep I.M. Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Aplastic anaemia",
        "description": "Aplastic anaemia, 50-150mg weekly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 150
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Anaemia due to cytotoxic therapy",
        "description": "Anaemia due to cytotoxic therapy, 200mg weekly starting 2 weeks prior ot cytotoxic therapy and continuing until blood count is normal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "notes": "weekly starting 2 weeks prior ot cytotoxic therapy and continuing until blood count is normal."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not Applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 289,
    "genericName": "Clomiphene",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "50mg (1 tab.) daily for 5 consecutive days starting on within about 5 days of onset of menstrual cycle (preparably 2nd day). Or, At any time if cycle has ceased. Ovulation usually occurs 6 to 10 days following the last day of treatment. In absence of satisfactory result, daily 100mg may be given in the subsequent cycle as a rule for 3 (not more then 6) cycle.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "5 consecutive days starting on within about 5 days of onset of menstrual cycle (preparably 2nd day)."
          },
          {
            "type": "primaryFollowup",
            "notes": "At any time if cycle has ceased. Ovulation usually occurs 6 to 10 days following the last day of treatment."
          },
          {
            "type": "maintenance",
            "condition": "in absence of satisfactory result",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "notes": "may be given in the subsequent cycle as a rule for 3 (not more then 6) cycle."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Oligospermia",
        "description": "Oligospermia 50mg daily for 6 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Secondary amenorrhoea",
        "description": "Secondary amenorrhoea-50mg daily for 5 days starting at any time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: not Applicable.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 290,
    "genericName": "Follitropin Alfa",
    "doseList": [
      {
        "description": "Follitropin alfa is intended for subcutaneous or intramuscular administration. The powder should be reconstituted immediately prior to use with the diluents provided. In order to avoid the Injection of large volumes, up to 3 containers of Follitropin alfa 75 or 150 may be dissolved in 1 ml of diluents.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Follitropin alfa is intended for subcutaneous or intramuscular administration. The powder should be reconstituted immediately prior to use with the diluents provided. In order to avoid the Injection of large volumes, up to 3 containers of Follitropin alfa 75 or 150 may be dissolved in 1 ml of diluents."
          }
        ]
      }
    ]
  },
  {
    "serial": 291,
    "genericName": "Follitropin beta",
    "doseList": [
      {
        "route": "Injection",
        "indication": "Anovolation",
        "description": "A sequential treatment is recommended, initially a daily dose of 75 i.u FSH activity, which is to be continued for at least 7 days; If no ovarian response the daily dose is then gradually increased until follicle growth and/or plasma Estadiol levels indicate an adequate pharmacodynamic response. The daily dose is then maintained until preovulary conditions are fetched when there is  ultrasonographic evidence of a dominant follicle of at least 18 mm in diameter and or when plasma estadial 14 days of treatmet is suffient to reach this state.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 75,
              "max": 75
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "f no ovarian response the daily dose is then gradually increased until follicle growth and/or plasma Estadiol levels indicate an adequate pharmacodynamic response."
          },
          {
            "type": "maintenance",
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "notes": "The daily dose is then maintained until preovulary conditions are fetched when there is  ultrasonographic evidence of a dominant follicle of at least 18 mm in diameter and or when plasma estadial 14 days oftreatmet is suffient to reach this state."
          }
        ]
      }
    ]
  },
  {
    "serial": 292,
    "genericName": "Human Chorionic Gonadotrophin (HCG)",
    "doseList": [
      {
        "route": "Injection",
        "condition": "in the male",
        "indication": "in the male- Hypogonadotrophic hypogonadism",
        "description": "in the male- Hypogonadotrophic hypogonadism, 1000-2000 i.u 2 to 3 times per week for at least 3 months before any improvement in spermato-genesis can be expected. If the case is sterility, additional doses of an FSH (containing 75 i.u FSH)are to be given daily or 2 to 3 times a week. During the treatment testosterone replacement therapy should be suspended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1000,
              "max": 2000
            },
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3
            }
          },
          {
            "type": "primary",
            "condition": "f the case is sterility",
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "notes": "additional doses of an FSH (containing 75 i.u FSH)are to be given. During the treatment testosterone replacement therapy should be suspended."
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "in the male",
        "indication": "Delayed puberty",
        "description": "Delayed puberty, 15000 i.u 2 to 3 times a week for at least 6 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 15000,
              "max": 15000
            },
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "in the male",
        "indication": "Cryptorchidism",
        "description": "Delayed puberty, 15000 i.u 2 to 3 times a week for at least 6 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 15000,
              "max": 15000
            },
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "condition": "in the male",
        "indication": "Cryptorchidism",
        "description": "Cryptorchidism, under 2 years of age 250 i.u twice weekly for 6 weeks; Under 6 years 500-1000 i.u twice weekly for 6 weeks; Over 6 years 1500 i.u twice weekly for 6 weeks. If necessary this treatment can be repeated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "condition": "in the male",
        "indication": "Cryptorchidism",
        "description": "Cryptorchidism, under 2 years of age 250 i.u twice weekly for 6 weeks; Under 6 years 500-1000 i.u twice weekly for 6 weeks; Over 6 years 1500 i.u twice weekly for 6 weeks. If necessary this treatment can be repeated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 500,
              "max": 1000
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "condition": "in the male",
        "indication": "Cryptorchidism",
        "description": "Cryptorchidism, under 2 years of age 250 i.u twice weekly for 6 weeks; Under 6 years 500-1000 i.u twice weekly for 6 weeks; Over 6 years 1500 i.u twice weekly for 6 weeks. If necessary this treatment can be repeated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1500,
              "max": 1500
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6
            },
            "notes": "f necessary this treatment can be repeated."
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "in female",
        "indication": "nduction of ovulation and pregnancy",
        "description": "nduction of ovulation and pregnancy, 5000-10,000 i.u for one time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 5000,
              "max": 10000
            },
            "notes": "for one time."
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "in female",
        "indication": "Luteal phase support",
        "description": "Luteal phase support, 1000-3000 i.u, may be repeated 2 to 3 times, each may be given within 9 days following ovulationor embryo transfer.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1000,
              "max": 3000
            },
            "notes": "may be repeated 2 to 3 times, each may be given within 9 days following ovulation or embryo transfer."
          }
        ]
      }
    ]
  },
  {
    "serial": 293,
    "genericName": "Menotrophin",
    "doseList": [
      {
        "route": "Injection",
        "description": "By deep I.M Injection 75 units to 150 units, accorfing to patient’s response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit",
            "amount": {
              "min": 75,
              "max": 150
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 294,
    "genericName": "Urofollitrophin",
    "doseList": [
      {
        "route": "Injection",
        "description": "By deep I.M Injection, 75 i.u to 150 i.u, accorfing to patient’s response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u.",
            "amount": {
              "min": 75,
              "max": 150
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 295,
    "genericName": "Somatropin",
    "doseList": [
      {
        "route": "Injection",
        "description": "0.5-0.7 units/kg (Turner Syndrome, 1 unit/kg) weekly divided into 6 or 7 doses for subcutaneous Injection (alternatively divided into 2 or 3 doses for intramuscular Injection, but more painful).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit/kg",
            "amount": {
              "min": 0.5,
              "max": 0.7
            },
            "notes": "weekly divided into 6 or 7 doses for subcutaneous Injection"
          },
          {
            "type": "primary",
            "condition": "Turner Syndrome",
            "unit": "unit/kg",
            "amount": {
              "min": 1,
              "max": 7
            },
            "notes": "weekly divided into 6 or 7 doses for subcutaneous Injection"
          },
          {
            "type": "alternate",
            "condition": "for intramuscular Injection",
            "notes": "alternatively divided into 2 or 3 doses for intramuscular Injection"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Climacteric or vasomotor  symptoms following natural or surgical; menopause, & other post-menopausal problems",
        "secondaryIndication": "in case of missed pill",
        "description": "in case of missed pill, if no more than 12 hours have passed, the pill should be taken immediately, otherwise the next dose should be continued as before.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "in case of missed pill, if no more than 12 hours have passed, the pill should be taken immediately, otherwise the next dose should be continued as before."
          }
        ]
      }
    ]
  },
  {
    "serial": 296,
    "genericName": "Tibolone",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Climacteric or vasomotor  symptoms following natural or surgical menopause; & other post-menopausal problems",
        "description": "2.5mg daily preferably at the same time. Improvementof symptoms generally occurs within a few weeks, but optimal results are obtained when therapy is continued for at 1wast 3 months. At the recommended dosage, it may be used uninterruptedly for longer periods.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Climacteric or vasomotor  symptoms following natural or surgical menopause; & other post-menopausal problems",
        "secondaryIndication": "To prevent osteoporosis in post-menopausal women or after oophorectomy",
        "description": "To prevent osteoporosis in post-menopausal women or after oophorectomy at a rate of 2.5mg/day is needed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 2.5,
              "max": 2.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Climacteric or vasomotor  symptoms following natural or surgical; menopause, & other post-menopausal problems",
        "secondaryIndication": "in case of missed pill",
        "description": "in case of missed pill, if no more than 12 hours have passed, the pill should be taken immediately, otherwise the next dose should be continued as before.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "in case of missed pill, if no more than 12 hours have passed, the pill should be taken immediately, otherwise the next dose should be continued as before."
          }
        ]
      }
    ]
  },
  {
    "serial": 297,
    "genericName": "Somatostatin",
    "doseList": [
      {
        "route": "Injection",
        "description": "Administer at a rate of 250mcg/hour or 6mg (2 amps) in 24 hours in a continuous Infusion until documented cessation of bleeding for upto even 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/hour",
            "amount": {
              "min": 250,
              "max": 250
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "until documented cessation of bleeding",
            "treatmentPeriod": {
              "unit": "day",
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "for bleeding",
        "description": "Administer at a rate of 250mcg/hour or 6mg (2 amps) in 24 hours in a continuous Infusion until documented cessation of bleeding for upto even 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "hour",
              "min": 5,
              "max": 120
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Prophylaxis",
        "description": "Prophylaxis, 120-140 hours",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "hour",
              "min": 120,
              "max": 140
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Fistulae",
        "description": "Fistulae, 5-15 days",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "day",
              "min": 5,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 298,
    "genericName": "Cetrorelix",
    "doseList": [
      {
        "route": "Injection",
        "description": "Cetrorelix 0.25mg is for subcutaneous Injection into the lower abdominal wall. The content of 1 vial (0.25mg cetrorelix) is to be administered once daily, at 24 hours intervals, either in the morning or in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "doseTime": {
              "morning": true
            },
            "alternateDoseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "Administration in the morning",
        "description": "Treatment with cetrorelix 0.25mg in the morning should commence on day 5 or 6 of ovarian stimulation (approximately 96 to 120 hours after start of ovarian stimulation)with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period including the day of ovulation induction.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Treatment with cetrorelix 0.25mg in the morning should commence on day 5 or 6 of ovarian stimulation (approximately 96 to 120 hours after start of ovarian stimulation)with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period including the day of ovulation induction."
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "Administration in the evening",
        "description": "Treatment with cetrorelix 0.25mg in the evening should commence on day 5 of ovarian stimulation (approximately 96 to 108 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Treatment with cetrorelix 0.25mg in the evening should commence on day 5 of ovarian stimulation (approximately 96 to 108 hours after start of ovarian stimulation) with urinary or recombinant gonadotropins and is to be continued throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction."
          }
        ]
      }
    ]
  },
  {
    "serial": 299,
    "genericName": "Danazol",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Endometriosis",
        "description": "200-800mg daily in up to 4 divided doses, adjusted to achieve amenorrhea, usually for 6 months (up to 9 months in some cases).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 800
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 6
            },
            "alternateTreatmentPeriod": {
              "condition": "in some cases",
              "unit": "month",
              "max": 9
            },
            "notes": "in up to 4 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Menorrhagia",
        "description": "200mg daily, usually for 3 months (but in view of its side-effects, treatment with other drugs may be preferable).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "month",
              "max": 3
            },
            "notes": "but in view of its side-effects, treatment with other drugs may be preferable"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Severe cyclical mastalgia",
        "description": "100-400mg daily usually for 3-6 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Benign breast cysts",
        "description": "300mg daily usually for 3-6 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Pre-opeative thinning of endometrium",
        "description": "400-800mg daily in up to 4 divided doses for 3 -6 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 800
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            },
            "notes": "daily in up to 4 divided doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Hereditary angioedema",
        "description": "Start with 200mg 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 300,
    "genericName": "Norgestimate 0.25mg & ethinylestradiol 0.035mg tab.",
    "doseList": [
      {
        "description": "1 Tablet daily regularly for 21 days starting on 5th day of menstruation until 26th day. Then after an interval of 7 days start the next course.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "starting on 5th day of menstruation until 26th day."
          },
          {
            "type": "primaryFollowup",
            "Interval": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "notes": "Then after an interval of 7 days start the next course."
          }
        ]
      }
    ]
  },
  {
    "serial": 301,
    "genericName": "Lyndiol tab.",
    "doseList": [
      {
        "description": "1 Tablet daily regularly for 22 days stating on 5th day of menstruation until 26 day. Then after an interval of 7 days start the next course.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 22,
              "max": 22
            },
            "notes": "starting on 5th day of menstruation until 26th day."
          },
          {
            "type": "primaryFollowup",
            "Interval": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "notes": "Then after an interval of 7 days start the next course."
          }
        ]
      }
    ]
  },
  {
    "serial": 302,
    "genericName": "Ethinylestradiol 0.03mg & Desogesfrel (a progestagen) 0 . 1 5mg/ tab.",
    "doseList": [
      {
        "description": "1 Tablet daily regularly for 21 days stating on 5th day of menstruation, Then after an interval of 7 days start the next course.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 21,
              "max": 21
            },
            "notes": "stating on 5th day of menstruation"
          },
          {
            "type": "primaryFollowup",
            "Interval": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "notes": "Then after an interval of 7 days start the next course."
          }
        ]
      }
    ]
  },
  {
    "serial": "302B",
    "genericName": "Lynestrenol 1 mg & Ethinyloestradiol 0.05mg/ tab.",
    "doseList": [
      {
        "description": "1 Tablet daily in the evening regularly for 22 days stating on 5th day of menstruation, Then after an interval of 6 days start the next course.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 22,
              "max": 22
            },
            "notes": "stating on 5th day of menstruation"
          },
          {
            "type": "primaryFollowup",
            "Interval": {
              "unit": "day",
              "min": 6,
              "max": 6
            },
            "notes": "Then after an interval of 6 days start the next course."
          }
        ]
      }
    ]
  },
  {
    "serial": 303,
    "genericName": "Levonorgestrel 0.75 mg tab.",
    "doseList": [
      {
        "description": "1 Tablet within 72 hours after the event of unprotected intercourse and a second one 12 hours after the first.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "within 72 hours after the event of unprotected intercourse"
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "a second one 12 hours after the first"
          }
        ]
      }
    ]
  },
  {
    "serial": 304,
    "genericName": "Penicillin G",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in general infection",
        "description": "5 to 10 lac. Units (300-600mg) slow I.V or I.M 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac. Unit",
            "amount": {
              "min": 5,
              "max": 10
            },
            "volume": {
              "unit": "mg",
              "min": 300,
              "max": 600
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in Syphilis",
        "description": "in Syphilis, total dose should not be less than 50 lac units.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac. Unit",
            "amount": {
              "min": 50
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in gonorrhea",
        "description": "in gonorrhea, 5 lac. units 8 or 12 hourly daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac. Unit",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in gonorrhea",
        "description": "in gonorrhea, 5 lac. units 8 or 12 hourly daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac. Unit",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "ntrathecal Injection",
        "description": "10,000-20,000 units once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Unit",
            "amount": {
              "min": 10000,
              "max": 20000
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Meningitis",
        "description": "by slow I.V Injection or by Infusion 4,00,000 units/kg/day in 4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "units/kg/day",
            "amount": {
              "min": 400000,
              "max": 400000
            },
            "notes": "in 4 divided doses"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "up to 12 yrs. 10-12 mg/kg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neonate",
        "description": "Neonate, 30mg/kg daily in divided doses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 305,
    "genericName": "Penicillin V",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "250-500mg every 6 hours, at least 30 minutes before food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "up to 1 year 62.5mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1-5 years 125mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years 250mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 306,
    "genericName": "Benzathine penicillin",
    "doseList": [
      {
        "route": "Injection",
        "description": "2 Injection (12 lac) weekly or longer intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac",
            "amount": {
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Rheumatic fever",
        "description": "3 Rheumatic fever, 1 vial (12 lac) deep I.M. 4 weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "lac",
            "amount": {
              "min": 12,
              "max": 12
            },
            "repeated": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 306,
    "genericName": "Cloxacillin",
    "doseList": [
      {
        "route": "mouth",
        "description": "By mouth, 500mg 6 hourly, at least 30 minutes before food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By I.M. inj. 250mg 4-6 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By I.inj. 500mg-1gm every 4-6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 1000
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child- any route, ¼/-1/2 Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child- any route, ¼-1/2 Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child- any route, ¼-1/2 Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 307,
    "genericName": "Dicloxacillin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "weighing 40kg or more",
        "indication": "For mild-to moderate upper- respiratory and localized skin and soft-tissue infections due to sensitive organisms",
        "description": "Adults and Children weighing 40kg or more 250mg 6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "weighing 40kg or more",
        "indication": "For mild-to moderate upper- respiratory and localized skin and soft-tissue infections due to sensitive organisms",
        "description": "Adults and Children weighing 40kg or more 250mg 6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "weighing less than 40kg",
        "indication": "For mild-to moderate upper- respiratory and localized skin and soft-tissue infections due to sensitive organisms",
        "description": "Children weighing less than 40kg 12.5mg/kg/day 6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "weighing 40kg or more",
        "indication": "For more severe linections such as, lower respiratory tract of disseminated infections",
        "description": "Adult and Children weighing 40kg or more 500mg 6-hourly or higher.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "weighing 40kg or more",
        "indication": "For more severe linections such as, lower respiratory tract of disseminated infections",
        "description": "Adult and Children weighing 40kg or more 500mg 6-hourly or higher.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "weighing less than 40kg",
        "indication": "For mild-to moderate upper- respiratory and localized skin and soft-tissue infections due to sensitive organisms",
        "description": "Children weighing less than 40kg, 25mg/kg/day or higher in 6-hourly divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 308,
    "genericName": "Flucloxacillin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "250mg every 6 hours, at list 30 min before food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By I.M Injection, 250mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By I.V Injection or by Infusion, 0.25-1gm every 6 hours. Doses may be doubled in severe infections.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.25,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "notes": "Doses may be doubled in severe infections."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "any route, under 2 yrs. Quarter Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "any route, under 2 yrs. Quarter Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "any route, under 2 yrs. Quarter Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.0625,
              "max": 0.25
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "notes": "Doses may be doubled in severe infections."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 10
        },
        "description": "any route, under 2 yrs. Quarter Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 10
        },
        "description": "any route, under 2 yrs. Quarter Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 10
        },
        "description": "age 2-10 yrs. Half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.125,
              "max": 0.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "notes": "Doses may be doubled in severe infections."
          }
        ]
      }
    ]
  },
  {
    "serial": 309,
    "genericName": "Ampicillin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "250-500mg 6 hourly, 5-7 days or more (atleast 30 min before meal).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Gonorrhoea",
        "description": "Gonorrhoea, 2gm as a single dose with probenecid 1 gm.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "genericName": "probenecid",
              "quantity": {
                "unit": "gm",
                "min": 1,
                "max": 1
              }
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "UTI",
        "description": "UTI, 500mg every 8 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By I.M. or I.inj. 500mg 4-6 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "Higher doses in meningitis."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child, any route ½ Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            },
            "connectionToMeal": {
              "when": "before",
              "minute": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Gonorrhoea",
        "description": "Child, any route ½ Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "genericName": "probenecid",
              "quantity": {
                "unit": "gm",
                "min": 0.5,
                "max": 0.5
              }
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "UTI",
        "description": "UTI, 500mg every 8 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By I.M. or I.inj. 500mg 4-6 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "Higher doses in meningitis."
          }
        ]
      }
    ]
  },
  {
    "serial": 310,
    "genericName": "Amoxycillin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "250mg (or 500mg in severe infections) every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "in severe infections",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Up to 10 yrs. 1/2 Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "in severe infections",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "upto 2 yrs. ¼-1/2 Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "in severe infections",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Severe and recurrent purulent respiratory infection",
        "description": "Severe and recurrent purulent respiratory infection, 3 gm every 12 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "UTI",
        "description": "UTI, 3 gm stat and repeated after 10-12 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 10,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Gonorrhoea",
        "description": "Gonorrhoea, single dose of 3 gm with probenecid 1gm",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 3,
              "max": 3
            },
            "additionalItem": {
              "genericName": "probenecid",
              "quantity": {
                "unit": "gm",
                "min": 1,
                "max": 1
              }
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 10
        },
        "indication": "Otitis media",
        "description": "Otitis media, Child 3-10 years, 750mg 2 times daily for 2 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "description": "1gm every 6 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "ageGroup": "Child",
        "description": "Child, 50-100mg/kg. daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "in bacterial endocarditis",
        "description": "Single 3 gm dose one hour before dental procedure form which bacteraemia may arise; Repeat 6 hours later if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "in bacterial endocarditis",
        "description": "Child, 1/2 Adult dose. Repeat 6 hours later if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 311,
    "genericName": "Amoxy 875 tab.",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "adult",
        "indication": "same as Amoxycillin",
        "description": "The usual dose of amoxicillin 250mg or 500mg is 6 to 8 hourly; But, the dosage schedule of amoxicillin 875 is 12 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "amoxicillin 875",
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 312,
    "genericName": "Co-amoxiclav",
    "doseList": [
      {
        "route": "mouth",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult and Children over 12 years, the usual dose is amoxicillin 250mg (or co-amoxiclav 375mg)8 hourly taken with or before meals; for severe infections, amoxicillin 500mg (or co-amoxiclav 625mg) may be given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "connectionToMeal": {
              "when": "with or before meals"
            },
            "notes": "amoxicillin 250mg (or co-amoxiclav 375mg)"
          },
          {
            "type": "alternative",
            "condition": "for severe infections",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "notes": "amoxicillin 500mg (or co-amoxiclav 625mg)"
          }
        ]
      },
      {
        "route": "mouth",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "For Children below 12 years 5ml to 10ml of suspension 8 hourly according to age and severity of infection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "suspension 8 hourly according to age and severity of infection."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Amoxycillin 1 gm (or co-amoxiclav 1.2gm) 8 hourly by I.V Injection over 3-4 minutes or slowly by I.Infusion; in case of more serious infections, may  be given 6 hourly instead of 8 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "duration": {
              "unit": "minute",
              "min": 3,
              "max": 4
            },
            "notes": "Amoxycillin 1 gm (or co-amoxiclav 1.2gm"
          },
          {
            "type": "alternative",
            "condition": "in case of more serious infections",
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "nfants to age 3 months, amoxicillin 25mg/kg 8 hourly (or 12 hourly during perinatal period or in case of premature infants).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "during perinatal period or in case of premature infants",
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3,
          "max": 144
        },
        "description": "nfants to age 3 months, amoxicillin 25mg/kg 8 hourly (or 12 hourly during perinatal period or in case of premature infauts).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "condition": "in case of more serious infections",
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ],
        "notes": "in all cases, duration of treatment should be as that of amoxycilin therapy."
      }
    ]
  },
  {
    "serial": 313,
    "genericName": "Pivmecillinam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "U.T.I- acute cystitis",
        "description": "U.T.I- acute cystitis, initially 400mg then 200mg 6-8 hourly daily to a total of 2gms (i.e 3 days); In complicated UTusual treatment time is 1-2 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "a total of 2gms (i.e 3 days)"
          },
          {
            "type": "alternative",
            "condition": "in complicated UTI",
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Recurrent bacteriuria",
        "description": "Recurrent bacteriuria- 400 mg 6-8 hourly",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Salmonellosis",
        "description": "Salmonellosis- 1.2 to 2.4 gm daily for 14 days. All doses are taken with or immediately after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.2,
              "max": 2.4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "connectionToMeal": {
              "when": "with or immediately after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "UTI",
        "description": "UTI- Under 40kg, 20-40mg/kg daily in 6 or 8 hourly, divided doses; Over 40kg. same as Adult, usually for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 40kg",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "primary",
            "condition": "Over 40kg",
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "notes": "same as Adult"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Salmonellosis",
        "description": "Salmonellosis-  Under 40kg, 30-60mg/kg daily in 6 or 8 hourly, divided doses; Over 40kg. same as Adult, All for 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 40kg",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 60
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "primary",
            "condition": "Over 40kg",
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "notes": "same as Adult"
          }
        ]
      }
    ]
  },
  {
    "serial": 314,
    "genericName": "Cephalexin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "250-500 mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "25-50mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 315,
    "genericName": "Cefadroxil",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1gm per day in single or divided doses (b.i.d.)for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "30mg/kg/day in a single or in divided doses every 12 hours for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "indication": "Urinary tract infections",
        "description": "Urinary tract infections: for uncomplicated infections 1 or 2 gm per day in single or divided doses (B.i.d.); For all other UTIs 2gm pere day in divided doses (b.i.d)",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "for uncomplicated infections",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "For all other UTIs",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Urinary tract infections",
        "description": "30mg/kg/day in divided doses every 12 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "indication": "Skin & soft tissue infections",
        "description": "1gm per day in single or divided doses (b.i.d)",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "for uncomplicated infections",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Skin & soft tissue infections",
        "description": "30mg/kg/day in divided doses every 12 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 316,
    "genericName": "Cephradine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "250-500 mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "25-50mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "0.5-1 gm every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "50-100 mg/kg daily in 6 hourly divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 317,
    "genericName": "Cefaclor",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "250mg 8 hourly; in severe infections, double the dose, maximum 4 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "primary",
            "condition": "in severe infections",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "notes": "maximum 4 gm daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1
        },
        "description": "over 1 month 20mg/kg daily in 3 divided doses; insevere infections, double the dose maximum 1 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "in 3 divided doses"
          },
          {
            "type": "primary",
            "condition": "in severe infections",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "notes": "maximum 1 gm daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 12
        },
        "description": "1 month-1year, 62.5mg 8- hourly; 1-5 years, 125mg; Over 5 year, 250mg; In all cases doses doubled for severe infections.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "in all cases doses doubled for severe infections"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "1 month-1 year, 62.5mg 8- hourly; 1-5 years, 125mg; Over 5 year, 250mg; In all cases doses doubled for severe infections.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "notes": "in all cases doses may be doubled for severe infections"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "1 month-1 year, 62.5mg 8- hourly; 1-5 years, 125mg; Over 5 year, 250mg; In all cases doses doubled for severe infections.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "notes": "in all cases doses doubled for severe infections"
          }
        ]
      },
      {
        "indication": "Dosage schedule for 375mg CD/ER preparation",
        "description": "This CD (convenient dose)/ER (extended release) is considered as a suitable dose for the patients to be given over 12 hourly, if the concerned physician desires.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 318,
    "genericName": "Cefuroxime",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "250mg twice daily, doubled in bronchitis and pneumonia",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          },
          {
            "type": "primary",
            "condition": "in bronchitis and pneumonia",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "UTI, 125mg twice daily, doubled in pyelonephritis",
        "subDoseList": [
          {
            "type": "primary",
            "indication": "UTI",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            }
          },
          {
            "type": "primary",
            "condition": "pyelonephritis",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Gonorrhoea",
        "description": "Gonorrhoea, 1 gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "over 5 years, 125 mg twice daily, if necessary doubled in otitis media.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "f necessary doubled in otitis media."
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "ageGroup": "Adult",
        "description": "750 mg every 6-8 hours; 1.5gm every 6-8 hours in severe infections; single doses over 750 mg I.V route only.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "primary",
            "condition": "in severe infections",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ],
        "notes": "single doses over 750 mg I.V route only"
      },
      {
        "route": "Injection or Infusion",
        "ageGroup": "Child",
        "description": "30-100mg/kg daily in 3-4 divided doses (2-3 divided doses in neonates)Gonorrhoea, 1.5gm as a single dose by I.M. Injection (divided between 2 sites)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 100
            },
            "notes": "(2-3 divided doses in neonates)"
          },
          {
            "type": "primary",
            "condition": "Gonorrhoea",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "notes": "as a single dose by I.M. Injection (divided between 2 sites)"
          }
        ]
      },
      {
        "indication": "Surgical prophylaxis",
        "description": "1.5gm by I.V Injection at induction; may be supplemented with 750mg I.M. 8 & 16 hours later (abdominal, pelvic, and orthopaedic operations) or followed by 750mg I.M. every 8 hours",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            }
          },
          {
            "type": "supplementary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "notes": "8 & 16 hours later (abdominal, pelvic, and orthopaedic operations)"
          },
          {
            "type": "alternativeSupplementary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "200-240 mg/kg daily (in 3-4 divided doses) reduced to 100mg/kg daily after 3 days or on chinical improvement",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 200,
              "max": 240
            },
            "notes": "in 3-4 divided doses"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "notes": "after 3 days or on chinical improvement"
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "description": "100mg/kg daily reduced to 50mg/kg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 319,
    "genericName": "Cefdinir",
    "doseList": [
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "description": "The recommended total daily dose for all infections is 600mg. 600mg once daily dosing or 300mg twice-daily dosing for 10 days is equally effective in all cases.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "description": "The recommended total daily dose for all infections is 600mg. 600mg once daily dosing or 300mg twice-daily dosing for 10 days is equally effective in all cases.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Community acquired pneumonia",
        "description": "Community acquired pneumonia- 300mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Acute exacerbation of chronic bronchitis",
        "description": "Acute exacerbation of chronic bronchitis- 300mg 12 hourly for 5-10 days or 600mg once daily for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Acute maxillary sinusitis",
        "description": "Acute maxillary sinusitis- 300 mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Pharyngitis/tonsillitis",
        "description": "Pharyngitis/tonsillitis- 300mg 12 hourly for 5-10 days or 600mg once daily for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Uncomplicated skin and skin structure infections",
        "description": "Uncomplicated skin and skin structure infections- 300 mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Community acquired pneumonia",
        "description": "Community acquired pneumonia- 300mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Acute exacerbation of chronic bronchitis",
        "description": "Acute exacerbation of chronic bronchitis- 300mg 12 hourly for 5-10 days or 600mg once daily for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Acute maxillary sinusitis",
        "description": "Acute maxillary sinusitis- 300 mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Pharyngitis/tonsillitis",
        "description": "Pharyngitis/tonsillitis- 300mg 12 hourly for 5-10 days or 600mg once daily for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "indication": "Uncomplicated skin and skin structure infections",
        "description": "Uncomplicated skin and skin structure infections- 300 mg 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "indication": "Acute bacterial otitis media",
        "description": "Acute bacterial otitis media- 7mg/kg once daily for 10 days. Cefdinir may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7,
              "max": 7
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "indication": "Acute maxillary sinusitis",
        "description": "Acute maxillary sinusitis- 7mg/kg 12 hourly for 10 days or 14mg/kg once daily for 10 days. Cefdinir may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7,
              "max": 7
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 14,
              "max": 14
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "indication": "Pharyngitis/tonsillitis",
        "description": "Pharyngitis/tonsillitis- 7mg/kg 12 hourly for 5-10 days or 14mg/kg once daily for 10 days. Cefdinir may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7,
              "max": 7
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 14,
              "max": 14
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "indication": "Uncomplicated skin and skin structure infections",
        "description": "Uncomplicated skin and skin structure infections-7mg/kg 12 hourly for 10 days. Cefdinir may be taken without regard to meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7,
              "max": 7
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 320,
    "genericName": "Cefixime",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200-400mg daily according to the severity of infection, given either in a single or 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "notes": "given either in a single or 2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "description": "200-400mg daily according to the severity of infection, given either in a single or 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "notes": "given either in a single or 2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly patients may be Given the same dose as recommended for Adults. 200-400mg daily according to the severity of infection, given either in a single or 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "notes": "given either in a single or 2 divided doses"
          }
        ]
      },
      {
        "indication": "in severe Renal Impairment",
        "description": "Renal function should be assessed and dosage should be adjusted in severe Renal Impairment.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Renal function should be assessed and dosage should be adjusted in severe Renal Impairment."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "description": "Child over 6 months 8mg/kg daily in single or 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "notes": "daily in single or 2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "description": "As a general guide of dosage, may be given as following-6 months to 1 year 75mg daily; 1-4 years 100mg daily; 5-10years 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 4
        },
        "description": "As a general guide of dosage, may be given as following-6 months to 1 year 75mg daily; 1-4 years 100mg daily; 5-10years 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "description": "As a general guide of dosage, may be given as following-6 months to 1 year 75mg daily; 1-4 years 100mg daily; 5-10years 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "typhoid",
        "description": "in typhoid dosage should be 10mg/kg/day for 14 days. The usual course of treatment is 7 days. This may be continued for up to 14 days as in typhoid or in any sever infection if the physicians desire.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 10,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "notes": "The usual course of treatment is 7 days. This may be continued for up to 14 days as in typhoid or in any sever infection if the physicians desire."
          }
        ]
      }
    ]
  },
  {
    "serial": 321,
    "genericName": "Cefotaxime",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in mild to moderate infection",
        "description": "in mild to moderate infection, 1 gm every 12 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in severe infection",
        "description": "in severe infection dosage may be increased up to 12 gm  daily divining 3 or 4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "max": 12
            },
            "notes": "daily divining 3 or 4 divided doses."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "The usual dosage range is 100-150mg/kg/day in 2 to 4 divided doses; in very severe infections dosage of upto 200mg/kg/day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 100,
              "max": 150
            },
            "notes": "in 2 to 4 divided doses."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "in very severe infections",
        "description": "The usual dosage range is 100-150mg/kg/day in 2 to 4 divided doses; in very severe infections dosage of upto 200mg/kg/day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "description": "The recommended dosage is 50mg/kg/day in 2 to 4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 50,
              "max": 50
            },
            "notes": "in 2 to 4 divided doses"
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "indication": "in very severe infections",
        "description": "in severe infections 150-200mg/kg/day in divided doses may be given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 150,
              "max": 200
            },
            "notes": "in divided doses may be given."
          }
        ]
      }
    ]
  },
  {
    "serial": 322,
    "genericName": "Cefpodoxime",
    "doseList": [
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Acute community",
        "secondaryIndication": "acquired pneumonia",
        "description": "Acute community- acquired pneumonia-200mg 12 hourly for 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Acute bacteria exacerbation of chronic bronchitis",
        "description": "Acute bacteria exacerbation of chronic bronchitis-200mg 12 hourly for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Uncomplicated gonorrhea (men/women)",
        "description": "Uncomplicated gonorrhea (men/women)-200mg single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Rectal gonococcal infection in women",
        "description": "Rectal gonococcal infection in women- 200mg single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Skin & soft tissue infection",
        "description": "Skin & soft tissue infection- 400mg 12 hourly for 7 to 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Pharyngitis and/or Tonsillitis",
        "description": "Pharyngitis and/or Tonsillitis- 100mg 12 hourly for 5 to 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Uncomplicated urinary tract infection",
        "description": "Uncomplicated urinary tract infection- 100mg 12 hourly for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "indication": "Acute maxillary sinusitis",
        "description": "Acute maxillary sinusitis-  200mg 12 hourly for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 0.5,
          "max": 6
        },
        "description": "15 days- 6 months, 4mg/kg every 12 hours; 6 months – 2 years, 40mg every 12 hours; 3-8 years, 80mg every 12 hours; Over 9 years 100mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 2
        },
        "description": "15 days- 6 months, 4mg/kg every 12 hours; 6 months – 2 years, 40mg every 12 hours; 3-8 years, 80mg every 12 hours; Over 9 years 100mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 8
        },
        "description": "15 days- 6 months, 4mg/kg every 12 hours; 6 months – 2 years, 40mg every 12 hours; 3-8 years, 80mg every 12 hours; Over 9 years 100mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9
        },
        "description": "15 days- 6 months, 4mg/kg every 12 hours; 6 months – 2 years, 40mg every 12 hours; 3-8 years, 80mg every 12 hours; Over 9 years 100mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 323,
    "genericName": "Ceftazidime",
    "doseList": [
      {
        "route": "Injecton or Infusion",
        "description": "1gm every 8 hours or 2 gm every 12 hours; 2 gm every 8-12 hours in severe infections; Single doses over 1gm intravenous route only; Elderly usual maximum 3gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "alternative",
            "condition": "in severe infections",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ],
        "notes": "Single doses over 1gm intravenous route only; Elderly usual maximum 3gm daily"
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 2
        },
        "description": "Up to 2 months 25-60mg/kg daily in 2 divided doses, over 2months 30-100 mg/kg daily in 2-3 divided doses; Upto 150mg/kg daily if immune compromised or meningitis; Intravenous route recommended for Children. Urinary tract and less serious infections, 0.5-1gm every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 60
            },
            "notes": "daily in 2 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 2
        },
        "description": "Up to 2 months 25-60mg/kg daily in 2 divided doses, over 2 months 30-100 mg/kg daily in 2-3 divided doses; Upto 150mg/kg daily if immune compromised or meningitis; Intravenous route recommended for Children. Urinary tract and less serious infections, 0.5-1gm every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 10
            },
            "notes": "daily in 2-3 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "If immune compromised or meningitis",
        "description": "Up to 2 months 25-60mg/kg daily in 2 divided doses, over 2months 30-100 mg/kg daily in 2-3 divided doses; Upto 150mg/kg daily if immune compromised or meningitis; Intravenous route recommended for Children. Urinary tract and less serious infections, 0.5-1gm every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "max": 150
            },
            "notes": "daily in 2-3 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Urinary tract and less serious infections",
        "description": "Up to 2 months 25-60mg/kg daily in 2 divided doses, over 2months 30-100 mg/kg daily in 2-3 divided doses; Upto 150mg/kg daily if immune compromised or meningitis; Intravenous route recommended for Children. Urinary tract and less serious infections, 0.5-1gm every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "indication": "Pseudomonal lung infection in cystic fibrosis",
        "secondaryIndication": "Adult with normal renal function",
        "description": "Adult with normal renal function 100-150mg/kg daily; In 3 divided doses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 150
            },
            "notes": "in 3 divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Pseudomonal lung infection in cystic fibrosis",
        "description": "Child up to 150mg/kg daily; Intravenous route recommended for Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "max": 150
            },
            "notes": "in 3 divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 324,
    "genericName": "Ceftibuten",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Child over 10 years (over 45kg), 400mg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10
        },
        "description": "Adult and Child over 10 years (over 45kg), 400mg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "over 45 kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5
        },
        "description": "Child over 6 months, as oral suspension, 9mg/kg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 9,
              "max": 9
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 325,
    "genericName": "Ceftriaxone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Usual dosage for Adults and Children over 12 yrs, 1-2 gm once daily (every 24 ours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Usual dosage for Adults and Children over 12 yrs, 1-2 gm once daily (every 24 ours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "ageRange": {
          "unit": "week",
          "max": 2
        },
        "description": "Neonates (up to 2 weeks), 20-50mg/kg daily (onces daily), not to exceed 50mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "not to exceed 50mg/kg."
          }
        ]
      },
      {
        "ageGroup": "infant",
        "ageRange": {
          "unit": "week",
          "min": 3
        },
        "description": "a daily dose of 20-80mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 80
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "ageGroup": "infant",
        "ageRange": {
          "unit": "week",
          "min": 3
        },
        "description": ".doses of 50mg or more per kg should be given by Infusion over at least 30mins.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "indication": "Meningitis",
        "secondaryIndication": "N. meningitides",
        "description": "Meningitis: infants and Children-Treatment begins with dose ojf 100mg/kg (not to exceed 4gm.) once daily. The best result have been found with be following duration of therapy- N. meningitides-4 days. H. influenza-6 days. S. pneumoniae-7 days. Enterobacteriaceae-10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "day",
              "min": 4,
              "max": 4
            },
            "notes": "not to exceed 4gm"
          }
        ]
      },
      {
        "ageGroup": "infant",
        "indication": "Meningitis",
        "secondaryIndication": "H. influenza",
        "description": "Meningitis: infants and Children-Treatment begins with dose ojf 100mg/kg (not to exceed 4gm.) once daily. The best result have been found with be following duration of therapy- N. meningitides-4 days. H. influenza-6 days. S. pneumoniae-7 days. Enterobacteriaceae-10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "day",
              "min": 6,
              "max": 6
            },
            "notes": "not to exceed 4gm"
          }
        ]
      },
      {
        "ageGroup": "infant",
        "indication": "Meningitis",
        "secondaryIndication": "S. pneumoniae",
        "description": "Meningitis: infants and Children-Treatment begins with dose ojf 100mg/kg (not to exceed 4gm.) once daily. The best result have been found with be following duration of therapy- N. meningitides-4 days. H. influenza-6 days. S. pneumoniae-7 days. Enterobacteriaceae-10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "day",
              "min": 7,
              "max": 7
            },
            "notes": "not to exceed 4gm"
          }
        ]
      },
      {
        "ageGroup": "infant",
        "indication": "Meningitis",
        "secondaryIndication": "Enterobacteriaceae",
        "description": "Meningitis: infants and Children-Treatment begins with dose ojf 100mg/kg (not to exceed 4gm.) once daily. The best result have been found with be following duration of therapy- N. meningitides-4 days. H. influenza-6 days. S. pneumoniae-7 days. Enterobacteriaceae-10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "day",
              "min": 10,
              "max": 14
            },
            "notes": "not to exceed 4gm"
          }
        ]
      }
    ]
  },
  {
    "serial": 326,
    "genericName": "Cefepime",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Moderate to severe pneumonia",
        "description": "Moderate to severe pneumonia- 1gm to 2 gm I.V 12 hourly for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Mild to moderate uncomplicated or complicated urinary tract infections",
        "description": "Mild to moderate uncomplicated or complicated urinary tract infections – 0.5gm to 1 gm I.V or I.M 12 hourly for 7-10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Complicated intra-abdominal infections",
        "description": "Complicated intra-abdominal infections- 2gm I.V 12 hourly for 7-10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Empiric therapy for febrile neutropenic patients",
        "description": "Empiric therapy for febrile neutropenic patients- 2 gm I.V 12  hourly for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 192
        },
        "condition": "in weight up to 40kg",
        "indication": "Pneumonia",
        "description": "The maximum dose for peadiatric patients should not exceed the recommended Adult dose. Pneumonia- 50mg/kg I.Vor I.M 12 hourly for 10 day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 192
        },
        "condition": "in weight up to 40kg",
        "indication": "Bacterial meningitis",
        "description": "Bacterial meningitis- 50mg/kg I.V or I.M 8 hourly for 7-10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 192
        },
        "condition": "in weight up to 40kg",
        "indication": "Uncomplicated or complicated urinary tract infections (including pyelonephritis)",
        "description": "Uncomplicated or complicated urinary tract infections (including pyelonephritis)- 50mg/kg I.V or I.M 12 hourly for 7-10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 192
        },
        "condition": "in weight up to 40kg",
        "indication": "Uncomplicated skin structure infections",
        "description": "Uncomplicated skin structure infections- 50mg/kg I.V or I.M 12 hourly for 10 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 192
        },
        "condition": "in weight up to 40kg",
        "indication": "Febrile neutropenic patients",
        "description": "Febrile neutropenic patients- 50mg/kg I.V or I.M 8 hourly for 7 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 327,
    "genericName": "Cefpirome",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for moderate to severe infections in Adult patients with normal renal function",
        "secondaryIndication": "Complicated upper & lower urinary tract infections",
        "description": "Complicated upper & lower urinary tract infections- 1gm 12 hourly twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for moderate to severe infections in Adult patients with normal renal function",
        "secondaryIndication": "Skin & soft tissue infections",
        "description": "Skin & soft tissue infections-1gm 12 hourly twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for moderate to severe infections in Adult patients with normal renal function",
        "secondaryIndication": "3.  Lower respiratory tract infections",
        "description": "3.  Lower respiratory tract infections- 1 to 2 gm 12 hourly twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for moderate to severe infections in Adult patients with normal renal function",
        "secondaryIndication": "Bacteremia/septicemia and sever infections",
        "description": "Bacteremia/septicemia and sever infections-2gm 12 hourly twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for moderate to severe infections in Adult patients with normal renal function",
        "secondaryIndication": "Infections in neutropenic patients",
        "description": "Infections in neutropenic patients-2gm 12 hourly twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 328,
    "genericName": "Aztreonam",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "1gm every 8 hours or 2gm every 12 hours; Single doses over 1 gm I.V route only.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "severe infections (including systemic pseudomonas aeruginosa and lung infections in cystic fibrosis)",
        "description": "2 gm every 6-8 hours for severe infections (including systemic pseudomonas aeruginosa and lung infections in cystic fibrosis); Single doses over 1 gm I.V route only.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "week",
          "min": 1
        },
        "description": "over 1 week, by I.V Injection or Infusion, 30mg/kg every 6-8 hours; maximum 8gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "maximum 8gm daily"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Urinary-tract infections",
        "description": "Urinary-tract infections, 0.5-1gm every 8-12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Gonorrhoea/cystisis",
        "description": "Gonorrhoea/cystisis, by I.M Injection, 1gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 329,
    "genericName": "Meropenem",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "500mg I.V every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Nosocomial pneumonias, peritonitis, presumed infections in neutropenic patients and septicaemia",
        "description": "Nosocomial pneumonias, peritonitis, presumed infections in neutropenic patients and septicaemia-1gm I.V every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Renal impairment",
        "description": "dosage should be reduced in patients with creatinine clearance less than 51ml/min. Creatinine clearance (ml/min) 26-50, Dose (based on unit doses of 500mg, 1gm, 2 gm) One unit dose, Frequency Every 12 Hours. Creatinine clearance (ml/min) 10-25, Dose (based on unit doses of 500mg, 1gm, 2 gm) One-half unit dose, Frequency Every 12 Hours. Creatinine clearance (ml/min) <10, Dose (based on unit doses of 500mg, 1gm, 2 gm) One-half unit dose, Frequency Every 12 Hours",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Creatinine clearance (ml/min) 26-50",
            "unit": "unit",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "primary",
            "condition": "Creatinine clearance (ml/min) 10-25",
            "unit": "unit",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "primary",
            "condition": "Creatinine clearance (ml/min) <10",
            "unit": "unit",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 0,
          "max": 3
        },
        "description": "0-3 months- not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.25,
          "max": 12
        },
        "description": "3 months-12 years - 10-20mg/kg I.V every 8 hours depending on type and severity of infection, susceptibility of the pathogens and the condition of the patient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "condition": "Children over 50kg weight",
        "description": "Children over 50kg weight- Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Children over 50kg weight- Adult dose."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Meningitis",
        "description": "Meningitis-40mg/kg I.V every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 330,
    "genericName": "Tetracycline",
    "doseList": [
      {
        "route": "mouth",
        "description": "By mouth, 250-500mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "I.M. Injection",
        "description": "By I.M. inj, 100-200mg every 6-8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "description": "By I.V. Infusion, 500mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "indication": "Early syphilis",
        "description": "Early syphilis, 500mg every 6 hours for 15 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "indication": "Non-gonococcal urethritis",
        "description": "Non-gonococcal gonococcal urethritis, 500mg every 6 hours for 7-21 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 21
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 331,
    "genericName": "Oxytetracycline",
    "doseList": [
      {
        "route": "mouth",
        "description": "250-500 mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "description": "100mg every 8-12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "description": "250-500mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 332,
    "genericName": "Doxycycline",
    "doseList": [
      {
        "description": "200mg on 1st day, then 100mg (1 cap) daily (twice in severe infections including chronic UTI).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on 1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "condition": "in severe infections including chronic UTI",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Acne",
        "description": "Acne, 50mg daily for 6-12 weeks or longer.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 333,
    "genericName": "Amikacin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "15mg/kg/day in two equally divided doses (equivalent to 500mg bid in Adults).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "in two equally divided doses (equivalent to 500mg bid in Adults)."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "15mg/kg/day in two equally divided doses (equivalent to 500mg bid in Adults). Use of the 100mg/2ml strength is recommended for Children for the accurate measurement of the appropriate dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "Use of the 100mg/2ml strength is recommended for Children for the accurate measurement of the appropriate dose."
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "condition": "Neonates & premature Children",
        "description": "An initial loading dose of 10mg/kg followed b 15mg/kg/day in two equally divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg/day",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "condition": "Neonates & premature Children",
        "indication": "Mild impairment",
        "description": "500mg every 18 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 18,
              "max": 18
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "condition": "Neonates & premature Children",
        "indication": "Moderate impairment",
        "description": "500mg every 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "condition": "Neonates & premature Children",
        "indication": "Severe impairment",
        "description": "250mg every 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 334,
    "genericName": "Gentamicin",
    "doseList": [
      {
        "route": "Injection or Infusion",
        "description": "5mg/kg daily in divided doses at 6 or 8 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "Other systemic infections",
        "description": "Other systemic infections 2-5mg daily at divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "in Renal Impairment",
        "description": "in Renal Impairment the interval between successive doses shoud be increased to 12 hours when creatinine clearance is 30-70 ml/minimum 24 hours for 10-30ml/minimum 48 hours for 5-10ml/minimum 3-4 days after dailysis for less than 5 ml/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "creatinine clearance is 30-70 ml/min",
            "Interval": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "primary",
            "condition": "creatinine clearance is 10-30ml/min",
            "Interval": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          },
          {
            "type": "primary",
            "condition": "creatinine clearance is 5-10ml/min",
            "Interval": {
              "unit": "hour",
              "min": 48,
              "max": 48
            }
          },
          {
            "type": "primary",
            "condition": "creatinine clearance is less than 5 ml/min",
            "Interval": {
              "unit": "day",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "Gonorrhoea",
        "description": "240 mg as a single dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 240,
              "max": 240
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "week",
          "max": 2
        },
        "indication": "Gonorrhoea",
        "description": "up to 2 wks. 3 mg/kg 12 hourly; 2 wks to 12 yrs, 2 mg/kg every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "week",
          "min": 2
        },
        "indication": "Gonorrhoea",
        "description": "up to 2 wks. 3 mg/kg 12 hourly; 2 wks to 12 yrs, 2 mg/kg every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "ntrathecal Injection",
        "description": "1 mg daily, with 2-4 mg/kg daily by I.M Injection n divided doses every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "notes": "with 2-4 mg/kg daily by I.M Injection"
          }
        ]
      }
    ]
  },
  {
    "serial": 335,
    "genericName": "Netilmicin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By I.M Injection or by I.V Injection over 3-5 minutes or by Infusion, 4-6 mg/kg daily, as a single daily dose or in divided doses every 8 or 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 4,
              "max": 6
            },
            "duration": {
              "unit": "minute",
              "min": 3,
              "max": 5
            },
            "notes": "as a single daily dose or in divided doses every 8 or 12 hours"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in severe infections",
        "description": "in severe infections, up to 7.5 mg/kg daily in dvided doses every 8 hours (reduced as soon as clinically indicated, usually within 48 hours)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "max": 7.5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "reduced as soon as clinically indicated, usually within 48 hours"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "infant",
        "ageRange": {
          "unit": "week",
          "min": 1
        },
        "description": "nfant over 1 week, 3 mg/kg every 1 week 2.5-3mg/kg every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 2.5,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "2-2.5mg/kg every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2.5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Urinary-Tract infection",
        "description": "Urinary-Tract infection, 150mg as a single daily dose for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Gonorrhoea",
        "description": "Gonorrhoea, 300mg as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 336,
    "genericName": "Tobramycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3mg/kg/day; in serious cases 4-5mg/kg/day, then in improvement 3mg/kg/day, I.M or I.in 3 divided dose for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "condition": "in serious cases",
            "unit": "mg/kg/day",
            "amount": {
              "min": 4,
              "max": 5
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg/day",
            "amount": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "3-5 mg/kg/day in 3 divided doses for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 3,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            },
            "notes": "in 3 divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 337,
    "genericName": "Erythromycin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult: 250-500mg every 6 hours; serious infections, upto 4 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "alternative",
            "condition": "serious infections",
            "unit": "gm",
            "amount": {
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Child: Upto 2 years 125mg every 6 hours, 2-8 years 250mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 8
        },
        "description": "Child: Upto 2 years 125mg every 6 hours, 2-8 years 250mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Acne",
        "description": "Acne, 250mg twice daily; maintenance 250mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Adult- 100mg every 4 to 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child- 25-50 mg/kg body-wt. I.M or I.daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 338,
    "genericName": "Azithromycin",
    "doseList": [
      {
        "description": "500mg once daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "description": "Child, over 6 months 10mg/kg once daily for 3 days; Or body-weight 15-25kg, 200mg once daily for 3 days; Body-weight 26-35kg, 300mg once daily for 3 days. Genital chiamydial infections, 1 gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "condition": "body-weight 15-25kg",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "condition": "Body-weight 26-35kg",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "condition": "Genital chiamydial infections",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 339,
    "genericName": "Clarithromycin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult- 250 mg every 12 hours for 7 days, increased in severe infections to 500mg every 12 hours for up to 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased in severe infections",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child- Body weight under 8kg, 7.5mg/kg twice daily; 8-11 kg (1-2 years), 62.5mg twice daily; 12-19 kg (3-6 years), 125mg twice daily; 20-29 kg (7-9 years), 187.5 mg twice daily; 30-40kg (10-12 years), 250mg twice daily;",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Body weight under 8kg",
            "unit": "mg/kg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "description": "Child- Body weight under 8kg, 7.5mg/kg twice daily; 8-11 kg (1-2 years), 62.5mg twice daily; 12-19 kg (3-6 years), 125mg twice daily; 20-29 kg (7-9 years), 187.5 mg twice daily; 30-40kg (10-12 years), 250mg twice daily;",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Body weight 8-11 kg",
            "unit": "mg/kg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 6
        },
        "description": "Child- Body weight under 8kg, 7.5mg/kg twice daily; 8-11 kg (1-2 years), 62.5mg twice daily; 12-19 kg (3-6 years), 125mg twice daily; 20-29 kg (7-9 years), 187.5 mg twice daily; 30-40kg (10-12 years), 250mg twice daily;",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Body weight 12-19 kg",
            "unit": "mg/kg",
            "amount": {
              "min": 125,
              "max": 125
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 9
        },
        "description": "Child- Body weight under 8kg, 7.5mg/kg twice daily; 8-11 kg (1-2 years), 62.5mg twice daily; 12-19 kg (3-6 years), 125mg twice daily; 20-29 kg (7-9 years), 187.5 mg twice daily; 30-40kg (10-12 years), 250mg twice daily;",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Body weight 20-29 kg",
            "unit": "mg/kg",
            "amount": {
              "min": 187.5,
              "max": 187.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 10,
          "max": 12
        },
        "description": "Child- Body weight under 8kg, 7.5mg/kg twice daily; 8-11 kg (1-2 years), 62.5mg twice daily; 12-19 kg (3-6 years), 125mg twice daily; 20-29 kg (7-9 years), 187.5 mg twice daily; 30-40kg (10-12 years), 250mg twice daily;",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Body weight 30-40 kg",
            "unit": "mg/kg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 340,
    "genericName": "Roxithromycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "300mg once daily or 150mg twice daily for at least two days after resolution of symptoms; A normal course of therapy is between 5 and 10 days. In severe  Hepatic impairment the dose is 150mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "condition": "in severe Hepatic impairment",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ],
        "notes": "A normal course of therapy is between 5 and 10 days."
      },
      {
        "ageGroup": "Child",
        "description": "2.5-5 mg/kg body weight twice a day. The following general guidelines can he followed- 6-11kg, 25mg 12 hourly; 12-23kg, 50mg 12 hourly; 24-40kg, 100mg 12 hourly; A  normal course of therapy is between 5 and 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "6-11kg",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "12-23kg",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "24-40kg",
            "unit": "mg/kg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 341,
    "genericName": "Spiramycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "6 to9 MIU/day to be divided in 2 or 3 doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "MIU/day",
            "amount": {
              "min": 6,
              "max": 9
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- weight more than 20kg, 1.5 MIU per 10kg of body weight per day, to be divided in 2 or 3 doses.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "weight more than 20kg",
            "unit": "MIU/10kg/day",
            "amount": {
              "min": 1.5,
              "max": 1.5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis of meningococcal meningitis",
        "description": "Adult, 3 MIU/12 hours for 5 days",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "weight more than 20kg",
            "unit": "MIU/12hour",
            "amount": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Prophylaxis of meningococcal meningitis",
        "description": "Children, 75,000 IU/12 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "weight more than 20kg",
            "unit": "U/12hour",
            "amount": {
              "min": 75000,
              "max": 75000
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 342,
    "genericName": "Dalacin C Cap.",
    "doseList": [
      {
        "route": "mouth",
        "indication": "patients weigh serious infections",
        "description": "By mouth: The usual Adult dosage for patients weigh serious infections is 150-300mg every 6 hours. For more severe infections 300-450mg every 6 hours is advised.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "For more severe infections",
        "description": "By mouth: The usual Adult dosage for patients weigh serious infections is 150-300mg every 6 hours. For more severe infections 300-450mg every 6 hours is advised.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 450
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "For acute pharyngitis/tonsillitis",
        "description": "For acute pharyngitis/tonsillitis, the recommended dosage is 300mg every 12 hours for 10 days. To avoid the possibility of esophageal irritation, capsules should be taken with a full glass of water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "notes": "To avoid the possibility of esophageal irritation, capsules should be taken with a full glass of water."
          }
        ]
      }
    ]
  },
  {
    "serial": 343,
    "genericName": "Dalacin Inj.",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "for infections of the intra-abdominal area, female pelvis and other complicated or serious infections",
        "description": "The usual Adult daily dosage for infections of the intra-abdominal area, female pelvis and other complicated or serious infections is 2400-2700mg/day given divided in 2,3 or 4 equal doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 2400,
              "max": 2700
            },
            "notes": "given divided in 2,3 or 4 equal doses."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Less complicated infections due to more susceptible microorganisms",
        "description": "Less complicated infections due to more susceptible microorganisms may respond to lower doses such as 1200mg/day given divided in 3 or 4 equal doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 1200,
              "max": 2700
            },
            "notes": "divided in 3 or 4 equal doses"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1
        },
        "description": "Over 1 month of age, The dosage is 20-40mg/kg/day divided in 3 or 4 equal dose. Single intramuscular doses of greater than 600mg are not recommended. The concentration of clindamycin in diluents fo r Infusion should not exceed 18mg per ml and Infusion rates should not exceed  30mg per minute. Administration of more than 1200mg in a single Infusion is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 20,
              "max": 40
            },
            "notes": "divided in 3 or 4 equal dose."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neonate",
        "ageRange": {
          "unit": "month",
          "max": 1
        },
        "description": "in neonates (under 1 month of age), the dose is 15-20mg/kg/day divided in 2,3 or 4 equal doses. Single intramuscular doses of greater than 600mg are not recommended. The concentration of clindamycin in diluents fo r Infusion should not exceed 18mg per ml and Infusion rates should not exceed  30mg per minute. Administration of more than 1200mg in a single Infusion is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 15,
              "max": 20
            },
            "notes": "divided in 2,3 or 4 equal doses."
          }
        ]
      }
    ]
  },
  {
    "serial": 344,
    "genericName": "Chloramphenicol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult- 250-500mg every 6 hours, Or 50 mg/kg/day in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "alternative",
            "unit": "mg/kg/day",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By I.V or I.M Injection, 1gm every 6-8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Pyogenic meningitis",
        "description": "Child, Pyogenic meningitis, 50-100mg/kg daily in divided doses every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neoborn",
        "description": "Neoborn & Premature infants,25mg/kg body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Premature infants",
        "description": "Neoborn & Premature infants,25mg/kg body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 345,
    "genericName": "Fusidic acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: 500 every 8 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Use suspension",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Use suspension"
          }
        ]
      }
    ]
  },
  {
    "serial": 346,
    "genericName": "Linezolid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "",
        "description": "The usual Adult dose of linezolid is 400-600mg 12 hourly regardless of meals for 7-28 days depending on the type and severity of the infection and the patients clinical response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 600
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 28
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Vancomycin-resistant enterococcus faecium infection including concurrent bacteremia",
        "description": "Vancomycin-resistant enterococcus faecium infection including concurrent bacteremia: 600mg 12 hourly for 14 to 28 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 28
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Uncomplicated skin and skin structure infection",
        "description": "Uncomplicated skin and skin structure infection: 400mg 12 hourly for 10 to 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 14
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly Patients: No dose adjustment is required for elderly patients.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "No dose adjustment is required for elderly patients."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: Studies using doses higher than 10mg/kg/days every 12 have not been conducted in peadiatric patients. Not studied in infants below 3 months of age.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "Children: Studies using doses higher than 10mg/kg/days every 12 have not been conducted in peadiatric patients. Not studied in infants below 3 months of age.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 347,
    "genericName": "Spectinomycin",
    "doseList": [
      {
        "condition": "male",
        "description": "Male- Single 2 gm dose (5ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "condition": "female",
        "description": "Female- single 4 gm dose (10mg) I.M deep in the buttock.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: Not recommended; But, if no alternative, 40mg/kg over 2 years of age.",
        "subDoseList": [
          {
            "type": "primary",
            "notRecommended": true
          },
          {
            "type": "alternative",
            "condition": "f no alternative, over 2 years of age.",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 40
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 348,
    "genericName": "Vancomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The usual I.dose is 500mg for every 6 hours or 1 gm every 12 hours. A 500mg dose of vancomycin should be infused over a period of at least 50minutes, whereas a 1 gm dose should be administered over a period of at least 2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "duration": {
              "unit": "minute",
              "min": 50
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "hour",
              "min": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "The paediatric dosage of vancomycin is calculated on the basis of 10mg/kg body weight every 6 hours after an initial loading dose of 15mg/kg. Each dose should be administered over a period of at least 60 minutes.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15
            },
            "duration": {
              "unit": "minute",
              "min": 60
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "nfants & Neonates: In neonates and young infants, the total daily I.dosage may be lower. An initial dose of 15mg/kg is suggested, followed by 10mg/kg every eight hours there-after until one month of age.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "notes": "until one month of age."
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "description": "nfants & Neonates: In neonates and young infants, the total daily I.dosage may be lower. An initial dose of 15mg/kg is suggested, followed by 10mg/kg every eight hours there-after until one month of age.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "notes": "until one month of age."
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "pseudomembranous colitis produced by C. difficile",
        "description": "Oral administration: The usual Adult total daily dosage for antibiotic associated pseudomembranous colitis produced by C. difficile is 500mg to 2 gm given in 3 or 4 divided doses for 7 to 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 2000
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "pseudomembranous colitis produced by C. difficile",
        "description": "The total daily dosage in Children is 40mg/kg body-weight in 3 or 4 divided doses. The total daily dosage should not exceed 2gm.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 40
            },
            "notes": "The total daily dosage should not exceed 2gm."
          }
        ]
      }
    ]
  },
  {
    "serial": 349,
    "genericName": "Sulphadiazine",
    "doseList": [
      {
        "route": "deep I.M inj. Or I.Infusion",
        "description": "By deep I.M inj. Or I.V. Infusion, 2gm initially then 1 gm every 6 hours for 2 days, followed by oral treatment for a further 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "condition": "oral treatment",
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "condition": "f Injection is to available",
        "description": "f Injection is to available, By mouth, 2gm (4 tab) on the first time there after 1 gm (2 tab) 4-6 hourly for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            },
            "volume": {
              "unit": "gm",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "gm",
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 350,
    "genericName": "Suphadimidine",
    "doseList": [
      {
        "route": "mouth",
        "description": "Initially 2 gm (4 Tablet) then 4 gm daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "2gm initially, then 0.5-1 gm every 6-8 hours. .",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 351,
    "genericName": "Sulphasalazine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 Tablet 4 times daily; Maintenance, 4 Tablet Daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Rheumatoid arthritis",
        "description": "Initially 1 tab. Daily for one week increasing by one each week to maximum 6 daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "max": 4
            },
            "notes": "ncreasing by one each week to maximum 6"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Child:Under 2 years not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Over 2 years 40-60mg/kg daily; Maintenance, 20-30 mg/kg. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 60
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 352,
    "genericName": "Co-trimoxazole",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "960mg(2 tab or 20ml) twice daily (12 hourly).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 960,
              "max": 960
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "week",
          "max": 6
        },
        "description": "Under 6 wks. Not recommended; 6 wks. To 5 months, 120mg (2.5ml); 6 months to 5 yrs. 240mg (5ml); 6 yrs. To 12 yrs. 480mg (10ml), all twice daily.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 1.5,
          "min": 5
        },
        "description": "Under 6 wks. Not recommended; 6 wks. To 5 months, 120mg (2.5ml); 6 months to 5 yrs. 240mg (5ml); 6 yrs. To 12 yrs. 480mg (10ml), all twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "volume": {
              "unit": "ml",
              "min": 2.5,
              "max": 2.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 0.5,
          "min": 5
        },
        "description": "Under 6 wks. Not recommended; 6 wks. To 5 months, 120mg (2.5ml); 6 months to 5 yrs. 240mg (5ml); 6 yrs. To 12 yrs. 480mg (10ml), all twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 480,
              "max": 480
            },
            "volume": {
              "unit": "ml",
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "I.M Injection or I.Infusion",
        "ageGroup": "Child",
        "description": "By I.M Injection or I.V. Infusion, 960 mg every 12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 960,
              "max": 960
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 353,
    "genericName": "Ciprofloxacin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Urinary tract infections",
        "description": "Urinary tract infections: Mild to moderate infection, 250mg every 12 hours; complicated infections, caused by organisms not highly susceptible to drug, 500mg every12 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Mild to moderate infection",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "primary",
            "condition": "complicated infections, caused by organisms not highly susceptible to drug",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "nfectious Diarrhoea",
        "description": "nfectious Diarrhoea: 500mg every 12 hrs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Lower respiratory tract, skin & soft tissue, bone & joint infections",
        "description": "Lower respiratory tract, skin & soft tissue, bone & joint infections: in mild to moderate infections in all cases, usual dosage is 500mg every 12 hours; a dosage of 750mg every 12 hours may be needed, specially in bone and joint infections or when infections are severe or complicated.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in mild to moderate infections in all cases",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          },
          {
            "type": "primary",
            "condition": "in bone and joint infections or when infections are severe or complicated.",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Gonorrhoea",
        "description": "nfectious Diarrhoea: 500mg every 12 hrs.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "possible coexisting Chlamydia infection",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "primary",
            "condition": "in the treatment of chancroid",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Surgical prophylaxis",
        "description": "Surgical prophylaxis: A single dose of ciprofloxacin 750mg is given 60-90 minutes before the procedure.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "possible coexisting Chlamydia infection",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "notes": "given 60-90 minutes before the procedure"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Nor recommended but where benefit outweighs risk, by mouth 7.5-15mg/kg daily in 2 divided dose.",
        "subDoseList": [
          {
            "type": "primary",
            "notRecommended": true
          },
          {
            "type": "alternative",
            "condition": "where benefit outweighs risk",
            "unit": "mg/kg",
            "amount": {
              "min": 7.5,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "condition": "Dosage of XR Tablets",
        "indication": "in patients with complicated urinary tract infections and acute uncomplicated pyelonephritis, who have a creatinine clearance of <30ml/min",
        "description": "in patients with complicated urinary tract infections and acute uncomplicated pyelonephritis, who have a creatinine clearance of <30ml/min , ciprofloxacin XR 500mg can be used for 7-14 days. Patients whose therapy is started with ciprofloxacin I.for UTIs may be switched to ciprofloxacin XR 500mg Tablet when clinically indicated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "UTand Ginfections",
        "description": "By I.Infusion (over 30-60 mins): The usual recommended dosage schedule for Adults is as follows; UTand Ginfections:100-200mg I.12 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 60
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Gonorrhoea",
        "description": "By I.Infusion (over 30-60 mins): The usual recommended dosage schedule for Adults is as follows; Gonorrhoea: 100 mg I.single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 60
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Gonorrhoea",
        "description": "By I.Infusion (over 30-60 mins): The usual recommended dosage schedule for Adults is as follows; Other infections: 200mg I.12 hourly.: 100 mg I.single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 60
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "description": "Not recommended, but where benefit outweighs risk, 5-10mg/kg daily in 2 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "notRecommended": true
          },
          {
            "type": "alternative",
            "condition": "where benefit outweighs risk",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "description": "in case of marked Renal Impairment (creatinine clearance <20ml/min), the total daily dosage should be halved. Duration of treatment: For acute infection the usual treatment period is 5 to 7 days (I.V.), then if required to continue the therapy may be changed to oral Tablet.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in case of marked Renal Impairment (creatinine clearance <20ml/min)",
            "notes": "the total daily dosage should be halved."
          },
          {
            "type": "primary",
            "condition": "For acute infection",
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 354,
    "genericName": "Gatifloxacin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Acute bacterial exacerbation of chronic bronchitis",
        "description": "Acute bacterial exacerbation of chronic bronchitis- 400mg once daily for 5 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Acute sinusitis",
        "description": "Acute sinusitis- 400mg once daily for 10 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Community-acquired pneumonia",
        "description": "Community-acquired pneumonia- 400mg once daily for 7-14 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Uncomplicated sin & skin structure infections",
        "description": "Uncomplicated sin & skin structure infections- 400mg once daily for 7-14 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Uncomplicated urinary tract infections (cystitis)",
        "description": "Uncomplicated urinary tract infections (cystitis)- 400mg or 200mg single dose for 3 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "vComplicated urinary tract infections",
        "description": "vComplicated urinary tract infections- 400mg once daily for 7-14 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "viPyelonephritis",
        "description": "viPyelonephritis- 400mg once daily for 7-14 days. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "vUncomplicated urethral and cervical gonorrhea",
        "description": "vUncomplicated urethral and cervical gonorrhea- 400mg single dose. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "x. Acute, uncomplicated rectal infections in women",
        "description": "x. Acute, uncomplicated rectal infections in women- 400mg single dose. The dose may be taken with or without meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "connectionToMeal": {
              "when": "with or without meals"
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Acute bacterial exacerbation of chronic bronchitis",
        "description": "Acute bacterial exacerbation of chronic bronchitis- 400mg I.V.once daily for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Acute sinusitis",
        "description": "Acute sinusitis- 400mg I.once daily for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Community-acquired pneumonia",
        "description": "Community-acquired pneumonia- 400mg I.once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Uncomplicated sin & skin structure infections",
        "description": "Uncomplicated sin & skin structure infections- 400mg I.once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Uncomplicated urinary tract infections (cystitis)",
        "description": "Uncomplicated urinary tract infections (cystitis)- 400mg I.or 200mg I.single dose for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "vComplicated urinary tract infections",
        "description": "vComplicated urinary tract infections- 400mg I.once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "viPyelonephritis",
        "description": "viPyelonephritis- 400mg I.once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "vUncomplicated urethral and cervical gonorrhea",
        "description": "vUncomplicated urethral and cervical gonorrhea- 400mg I.single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "x. Acute, uncomplicated rectal infections in women",
        "description": "x. Acute, uncomplicated rectal infections in women- 400mg I.single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "ncase of Renal Insufficiency",
        "secondaryIndication": "f the Creatinine clearance is <40ml/min and hem dailysis occurred or continuous peritoneal dailysis is present",
        "description": "ncase of Renal Insufficiency: If the Creatinine clearance is <40ml/min and hem dailysis occurred or continuous peritoneal dailysis is present, the starting dose will be 200mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 355,
    "genericName": "Levofloxacin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Exacerbation of chronic bronchitis",
        "description": "Exacerbation of chronic bronchitis, 250-500mg daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Acute sinusitis",
        "description": "Acute sinusitis, 500mg once daily for 10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Community-acquired pneumonia",
        "description": "Community-acquired pneumonia, 500mg once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Complicated urinary tract infections & acute pyelonephritis",
        "description": "Complicated urinary tract infections & acute pyelonephritis, 250mg once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Uncomplicated skin and soft-tissue infections",
        "description": "Uncomplicated skin and soft-tissue infections, 500mg once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "vComplicated skin and soft-tissue infuctions",
        "description": "vComplicated skin and soft-tissue infuctions, 750mg once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Children: Not recommended for Children (<18 years of age).",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": ".Infusion",
        "indication": "Exacerbation of chronic bronchitis",
        "description": "Exacerbation of chronic bronchitis, 250-500mg I.daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Acute sinusitis",
        "description": "Acute sinusitis, 500mg I.once daily for 10-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 14
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Community-acquired pneumonia",
        "description": "Community-acquired pneumonia, 500mg I.once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Complicated urinary tract infections & acute pyelonephritis",
        "description": "Complicated urinary tract infections & acute pyelonephritis, 250mg I.once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Uncomplicated skin and soft-tissue infections",
        "description": "Uncomplicated skin and soft-tissue infections, 500mg I.once daily for 7-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "vComplicated skin and soft-tissue infuctions",
        "description": "vComplicated skin and soft-tissue infuctions, 750mg I.once daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Children: Not recommended for Children (<18 years of age).",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 356,
    "genericName": "Lomefloxacin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "For treatment of lower respiratory tract infections or uncomplicated and complicated urinary tract infections",
        "description": "For treatment of lower respiratory tract infections or uncomplicated and complicated urinary tract infections, the usual Adult dose is 400mg once daily for 10 days (14 days for complicated UTI).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "alternativeTreatmentPeriod": {
              "condition": "for complicated UTI",
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "For prophylaxis in patients undergoing transurethral surgical procedures",
        "description": "For prophylaxis in patients undergoing transurethral surgical procedures- a single dose of 400mg 2-6 hours prior to the procedure in Adults.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "notes": "2-6 hours prior to the procedure in Adults"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "in patients with a creatinine clearance>10ml/min but <40ml/min",
        "description": "in patients with a creatinine clearance>10ml/min but <40ml/min, the recommended dosage is an initial loading dose fo 400mg followed by daily maintenance dose of 200mg once daily for the duration of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 357,
    "genericName": "Moxifloxacin",
    "doseList": [
      {
        "indication": "Acute bacterial sinusitis",
        "description": "400mg once daily for 10 days. Moxifloxacin may be taken with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "indication": "Acute bacterial exacerbation of chronic bronchitis",
        "description": "400mg once daily for 5 daysI.Moxifloxacin may be taken with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "indication": "Community-acquired pneumonia",
        "description": "400mg once daily for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "indication": "Skin and skin structure infection",
        "description": "400mg once daily for 7 daysI.Moxifloxacin may be taken with or without food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 358,
    "genericName": "Ofloxacin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "U.T.I",
        "description": "U.T.I- 200-400mg daily Preferably in the morning, increased if necessary in upper U.T.to 400mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Lower R.T.I",
        "description": "Lower R.T.I, 400mg daily preferably in the morning, increased if necessary to 400mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Uncomplicated gonorrhea",
        "description": "Uncomplicated gonorrhea, 400mg as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Non-gonococcal urethritis and cervicitis",
        "description": "Non-gonococcal urethritis and cervicitis, 400mg daily in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Complicated U.T.I",
        "description": "Complicated U.T.I, 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Lower R.T.I",
        "description": "Lower R.T.I, 200mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Septicaemia",
        "description": "Septicaemia, 200mg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Severe or complicated infections",
        "description": "Severe or complicated infections, dose may be increased to 400mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 359,
    "genericName": "Pefloxacine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "400mg 12 hourly with meals to avoid g.symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "By Injection, 400mg (1amp.) diluted in 250ml of 5% glucose in aqua, as a slow one-hour Infusion, twice daily. Pefloxacine should not be diluted in any solution containing chloride ions. Initial dose may be 800mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "duration": {
              "unit": "hour",
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "5% glucose",
              "quantity": {
                "unit": "ml",
                "min": 250,
                "max": 250
              }
            },
            "notes": "Pefloxacine should not be diluted in any solution containing chloride ions. Initial dose may be 800mg."
          }
        ]
      }
    ]
  },
  {
    "serial": 360,
    "genericName": "Sparfloxacin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "400mg on day 1, followed by 200mg/day for 5 to 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on day 1"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in renal failure of third degree severity (creatinine clearance< 30ml/min)",
        "description": "in renal failure of third degree severity (creatinine clearance< 30ml/min) dosage modification is recommended- 400mg on day 1, 200mg/day on day 2 & 3 followed by 200mg every 48 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on day 1"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "notes": "on day 2 & 3"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "hour",
              "min": 48,
              "max": 48
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Children: below 12 years not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 361,
    "genericName": "Streptomycin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Tuberculosis",
        "description": "0.75-1 gm. Daily or 0.75-1gm 3 times a week (for fully supervised intermittent therapy) I.M. Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.75,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 0.75,
              "max": 1
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Tuberculosis",
        "description": "Child, usually 30mg/kg up to 1 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "notes": "up to 1 gm daily"
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Adult",
        "indication": "Not-tuberculous infections",
        "description": "Adult- 1gm/ day I.M inj. 3-7 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Not-tuberculous infections",
        "description": "Child, 22 to 40 mg/kg daily may be given in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 22,
              "max": 40
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 362,
    "genericName": "Rifampicin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "Under 50kg",
        "description": "Adult, Under 50kg 450mg daily before breakfast; 50kg and over 600mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 450,
              "max": 450
            },
            "connectionToMeal": {
              "when": "before breakfast"
            },
            "doseTime": {
              "breakfast": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "50kg and over",
        "description": "Adult, Under 50kg 450mg daily before breakfast; 50kg and over 600mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, 10mg/kg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "mouth",
        "alternateRoiute": ".Injection",
        "ageGroup": "Child",
        "indication": "Brucellosis & Legionnaires",
        "description": "0.6-1.2gm daly in 2-4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.6,
              "max": 1.2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "alternateRoiute": ".Injection",
        "ageGroup": "Child",
        "indication": "Leprosy",
        "description": "Leprosy,600mg once monthly (450mg for those weighing less than 35kg) along with other antileprotic drug/drugs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesMonthly": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "for those weighing less than 35kg",
            "unit": "gm",
            "amount": {
              "min": 450,
              "max": 450
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 363,
    "genericName": "soniazid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "300mg daily.(both Adult and Child)for intermittent supervised therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "10mg/kg (maximum 300mg) daily or 15mg/kg 3 times a week (both Adult and Child)for intermittent supervised therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "notes": "(maximum 300mg) daily"
          },
          {
            "type": "alternate",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "3 times a week"
          }
        ]
      }
    ]
  },
  {
    "serial": 364,
    "genericName": "Ethambutol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis & treatment",
        "description": "15 mg/kg daily as a single dose or 25mg/kg daily in the initial phage followed by 15mg/kg daily in the continuous phage.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            }
          },
          {
            "type": "alternative",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            }
          },
          {
            "type": "alternativeFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "For supervised intermittent treatment",
        "description": "For supervised intermittent treatment-30mg/kg 3 times a week or 45 mg/kg 2 times a week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "unit": "mg/kg",
            "amount": {
              "min": 45,
              "max": 45
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Treatment",
        "description": "Treatment, 25 mg/kg daily as a single dose for 2 months, then 15mg/kg body-wt, daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Prophylaxis",
        "description": "Prophylaxis- 15mg/kg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Prophylaxis",
        "description": "Tuberculous meningitis, 25mg/kg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 365,
    "genericName": "Pyrazinamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Under 50kg 1.5gm, 50kg and over 2 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50kg",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            }
          },
          {
            "type": "primary",
            "condition": "50kg and over",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, 35mg/kg daily for first 2 months only.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50kg",
            "unit": "mg/kg",
            "amount": {
              "min": 35,
              "max": 35
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Intermittent supervised therapy",
        "description": "Adult- under 50kg 2 gm 3 times a week, 50kg and over 2.5gm",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50kg",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primary",
            "condition": "50kg and over",
            "unit": "gm",
            "amount": {
              "min": 2.5,
              "max": 2.5
            }
          },
          {
            "type": "alternative",
            "condition": "Under 50kg",
            "unit": "gm",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "condition": "50kg and over",
            "unit": "gm",
            "amount": {
              "min": 3.5,
              "max": 3.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Intermittent supervised therapy",
        "description": "Child,50mg/kg 3 times a week",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "unit": "mg/kg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 366,
    "genericName": "sorifam- (150 + 100)",
    "doseList": [
      {
        "description": "Under 50kg.body-wt. 3 caps. As a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50kg.body-wt.",
            "unit": "capsule",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "As a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 367,
    "genericName": "sorifam- (300+150)",
    "doseList": [
      {
        "description": "Over 50 kg. body- wt. 2 caps. As a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50 kg. body- wt.",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "As a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 368,
    "genericName": "Myzid cap",
    "doseList": [
      {
        "description": "Over 50kg. 2 caps. Daily as a single dose efore breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50 kg.",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "daily as a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 369,
    "genericName": "Rifagen 300 cap",
    "doseList": [
      {
        "description": "Over 50 kg. body-wt. 2 tabs, as a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50 kg. body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "as a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 370,
    "genericName": "Rifazid 450 tab",
    "doseList": [
      {
        "description": "1 tab. Daily in a single dose before breakfast for the patients under 50kg body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients under 50kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 371,
    "genericName": "Rifazid 150 tab",
    "doseList": [
      {
        "description": "Under 50 kg body-wt. 3 Tablet daily as a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50 kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 372,
    "genericName": "Rifazid 300 tab",
    "doseList": [
      {
        "description": "Over 50kg 2 Tablet Daily as a single dose before breakfast",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 373,
    "genericName": "Rifazid 450 tab",
    "doseList": [
      {
        "description": "1 Tablet daily in a single dose before breakfast for the patients under 50kg body-wt",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients under 50kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 374,
    "genericName": "Rimactazid 150/75",
    "doseList": [
      {
        "description": "Under 50 kg body-wt. 3 Tablets daily as a single dose before breakfast",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50 kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 375,
    "genericName": "Rimactazid 300 tab",
    "doseList": [
      {
        "description": "Over 50kg 2 Tablets daily as a single dose before breakfast",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 376,
    "genericName": "Rimactazid 450 tab",
    "doseList": [
      {
        "description": "1 Tablet daily in a single dose before breakfast for the patients under 50kg body-wt",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "patients under 50kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 377,
    "genericName": "Rifazid 300 Z tab",
    "doseList": [
      {
        "description": "Over 50 kg. (2+4) Tablet Daily as a single dose before breakfast",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50 kg.",
            "unit": "Tablet",
            "amount": {
              "min": null,
              "max": null
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 378,
    "genericName": "Rifazid 450 Z tab.",
    "doseList": [
      {
        "description": "Over 50kg body wt, one blister strip of rimactazid-450+Z (i.e 1+3 Tablet) daily as a single dose before breakfast, for the first 2 months of treatment followed by 1 Tablet of rimactazid-450 +Z  or 2 Tablets of rimactazid-300 daily for the next 4 months to complete a 6-months course of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg body wt",
            "unit": "blister strip",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before breakfast"
            },
            "doseTime": {
              "breakfast": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "condition": "rimactazid-300",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 379,
    "genericName": "Rimactazid150/75+Z",
    "doseList": [
      {
        "description": "Under 50kg body-wt (3+3) Tablet Daily as a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Under 50kg body-wt.",
            "unit": "Tablet",
            "amount": {
              "min": null,
              "max": null
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 380,
    "genericName": "Rimactazid300+Z",
    "doseList": [
      {
        "description": "Over 50kg. (2+4) Tablet Daily as a single dose before breakfast.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg.",
            "unit": "Tablet",
            "amount": {
              "min": null,
              "max": null
            },
            "notes": "a single dose before breakfast"
          }
        ]
      }
    ]
  },
  {
    "serial": 381,
    "genericName": "Rimactazid450+Z",
    "doseList": [
      {
        "description": "Over 50kg body wt. one blister strip of rimactazid-450+Z (i.e 1+3 Tablet) daily as a single dose before breakfast, for the first 2 months of treatment followed by a Tablet of rimactazid-450 or 2 Tablets of rimactazid-300 daily for the next 4 months ot complete a 6 months course of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Over 50kg body wt",
            "unit": "blister strip",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before breakfast"
            },
            "doseTime": {
              "breakfast": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "condition": "rimactazid-300",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 383,
    "genericName": "Dapsone",
    "doseList": [
      {
        "description": "Treatment of leprosy started on a low dose (1/4 th of the standard) which then gradually increased so as to take 6 or 8 weeks to reach the standard. The following regimens have been used; 100-200 mg once a day or 200-400mg twice a week or 300-600mg once a week or 1-2 mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            },
            "notes": "Treatment of leprosy started on a low dose (1/4 th of the standard) which then gradually increased so as to take 6 or 8 weeks to reach the standard."
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "AlternativePrimaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "AlternativePrimaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 600
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "AlternativePrimaryFollowup",
            "unit": "mg/kg/day",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Dermatitis herpetiformis",
        "ageGroup": "Adult",
        "description": "Adult, initially 50-100mg daily modified according to response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 384,
    "genericName": "Acyclovir",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Treatment",
        "description": "Treatment- 1 tab. (or 5ml syp.) 5 times daily at 4 hourly intervals omitting the night time dose) for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternative",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Prophylaxis- 1 tab. Or 5ml 4 times daily at 6 hourly intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "Interval": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "Interval": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "Treatment",
        "description": "Treatment- Under 2 years, ½ tab. Or 2.5ml 5 times daily at 4 hourly intervals for 5 days. Over 2 years, ½ tab. 4 times daily at 6 hourly intervals; over 2 years, same as Adult.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternative",
            "unit": "ml",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "indication": "Treatment",
        "description": "Treatment- Under 2 years, ½ tab. Or 2.5ml 5 times daily at 4 hourly intervals for 5 days. Over 2 years, ½ tab. 4 times daily at 6 hourly intervals; over 2 years, same as Adult.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "Interval": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 385,
    "genericName": "Zidovudine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Monotherapy in Adults",
        "description": "Monotherapy in Adults- Although a broad range of dosage regiments has been employed, 500 or 600mg/day in two to five divided doses has been commonly used worldwide. Alternatively, a daily dosage of 1000mg in two divided doses has been shown to be effective.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 500,
              "max": 600
            },
            "notes": "in two to five divided doses"
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "notes": "in two divided doses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3
        },
        "indication": "Monotherapy in Children",
        "description": "Monotherapy in Children- In Children over the age of 3 months the recommended starting dosage is 180mg/m^2 body surface area every 6 hours (720mg/m2/day). The maximum dosage should not exceed 200mg every 6 hours. The optimum dosage regimen remains to be determined and may vary from patient to patient. A range of dosage, generally between 120 and 180mg/m2 every 6 hours (between 480 and 720mg/m2/day), has been used.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 180,
              "max": 180
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 386,
    "genericName": "Efavirenz",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dosage of efaviranz is 600mg orally, once daily, in combination with a protease inhibitor and nucleoside analogue reverse transcriptase inhibitors (NRTIs). Efavirenz may be taken with or without food; however, a high fat meal may increase the absorption of efavirenz and should be avoided. In order to improve the tolerability of nervous system side effects, bedtime dosing is recommended during the first 2 to 4 weeks of therapy and in patients who continue to experience these symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "genericName": "NRTIs"
            },
            "connectionToMeal": {
              "when": "with or without food"
            },
            "doseTime": {
              "condition": "in order to improve the tolerability of nervous system side effects and in patients who continue to experience these symptoms.",
              "bedtime": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3
        },
        "condition": "weighing between 10 and 40kg",
        "description": "Peadiatric patients: The peadiatric patients include 3 years of age or older and weighing between 10 and 40kg. The recommended dosage of efavirenz is given orally, once daily at a rate- body weight 10 to <15kg,200mg; to <20kg, 250mg; 20 to <25kg, 300mg; 25 to <32.5kg, 350mg; 32.5 to <40kg, 400mg. The recommended dosage for peadiatric patients weighinggreater then 40kg is 600mg (as Adult), once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "body weight 10 to <15kg",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "body weight 10 to <20kg",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "body weight 20 to <25kg",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "body weight 25 to <32.5kg",
            "unit": "mg",
            "amount": {
              "min": 350,
              "max": 350
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "body weight 32.5 to <40kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "body weight greater then 40kg ",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 387,
    "genericName": "Nelfinavir",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose is 1250mg (250mg x 5 Tablet) twice daily or 750mg (250 x3 Tablet) three times daily. Nefinavir should be taken with a meal. Antiviral activity is enhanced when nelfinavir is administered in combination with nucleoside analogues (e.g lamivudine). Therefore, it is recommended that nelfinavir be used in combination with nucleoside analogues.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1250,
              "max": 1250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "genericName": "nucleoside analogues (e.g lamivudine)"
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalItem": {
              "genericName": "nucleoside analogues (e.g lamivudine)"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 13
        },
        "description": "Children (2-13 years): The recommended oral dose is 20-30mg/kg per dose, 3 times daily with a meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with a meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Peadiatric use:The safety, effectiveness and pharmacokinetics of nelfinavir have not been evaluated yet in peadiatric patients below the age of 2 years.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 388,
    "genericName": "Lamivudine + Zidovudine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: The recommended oral dose of lamivudine and zidovudine combined preparation is as follows: for Adults and adolescents of age 12 years and above- 1 Tablet (lamivudine 150mg + zidovudine 300mg) twice daily. After successful therapy with low dose nevirapine for two weeks, patients can be switched over to 200mg b.i.d dose provided they have not demonstrated any hypersensitivity reaction (rash, abnormal liver function tests) during their initial exposure.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "After successful therapy with low dose nevirapine for two weeks, patients can be switched over to 200mg b.i.d dose provided they have not demonstrated any hypersensitivity reaction (rash, abnormal liver function tests)during their initial exposure to nevirapine."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult: The recommended oral dose of lamivudine and zidovudine combined preparation is as follows: for Adults and adolescents of age 12 years and above- 1 Tablet (lamivudine 150mg + zidovudine 300mg) twice daily. After successful therapy with low dose nevirapine for two weeks, patient scan be switched over to 200mg b.i.d dose provided they have not demonstrated any hypersensitivity reaction (rash, abnormal liver function tests) during their initial exposure.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "After successful therapy with low dose nevirapine for two weeks, patients can be switched over to 200mg b.i.d dose provided they have not demonstrated any hypersensitivity reaction (rash, abnormal liver function tests)during their initial exposure."
          }
        ]
      }
    ]
  },
  {
    "serial": 389,
    "genericName": "Lamivudine",
    "doseList": [
      {
        "indication": "Treatment of chronic hepatitis-B",
        "description": "Treatment of chronic hepatitis-B: The recommended dose of lamivudine is 100mg once a day. The Tablet should be swallowed whole with water and can be adjusted by the physician if there is any renal impairrment. The duration of treatment will be decided by the physician depending on the clinical condition of the patient. If the patient forgets to take the schedule dose in time, take it is soon as remembered & then continue to take it  as instructed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "The Tablet should be swallowed whole with water and can be adjusted by the physician if there is any renal impairrment."
          }
        ]
      },
      {
        "indication": "Treatment of HIV-infection & AIDS",
        "description": "Treatment of chronic hepatitis-B: The recommended dose of lamivudine is 100mg once a day. The Tablet should be swallowed whole with water and can be adjusted by the physician if there is any renal impair-rment. The duration of treatment will be decided by the physician depending on the clinical condition of the patient. If the patient forgets to take the schedule dose in time, take it is soon as remembered & then continue to take it  as instructed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "genericName": "Zidovudine",
              "quantity": {
                "unit": "mg",
                "min": 600,
                "max": 600
              }
            },
            "notes": "in 2 or 3 divided doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 390,
    "genericName": "Adefovir Dipivoxil",
    "doseList": [
      {
        "route": "mouth",
        "description": "The recommended dose of adefovir in chronic hepatitis B patients is 10mg once daily, taken orally, without regard to food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Dose adjustment in Renal Impairment",
        "description": "The recommended dose of adefovir in chronic hepatitis B patients is 10mg once daily, taken orally, without regard to food.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "If creatinine clearance is >50ml/min",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          },
          {
            "type": "primary",
            "condition": "If creatinine clearance is 20-49ml/min",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 48,
              "max": 48
            }
          },
          {
            "type": "primary",
            "condition": "If creatinine clearance is 10-19ml/min",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 72,
              "max": 72
            }
          },
          {
            "type": "primary",
            "condition": "If the patient is under haemodailysis",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Peadiatric use: Safety and effectiveness in peadiatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 391,
    "genericName": "Peginterferon ALFA-2a/2b",
    "doseList": [
      {
        "route": "Injection",
        "description": "The recommended duration of treatment: Patients infected with hepatitis C virus (genotype 2 and 3) previously untreated with interferon, should be treated with interferon or peginterferon alfa and ribavirin for 24 weeks. Patients infected with hepatitis C virus (genotype 1 and 4) previously untreated with interferon, should be treated with interferon or peginterferon alfa and ribavirin for 12 to 48 weeks. After 12 weeks to treatment virologic response should be accessed, and if the viral load has been reduced to less than 1% of the load at the start of treatment, the combination should be continued for a total of 48 weeks; But, if the viral load exceeds 1% of the load at the start of treatment, therapy should be discontinued.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Patients infected with hepatitis C virus (genotype 2 and 3) previously untreated with interferon",
            "treatmentPeriod": {
              "unit": "week",
              "min": 24,
              "max": 24
            }
          },
          {
            "type": "primary",
            "condition": "Patients infected with hepatitis C virus (genotype 1 and 4) previously untreated with interferon",
            "treatmentPeriod": {
              "unit": "week",
              "min": 12,
              "max": 48
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Patients infected with hepatitis C virus (genotype 1 and 4) previously untreated with interferon",
            "notes": "After 12 weeks of treatment virologic response should be accessed, and if the viral load has been reduced to less than 1% of the load at the start of treatment, the combination should be continued for a total of 48 weeks; But, if the viral load exceeds 1% of the load at the start of treatment, therapy should be discontinued."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Chronic hepatitis C (genotypes 1 & 4)",
        "description": "body weight <75kg, ribavirin daily 400mg in the morning and 600mg in the evening; Body weight >75kg, ribavirin daily 600mg in the morning and 600mg in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "body weight <75kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primary",
            "condition": "body weight <75kg",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "doseTime": {
              "evening": true
            }
          },
          {
            "type": "primary",
            "condition": "Body weight >75kg",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Chronic hepatitis C(genotypes 2 & 3)",
        "description": "Adult, (of any body weight),ribavirin daily 400mg in the morning and 400mg in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "body weight <75kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Peginterferon alfa 2a/2b",
        "description": "Adult- 180mcg once weekly subcutaneously. Duration: 48 weeks in cases of genotype 1 & 4; 24 weeks in cases of genotype 2 &3. Ribavirin may be administered without regard to food, but should be administered in a consistent manner. Drink plenty of water while being treated with this medication; drinking water will decrease the risk of serious side effects.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in cases of genotype 1 & 4",
            "unit": "mcg",
            "amount": {
              "min": 180,
              "max": 180
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 48,
              "max": 48
            }
          },
          {
            "type": "primary",
            "condition": "in cases of genotype 2 & 3",
            "unit": "mcg",
            "amount": {
              "min": 180,
              "max": 180
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Patients under 18 years: the safety and efficacy of peginterferon alfa has not yet been established in these patients.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 392,
    "genericName": "Ribavirin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Chronic hepatitis C (all genotypes 1,2,3 &4)",
        "description": "Adult, body weight < 75kg, ribavirin daily 400mg in the morning and 600mg in the evening; Body weight > 75kg, ribavirin daily 600mg in the morning and 600mg in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "body weight < 75kg",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "primary",
            "condition": "body weight < 75kg",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "doseTime": {
              "evening": true
            }
          },
          {
            "type": "primary",
            "condition": "Body weight > 75kg",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Interferon alfa 2a/2b:Chronic hepatitis C (all genotypes 1,2,3 & 4)",
        "description": "Adult, 3 MIU 3 times weekly subcutaneously. Duration: 48 weeks in cases of genotype 1 & 4; 24 weeks in cases of genotype 2 & 3.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in cases of genotype 1 & 4",
            "unit": "MIU",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 48,
              "max": 48
            }
          },
          {
            "type": "primary",
            "condition": "in cases of genotype 2 & 3.",
            "unit": "MIU",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Peadiatric patients: Safety and efficacy of ribavirin has not been established in patients below the age of 18 yrs.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 393,
    "genericName": "Amantadine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The daily dosage of amantadine hydrochloride is 200mg (2 capsules or 4 tsf of syrup) given as a single dose or in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "ageRange": {
          "unit": "year",
          "min": 65
        },
        "description": "Elderly: In person 65 years of age or older, the daily dosage of amantadine hydrochloride is 100mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 9
        },
        "description": "Children: 1-9 years of age- the total daily dose is 4.4-8.8 mg/kg/day, but should not exceed 150mg/day; 9-12 years of age – the total daily dose is 200mg given in two divided doses. The 100mg daily dose has not been studied in Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 4.4,
              "max": 8.8
            },
            "notes": "should not exceed 150mg/day"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9,
          "max": 12
        },
        "description": "Children: 1-9 years of age- the total daily dose is 4.4-8.8 mg/kg/day, but should not exceed 150mg/day; 9-12 years of age – the total dailydose is 200mg givenin two divided doses. The 100mg daily dose has not been studied in Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "notes": "The 100mg daily dose has not been studied in Children"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage of Parkinsonism",
        "description": "The usual dose of amantadine hydrochloride is 100mg twice daily when used alone. The initial dose of amantadine hydrochloride is 100mg daily for patients with serious associated medical illnesses or who are receiving high doses of patients with serious associated medical illnesses or who are receiving high doses or  other antiparkinson drugs. After one to several weeks at 100mg once daily, the dose may be increased to 100mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage for drug induced extrapyramidal reactions",
        "description": "The usual dose of amantadine hydrochloride is 100mg twice daily. Occasionally patients whose responses are not optimal with amantadine 200mg daily dose, an increase up to 300mg daily in divided doses may be benifited.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "patients whose responses are not optimal with amantadine 200mg daily dose",
            "unit": "mg",
            "amount": {
              "max": 300
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage for impaired renal function",
        "condition": "Clearance 30-50ml/min",
        "description": "Depending upon creatinine clearance, the following dosage adjustments are recommended: Clearance 30-50ml/min-200mg 1st day and 100mg each day thereafter. Clearance 15-29ml/min- 200mg 1st day followed by 100mg on alternate days. Clearance <15ml/min- 200mg every 7 days. The recommended dosage for patients on hemodailysis is 200mg every 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage for impaired renal function",
        "condition": "Clearance 15-29ml/min",
        "description": "Depending upon creatinine clearance, the following dosage adjustments are recommended:Clearance 30-50ml/min- 200mg 1st day and 100mg each day thereafter. Clearance 15-29ml/min- 200mg 1st day followed by 100mg on alternate days. Clearance <15ml/min- 200mg every 7 days. The recommended dosage for patients on hemodailysis is 200mg every 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "notes": "on alternate days"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage for impaired renal function",
        "condition": "Clearance <15ml/min",
        "description": "Depending upon creatinine clearance, the following dosage adjustments are recommended: c. Clearance 30-50ml/min- 200mg 1st day and 100mg each day thereafter. c. Clearance 15-29ml/min - 200mg 1st day followed by 100mg on alternate days.  Clearance <15ml/min - 200mg every 7 days. The recommended dosage for patients on hemodailysis is 200mg every 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dosage for impaired renal function",
        "secondaryIndication": "for patients on hemodailysis",
        "description": "Depending upon creatinine clearance, the following dosage adjustments are recommended:Clearance 30-50ml/min - 200mg 1st day and 100mg each day thereafter.  Clearance 15-29ml/min -200mg 1st day followed by 100mg on alternate days.  Clearance <15ml/min -200mg every 7 days. The recommended dosage for patients on hemodailysis is 200mg every 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "repeated": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 394,
    "genericName": "Griseofulvin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "500mg-1gm daily preferably in divided doses (or as single dose) after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 1000
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "10mg/kg body-wt. daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 395,
    "genericName": "Nystatin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Tablet, Adult- 1-2 Tablet 4 times daily. Drop, Adult- 1ml 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Tablet",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primary",
            "condition": "drop",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- 1ml 4 times.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "indication": "Prophylaxis in neonates",
        "description": "Prophylaxis in neonates, 1ml daily. For oral lesions retain suspension in the mouth for a while.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 396,
    "genericName": "Fluconazole",
    "doseList": [
      {
        "route": "mouth",
        "description": "By mouth, A single dose of 150mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Mucosal candidiasis",
        "description": "50mg daily (100mg daily in unusually difficult infections) given for 7-14 days in oropharyngeal candidiasis (maximum 14 days except in severely immunocompromised patients); for 14 days in atrophic oral candidiasis associated with dentures; for 14-30 days in other mucosal infections.",
        "subDoseList": [
          {
            "type": "primary",
            "secondaryIndication": "in oropharyngeal candidiasis",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          },
          {
            "type": "alternative",
            "condition": "in unuusually difficult infections",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          },
          {
            "type": "alternative",
            "condition": "in atrophic oral candidiasis associated with dentures",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          },
          {
            "type": "alternative",
            "condition": "in other mucosal infections",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 30
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Mucosal candidiasis",
        "description": "Tinea pedis, corporis, cruris, versicolor, and dermal candidiasis, by mouth, 50mg daily for  2-4 weeks (for up to 6 weeks in tinea pedis); max . duration of treatment 6 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Tinea pedis, corporis, cruris, versicolor, and dermal candidiasis",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "notes": "maximum duration of treatment 6 weeks"
          },
          {
            "type": "primary",
            "condition": "in tinea pedis",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth or Infusion",
        "indication": "Systemic candidiasis and cryptococal infections",
        "description": "Systemic candidiasis and cryptococal infections, By mouth or I.V. Infusion, 400mg initially then 200mg daily, increased in necessary to 400mg daily; Treatment continued according to response (at least 6-8weeks for cryptococcal meningitis).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          },
          {
            "type": "maintenance",
            "condition": "Increased if necessary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "route": "mouth or Infusion",
        "indication": "Systemic candidiasis and cryptococal infections",
        "secondaryIndication": "Prevention of relapse of cryptococcal meningitis in AIDS patients after completion or primary therapy",
        "description": "Prevention of relapse of cryptococcal meningitis in AIDS patients after completion or primary therapy, 100-200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "mouth or Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "over 1 years (see cautions), By mouth or I.V. Infusion, Superficial candidal infections, 1-2 mg/kg daily; systemic candidiasis and cryptococcal infections, 3-6mg/kg daily (in serious life-threatening infections up to 12 mg/kg daily has been given to Children aged 5-13 years-maximum 400mg daily)",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Superficial candidal infections",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "systemic candidiasis and cryptococcal infections",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth or Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 13
        },
        "indication": "in serious life-threatening infections",
        "description": "over 1 years (see cautions), By mouth or I.V. Infusion, Superficial candidal infections, 1-2 mg/kg daily; systemic candidiasis and cryptococcal infections, 3-6mg/kg daily (in serious life-threatening infections up to 12 mg/kg daily has been given to Children aged 5-13 years-maximum 400mg daily)",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Superficial candidal infections",
            "unit": "mg/kg",
            "amount": {
              "max": 12
            },
            "notes": "maximum 400mg daily"
          }
        ]
      }
    ]
  },
  {
    "serial": 397,
    "genericName": "traconazole",
    "doseList": [
      {
        "indication": "Oropharyngeal candidiasis",
        "description": "Oropharyngeal candidiasis- 100mg daily (200mg daily in AIDS or neutropenia)for 15 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "indication": "Oropharyngeal candidiasis",
        "secondaryIndication": "in AIDS or neutropenia",
        "description": "Oropharyngeal candidiasis- 100mg daily (200mg daily in AIDS or neutropenia)for 15 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "indication": "Vulvovaginal candidiasis",
        "description": "Vulvovaginal candidiasis- 200mg twice daily for 1 day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Pityriasis versicolor",
        "description": "Pityriasis versicolor- 200mg daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "indication": "Tinea corpris & tinea cruris",
        "description": "Tinea corpris & tinea cruris- 100mg daily for 15 days or 200mg daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 15,
              "max": 15
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "indication": "Tinea pedis & tinea manuum",
        "description": "Tinea pedis & tinea manuum- 100mg daily for 30 days or 200mg twice daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "indication": "Onychomycosis",
        "description": "Onychomycosis- 200mg daily for 3 months or a course of 200mg twice daily for 7 days; subsequent courses should be repeated after 21 day interval",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "day",
              "min": 21,
              "max": 21
            }
          }
        ]
      },
      {
        "indication": "Fingenails",
        "description": "Fingenails- two course",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "course",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Toenails",
        "description": "Toenails- three courses",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "course",
            "amount": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Histoplasmosis",
        "description": "Histoplasmosis- 200mg 1-2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Histoplasmosis",
        "indication": "Maintenance in AIDS patients to prevent relapse of underlying fungal infection and prophylaxis in neutropenia when standard therapy is inappropriate",
        "description": "Maintenance in AIDS patients to prevent relapse of underlying fungal infection and prophylaxis in neutropenia when standard therapy is inappropriate- 200mg once daily, increased to 200mg twice daily if low plasma concentration is detected.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f low plasma concentration is detected.",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Histoplasmosis",
        "description": "Children- The recommended dose is 3 to 5mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 398,
    "genericName": "Ketoconazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200-400mg once daily with meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "connectionToMeal": {
              "when": "with meals"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "3mg/kg. daily with food. ",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "indication": "Vaginal candidiasis",
        "description": "200mg with food every 12 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "connectionToMeal": {
              "when": "with food"
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 399,
    "genericName": "Miconazole",
    "doseList": [
      {
        "condition": "Micoral oral gel",
        "description": "Micoral oral gel should be taken after meals. The recommended dosage is 15mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 15,
              "max": 15
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Adult: 1 to 2 tsf (5 to 10ml) of gel 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "Children: age 6 years and over, 1 tsf of gel 4 times daily; Age 2-6 years, 1 tsf (5ml) of gel twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "description": "Children: age 6 years and over, 1 tsf of gel 4 times daily; Age 2-6 years, 1 tsf (5ml) of gel twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "nfants under 2 years, half tsf (2.5ml) of gel twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "description": "Alternatively, for localized lesions of the mouth, a small amount of gel may be applied directly to the affected area with a clean finger, 2 to 4 times daily. Treatment should be continued for upto 2 days after symptoms have cleared.",
        "subDoseList": [
          {
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "treatmentPeriod": {
              "notes": "Treatment should be continued for upto 2 days after symptoms have cleared."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 400,
    "genericName": "Terbinafine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Ringworm infection",
        "description": "Ringworm infection- 250mg daily usually for 2-6 weeks in tinea pedis, 2-4 weeks in tinea cruris, 4 weeks in tinea corporis.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in tinea pedis",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 6
            }
          },
          {
            "type": "primary",
            "condition": "in tinea cruris",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "primary",
            "condition": "in tinea corporis",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "indication": "Nail infection",
        "description": "Nail infection- 6 weeks-3 months or longer in nail infections",
        "subDoseList": [
          {
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 12
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 401,
    "genericName": "Metronidazole",
    "doseList": [
      {
        "condition": "Oral preparation",
        "indication": "Amoebiasis",
        "description": "Amoebiasis, 800 mg thrice daily for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 10
        },
        "condition": "Oral preparation",
        "indication": "Amoebiasis",
        "description": "Child, 7-10 yrs, 400mg; 3-7 yrs. 200mg tds.; 1-3 years 100mg every 8 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "condition": "Oral preparation",
        "indication": "Amoebiasis",
        "description": "Child, 7-10 yrs, 400mg; 3-7 yrs. 200mg tds.; 1-3 years 100mg every 8 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "condition": "Oral preparation",
        "indication": "Amoebiasis",
        "description": "Child, 7-10 yrs, 400mg; 3-7 yrs. 200mg tds.; 1-3 years 100mg every 8 hours for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "condition": "Oral preparation",
        "indication": "Giardiasis",
        "description": "Giardiasis, 2gm daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 10
        },
        "condition": "Oral preparation",
        "indication": "Giardiasis",
        "description": "Child, 1-3 yrs, 500mg daily; 3-7 yrs. 600-800mg daily; 7-10 yrs. 1 gm daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "condition": "Oral preparation",
        "indication": "Giardiasis",
        "description": "Child, 1-3 yrs, 500mg daily; 3-7 yrs. 600-800mg daily; 7-10 yrs. 1 gm daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 800
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "condition": "Oral preparation",
        "indication": "Giardiasis",
        "description": "Child, 1-3 yrs, 500mg daily; 3-7 yrs. 600-800mg daily; 7-10 yrs. 1 gm daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "condition": "Oral preparation",
        "indication": "Trichomoniasis",
        "description": "Trichomoniasis, 200mg 3 times daily for 7 days or 400mg every 12 hours for 7 days or 800mg in the morning and 1.2gm at night for 2 days, or 2 gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            },
            "doseTime": {
              "morning": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "condition": "Oral preparation",
        "indication": "Trichomoniasis",
        "description": "Child, 50mg 8 hourly (1-3 yrs.). 100mg 12 hourly (3-7 yrs.), 100mg 8 hourly (7-10 yrs.). All for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "condition": "Oral preparation",
        "indication": "Trichomoniasis",
        "description": "Child, 50mg 8 hourly (1-3 yrs.). 100mg 12 hourly (3-7 yrs.), 100mg 8 hourly (7-10 yrs.). All for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 7,
          "max": 10
        },
        "condition": "Oral preparation",
        "indication": "Trichomoniasis",
        "description": "Child, 50mg 8 hourly (1-3 yrs.). 100mg 12 hourly (3-7 yrs.), 100mg 8 hourly (7-10 yrs.). All for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "condition": "Oral preparation",
        "indication": "Anaerobic infections",
        "description": "Anaerobic infections, 400mg 3 times daily for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Oral preparation",
        "indication": "Anaerobic infections",
        "description": "Child, 7.5mg/kg every 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      },
      {
        "condition": "Oral preparation",
        "indication": "Amoebic abscess",
        "description": "Amoebic abscess, 400mg 3 times daily for 5-10 days. The course may be repeated after 2 weeks if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            },
            "notes": "The course may be repeated after 2 weeks if necessary."
          }
        ]
      },
      {
        "condition": ".V preparation",
        "description": ".V preparation: 100ml Injection is given by I.Infusion immediately before, during or after colonic op[eration at the rate of 5ml per minute. This should be repeated 8 hourly until oral medication can be given to complete a 7 day course of treatment. In case of suppository, use rectally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "m1",
            "amount": {
              "min": 100,
              "max": 100
            },
            "nfusionRate": {
              "unit": "ml/minute",
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 402,
    "genericName": "Diloxanide Furoate",
    "doseList": [
      {
        "description": "500mg 3 times (every 8 hours) daily for 10 days, give alone for chronic infection or following 5 days of metronidazole treatment in acute dysenteric infection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "notes": "give alone for chronic infection or following 5 days of metronidazole treatment in acute dysenteric infection."
          }
        ]
      }
    ]
  },
  {
    "serial": 403,
    "genericName": "Ornidazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Amoebiasis",
        "description": "Adults, 500mg twice daily for 5-7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Amoebiasis",
        "description": "Children, 25mg/kg once daily for 5-10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Amoebic dysentery",
        "description": "Adults, 1.5gm as a single dose for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Amoebic dysentery",
        "description": "Children, 40mg/kg once daily for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Giardiasis",
        "description": "Adults, 1.5mgm once daily for 1-2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Giardiasis",
        "description": "Children, 40mg/kg once daily for 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Trichomoniasis",
        "description": "Adults, 1.5gm as a single dose or 500mg twice daily for 5 days, sexual partner shouldbe simultaneously treated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Trichomoniasis",
        "description": "Children, 25mg/kg as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Bacterial vaginosis",
        "description": "Adults, 1.5gm once or 500mg twice daily for 5-7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 7
            }
          }
        ]
      },
      {
        "indication": "Anaerobic bacterial infections",
        "description": "Anaerobic bacterial infections- initiate oral therapy as soon as possible.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "nitiate oral therapy as soon as possible."
          }
        ]
      }
    ]
  },
  {
    "serial": 404,
    "genericName": "Secnidazole",
    "doseList": [
      {
        "route": "mouth",
        "description": "The usual Adult dosage is 2gm once only, just before meals. For Hepatic amoebiasis, the Adult dosage is 1.5gm/day, in a single or divided dose, just before meals, for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "just before meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "For Hepatic amoebiasis",
        "description": "The usual Adult dosage is 2gm once only, just before meals. For Hepatic amoebiasis, the Adult dosage is 1.5gm/day, in a single or divided dose, just before meals, for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm/day",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "connectionToMeal": {
              "when": "just before meals"
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 405,
    "genericName": "Tinidazole",
    "doseList": [
      {
        "indication": "Amoebiasis",
        "description": "Amoebiasis, 2gm daily in a single dose for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Giardiasis",
        "description": "Giardiasis, 2gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Trichomoniasis",
        "description": "Trichomoniasis, 2gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "mouth",
        "indication": "Anaerobic infections",
        "description": "Anaerobic infections, By mouth, 2 gm initially then 1 gm daily for minimum 5-6 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 6
            }
          }
        ]
      },
      {
        "indication": "Prophylaxis",
        "description": "Prophylaxis- 2 gm as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Prophylaxis",
        "description": "by Injection, Treatment- 800mg by slow I.Infusion followed by 800mg I.daily (until oral maintenance) & prophylaxis, 1600mg by slow I.Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "(until oral maintenance) & prophylaxis",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 160,
              "max": 160
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children, 50-60 mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/day",
            "amount": {
              "min": 50,
              "max": 60
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 406,
    "genericName": "Paichish tab. Hamdard",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablets twice or thrice a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "(6-12 years), 1 Tablet twice or thrice a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 407,
    "genericName": "Saffodin Tab",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablets twice or thrice a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "(6-12 years), 1 Tablet twice or thrice a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 408,
    "genericName": "Chloroquine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Malaria",
        "description": "Adult, 600mg stat then 300mg after 6 to 8 hours, then 300 mg daily (single dose) for 2 days. (approx. total cumulative dose of 25mg/kg of base). Chloroquine better take after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "after 6 to 8 hours"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Malaria",
        "description": "Child, initial dose of 10mg/kg (of base) then a single dose of 5mg/kg after 6-8 hours then a single dose of 5mg/kg daily for 2 days. Chloroquine better take after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "after 6 to 8 hours"
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Adult, 2 Tablet As a single dose on the same day each week; start 2 weeks before entering endemic area and continue for 4 weeks after leaving. Chloroquine better take after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "As a single dose on the same day each week; start 2 weeks before entering endemic area and continue for 4 weeks after leaving."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Prophylaxis",
        "description": "Child, 5 mg/kg (of base) at weekly intervals; start 2 weeks before entering epidemic area and continue for 4 weeks after leaving. Chloroquine better take after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "at weekly intervals; start 2 weeks before entering epidemic area and continue for 4 weeks after leaving."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Amoebic hepatitios",
        "description": "Adult, 4 tab. Daily for 2 days then 1 tab 2 times daily for 2-3 weeks. Chloroquine better take after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet/day",
            "amount": {
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Amoebic hepatitios",
        "description": "Child, Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 409,
    "genericName": "Avloquin Syp. ACI",
    "doseList": [
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "Prophylaxis",
        "description": "Prophylaxis- under 1 year not recommended; 1-4 years. 2 tsf; 4-8 yrs. 3 tsf; 8-12 yrs. 4-5 tsf.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 4
        },
        "indication": "Prophylaxis",
        "description": "Prophylaxis- under 1 year not recommended; 1-4 years. 2 tsf; 4-8 yrs. 3 tsf; 8-12 yrs. 4-5 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 8
        },
        "indication": "Prophylaxis",
        "description": "Prophylaxis- under 1 year not recommended; 1-4 years. 2 tsf; 4-8 yrs. 3 tsf; 8-12 yrs. 4-5 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8,
          "max": 12
        },
        "indication": "Prophylaxis",
        "description": "Prophylaxis- under 1 year not recommended; 1-4 years. 2 tsf; 4-8 yrs. 3 tsf; 8-12 yrs. 4-5 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "Treatment",
        "description": "Treatment- Under 1 year, initial 1-2 tsf followed by 1 tsf after 6 hours, then 1 tsf daily for 4 times; 1-4 yrs. 3-4 tsf. + 2 tsf then 2 tsf daily for four days; 4-8 yrs. 4-6 tsf. + 3 tsf then 3 tsf daily for 4 days; 8-12 yrs. 6-9 tsf + 3 tsf then 4 tsf daily for 4 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "after 6 hours"
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "for 4 times"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 4
        },
        "indication": "Treatment",
        "description": "Treatment- Under 1 year, initial 1-2 tsf followed by 1 tsf after 6 hours, then 1 tsf daily for 4 times; 1-4 yrs. 3-4 tsf. + 2 tsf then 2 tsf daily for four days; 4-8 yrs. 4-6 tsf. + 3 tsf then 3 tsf daily for 4 days; 8-12 yrs. 6-9 tsf + 3 tsf then 4 tsf daily for 4 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 8
        },
        "indication": "Treatment",
        "description": "Treatment- Under 1 year, initial 1-2 tsf followed by 1 tsf after 6 hours, then 1 tsf daily for 4 times; 1-4 yrs. 3-4 tsf. + 2 tsf then 2 tsf daily for four days; 4-8 yrs. 4-6 tsf. + 3 tsf then 3 tsf daily for 4 days; 8-12 yrs. 6-9 tsf + 3 tsf then 4 tsf daily for 4 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8,
          "max": 12
        },
        "indication": "Treatment",
        "description": "Treatment- Under 1 year, initial 1-2 tsf followed by 1 tsf after 6 hours, then 1 tsf daily for 4 times; 1-4 yrs. 3-4 tsf. + 2 tsf then 2 tsf daily for four days; 4-8 yrs. 4-6 tsf. + 3 tsf then 3 tsf daily for 4 days; 8-12 yrs. 6-9 tsf + 3 tsf then 4 tsf daily for 4 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 6,
              "max": 9
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 410,
    "genericName": "Mefloquine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Chemoprophylaxis",
        "description": "Adult, 250mg each week starting 1-2 weeks before departure and continued for 4 weeks after leaving malarious area.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            },
            "notes": "each week starting 1-2 weeks before departure and continued for 4 weeks after leaving malarious area"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "condition": "15-19kg",
        "indication": "Chemoprophylaxis",
        "description": "Child, 2-5 years (15-19kg)quarter Adult dose, 6-8 years (20-30kg) half Adult dose, 9-11 years (31-45kg) three-quarters Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 62.5,
              "max": 62.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 8
        },
        "condition": "20-30kg",
        "indication": "Chemoprophylaxis",
        "description": "Child, 2-5 years (15-19kg)quarter Adult dose, 6-8 years (20-30kg) half Adult dose, 9-11 years (31-45kg) three-quarters Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9,
          "max": 11
        },
        "condition": "31-45kg",
        "indication": "Chemoprophylaxis",
        "description": "Child, 2-5 years (15-19kg)quarter Adult dose, 6-8 years (20-30kg) half Adult dose, 9-11 years (31-45kg) three-quarters Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 187.5,
              "max": 187.5
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Teatment",
        "description": "Adult, by mouth, 20mg/kg (of base) as a single dose (up to maximum 1.5gm) or preferably in 2 divided doses 6-8 hours apart.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "as a single dose, up to maximum 1.5gm"
          },
          {
            "type": "alternative",
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "in 2 divided doses 6-8 hours apart."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Teatment",
        "description": "Children, by mouth, 20mg/kg as a single dose or preferably in 2 divided doses 6-8 hours apart.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "as a single dose"
          },
          {
            "type": "alternative",
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "notes": "in 2 divided doses 6-8 hours apart."
          }
        ]
      }
    ]
  },
  {
    "serial": 411,
    "genericName": "Primaquine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "15mg (1 Tablet) daily for 14-21 days following a course of chloroquine or amodiaquine.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 21
            },
            "notes": "following a course of chloroquine or amodiaquine."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, half the Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 412,
    "genericName": "Pyrimethamine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "25-50mg, once a week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "notes": "once a week."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "5-12 yrs. Half Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 25
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "under 5 yrs. Quarter Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6.25,
              "max": 12.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 413,
    "genericName": "Quinine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult, 600mg every 8 hours for 7days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child, 1010mg/kg 8 hourly for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1010,
              "max": 1010
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "By Injection: If the patient is seriously ill, I.quinine should be given- loading dose 20mg/kg infuse over 4 hours; then maintenance dose- 10mg/kg infuse over 4 hours, every 8-12 hurly followed by oral quinine.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "duration": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "duration": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 414,
    "genericName": "Sulfadoxin + Pyrimethamine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "description": "Over 14 yrs. 2-3 Tablet As a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "description": "Child: under 4 yrs. ½ tab; 4-8 yrs. 1 tab; 9-12 yrs. 2 tab. All as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 8
        },
        "description": "Child: under 4 yrs. ½ tab; 4-8 yrs. 1 tab; 9-12 yrs. 2 tab. All as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9,
          "max": 12
        },
        "description": "Child: under 4 yrs. ½ tab; 4-8 yrs. 1 tab; 9-12 yrs. 2 tab. All as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "indication": "Prophylaxis",
        "description": "Over 14 yrs. 1 tab. Weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "indication": "Prophylaxis",
        "description": "under 4 yrs. ¼ Adult dose; 4/8 yrs. ½ Adult dose; 9/14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.25,
              "max": 0.25
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 8
        },
        "indication": "Prophylaxis",
        "description": "under 4 yrs. ¼ Adult dose; 4/8 yrs. ½ Adult dose; 9/14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 9,
          "max": 12
        },
        "indication": "Prophylaxis",
        "description": "under 4 yrs. ¼ Adult dose; 4/8 yrs. ½ Adult dose; 9/14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.75,
              "max": 0.75
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 415,
    "genericName": "Artemether/Lumefantrine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Genera",
        "description": "Genera- 4 Tablets at initial diagnosis and then after 8, 24 and 48 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "and then after 8, 24 and 48 hours"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Treatment of multi-drug resistant malaria and non-immune patients",
        "description": "Treatment of multi-drug resistant malaria and non-immune patients- A 3 day course comprising 4 Tablets at initial diagnosis, again after 8 hours, and then twice daily for the following two days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Stand-by Emergency treatment",
        "description": "Stand-by Emergency treatment- A 3 day course comprising 4 Tablets at the onset of symptoms, again after 8 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 3 Tablets at initial diagnosis  (depending on body-weight) and then after 8, 24 and 48 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "and then after 8, 24 and 48 hours"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Treatment of multi-drug-resistant malaria and non-immune patients",
        "description": "Treatment of multi-drug-resistant malaria and non-immune patients: A 3-day course comprising one to three Tablets at initial diagnosis (depending on body-weight)again after 8 hours and then twice daily on the following two days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Stand-by emergency treatment",
        "description": "Stand-by emergency treatment: a 3-day course comprising one to three Tablets at the onset of symptoms (depending on body-weight), again after 8 hours, and then twice daily on the following two days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 416,
    "genericName": "Artesunate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "4 days treatment- On the 1st day 2 Tablets twice and 2nd day onward 1 Tablet twice daily for remaining 4 days (i.e total 12 Tablets).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on the 1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 3
        },
        "description": "1-3 years; 5 days treatment- on the 1st day ½ Tablet twice and 2nd day onward ¼ Tablet twice daily for remaining 4 days (i.e total 3 Tablets).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on the 1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 5
        },
        "description": "4-5 years: 5 days treatment- on the 1st day 1 Tablet twice and 2nd day onward ½  Tablet twice daily for remaining 4 days (i.e total 6 Tablets)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on the 1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 years: 5 days treatment- on the 1st day 1 ½ Tablet twice, 2nd day 1 Tablet twice and 3rd day onward ½ Tablet twice daily for remaining 3 days (i.e total 8 Tablets).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on the 1st day"
          },
          {
            "type": "primaryFollowup",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            },
            "notes": "on the 2nd day"
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Prophylaxis",
        "description": "Prophylaxis: 100mg Tablet once a week, from 1 week before entering malarial areas, to 4 weeks after leaving the area.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 5,
              "max": 5
            },
            "notes": "from 1 week before entering malarial areas, to 4 weeks after leaving the area"
          }
        ]
      }
    ]
  },
  {
    "serial": 417,
    "genericName": "Sodium Stibogluconate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1ml (100mg) for hypersensitivity test, followedby 300-400mg after few hours, then 400-500mg daily I.M Injection for 10 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 400
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children, Dosage should be reduced proportionately to the body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Dosage should be reduced proportionately to the body weight."
          }
        ]
      }
    ]
  },
  {
    "serial": 418,
    "genericName": "Levamisole",
    "doseList": [
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 4
        },
        "description": "1-4 years 40-50mg; 5-12 years 80-100mg; Above 12 years and Adult, 120- 150mg ina single dose at night may be repeated after 1 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "1-4 years 40-50mg; 5-12 years 80-100mg; Above 12 years and Adult, 120- 150mg ina single dose at night may be repeated after 1 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "1-4 years 40-50mg; 5-12 years 80-100mg; Above 12 years and Adult, 120- 150mg ina single dose at night may be repeated after 1 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 150
            },
            "doseTime": {
              "night": true
            },
            "repeated": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "1-4 years 40-50mg; 5-12 years 80-100mg; Above 12 years and Adult, 120- 150mg ina single dose at night may be repeated after 1 week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 150
            },
            "doseTime": {
              "night": true
            },
            "repeated": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 4
        },
        "condition": "syrup",
        "description": "1-4yrs. 1 tsf. 5-12 yrs. 2 tsf; Above 12 years and Adult, 2 tsf in a single dose at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "condition": "syrup",
        "description": "1-4yrs. 1 tsf. 5-12 yrs. 2 tsf; Above 12 years and Adult, 2 tsf in a single dose at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "condition": "syrup",
        "description": "1-4yrs. 1 tsf. 5-12 yrs. 2 tsf; Above 12 years and Adult, 2 tsf in a single dose at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "syrup",
        "description": "1-4yrs. 1 tsf. 5-12 yrs. 2 tsf; Above 12 years and Adult, 2 tsf in a single dose at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 419,
    "genericName": "Mebendazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "roundworm, hookworm & whipworm",
        "description": "Adult and Children over 2 years, roundworm, hookworm & whipworm- 100mg twice daily (morning & evening) for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "indication": "roundworm, hookworm & whipworm",
        "description": "Adult and Children over 2 years, roundworm, hookworm & whipworm- 100mg twice daily (morning & evening) for 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "roundworm, hookworm & whipworm",
        "description": "Threadworm- 100mg in a single dose for all age, a second dose may e given after 2-3 wks. If not cured.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f not cured",
            "repeated": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 420,
    "genericName": "Albendazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in cases of Enterobius vermicularis, tricuris ftichiura, Ascaris lumbricoides, Ancylostoma Duodenale and Necator americanus.",
        "description": "Usual dose in both Adults and Children over 2 years of age, 400mg (two Tablets) as a single dose in cases of Enterobius vermicularis, tricuris ftichiura, Ascaris lumbricoides, Ancylostoma Duodenale and Necator americanus.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "indication": "in cases of Enterobius vermicularis, tricuris ftichiura, Ascaris lumbricoides, Ancylostoma Duodenale and Necator americanus.",
        "description": "Usual dose in both Adults and Children over 2 years of age, 400mg (two Tablets) as a single dose in cases of Enterobius vermicularis, tricuris ftichiura, Ascaris lumbricoides, Ancylostoma Duodenale and Necator americanus.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "indication": "in cases of Strongy loidiasis or Taeniasis albandazole",
        "description": "in cases of Strongy loidiasis or Taeniasis albandazole’ 400mg as a single dose should be given for 3 consecutive days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "in cases of Strongy loidiasis or Taeniasis albandazole",
        "description": "Children under 2 yrs. A single dose of 200mg is effective in common Injections. ",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "indication": "in hymenolepis nana infections",
        "description": "in hymenolepis nana infections a dose of 400mg for 3 consecutive days has been found to be effective. If the patients is not cured on follow-up after three weeks, a second course of treatment is invicated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 421,
    "genericName": "Pyrantel pamoate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Ascaris lumbricoides alone",
        "description": "Adult and Children over 6 months- Ascaris lumbricoides alone, a single dose of 5 mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "indication": "Ascaris lumbricoides alone",
        "description": "Adult and Children over 6 months- Ascaris lumbricoides alone, a single dose of 5 mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Mixed infections involving ascaris lumbricoides",
        "description": "Mixed infections involving ascaris lumbricoides, a single dose of 10 mg/kg is given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "indication": "Mixed infections involving ascaris lumbricoides",
        "description": "Mixed infections involving ascaris lumbricoides, a single dose of 10 mg/kg is given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Adult 625mg (5 tabs or 3 tsf) in a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 625,
              "max": 625
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 4
        },
        "description": "Children (over 6 months): 6 months to 4 yrs. 125mg (1 tab. Or 0.5 tsf); 4 to 10 yrs. 250mg (2 tabs or 1 tsf); 11 to 15 yrs. 375mg (3Tablet Or 1.5 tsf)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 10
        },
        "description": "Children (over 6 months): 6 months to 4 yrs. 125mg (1 tab. Or 0.5 tsf); 4 to 10 yrs. 250mg (2 tabs or 1 tsf); 11 to 15 yrs. 375mg (3Tablet Or 1.5 tsf)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 11,
          "max": 15
        },
        "description": "Children (over 6 months): 6 months to 4 yrs. 125mg (1 tab. Or 0.5 tsf); 4 to 10 yrs. 250mg (2 tabs or 1 tsf); 11 to 15 yrs. 375mg (3Tablet Or 1.5 tsf)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 375,
              "max": 375
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Children, before 6 months- not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 422,
    "genericName": "Niclosamide",
    "doseList": [
      {
        "indication": "Tenia solium",
        "description": "Tenia solium, 2 gm as a single dose after a light breakfast, followed by purgative after 2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after a light breakfast"
            },
            "notes": "followed by purgative after 2 hours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "Tenia solium",
        "description": "Child, up to 2 yrs. 500mg, 2-6 yrs. 1gm. As a single dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "indication": "Tenia solium",
        "description": "Child, up to 2 yrs. 500mg, 2-6 yrs. 1gm. As a single dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Tenia saginata and diphyllobothrium latum, as for Tenia solium",
        "description": "Tenia saginata and diphyllobothrium latum, as for Tenia solium but half the dose may be taken after breakfast and the remainder one hours followed by a purgative after a further 2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "half the dose may be taken after breakfast and the remainder one hours followed by a purgative after a further 2 hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 423,
    "genericName": "Diethyl Carbamazine",
    "doseList": [
      {
        "description": "6mg/kg body-wt daily in divided doses for 3-4 weeks. To minimize reactions treatment is commenced with a dose of 1mg/kg and increase gradually over 3 days to 6mg/kg. Close medical supervision is necessary particularly in the early phage of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "notes": "To minimize reactions treatment is commenced with a dose of 1mg/kg and increase gradually over 3 days to 6mg/kg."
          }
        ]
      }
    ]
  },
  {
    "serial": 423,
    "genericName": "Aspirin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "300-900mg in water, 4 to 6 hourly when necessary (usually after meal); maximum 4 gm. Daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 900
            },
            "additionalItem": {
              "temName": "water"
            },
            "repeated": {
              "condition": "when necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "maximum 4 gm. Daily."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Angina pectoris",
        "description": "Angina pectoris- 150-300mg daily (after meal).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 300
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Acute myocardial infarction",
        "description": "Acute myocardial infarction- 300mg stat & then 75-150mg daily for at least 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 150
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "description": "Child- under 12 years- not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 424,
    "genericName": "Paracetamol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: 0.5-1gm (1-2 Tablets or 4-8 tsf syrup) 4-6 times daily, upto a maximum of 4gm in 24 ours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            },
            "notes": "upto a maximum of 4gm in 24 ours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "condition": "syrup",
        "description": "Under 3 months, usually not recommended; Only can be given on doctor’s advice, as for post immunization pyrexia at 2 months age- 60mg (or ½ tsf) or 10mg/kg (or 5mg/kg if jaundiced); 3months to 1 year- 60-120mg (1/2-1 tsf); 1 to 5 years- 1-2 tsf; 6-12 years 2-4 tsf. These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 2
        },
        "condition": "syrup",
        "indication": "as for post immunization pyrexia",
        "description": "Under 3 months, usually not recommended; Only can be given on doctor’s advice, as for post immunization pyrexia at 2 months age- 60mg (or ½ tsf) or 10mg/kg (or 5mg/kg if jaundiced); 3months to 1 year- 60-120mg (1/2-1 tsf); 1 to 5 years- 1-2 tsf; 6-12 years 2-4 tsf. These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            }
          },
          {
            "type": "alternative",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "f jaundiced",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.25,
          "max": 1
        },
        "condition": "syrup",
        "description": "Under 3 months, usually not recommended; Only can be given on doctor’s advice, as for post immunization pyrexia at 2 months age- 60mg (or ½ tsf) or 10mg/kg (or 5mg/kg if jaundiced); 3months to 1 year- 60-120mg (1/2-1 tsf); 1 to 5 years- 1-2 tsf; 6-12 years 2-4 tsf. These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 120
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "condition": "syrup",
        "description": "Under 3 months, usually not recommended; Only can be given on doctor’s advice, as for post immunization pyrexia at 2 months age- 60mg (or ½ tsf) or 10mg/kg (or 5mg/kg if jaundiced); 3months to 1 year- 60-120mg (1/2-1 tsf); 1 to 5 years- 1-2 tsf; 6-12 years 2-4 tsf. These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "condition": "syrup",
        "description": "Under 3 months, usually not recommended; Only can be given on doctor’s advice, as for post immunization pyrexia at 2 months age- 60mg (or ½ tsf) or 10mg/kg (or 5mg/kg if jaundiced); 3months to 1 year- 60-120mg (1/2-1 tsf); 1 to 5 years- 1-2 tsf; 6-12 years 2-4 tsf. These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "condition": "syrup",
        "description": "Under 3 months, not recommended; Only  can be given on doctor’s advice, as for poft immudization pyrexia at 2 months age 40mg to 60mg (or 0.5-0.75ml) or 10mg/kg (or 5mg/kg if jaundiced); 3 months to 1 years- 60mg to 120mg (0.75-1.5ml); 1 to 2 years- 120mg (1.5ml). These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 2
        },
        "condition": "syrup",
        "indication": "as for poft immudization pyrexia",
        "description": "Under 3 months, not recommended; Only  can be given on doctor’s advice, as for poft immudization pyrexia at 2 months age 40mg to 60mg (or 0.5-0.75ml) or 10mg/kg (or 5mg/kg if jaundiced); 3 months to 1 years- 60mg to 120mg (0.75-1.5ml); 1 to 2 years- 120mg (1.5ml). These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 60
            }
          },
          {
            "type": "alternative",
            "condition": "f jaundiced",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.25,
          "max": 1
        },
        "condition": "syrup",
        "indication": "as for poft immudization pyrexia",
        "description": "Under 3 months, not recommended; Only  can be given on doctor’s advice, as for poft immudization pyrexia at 2 months age 40mg to 60mg (or 0.5-0.75ml) or 10mg/kg (or 5mg/kg if jaundiced); 3 months to 1 years- 60mg to 120mg (0.75-1.5ml); 1 to 2 years- 120mg (1.5ml). These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 120
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "condition": "syrup",
        "indication": "as for poft immudization pyrexia",
        "description": "Under 3 months, not recommended; Only  can be given on doctor’s advice, as for poft immudization pyrexia at 2 months age 40mg to 60mg (or 0.5-0.75ml) or 10mg/kg (or 5mg/kg if jaundiced); 3 months to 1 years- 60mg to 120mg (0.75-1.5ml); 1 to 2 years- 120mg (1.5ml). These doses may be repeated every 4-6 hours when necessary (maximum of 4 doses in 24 hours).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "repeated": {
              "condition": "f necessary",
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "condition": "Suppository",
        "indication": "as for poft immudization pyrexia",
        "description": "Suppository: Children below 5 years- 125-250mg suppository 2-3 times a day; 6-12 years 250-500mg suppository 2-3 times a day. In all cases suppository should be used rectally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "condition": "Suppository",
        "indication": "as for poft immudization pyrexia",
        "description": "Suppository: Children below 5 years- 125-250mg suppository 2-3 times a day; 6-12 years 250-500mg suppository 2-3 times a day. In all cases suppository should be used rectally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 425,
    "genericName": "Paracetamol + Caffeine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult & adolescents over 12 years: 1-2 Tablets in every 4 hours, or as heeded. Maximum dose is 8 Tablets in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "Maximum dose is 8 Tablets in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult & adolescents over 12 years: 1-2 Tablets in every 4 hours, or as heeded. Maximum dose is 8 Tablets in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "Maximum dose is 8 Tablets in 24 hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 426,
    "genericName": "Novalgin inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 gm. (4-6ml) daily I.M in divided doses. The solution should always be warmed to body temp. Before Injection. I.May be given slowly (2ml/min)if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 12
        },
        "description": "2-12 yrs 0.5-2 ml daily in divided doses or us required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 427,
    "genericName": "Morphine",
    "doseList": [
      {
        "route": "s.c or I.M Injection",
        "indication": "Acute pain",
        "description": "By s.c or by I.M Injection, 10mg every 4 hours (if necessary, 15mg for heavier paticnts).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 1
        },
        "indication": "Acute pain",
        "description": "up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5mg, 6-12 years 5-10mg. By slow I.V Injection, quarter to half corresponding I.M dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 12
        },
        "indication": "Acute pain",
        "description": "up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5mg, 6-12 years 5-10mg. By slow I.V Injection, quarter to half corresponding I.M dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Acute pain",
        "description": "up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5mg, 6-12 years 5-10mg. By slow I.V Injection, quarter to half corresponding I.M dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Acute pain",
        "description": "up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5mg, 6-12 years 5-10mg. By slow I.V Injection, quarter to half corresponding I.M dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "indication": "Pre-poerative sedation",
        "description": "By s.c or I.M Injection up to 10mg 60-90 minutes before operation",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 10
            },
            "connectionToSurgery": {
              "when": "before operation",
              "minute": {
                "min": 60,
                "max": 90
              }
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "indication": "Pre-poerative sedation",
        "description": "Child, by I.M Injection 150mcg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "indication": "Post-operative pain",
        "description": "By s.c or I.M Injection, 10mg every 2-4 hours (if necessary, 15mg for heavier patients)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 1
        },
        "indication": "Post-operative pain",
        "description": "Child up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5 mg, 6-12 years 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 1,
          "max": 12
        },
        "indication": "Post-operative pain",
        "description": "Child up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5 mg, 6-12 years 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Post-operative pain",
        "description": "Child up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5 mg, 6-12 years 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 5
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Post-operative pain",
        "description": "Child up to 1 month 150mcg/kg, 1-12 months 200mcg/kg, 1-5 years 2.5-5 mg, 6-12 years 5-10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "Myocardial injaretion",
        "description": "By slow I.V Injection (2mg/minute), 10mg followed by a further 5-10mg if necessary. Elderly or frail patients, reduce dose by half.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "nfusionRate": {
              "unit": "mg/minute",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ],
        "notes": "Elderly or frail patients, reduce dose by half."
      }
    ]
  },
  {
    "serial": 428,
    "genericName": "Nalbuphine",
    "doseList": [
      {
        "route": ".or I.M Injection",
        "condition": "70kg patients",
        "indication": "Moderate to severe pain",
        "description": "Moderate to severe pain: By I.V or I.M Injection 10-20mg for 70kg patients, adjusted as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "route": ".or I.M Injection",
        "ageGroup": "Child",
        "indication": "Moderate to severe pain",
        "description": "Moderate to severe pain: Child up to 0.3mg/kg repeated once or twice as necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 0.3
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".or I.M Injection",
        "indication": "in balanced anesthesia",
        "description": "in balanced anesthesia: by I.V or I.M Injection 0.1-0.2mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.1,
              "max": 0.2
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "Obstetrical analgesia during labor and delivery",
        "description": "Obstetrical analgesia during labor and delivery: By I.V Injection 0.3-1mg/kg over 10-15 minutes with maintenance dose of 0.25-0.5mg/kg in single I.administration as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 1
            },
            "duration": {
              "unit": "minute",
              "min": 10,
              "max": 15
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 0.25,
              "max": 0.5
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "ntra-operative analgesia",
        "description": "ntra-operative analgesia: By I.V Injection 0.25-0.5mg/kg at 30 minutes intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "Interval": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "route": ".or I.M Injection",
        "ageGroup": {
          "unit": "year",
          "min": 1.5,
          "max": 15
        },
        "description": "Children from 18 months to 15 years old: Usually 0.2mg/kg given preferably by I.V or I.M Injection. Maintenance doses may be given at intervals of 4 to 6 hours or the doses must be determined by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.2,
              "max": 0.2
            }
          },
          {
            "type": "maintenance",
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 429,
    "genericName": "Pentazocine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "25 to 100 mg 3 to 4 hourly after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Child- under 1 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 6
        },
        "description": "1-6 yrs. Use inj.",
        "subDoseList": [
          {
            "notes": "Use inj."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs. 25mg 3 to 4 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Moderate pain, 30 mg, severe pain 45-60 mg every 3-4 hours when necessary by soc or I.M or I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Moderate pain",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "primary",
            "condition": "severe pain",
            "unit": "mg",
            "amount": {
              "min": 45,
              "max": 60
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "slow I.V Injection",
        "indication": "Acute pulmonary oedema",
        "description": "By slow I.V Injection (2mg/minute)5-10mg",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "nfusionRate": {
              "unit": "mg/minute",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "s.c or I.M Injection",
        "indication": "Chronic pian",
        "description": "By s.c or I.M Injection 5-20mg regularly every 4 hours dose may be increased according to needs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 20
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 430,
    "genericName": "Pethidine",
    "doseList": [
      {
        "route": "njectoin",
        "ageGroup": "Adult",
        "indication": "General analgesia",
        "description": "General analgesia, 50-100 mg I.M daily four to six hourly or as required 25-50 mg by slow I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "by I.M Injection",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "alternative",
            "condition": "by slow I.V Injection",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Pre-anaesthetic",
        "description": "Pre-anaesthetic- 100mg I.M.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "obstetrical analgesia",
        "description": "obstetrical analgesia-50-100mg.I.M. repeat 1-3 hours later if necessary. Maximum 400mg. in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 3
            },
            "notes": "Maximum 400mg. in 24 hours."
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "General analgesia",
        "description": "General analgesia upto 1 years 1-2mg/kg; 1-5yrs. 12.5-25mg; 6-12 yrs 25-50mg by I.M inj. As or when required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "General analgesia",
        "description": "General analgesia upto 1 years 1-2mg/kg; 1-5yrs. 12.5-25mg; 6-12 yrs 25-50mg by I.M inj. As or when required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 12.5,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "General analgesia",
        "description": "General analgesia upto 1 years 1-2mg/kg; 1-5yrs. 12.5-25mg; 6-12 yrs 25-50mg by I.M inj. As or when required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 8
        },
        "indication": "Pre-anaesthetic",
        "description": "Pre-anaesthetic- uner 8 yrs. Not recommended; 8-12 yrs. 50mg intramuscularly.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8,
          "max": 12
        },
        "indication": "Pre-anaesthetic",
        "description": "Pre-anaesthetic- uner 8 yrs. Not recommended; 8-12 yrs. 50mg intramuscularly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 431,
    "genericName": "Tramadol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "By mouth, 50-100 mg not more often  than every 4 hours; total of more than 400mg daily not usually required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "max": 4
            },
            "notes": "Total of more than 400mg daily not usually required"
          }
        ]
      },
      {
        "route": "suppository",
        "ageGroup": "Adult",
        "description": "By suppository (rectal use), 50-100mg not more often than every 4 hours; Total of more than 400mg daily not usually required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "max": 4
            },
            "notes": "Total of more than 400mg daily not usually required"
          }
        ]
      },
      {
        "route": "I.M Injection or by I.injecton",
        "ageGroup": "Adult",
        "description": "By I.M Injection or by I.injecton (over 2-3 minutes or by I.V. Infusion, 50-100 mg every 4-6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "I.M Injection or by I.injecton",
        "ageGroup": "Adult",
        "indication": "Post-operative pain",
        "description": "Post-operative pain, 100mg initially then 50mg every 10-20 minutes if necessary during first hour to total maximum 250mg(including initial dose) in first hour, then 50-100mg every 4-6 hours, maximum 600mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "alternative",
            "condition": "f necessary during first hour",
            "unit": "mg",
            "amount": {
              "max": 250
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "minute",
              "min": 10,
              "max": 20
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "description": "By mouth, 50-100 mg not more often  than every 4 hours; total of more than 400mg daily not usually required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "max": 4
            },
            "notes": "Total of more than 400mg daily not usually required"
          }
        ]
      },
      {
        "route": "suppository",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "description": "By suppository (rectal use), 50-100mg not more often than every 4 hours; Total of more than 400mg daily not usually required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "max": 4
            },
            "notes": "Total of more than 400mg daily not usually required"
          }
        ]
      },
      {
        "route": "I.M Injection or by I.injecton",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "description": "By I.M Injection or by I.injecton (over 2-3 minutes or by I.V. Infusion, 50-100 mg every 4-6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "I.M Injection or by I.injecton",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "indication": "Post-operative pain",
        "description": "Post-operative pain, 100mg initially then 50mg every 10-20 minutes if necessary during first hour to total maximum 250mg(including initial dose) in first hour, then 50-100mg every 4-6 hours, maximum 600mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "alternative",
            "condition": "f necessary during first hour",
            "unit": "mg",
            "amount": {
              "max": 250
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "minute",
              "min": 10,
              "max": 20
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 432,
    "genericName": "Tramal Rtd.tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Usual dose 100mg twice daily, may be increased to 150-200mg twice daily if necessary; in most cases, 400mg daily orally is enough.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "in most cases, 400mg daily orally is enough."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 433,
    "genericName": "Rizatriptan",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "acute migraine attacks",
        "description": "Single doses of 5 or 10 mg of rizatriptan is indicated for the treatment of acute migraine attacks in Adults. Doses should be separated by at least 2 hours; No more than 30 mg should be given in any 24- hour period.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "notes": "No more than 30 mg should be given in any 24- hour period."
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "Interval": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "notes": "No more than 30 mg should be given in any 24- hour period."
          }
        ]
      }
    ]
  },
  {
    "serial": 434,
    "genericName": "Sumatriptan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "50mg (some patients may require 100mg) as soon as possible after onset; dose may be repeated after not less than 2 hours if migraine recurs; Maximum 300mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "condition": "f migraine recurs",
              "unit": "hour",
              "min": 2
            },
            "notes": "Maximum 300mg in 24 hours"
          },
          {
            "type": "alternative",
            "condition": "some patients may require",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "repeated": {
              "condition": "f migraine recurs",
              "unit": "hour",
              "min": 2
            },
            "notes": "Maximum 300mg in 24 hours"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "under 18 years not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "under 18 years not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 435,
    "genericName": "Zolmitriptan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose of zolmitriptan to teat a migraine attack is 2.5mg. If symptoms persist or return within 24 hours, a second dose has been shown to be effective. If a second dose is required, it should not be taken within 2 hours of the initial dose. If a patient dose not achieve satisfactory relief with 2.5 mg doses, sub sequent attacks can be treated with 5 mg doses of zolmitriptan. In the event of recurrent attacks, it is recommended that the total intake of zolmitriptan in a 24 hour period should not exceed 15 mg. Zolmitriptan is not indicated for prophylaxis of migraine.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "f a second dose is required, it should not be taken within 2 hours of the initial dose. , it is recommended that the total intake of zolmitriptan in a 24 hour period should not exceed 15 mg."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Use in Children: Safety and efficacy of Zolmitriptan in paediatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "elderly",
        "ageRange": {
          "unit": "year",
          "min": 65
        },
        "description": "Use in patients aged over 65 years:  Safety and efficacy of Zolmitriptan in individuals aged over 65 years have not been systematically evaluated.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "Patients with Hepatic impairment",
        "description": "Patients with Hepatic impairment: there is no clinical or pharmacokinetic experience in patients with Hepatic impairment treated with zolmitriptan.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 436,
    "genericName": "Ergotamine Tartrate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral, 2 mg at onset of attack repeated every 30 minutes if necessary; maximum 6mg daily (per attack), 10mg in any one week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "notes": "maximum 6mg daily (per attack), 10mg in any one week."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 437,
    "genericName": "Migrin tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablets at onset  of attac, repeated (if not relieved within half an hour) 1 Tablet every 30minutes if necessary. Maximum 6 Tablets daily; 10 in any one week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f not relieved within half an hour",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "notes": "Maximum 6 Tablets daily; 10 in any one week."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 438,
    "genericName": "Pizotifen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1.5mg at night or 500mcg 3 times daily, and if necessary, may be increased gradually to 3 mg daily; maximum Single dose 3 mg maximum daily dose may be up to 4.5mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "alternative",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "Single dose 3 mg maximum daily dose may be up to 4.5mg."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "up to 1.5mg daily in divided doses; maximum single dose at night 1mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 1.5
            },
            "notes": "maximum single dose at night 1mg."
          }
        ]
      }
    ]
  },
  {
    "serial": 439,
    "genericName": "Propranolol HCI",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "40mg 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, half Adult dose",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 440,
    "genericName": "Flunarizine",
    "doseList": [
      {
        "description": "The usual dose is 5 to 10mg daily, usually given at night to minimize the effects of drowsiness.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "max": 65
        },
        "indication": "Mignaine prophylazis",
        "description": "Mignaine prophylazis: Starting dose is 10mg daily (at night) for patients less than 65 years.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Maintenance treatment",
        "description": "Maintenance treatment: if a patitnt’s response is ssatisfactory and if a maintenance treatment is needed, the dose should be decreased so that each week the patient has 5 days treatment at the same daily dose and 2 successive drug free days. The recommended maximum dose is 10mg daily in Adults and 5 mg daily in Children (<40kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 10
            },
            "notes": "the dose should be decreased so that each week the patient has 5 days treatment at the same daily dose and 2 successive drug free days."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "<40kg",
        "indication": "Maintenance treatment",
        "description": "Maintenance treatment: if a patitnt’s response is ssatisfactory and if a maintenance treatment is needed, the dose should be decreased so that each week the patient has 5 days treatment at the same daily dose and 2 successive drug free days. The recommended maximum dose is 10mg daily in Adults and 5 mg daily in Children (<40kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 5
            },
            "notes": "the dose should be decreased so that each week the patient has 5 days treatment at the same daily dose and 2 successive drug free days."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Vertigo",
        "description": "Vertigo: The recommended maximum dose is 10mg daily in Adults and 5mg daily in Children (<40kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "<40kg",
        "indication": "Vertigo",
        "description": "Vertigo: The recommended maximum dose is 10mg daily in Adults and 5mg daily in Children (<40kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Epilepsy",
        "description": "Epilepsy: An optimal therapeutic dosage in epileptic patients receiving other antiepileptic drugs is 15mg to 20mg daily in Adults and 5 to 10mg daily in Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 20
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Epilepsy",
        "description": "Epilepsy: An optimal therapeutic dosage in epileptic patients receiving other antiepileptic drugs is 15mg to 20mg daily in Adults and 5 to 10mg daily in Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Peripheral vascular disorders",
        "description": "Peripheral vascular disorders: The recommended daily dose is 5-10mg  in the evening .",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 441,
    "genericName": "Benzocaine",
    "doseList": [
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Apply to the affected area up to 4 times daily or as directed by the physician. Children under 12 years of age: Should be supervised in the use of this product.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Apply to the affected area up to 4 times daily or as directed by the physician. Children under 2 years of age: Should be consulted with a physician or dentist prior to the use of this product. A small amount of gel should be applied either by the tip of a finger or by the applicator to the affected area and wait for 2-3 minutes for the action of the drug. When pain is gone mouth cavity should be rinsed with water.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 442,
    "genericName": "Penrif 15 cream",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply a thin layer of cream to the affected area a gently massage until cream disappears; apply not more than 3 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "max": 4
            },
            "notes": "Apply a thin layer of cream to the affected area a gently massage until cream disappears"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Apply a thin layer of cream to the affected area a gently massage until cream disappears; apply not more than 3 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "max": 4
            },
            "notes": "Apply a thin layer of cream to the affected area a gently massage until cream disappears"
          }
        ]
      }
    ]
  },
  {
    "serial": 443,
    "genericName": "Camphor + Eucalyptus Oil +menthol + thymol",
    "doseList": [
      {
        "description": "Rub on gently for 3-5 minutes on the chest & back 2-3 times daily & cover the rubbed area with warm clothes.",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "minute",
              "min": 3,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "condition": "Use as inhalation",
        "description": "Use as inhalation- 1 tsf of ointment tobe dissolved in boiled water and inhale the steam by mouth or nose as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "boiled water"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 444,
    "genericName": "Gaco Rub Oint. ",
    "doseList": [
      {
        "description": "Rub on gently 2-3 times daily or as required",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 445,
    "genericName": "Aceclofenac",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The maximum recommended dose is 200 mg daily, taken in two divided dose in the morning and in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "The maximum recommended dose is 200 mg daily, taken in two divided dose in the morning and in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: There is no clinical data  on the use of aceclofenac in Children.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "Hepatic insufficiency",
        "description": "Hepatic insufficiency: The dose of aceclofenac should be reduced in patients with Hepatic impairment. An initial daily dose of 100mg should be administered.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 446,
    "genericName": "Celecoxib",
    "doseList": [
      {
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- The recommended oral dose is 100-200mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Osteoarthritis",
        "description": "Osteoarthritis- The recommended oral dose is 200mg per day as a single dose or as 100mg twice daily. These doses can be given without regard to timing of meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 200,
              "max": 200
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Familial adenomatous polyposis (FAP)",
        "description": "Familial adenomatous polyposis (FAP)- To reduce the number of adenomatous colorectal polyps, the recommended oral dose is 400mg twice daily to be taken with food. Usual medical care for FAP patients should be continued with 100mg dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "Children, Not recommended below the age of 18 years.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 447,
    "genericName": "Diclofenac Sodium",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "By mouth: 75-150mg as enteric-coated (E.C)Tablet daily in 2 or 3 divided doses, preferably after food. Dosage of TR (timed release) capsule or SR (Sustained release) capsule or Tablet- 100mg (1 capsule or Tablet) once daily, preferably with food.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "as enteric-coated (E.C)Tablet",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 150
            },
            "connectionToMeal": {
              "when": "after food"
            }
          },
          {
            "type": "primary",
            "condition": "Dosage of TR (timed release) capsule or SR (Sustained release) capsule or Tablet",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "Acute exacerbations and post-operative",
        "description": "Acute exacerbations and post-operative- 75mg once daily (twice daily in severe cases) for maximum of 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 2
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "Ureteric colic",
        "description": "Ureteric colic,75mg then a further 75mg after 30 minutes if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "notes": "after 30 minutes"
          }
        ]
      },
      {
        "route": "Gel preparation",
        "description": "Apply 3-4 tiems daily with gentle massage.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "suppository",
        "description": "By rectum as suppositories: 75-150mg daily in divided doses. Maximum total  daily dose by any route 150mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "mouth or rectum",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "indication": "juvenile arthritis",
        "description": "1-12 years, juvenile arthritis, by mouth or by rectum, 1-3mg/kg daily in divided doses (25mg Tablets, 12.5mg and 25mg suppositories only).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth or rectum",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "indication": "juvenile arthritis",
        "description": "1-12 years, juvenile arthritis, by mouth or by rectum, 1-3mg/kg daily in divided doses (25mg Tablets, 12.5mg and 25mg suppositories only).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 448,
    "genericName": "Diclofenac free acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended initial daily dosage is 2-3 dispersible Tablets.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in milder cases",
        "description": "in milder cases & for Children over 14 years of age, 2 dispersible Tablets daily are usually sufficient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 14
        },
        "indication": "in milder cases",
        "description": "in milder cases & for Children over 14 years of age, 2 dispersible Tablets daily are usually sufficient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in dysmenorrhoea",
        "description": "in dysmenorrhoea 2 to maximum 4 Tablets (if necessary) may be given per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 14
        },
        "description": "Not recommended below 14 years of age.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 449,
    "genericName": "Diclofenac potassium",
    "doseList": [
      {
        "description": "Usual dosage, 100-150mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 150
            }
          }
        ]
      },
      {
        "indication": "in mild cases",
        "description": "in mild cases, 75-150mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 150
            }
          }
        ]
      },
      {
        "indication": "in primary dysmenorrhoea",
        "description": "in primary dysmenorrhoea, initially 50-100mg daily in divided doses; if necessary, dose can be increased during the course of several cycles to a maximum of 200mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "notes": "If necessary, dose can be increased during the course of several cycles to a maximum of 200mg/day."
          }
        ]
      }
    ]
  },
  {
    "serial": 450,
    "genericName": "Diclofenac Diethyl Amonium salt",
    "doseList": [
      {
        "description": "Apply 3-4 times daily with gentle massage. Therapy should be reviewed after 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 451,
    "genericName": "Etoricoxib",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Arthritis/osteoarthritis",
        "description": "Arthritis/osteoarthritis- 60mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- 90mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 90
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Analgesia, acute pain associated with dental surgery",
        "description": "Analgesia, acute pain associated with dental surgery- 120mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Primary dysmenorrhoea, chronic musculo-skeletal pain, including chronic lowback pain",
        "description": "Primary dysmenorrhoea, chronic musculo-skeletal pain, including chronic lowback pain-60mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "indication": "Arthritis/osteoarthritis",
        "description": "Arthritis/osteoarthritis- 60mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- 90mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 90
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "indication": "Analgesia, acute pain associated with dental surgery",
        "description": "Analgesia, acute pain associated with dental surgery- 120mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "indication": "Primary dysmenorrhoea, chronic musculo-skeletal pain, including chronic lowback pain",
        "description": "Primary dysmenorrhoea, chronic musculo-skeletal pain, including chronic lowback pain-60mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 452,
    "genericName": "Ibuprofen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "600-1200 mg daily in divided doses. Maximum 2400mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 600,
              "max": 1200
            },
            "notes": "Maximum 2400mg daily"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "description": "Usual dose 20mg/kg in divided doses, wich may be achieved as: 1-2 yrs. Half tsf 3-4 times daily; 3-7 yrs. 1 tsf 3-4 times daily; 8-12 yrs. 2 tsf 3-4 times daily; Below 1 year, not indicated. Dose should not exceed 500mg daily for Children weighing less than 30kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "description": "Usual dose 20mg/kg in divided doses, wich may be achieved as: 1-2 yrs. Half tsf 3-4 times daily; 3-7 yrs. 1 tsf 3-4 times daily; 8-12 yrs. 2 tsf 3-4 times daily; Below 1 year, not indicated. Dose should not exceed 500mg daily for Children weighing less than 30kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 8,
          "max": 12
        },
        "description": "Usual dose 20mg/kg in divided doses, wich may be achieved as: 1-2 yrs. Half tsf 3-4 times daily; 3-7 yrs. 1 tsf 3-4 times daily; 8-12 yrs. 2 tsf 3-4 times daily; Below 1 year, not indicated. Dose should not exceed 500mg daily for Children weighing less than 30kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Usual dose 20mg/kg in divided doses, wich may be achieved as: 1-2 yrs. Half tsf 3-4 times daily; 3-7 yrs. 1 tsf 3-4 times daily; 8-12 yrs. 2 tsf 3-4 times daily; Below 1 year, not indicated. Dose should not exceed 500mg daily for Children weighing less than 30kg.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "condition": "Children weighing less than 30kg.",
        "description": "Usual dose 20mg/kg in divided doses, wich may be achieved as: 1-2 yrs. Half tsf 3-4 times daily; 3-7 yrs. 1 tsf 3-4 times daily; 8-12 yrs. 2 tsf 3-4 times daily; Below 1 year, not indicated. Dose should not exceed 500mg daily for Children weighing less than 30kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 500
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 453,
    "genericName": "Indomethacin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral, 50-200mg daily in divided doses with food, milk or antacid.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 200
            },
            "additionalItem": {
              "temName": "food, milk or antacid"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Dysmenorrhoea",
        "description": "Dysmenorrhoea, up to 75mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 75
            }
          }
        ]
      },
      {
        "route": "Suppository",
        "ageGroup": "Adult",
        "description": "Suppository, 1 at night plus one in the morning if necessary or 1 at night supplemented during the day with caps or suspension. Upto a total of 200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "suppository",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true,
              "morning": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 454,
    "genericName": "Ketoprofen",
    "doseList": [
      {
        "condition": "Oral preparations",
        "indication": "rheumatic disease",
        "description": "rheumatic disease, 100-200mg daily in 2-4 divided doses with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "condition": "Oral preparations",
        "indication": "Pain & dysmenorrhoea",
        "description": "Pain & dysmenorrhoea, 50mg upto 3 times daily with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "condition": "CR/SR/TR capsules",
        "description": "CR/SR/TR capsules:100-200mg capsule once daily with food. These preparations are more advantageous, because, acid environment in the stomach prevents release of active drug, thus minumising Gastric irritation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "condition": "I.M injecton",
        "description": "By deep I.M injecton into the gluteal muscle: 50-100mg every 4 hours (maximum 200mg in 24 hours) for upto 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "notes": "maximum 200mg in 24 hours"
          }
        ]
      },
      {
        "condition": "suppository",
        "indication": "Rheumatic disease",
        "description": "Rheumatic disease, 100mg at bed time. Combined oral & rectal treatment, maximum total daily dose 200 mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "doseTime": {
              "bedtime": true
            },
            "notes": "Combined oral & rectal treatment, maximum total daily dose 200 mg."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "condition": "Use of gel preparation",
        "ageGroup": "Adult",
        "description": "Use of gel preparation: Adults & Children over 5 years- to be applied several times daily to skin in the painful & inflamed region. Apply gently but massage well to ensure gel penetration. Should be avoided in Children under 5 years of age. The gel can be used with occlusive dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "to be applied several times daily to skin in the painful & inflamed region."
          }
        ]
      },
      {
        "condition": "Use of gel preparation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Use of gel preparation: Adults & Children over 5 years- to be applied several times daily to skin in the painful & inflamed region. Apply gently but massage well to ensure gel penetration. Should be avoided in Children under 5 years of age. The gel can be used with occlusive dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "to be applied several times daily to skin in the painful & inflamed region."
          }
        ]
      },
      {
        "condition": "Use of gel preparation",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Use of gel preparation:  Should be avoided in Children under 5 years of age.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 455,
    "genericName": "Mefenamic acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "50mg 3 times daily after food; In case of menorrhagia starting on first day of menses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            },
            "notes": "In case of menorrhagia starting on first day of menses."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Use paediatric suspension. Under 6 months not recommended; Over 6 months, 25 mg/kg daily in divided doses for not longer than 7 days, except in juvenile chronic arthritis (still’s disease), after food.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 6
        },
        "description": "Use paediatric suspension Under 6 months not recommended; Over 6 months, 25 mg/kg daily in divided doses for not longer than 7 days, except in juvenile chronic arthritis (still’s disease), after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "treatmentPeriod": {
              "condition": "except in juvenile chronic arthritis (still’s disease)",
              "unit": "day",
              "max": 7
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 456,
    "genericName": "Meloxicam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Osteoarthritis",
        "description": "Osteoarthritis-7.5mg/day; If necessary, may be increased 1o 15mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg/day",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- 15mg/kdy; in elderly patients the recommended dose for long term treatment is 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Rheumatoid arthritis",
        "description": "Rheumatoid arthritis- 15mg/kdy; in elderly patients the recommended dose for long term treatment is 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Ankylosing spondylitis",
        "description": "15mg/day; in elderly patients the recommended dose is 7.5 mg/day. Do not exceed the dose of 15mg/day. The total daily amount should be taken as a single dose. Patients with increased risks for adverse reactions should start treatment with 7.5mg/day. In dailysis patients with severe renal failure the dose should not exceed 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Ankylosing spondylitis",
        "description": "15mg/day; in elderly patients the recommended dose is 7.5 mg/day. Do not exceed the dose of 15mg/day. The total daily amount should be taken as a single dose. Patients with increased risks for adverse reactions should start treatment with 7.5mg/day. In dailysis patients with severe renal failure the dose should not exceed 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 7.5,
              "max": 7.5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Ankylosing spondylitis",
        "secondaryIndication": "Patients with increased risks for adverse reactions",
        "description": "15mg/day; in elderly patients the recommended dose is 7.5 mg/day. Do not exceed the dose of 15mg/day. The total daily amount should be taken as a single dose. Patients with increased risks for adverse reactions should start treatment with 7.5mg/day. In dailysis patients with severe renal failure the dose should not exceed 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 7.5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Ankylosing spondylitis",
        "secondaryIndication": "in dailysis patients with severe renal failure",
        "description": "15mg/day; in elderly patients the recommended dose is 7.5 mg/day. Do not exceed the dose of 15mg/day. The total daily amount should be taken as a single dose. Patients with increased risks for adverse reactions should start treatment with 7.5mg/day. In dailysis patients with severe renal failure the dose should not exceed 7.5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "max": 7.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 18
        },
        "description": "The pharmacokinetics of meloxicam in paediatric patients under 18 years of age has not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 457,
    "genericName": "Naproxen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "350-500mg twice daily or 1gm once daily with meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 350,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Gout",
        "description": "Gout, 750mg initially then 250mg eight hourly until attack has passed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "condition": "until attack has passed",
              "unit": "hour",
              "min": 8,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Juvenile arthritis",
        "description": "Juvenile arthritis, 10mg/kg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Acute musculo-skeletal disorders",
        "description": "Acute musculo-skeletal disorders, 500mg initially, then 250mg every 6-8 hours as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Under 5 years, not recommended; 5-12 yrs. 10mg/kg body-wt. daily in two divided doses.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 12
        },
        "description": "Under 5 years, not recommended; 5-12 yrs. 10mg/kg body-wt. daily in two divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 458,
    "genericName": "Piroxicam",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "20mg daily as a single dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Musculo-skeletal disorders",
        "description": "Musculo-skeletal disorders, initially 40mg, daily for 2 days then 20mg.daily for 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Gout",
        "description": "Gout, initially 400mg, as a single dose, then 40mg, daily in single or divided doses for next 4-6 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Juvenile arthritis",
        "description": "Juvenile arthritis, less than 15kg body wt. 5mg daily; 16-35kg 10mg daily; 20-45kg 15mg daily; Over 46kg, 20mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "less than 15kg body wt.",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "primary",
            "condition": "16-35kg body wt.",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primary",
            "condition": "20-45kg body wt.",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          },
          {
            "type": "primary",
            "condition": "Over 46kg body wt.",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 459,
    "genericName": "Valdecoxib",
    "doseList": [
      {
        "indication": "Osteoarthritis and Adult rheumatoid arthritis",
        "description": "Osteoarthritis and Adult rheumatoid arthritis- the recommended dose of valdecoxib for the relief of the signs and symptoms of arthritis is 10mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Primary dysmenorrhoea",
        "description": "Primary dysmenorrhoea- The recommended dose is 20mg twice daily, or as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "notes": "or as required"
          }
        ]
      }
    ]
  },
  {
    "serial": 460,
    "genericName": "Tenoxicam",
    "doseList": [
      {
        "description": "20mg at the same time of day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "at the same time of day"
          }
        ]
      }
    ]
  },
  {
    "serial": 461,
    "genericName": "Benzydamine",
    "doseList": [
      {
        "description": "4 caps. Daily initially, followed by 2-3 caps. Daily after meal",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 4,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 463,
    "genericName": "Hydroxychloroquine",
    "doseList": [
      {
        "indication": "Acute and chronic rheumatoid arthritis",
        "description": "Acute and chronic rheumatoid arthritis: 400 to 600mg daily. When good response is obtained (usually 4 to 8 weeks), dose can be reduced to 50%.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 600
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "When good response is obtained",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 300
            }
          }
        ]
      },
      {
        "indication": "Systemic Lupus Erythematosus (SLE)",
        "description": "Systemic Lupus Erythematosus (SLE): 400mg once or twice daily for several weeks or months depending on response of the patients. Maintenance dose is 200 to 400mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "notes": "for several weeks or months depending on response of the patients."
            }
          },
          {
            "type": "maintenance",
            "condition": "When good response is obtained",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Malaria",
        "description": "Adults, as initial dose of 800mg followed by 400mg in 6-8 hours and 400mg on each of two consecutive days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 800,
              "max": 800
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 400,
              "max": 400
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Malaria",
        "description": "Children, a total dose calcutating 25mg/kg is administered in 3 days as follows: First dose-10mg base/kg (but not exceeding a single dose of 620mg base); Second dose- 5mg base/kg (but not exceeding a single dose of 310mg base) 6 hours after first dose; Third dose-5mg base/kg 18 hours after second dose; Fourth dose- 5mg base/kg 24 hours after third dose. Hydroxychloroquine sulphate BP 200mg equivalent to 155mg of base.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First dose",
            "unit": "mg base/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Second dose",
            "unit": "mg base/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "6 hours after first dose"
          },
          {
            "type": "primaryFollowup",
            "condition": "Third dose",
            "unit": "mg base/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "18 hours after second dose"
          },
          {
            "type": "primaryFollowup",
            "condition": "Fourth dose",
            "unit": "mg base/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "24 hours after third dose"
          }
        ]
      }
    ]
  },
  {
    "serial": 464,
    "genericName": "Leflunomide",
    "doseList": [
      {
        "description": "Initially a loading dose of 100mg once daily for 3 days.Then a maintenance dose of 20mg once daily. The dose may be decreased to 10mg daily if tolerability issues arise.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenanceFollowup",
            "condition": "If tolerability issues arise",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 465,
    "genericName": "Allopurinol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: Initially 100-300mg daily in divided doses;Maintenance, 200-600mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 300
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 600
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 466,
    "genericName": "Probenecid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "250mg twice daily after food for first week, then increase after a week to 500 mg. twice daily then up to 2gm daily in 2-4 divided doses according to plasma uric acid concentration and reduce for maintenance.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after food"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "gm",
            "amount": {
              "max": 2
            },
            "notes": "daily in 2-4 divided doses according to plasma uric acid concentration and reduce"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 467,
    "genericName": "Neostigmine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult- Neostigmine bromide 75-300mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 300
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "neonate",
        "description": "Child- Neonate, 1-5mg 4 hourly; others, 15-60mg daily divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 5
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Child- Neonate, 1-5mg 4 hourly; others, 15-60mg daily divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 60
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Adult- Neostigmine methyl sulplate 1-2.5 mg I.M or s.c daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2.5
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neonate",
        "description": "Child- Neonate, 0.05-0.25mg I.M or s.c 4 hourly; other 0.2-0.5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.05,
              "max": 0.25
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child- Neonate, 0.05-0.25mg I.M or s.c 4 hourly; other 0.2-0.5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.2,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 468,
    "genericName": "Baclofen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Starting dose-15mg/day; Maintenance dose- 30mg to 80mg/day in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 80
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Starting dose- 0.3mg/kg/day; Maintenance dose- 0.75mg to 2.5mg/kg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 0.3
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 0.75,
              "max": 2.5
            }
          }
        ]
      },
      {
        "indication": "Patients under haemodailysis",
        "description": "Patients under haemodailysis- 5mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 469,
    "genericName": "Eperison",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "usually 150mg daily in 3 divided doses after each meal; the dosage should be adjusted depending on the patient’s age and severity of symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "connectionToMeal": {
              "when": "after each meal"
            },
            "notes": "the dosage should be adjusted depending on the patient’s age and severity of symptoms."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: Yet not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 470,
    "genericName": "Tizanidine",
    "doseList": [
      {
        "indication": "Painful muscle spasm",
        "description": "Painful muscle spasm- 2mg thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Spasticity due to neurological disorders",
        "description": "Spasticity due to neurological disorders- maximum initial dose 6mg/day in 3 divided doses, then increase stepwise to 12 mg to 36mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 6
            },
            "notes": "then increase stepwise to 12 mg to 36mg/day"
          }
        ]
      }
    ]
  },
  {
    "serial": 471,
    "genericName": "Cyclobenzaprine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult and adolescents of age 15 years and over: The usual dose is 10mg 3 times daily orally. The daily dose should not exceed 60mg. Treatment for more than 2 or 3 weeks is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 15
        },
        "description": "Adult and adolescents of age 15 years and over: The usual dose is 10mg 3 times daily orally. The daily dose should not exceed 60mg. Treatment for more than 2 or 3 weeks is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Dose in elderly: Therapy with cyclobenzaprine in the elderly should be initiated with a 5mg dose and titrated slowly upword.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "indication": "Hepatic impairment",
        "secondaryIndication": "mild Hepatic impairment",
        "description": "Dose in Hepatic impairment: Cyclobenzaprine should  be used with caution in subjects with mild  Hepatic impairment starting with a 5mg dose and titrating slowly upward. The use of cyclobenzaprine in subjects with moderate to severe impairment is not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "indication": "Hepatic impairment",
        "secondaryIndication": "with moderate to severe impairment",
        "description": "Dose in Hepatic impairment: Cyclobenzaprine should  be used with caution in subjects with mild  Hepatic impairment starting with a 5mg dose and titrating slowly upward. The use of cyclobenzaprine in subjects with moderate to severe impairment is not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 15
        },
        "description": "Peadiatric use: Safety and effectiveness of cyclobenzaprine hydrochloride in peadiatric patients below 15 years of age have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 472,
    "genericName": "Bromelains, Trypsin + Protease",
    "doseList": [
      {
        "description": "Initially 2 Tablets 3 times daily;Maintenance 1 Tablet 3 times daily preferably before meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 473,
    "genericName": "Chlorpheniramine maleate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral, 12mg daily in divided (3 or 4) doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Parenteral, in allergic emergencies",
        "description": "Parenteral, in allergic emergencies, by s.c, I.M or slow I.V Injection, 10-20mg to a maximum of 40 mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "notes": "maximum of 40 mg in 24 hours."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Oral, under 6 yrs. Use syrup; upto 1 yr. 1mg (2.5ml) twice daily; 1-5 yrs. 1-2mg (2.5-5ml) 3 times daily; over 5 yrs. 2-4mg (5-10ml)3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "under 6 yrs. Use syrup"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Oral, under 6 yrs. Use syrup; upto 1 yr. 1mg (2.5ml) twice daily; 1-5 yrs. 1-2mg (2.5-5ml) 3 times daily; over 5 yrs. 2-4mg (5-10ml)3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "under 6 yrs. Use syrup"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Oral, under 6 yrs. Use syrup; upto 1 yr. 1mg (2.5ml) twice daily; 1-5 yrs. 1-2mg (2.5-5ml) 3 times daily; over 5 yrs. 2-4mg (5-10ml)3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "under 6 yrs. Use syrup"
          }
        ]
      }
    ]
  },
  {
    "serial": 474,
    "genericName": "Cyproheptadine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Usual Adult & adolescent dose: 4mg every 8 hours, the dosage may be increased as neede. For most patients the therapeutic range is 4-20mg a day. However, doses up to 32 mg a day have been used occasionally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "year",
              "min": 8,
              "max": 8
            },
            "notes": "For most patients the therapeutic range is 4-20mg a day. However, doses up to 32 mg a day have been used occasionally."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "description": "Usual Adult & adolescent dose: 4mg every 8 hours, the dosage may be increased as needed. For most patients the therapeutic range is 4-20mg a day. However, doses up to 32 mg a day have been used occasionally.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "year",
              "min": 8,
              "max": 8
            },
            "notes": "For most patients the therapeutic range is 4-20mg a day. However, doses up to 32 mg a day have been used occasionally."
          }
        ]
      },
      {
        "indication": "Appetite stimulation",
        "description": "Appetite stimulation: 4mg 3 times a day with meals (treatment period to promote weight gain should not exceed six months).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with meals"
            },
            "treatmentPeriod": {
              "condition": "treatment period to promote weight gain",
              "unit": "month",
              "max": 6
            }
          }
        ]
      },
      {
        "indication": "Vascular headache suppression",
        "description": "Vascular headache suppression: Initial dose, 4 mg at the start of the attack, repeated after thirty minutes if necessary; Maintenance, 4mg every four to six hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "repeated after thirty minutes if necessary",
            "repeated": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "description": "Usual paediatric dose: Children 2-6 years of age; 2mg every 8-12hours as needed, not to exceed 12mg per day. Children 6-14 years of age; 4mg every 8-12 hours as needed, not to exceed 16mg per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "notes": "not to exceed 12mg per day"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 14
        },
        "description": "Usual paediatric dose: Children 2-6 years of age; 2mg every 8-12hours as needed, not to exceed 12mg per day. Children 6-14 years of age; 4mg every 8-12 hours as needed, not to exceed 16mg per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "notes": "not to exceed 16mg per day"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "indication": "Appetite stimulation",
        "description": "Appetite stimulation: Children 2-6 years of age: initially 2mg 2-3 times  day with meals, the dosage may be increased if necessary, but not to exceed 8mg a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "max": 8
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 14
        },
        "indication": "Appetite stimulation",
        "description": "Appetite stimulation: Children 6-14 years of age: initially 2mg every 3-4 times a day with meals; The usual maintenance dose is 4 mg 2-3 times a day, but not to exceed 16mg a day (treatment period to promote weight gain should not exceed 3 months).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          },
          {
            "type": "maintenance",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "condition": "to promote weight gain",
              "unit": "month",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "Appetite stimulation",
        "description": "Below age 2 years- not recommenede.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 475,
    "genericName": "Dimethothiazine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "20-40mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Child: under 6 yrs. Not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs. 10-12mg twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 12
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 476,
    "genericName": "Diphenhydramine HCI",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "25mg 3 times daily with 50mg at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalDose": {
              "unit": "mg",
              "min": 50,
              "max": 50,
              "doseTime": {
                "bedtime": true
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Child: Before 6 yrs. Not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs. 25mg 3 to 4 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 477,
    "genericName": "Benamin Syp.",
    "doseList": [
      {
        "description": "2 tsf 3 times daily with 4 tsf at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalDose": {
              "unit": "t.s.f",
              "min": 4,
              "max": 4,
              "doseTime": {
                "bedtime": true
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 478,
    "genericName": "Hydroxyzine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Generalized anxiety disorders",
        "description": "Generalized anxiety disorders- The usual dose for the short-term management of anxiety is 50mg per day at bedtime or in divided doses; Increased if necessary to 50-100mg four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Symptomatic treatment of various allergic manifestations",
        "secondaryIndication": "Pruritus",
        "description": "Symptomatic treatment of various allergic manifestations- Pruritus, 10-25mg is initiated at bedtime and increased if necessary it 10-25mg four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Symptomatic treatment of various allergic manifestations",
        "secondaryIndication": "Chronic urticaria",
        "description": "Symptomatic treatment of various allergic manifestations- Chronic urticaria, usual starting dose is 1025mg four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Symptomatic treatment of various allergic manifestations",
        "secondaryIndication": "Atopic dermatitis",
        "description": "Symptomatic treatment of various allergic manifestations- Atopic dermatitis, 10mg two times daily to 25mg four times daily and increased if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Symptomatic treatment of various allergic manifestations",
        "secondaryIndication": "Acute contact dermatitis",
        "description": "Symptomatic treatment of various allergic manifestations- Acute contact dermatitis, 10-25mg two to four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "For Children over 6 years- the initial dose is 15-25mg daily, increased if necessary to 50-100mg daily in divided doses; 6 months to 6 years- the initial dose is 5-15mg daily, increased if necessary to 50mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 25
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 6
        },
        "description": "For Children over 6 years- the initial dose is 15-25mg daily, increased if necessary to 50-100mg daily in divided doses; 6 months to 6 years- the initial dose is 5-15mg daily, increased if necessary to 50mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 15
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "The pre-and post-operative sedative dose",
        "description": "The pre-and post-operative sedative dose in Children is 600mcg/kg body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 600,
              "max": 600
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 479,
    "genericName": "Mebhydrolin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: 50 or 100mg 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Child: up to 1 yr. 50-100mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "2-5 yrs, 50-150 mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 150
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "description": "5-10 yrs. 100-200mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 480,
    "genericName": "Pheniramine maleate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral- 75mg at bedtime. If patients suffering in the daytime, 75mg may be taken in the morning. In severe cases 150mg at night or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "doseTime": {
              "bedtime": true
            }
          },
          {
            "type": "alternative",
            "condition": "f patients suffering in the daytime",
            "unit": "mg",
            "amount": {
              "min": 75,
              "max": 75
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "in acute conditions",
        "description": "in acute conditions, 25 to 50mg I.M. or slow I.once or twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Oral- syrup is preparable; upto 1 year 7. 5mg 2 3 times daily; 1-5 yrs 7.5-15mg 2 to3 times daily; 6-12 yrs. 15 to 22.55mg 2 to 3 times dail.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Oral- syrup is preparable; upto 1 year 7. 5mg 2 3 times daily; 1-5 yrs 7.5-15mg 2 to3 times daily; 6-12 yrs. 15 to 22.55mg 2 to 3 times dail.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 15
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Oral- syrup is preparable; upto 1 year 7. 5mg 2 3 times daily; 1-5 yrs 7.5-15mg 2 to3 times daily; 6-12 yrs. 15 to 22.55mg 2 to 3 times dail.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 22.55
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Injection- 12.5 to 25mg 1-2 times I.M or slow I.daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12.5,
              "max": 25
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 481,
    "genericName": "Promethazine HCI",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Oral- 10 to 20 mg. 2 or 3 times daily, or 25mg at night increased to 50mg if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 20
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 25
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "25 to 50mg. deep I.M. inj. Or slow I.V Injection after dilution.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Oral- under 6 months not recommended; 6 months- 1 yrs. 5-10mg; 1-5 yrs. 5-15mg; Over 5 yrs.10-25mg. If two doses in 24 hours are required, use lower amount stated.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 0.5,
          "max": 1
        },
        "description": "Oral- under 6 months not recommended; 6 months- 1 yrs. 5-10mg; 1-5 yrs. 5-15mg; Over 5 yrs.10-25mg. If two doses in 24 hours are required, use lower amount stated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "notes": "f two doses in 24 hours are required, use lower amount stated"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Oral- under 6 months not recommended; 6 months- 1 yrs. 5-10mg; 1-5 yrs. 5-15mg; Over 5 yrs.10-25mg. If two doses in 24 hours are required, use lower amount stated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 15
            },
            "notes": "f two doses in 24 hours are required, use lower amount stated"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Oral- under 6 months not recommended; 6 months- 1 yrs. 5-10mg; 1-5 yrs. 5-15mg; Over 5 yrs.10-25mg. If two doses in 24 hours are required, use lower amount stated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            },
            "notes": "f two doses in 24 hours are required, use lower amount stated"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 5
        },
        "description": "Injection- Under 5 yrs. Not recommended; Over 5 yrs. 6.25-12.5 mg by deep I.M Injection.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Injection- Under 5 yrs. Not recommended; Over 5 yrs. 6.25-12.5 mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 6.25,
              "max": 12.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 482,
    "genericName": "Acrivastine",
    "doseList": [
      {
        "description": "8mg 3 times daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Child under 12 years, not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 483,
    "genericName": "Cetirizine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult, 10mg once daily or 5 mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Child over 6 years, 10mg once daily or 5 mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 6
        },
        "indication": "hay fever",
        "description": "Child 2-6 years, hay fever, 5mg daily or 2.5mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 484,
    "genericName": "Fexofenadine",
    "doseList": [
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "indication": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms",
        "description": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms: Children 6 to 11 years- 30mg twice daily, (a dose of 30mg once daily is recommended as the starting dose in peadiatric patients & in patients with decreased renal function).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "indication": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms",
        "secondaryIndication": "the starting dose in peadiatric patients & in patients with decreased renal function",
        "description": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms: Children 6 to 11 years- 30mg twice daily, (a dose of 30mg once daily is recommended as the starting dose in peadiatric patients & in patients with decreased renal function).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms",
        "description": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms: Children 6 to 11 years- 30mg twice daily, (a dose of 30mg once daily is recommended as the starting dose in peadiatric patients & in patients with decreased renal function).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "a dose of 60mg once daily is recommended as the starting dose"
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "mg",
            "amount": {
              "min": 180,
              "max": 180
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms",
        "description": "Seasonal allergic rhinitis, chronic idiopathic urticaria & other allergic symptoms: Children 6 to 11 years- 30mg twice daily, (a dose of 30mg once daily is recommended as the starting dose in peadiatric patients & in patients with decreased renal function).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "a dose of 60mg once daily is recommended as the starting dose"
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 120
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "mg",
            "amount": {
              "min": 180,
              "max": 180
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 485,
    "genericName": "Levocetirizine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult & Children over 6 years of age: Levocetirizine dihydrichloride 5mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "Adult & Children over 6 years of age: Levocetirizine dihydrichloride 5mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Patients with Renal Impairment",
        "description": "Patients with Renal Impairment: In moderate penal impairment, recommended dose is 5mg in every alternate day. In severe Renal Impairment, the dose interval should be increased to every third day.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in moderate penal impairment",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "in every alternate day"
          },
          {
            "type": "primary",
            "condition": "in severe Renal Impairment",
            "notes": "the dose interval should be increased to every third day."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Peadiatric use: Not recommended for use in Children less than 6 years of age.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 486,
    "genericName": "Loratadine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult, 10mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 12
        },
        "description": "Child, 2-12 yrs. Under 30kg 5mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "under 30 kg",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternate",
            "condition": "over 30 kg",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Below 2 years, safety & efficacy of loratadine has not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 487,
    "genericName": "Desloratadine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and adolescents of 12 years or over: Desloratadine 5mg once daily at any time with no regard to meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Adult and adolescents of 12 years or over: Desloratadine 5mg once daily at any time with no regard to meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "indication": "Patients with liver or Renal Impairment",
        "description": "Patients with liver or Renal Impairment- a starting dose of 5mg every alternate day is recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "every alternate day is recommended"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 11
        },
        "description": "6-11 years, 2.5mg (5ml syrup)once daily; 2-5 years, 1.25mg (2.5ml syrup) once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "6-11 years, 2.5mg (5ml syrup)once daily; 2-5 years, 1.25mg (2.5ml syrup) once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1.25,
              "max": 1.25
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 488,
    "genericName": "Ketotifen fumerate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2mg twice daily with food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "Child: under 2 years not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5
        },
        "description": "Over 5 years, half Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 489,
    "genericName": "Loratadine + Pseudoephedrine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose is one Tablet once daily. As this product contains pseudoephedrine which may cause agitation and Insomnia as side effects, it is recommended to be taken in the morning instead of night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "The recommended dose is one Tablet once daily. As this product contains pseudoephedrine which may cause agitation and Insomnia as side effects, it is recommended to be taken in the morning instead of night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Peadiatric use: Safety and effectiveness in Children below the age of 12 years have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 490,
    "genericName": "Anthisan Cream",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply locally two or three times dailyfor up to 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply locally two or three times dailyfor up to 3 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 491,
    "genericName": "Calamine",
    "doseList": [
      {
        "description": "Apply 3-4 times daily of up to 3-5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 492,
    "genericName": "Lignocaine",
    "doseList": [
      {
        "description": "Anaesthesia before e.g. venepuncture (not for infants), apply a thick layer under an occlusive dressing 1-5 hours before procedure; split skin grafting, apply a thick layer under an occlusive dressing 2-5 hours before procedure; genital warts (not of Children), apply up to 10gm 5-10 minutes before removal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "max": 10
            },
            "notes": "Anaesthesia before e.g. venepuncture (not for infants), apply a thick layer under an occlusive dressing 1-5 hours before procedure; split skin grafting, apply a thick layer under an occlusive dressing 2-5 hours before procedure; genital warts (not of Children), apply up to 10gm 5-10 minutes before removal."
          }
        ]
      }
    ]
  },
  {
    "serial": 493,
    "genericName": "Xylocalne gel astra",
    "doseList": [
      {
        "indication": "nto urethra",
        "description": "men 10ml followed by 3-5ml.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "men",
            "unit": "ml",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "men",
            "unit": "ml",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "indication": "nto urethra",
        "description": "women 3-5ml.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "women",
            "unit": "ml",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 494,
    "genericName": "Xylocaine",
    "doseList": [
      {
        "indication": "Surface anaesthesia",
        "description": "Surface anaesthesia, maximum 35gm in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 35,
              "max": 35
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 495,
    "genericName": "Tetracycline prepns",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply to the affected area on sterile gauze two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply to the affected area on sterile gauze two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 496,
    "genericName": "Tentamicin Prepns",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply to the affected area on sterile gauze two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 497,
    "genericName": "Mupirocin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "apply a small amount of ointment to the affected area 3 times a day for upto 10 days depending on the response.The area may be covered with a qauze dressing, patients not showing a clinical response within 7 days should be re-evaluated.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 10
            },
            "notes": "The area may be covered with a qauze dressing, patients not showing a clinical response within 7 days should be re-evaluated"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "apply a small amount of ointment to the affected area 3 times a day for upto 10 days depending on the response.The area may be covered with a qauze dressing, patients not showing a clinical response within 7 days should be re-evaluated.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 10
            },
            "notes": "The area may be covered with a qauze dressing, patients not showing a clinical response within 7 days should be re-evaluated"
          }
        ]
      }
    ]
  },
  {
    "serial": 498,
    "genericName": "Neomycin + Bacitracin or Neomycin + Batcitracin + Polymyxin B",
    "doseList": [
      {
        "indication": "Neomycin & bacitracin preparation",
        "description": "The preparations should be applied thinly over the affected area after clening it. Neomycin & bacitracin preparation: 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "indication": "Neomycin, Bacitracin & Polymyxim B Preparatio",
        "description": "The preparations should be applied thinly over the affected area after clening it. Neomycin, Bacitracin & Polymyxim B Preparatio: 1 to 3 daily applications should be continued until the infection is controlled and healing complete.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Both the preparationsare suitable for use in Children at the same doses as Adults, but the dose should be reduced in infants.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "description": "Neonates: Not recommended for use in neonates.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 499,
    "genericName": "Bivacyn",
    "doseList": [
      {
        "description": "Shake the aerosol can vigorously prior to application & spray the powder to the affected area once or several times daily from a distance of 20-25 cm.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1
            },
            "notes": "from a distance of 20-25 cm."
          }
        ]
      }
    ]
  },
  {
    "serial": 500,
    "genericName": "Facid cream/Oint",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      }
    ]
  },
  {
    "serial": 501,
    "genericName": "Fusidin Crime/Oint",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      }
    ]
  },
  {
    "serial": 502,
    "genericName": "Fusidate Oint",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply three or two times daily. Less frequent application if dressing used.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Less frequent application if dressing used"
          }
        ]
      }
    ]
  },
  {
    "serial": 503,
    "genericName": "Sulphonamide Prepns",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply in layer 3-5 mm thick. Change dressing 3 times a week for ulcers & daily for burs.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply in layer 3-5 mm thick. Change dressing 3 times a week for ulcers & daily for burs."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3
        },
        "description": "Child: Upto 3 months, not recommended; Others, same as Adult. Apply in layer 3-5 mm thick. Change dressing 3 times a week for ulcers & daily for burs.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply in layer 3-5 mm thick. Change dressing 3 times a week for ulcers & daily for burs."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "Child: Upto 3 months, not recommended;",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 504,
    "genericName": "Acyclovir Cream",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 5 times daily at 4 hourly intervals for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "at 4 hourly intervals"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply 5 times daily at 4 hourly intervals for 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "at 4 hourly intervals"
          }
        ]
      }
    ]
  },
  {
    "serial": 505,
    "genericName": "Docosanol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 5 times a day until healed. Treatment Should be started at earliest signs or symptoms of herpes infection (blisters, open sores, pain in the infected area, itching, burning tingling or numbness).",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "Apply 5 times a day until healed. Treatment Should be started at earliest signs or symptoms of herpes infection (blisters, open sores, pain in the infected area, itching, burning tingling or numbness).",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 506,
    "genericName": "Benzoic Acid + Salicylic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply locally on the affected area two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply locally on the affected area two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 507,
    "genericName": "Clotrimazole cream/solution",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply sparingly 2-3 times daily continuing for 14 days after lesion have healed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply sparingly 2-3 times daily continuing for 14 days after lesion have healed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "indication": "Nail infection",
        "description": "Apply daily under occlusive dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply daily under occlusive dressing"
          }
        ]
      }
    ]
  },
  {
    "serial": 508,
    "genericName": "Econazole / Miconazole",
    "doseList": [
      {
        "description": "Apply 2-3 times daily continuing for 14 days after lesion have healed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            }
          }
        ]
      },
      {
        "indication": "Nail infection",
        "description": "Apply daily under occlusive dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply daily under occlusive dressing"
          }
        ]
      }
    ]
  },
  {
    "serial": 509,
    "genericName": "Nystatin",
    "doseList": [
      {
        "description": "Apply 2-4 times daily continuing for 7 days after lesion have healed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 510,
    "genericName": "Terbinafine",
    "doseList": [
      {
        "indication": "Tinea corporis & cruris",
        "description": "Terbinafine can be applied once or twice daily. Cleanse and dry the affected areas thoroughly before application. Apply the cream to the affected skin and surrounding area in thin layer and rub lightly: Tinea corporis & cruris-1 to 2 weeks; Tinea Pedis- 1 week; Cutaneous candidiasis- 2 weeks; Pityriasis versicolor- 2 weeks. Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If thee are no sign of improvement after two weeks, the diagnosis should be verified.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "f thee are no sign of improvement after two weeks, the diagnosis should be verified."
          }
        ]
      },
      {
        "indication": "Tinea Pedis",
        "description": "Terbinafine can be applied once or twice daily. Cleanse and dry the affected areas thoroughly before application. Apply the cream to the affected skin and surrounding area in thin layer and rub lightly: Tinea corporis & cruris-1 to 2 weeks; Tinea Pedis- 1 week; Cutaneous candidiasis- 2 weeks; Pityriasis versicolor- 2 weeks. Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If thee are no sign of improvement after two weeks, the diagnosis should be verified.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "f thee are no sign of improvement after two weeks, the diagnosis should be verified."
          }
        ]
      },
      {
        "indication": "Cutaneous candidiasis",
        "description": "Terbinafine can be applied once or twice daily. Cleanse and dry the affected areas thoroughly before application. Apply the cream to the affected skin and surrounding area in thin layer and rub lightly: Tinea corporis & cruris-1 to 2 weeks; Tinea Pedis- 1 week; Cutaneous candidiasis- 2 weeks; Pityriasis versicolor- 2 weeks. Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If thee are no sign of improvement after two weeks, the diagnosis should be verified.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "notes": "f thee are no sign of improvement after two weeks, the diagnosis should be verified."
          }
        ]
      },
      {
        "indication": "Pityriasis versicolor",
        "description": "Terbinafine can be applied once or twice daily. Cleanse and dry the affected areas thoroughly before application. Apply the cream to the affected skin and surrounding area in thin layer and rub lightly: Tinea corporis & cruris-1 to 2 weeks; Tinea Pedis- 1 week; Cutaneous candidiasis- 2 weeks; Pityriasis versicolor- 2 weeks. Relief of clinical symptoms usually occurs within a few days. Irregular use or premature discontinuation of treatment carries the risk of recurrence. If thee are no sign of improvement after two weeks, the diagnosis should be verified.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "notes": "f thee are no sign of improvement after two weeks, the diagnosis should be verified."
          }
        ]
      }
    ]
  },
  {
    "serial": 511,
    "genericName": "Tioconazole",
    "doseList": [
      {
        "description": "Apply & massage gently into the affected & surrounding skin area once or twice a day. In intertriginous areas, apply sparingly & smoothed in well to avoid macerating effects. Duration: 1-6 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 512,
    "genericName": "Tolnaftate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 1-2 drops (for areas as large as hand) or 2-3 drops (to cover the toes & interdigital webs of one foot) 2 to 3 times daily for 2 or 3 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "for areas as large as hand",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "alternative",
            "condition": "to cover the toes & interdigital webs of one foot",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 513,
    "genericName": "Ketoconazole",
    "doseList": [
      {
        "condition": "Stage 1- Clean up",
        "description": "Stage 1- Clean up (twice weekly for 2-4 weeks): Apply a small quantity of shampoo to the scalp; use only a small amount of water, to ensure a high consentration of shampoo in the lather; Massage of shampoo lather into all parts of the scalp, leave the shampoo on the hair for 5 minutes before rinsing.",
        "subDoseList": [
          {
            "type": "primary",
            "timesWeekly": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "condition": "Stage 2- Prophylactic or maintenance use",
        "description": "Stage 2- Prophylactic or maintenance use (once weekly): When the dardruff is under control, it can be stabilized by washing once weekly with ketoconazole shampoo. Use normal shampoos on other occasions.",
        "subDoseList": [
          {
            "type": "primary",
            "timesWeekly": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 514,
    "genericName": "Benzyl benzoate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Scabies",
        "description": "Scabies- After a hot bath apply to whole body except head and face. Repeat the same within five days. Or, Apply for 3 consecutive days at 12 hourly intervals (morning & night) to the whole body except head & face. Change the clothes & sheets every morning to clean; the patient should have no bathduring the period, but a hot bath 12 hours after the last application.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternative",
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "doseTime": {
              "morning": true,
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Pediculosis",
        "description": "Pediculosis- Apply to the affected area and cleanse after 24 hours. Repeat two or three times if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: infants, use diluted with 3 parts water; others, use diluted with an equal quantity of water.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "nfants, use diluted with 3 parts water; others, use diluted with an equal quantity of water."
          }
        ]
      }
    ]
  },
  {
    "serial": 515,
    "genericName": "Crotamiton",
    "doseList": [
      {
        "indication": "Scabies",
        "description": "Scabies- Apply over the whole body omitting the head, neck & eyes, after a hot bath, and remove by washing on the following day. The application may be repeated 24 hours later, but a bath should not be taken until the following day.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 516,
    "genericName": "vermectin",
    "doseList": [
      {
        "indication": "Scabies",
        "description": "Scabies: 150mcg/kg of bodyweight as a single dose for one treatment. Treatment may be repeated two weeks after the first dose for immunocompromised patient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            },
            "repeated": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Filariasis",
        "description": "Filariasis: 20 to 200 mcg/kg of body weight as a single dose have been used.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 20,
              "max": 200
            }
          }
        ]
      },
      {
        "condition": "established for Children less than 15kg.",
        "description": "Children: Safety and efficacy have not been established for Children less than 15kg.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 517,
    "genericName": "Monosulfiram",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Dilute with two or three parts water and after through cleansing apply to whole body except head and face. If necessary repeat for two or three days.",
        "subDoseList": [
          {
            "type": "primary",
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "part",
                "min": 2,
                "max": 3
              }
            },
            "treatmentPeriod": {
              "notes": "f necessary repeat for two or three days."
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Dilute with two or three parts water and after through cleansing apply to whole body except head and face. If necessary repeat for two or three days.",
        "subDoseList": [
          {
            "type": "primary",
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "part",
                "min": 2,
                "max": 3
              }
            },
            "treatmentPeriod": {
              "notes": "f necessary repeat for two or three days."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 518,
    "genericName": "Permethrin",
    "doseList": [
      {
        "indication": "Scabies",
        "description": "Scabies, Apply over whole body and wash off after 8-24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply over whole body and wash off after 8-24 hours"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, Apply over whole body including face, neck, scalp and ears. If hands are washed with soap and water within 8 hours of application, cream should be reapplied.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply over whole body including face, neck, scalp and ears. If hands are washed with soap and water within 8 hours of application, cream should be reapplied."
          }
        ]
      }
    ]
  },
  {
    "serial": 519,
    "genericName": "Betamethasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply sparingly 2 or 3 times daily (cream for moist or wheeping surfaces, ointment for dry lichenified & scaly lesions).",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "cream for moist or wheeping surfaces, ointment for dry lichenified & scaly lesions"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply sparingly 2 or 3 times daily (cream for moist or wheeping surfaces, ointment for dry lichenified & scaly lesions).",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "cream for moist or wheeping surfaces, ointment for dry lichenified & scaly lesions"
          }
        ]
      }
    ]
  },
  {
    "serial": 520,
    "genericName": "Betamethasone + Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply sparingly 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply sparingly 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 521,
    "genericName": "Betamethasone + Fusidic ACID",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Uncovered lesions",
        "description": "apply sparingly 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Covered lesions",
        "description": "less frequent applications may be adequate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "less frequent applications may be adequate"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Uncovered lesions",
        "description": "apply sparingly 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Covered lesions",
        "description": "less frequent applications may be adequate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "less frequent applications may be adequate"
          }
        ]
      }
    ]
  },
  {
    "serial": 522,
    "genericName": "Betamethasone + Clotrimazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "ntinea cruris, tinea corporis and candidiasis",
        "description": "Gently massage sufficient amount of this cream into the affected and surrounding skin areas twice daily, in the morning and evening for two weeks intinea cruris, tinea corporis and candidiasis and four weeks intinea pedis. Clinical improvement, with relief of erythema and pruritus, usually occurs within the first 3 to 5 days of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "ntinea pedis",
        "description": "Gently massage sufficient amount of this cream into the affected and surrounding skin areas twice daily, in the morning and evening for two weeks intinea cruris, tinea corporis and candidiasis and four weeks intinea pedis. Clinical improvement, with relief of erythema and pruritus, usually occurs within the first 3 to 5 days of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "erythema and pruritus",
        "description": "Gently massage sufficient amount of this cream into the affected and surrounding skin areas twice daily, in the morning and evening for two weeks intinea cruris, tinea corporis and candidiasis and four weeks intinea pedis. Clinical improvement, with relief of erythema and pruritus, usually occurs within the first 3 to 5 days of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Children: The safety and effectiveness of this combination has not been established in Children below 12 years.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 523,
    "genericName": "Clobetasol Propionate",
    "doseList": [
      {
        "description": "Apply thinly 2-3 times daily, reducing frequence as condtion responds.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "reducing frequence as condtion responds."
          }
        ]
      }
    ]
  },
  {
    "serial": 524,
    "genericName": "Clobetasone Butyrate",
    "doseList": [
      {
        "description": "Apply thinly 1-2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 525,
    "genericName": "Clobetasol + Antibiotic + Antifungals",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply sparingly to the affected area once or twice daily until improvement occurs. In very resistant lesions, specially where there is hyperkeratosis, the anti-inflammatory effect of this preparation can be enhanced, if necessary, be occluding the treatment area with polytene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient’s condition being reviewed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 7,
              "notes": "until improvement occurs. In very resistant lesions, specially where there is hyperkeratosis, the anti-inflammatory effect of this preparation can be enhanced, if necessary, be occluding the treatment area with polytene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient’s condition being reviewed."
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "Apply sparingly to the affected area once or twice daily until improvement occurs. In very resistant lesions, specially where there is hyperkeratosis, the anti-inflammatory effect of this preparation can be enhanced, if necessary, be occluding the treatment area with polytene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient’s condition being reviewed.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 7,
              "notes": "until improvement occurs. In very resistant lesions, specially where there is hyperkeratosis, the anti-inflammatory effect of this preparation can be enhanced, if necessary, be occluding the treatment area with polytene. Treatment should not be continued for more than 7 days without medical supervision. If a longer course is necessary, it is recommended that treatment should not be continued for more than 4 weeks without the patient’s condition being reviewed."
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "This preparation is suitable for use in the elderly. Caution should be exercised in cases where a decrease in renal function exists and significant systemic absorption of neomycin sulphate may occur."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "This preparation is suitable for use in Children (2 years and over at the same dose as Adults.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "This preparation is suitable for use in Children (2 years and over at the same dose as Adults."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "description": "A possibility of increased absorption exists in very young Children, thus this is not recommended for use in neonates and infants (younger than 2 years).",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 526,
    "genericName": "Fluocinolone + Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 527,
    "genericName": "Fluticasone Propionate",
    "doseList": [
      {
        "description": "Apply thinly, cream once daily or ointment twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "cream",
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "ointment",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 528,
    "genericName": "Halcinonide",
    "doseList": [
      {
        "description": "Apply thinly 2-3 times daily, reducing frequency as condition responds.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 529,
    "genericName": "Halometasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply twice daily to the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply twice daily to the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 530,
    "genericName": "Sicorten Plus",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 2 or 3 times daily to the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply 2 or 3 times daily to the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 531,
    "genericName": "Hydrocortisone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply two or three times daily leaving a light surface layer; cover with dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply two or three times daily leaving a light surface layer; cover with dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 532,
    "genericName": "Hydrocortisone + Antibiotics",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply two or three times daily leaving a light surface layer; cover with dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": ": Apply two or three times daily leaving a light surface layer; cover with dressing.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 533,
    "genericName": "Hydrocortisone + Fusidic ACID",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply two to three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply two to three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 534,
    "genericName": "Hydrocortisone + Gentamicin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 535,
    "genericName": "Hydrocortisone + Clotrimazole Cream",
    "doseList": [
      {
        "description": "Apply locally 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 536,
    "genericName": "Hydrocortisone + MIconazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "t should be applied topically to the affected areas 2 or 3 times daily.The same dosage applies to both Adults and Children.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "t should be applied topically to the affected areas 2 or 3 times daily.The same dosage applies to both Adults and Children.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "in infants, long term continuous topical corticosteroid therapy should be avoided.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "nail lesions",
        "description": "Occlusive dressing is usually only necessary in the case of nail lesions.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Occlusive dressing is usually only necessary in the case of nail lesions"
          }
        ]
      }
    ]
  },
  {
    "serial": 537,
    "genericName": "Mometasone",
    "doseList": [
      {
        "description": "Apply thinly to the affected areas once daily until the lesion heals or for a duration of 3 weeks, whichever is sooner.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "until the lesion heals",
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "notes": "whichever is sooner"
          }
        ]
      }
    ]
  },
  {
    "serial": 538,
    "genericName": "Triamcinolone",
    "doseList": [
      {
        "description": "Apply  thinly to the affected areas 2-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 539,
    "genericName": "Triamcinolone + Econazole",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply a thin film to the affected areas 2 to 3 times daily. Continue the application for 2 weeks or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply a thin film to the affected areas 2 to 3 times daily. Continue the application for 2 weeks or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 540,
    "genericName": "Triamcinolone + Neomycin + Nystation + Gramicidin : Cream",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply a thin layer of film to the affected areas 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply a thin layer of film to the affected areas 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 541,
    "genericName": "Calcipotriol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "mild to moderate plaque psoriasis affecting up to 40% of skin area",
        "description": "Cream or ointment, mild to moderate plaque psoriasis affecting up to 40% of skin area, apply twice daily;Maximum 100gm weekly (less with scalp solution).",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "Maximum 100gm weekly (less with scalp solution)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child,Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 542,
    "genericName": "Daivonex: Cream",
    "doseList": [
      {
        "description": "Daivonex scalp solution should be applied twice daily (morning and evening) to the affected areas. The weekly dose should not exceed 60ml. When used together with daivonex ointment or cream. The total dose of calcipotriol should not exceed 5 mg per week corresponding to 100gm daivonex ointment or daivonex cream.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/week",
            "amount": {
              "max": 60
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          },
          {
            "type": "alternative",
            "condition": "When used together with daivonex ointment or cream",
            "unit": "mg/week",
            "amount": {
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 543,
    "genericName": "Coal-tar prepns",
    "doseList": [
      {
        "description": "Apply 1-3 times daily starting with low strength preparations.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 544,
    "genericName": "Fongitar Lifquid Stiefel/UniMed",
    "doseList": [
      {
        "description": "Wet the hair and massage the liquid into the hair, scalp and surrounding skin. Leave for 2-3 minutes then rinse thoroughly. Use 2-3 times weekly for at least 3 weeks or until the condition clears. For prevention of itchy and scaling scalp conditions, use once weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 545,
    "genericName": "Polytar Liquid Stiefel/UniMed",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Use as shampoo once or twice daily, or locally 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "shampoo",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "condition": "locally",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Use as shampoo once or twice daily, or locally 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "shampoo",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "condition": "locally",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 546,
    "genericName": "Dithranol Prepns",
    "doseList": [
      {
        "description": "Apply on the skin up to 2 times daily. The preparation is applied carefully to the lesion, covered with a dressing, & left for one hour. Applications are preferably left on the skin overnight but short contact applications of 30 minutes to an hour are also effective and are more convenient.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "duration": {
              "notes": "Applications are preferably left on the skin overnight but short contact applications of 30 minutes to an hour are also effective and are more convenient."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 547,
    "genericName": "Emollients",
    "doseList": [
      {
        "description": "Apply 2-3 times locally daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 548,
    "genericName": "Oilatum",
    "doseList": [
      {
        "description": "Oilatum emollient should always be weed with water, either added to the bath or applied to wet skin. Direct application to skin-wet the skin of the affected area and rub in a small quantity emollient, then rinse and pet dry.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Oilatum emollient should always be weed with water, either added to the bath or applied to wet skin. Direct application to skin-wet the skin of the affected area and rub in a small quantity emollient, then rinse and pet dry."
          }
        ]
      },
      {
        "condition": "Use in bath",
        "description": "Use in bath- add 1-3 capsful to an 8 inch bath of water, soak for 10-20 minutes. For infant bathing, add ½-2 capsful to a wash basin of water, apply gently over entire body with sponge and pat dry.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsful",
            "amount": {
              "min": 1,
              "max": 3
            },
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "nch bath of water",
                "min": 8,
                "max": 8
              }
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "condition": "Use in bath",
        "description": "For infant bathing, add ½-2 capsful to a wash basin of water, apply gently over entire body with sponge and pat dry.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsful",
            "amount": {
              "min": 0.5,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 549,
    "genericName": "chthammol Prepns",
    "doseList": [
      {
        "description": "Apply 1-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 550,
    "genericName": "Zinc + Castor Oil Prent",
    "doseList": [
      {
        "indication": "For eczema and dermatitis",
        "description": "Apply sparingly as required to the affected areas. For eczema and dermatitis, the areas should be washed with a soap alternative and patted dry. It should then be applied as soon as possible before the skin dries, and as required during the day.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "the areas should be washed with a soap alternative and patted dry. It should then be applied as soon as possible before the skin dries, and as required during the day."
          }
        ]
      },
      {
        "indication": "For nappy rash",
        "description": "For nappy rash, a soap alternative should also be used, and the ointment applied similarly (together with anti-fungal agent where indicated). The ointment should then be reapplied following each nappy change. Parents should be encouraged not to use nappies where possible until the rash settles.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "a soap alternative should also be used, and the ointment applied similarly (together with anti-fungal agent where indicated). The ointment should then be reapplied following each nappy change. Parents should be encouraged not to use nappies where possible until the rash settles."
          }
        ]
      },
      {
        "indication": "in vulvovaginitis and parietal symptoms",
        "description": "in vulvovaginitis and parietal symptoms, the ointment should be applied about three times daily after a wash, in a thin layer to protect the skin from moisture.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "the ointment should be applied about three times daily after a wash, in a thin layer to protect the skin from moisture."
          }
        ]
      }
    ]
  },
  {
    "serial": 551,
    "genericName": "Pimecrolimus",
    "doseList": [
      {
        "description": "Application of a thin layer of pimecrolimus 1% cream to the affected skin twice daily as long as sings and symptoms persist. The cream may be used on all skin areas, including the head and face, neck, and intertriginous areas. In the long-term management of atopic dermatitis (eczema), pimecrolimus 1 % cream treatment should begin at first appearance of signs and symptoms of atopic dermatitis to prevent flares of the disease.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 552,
    "genericName": "Tacrolimus",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply a thin layer of tacrolimus ointment to the affected skin areas twice daily and rub in gently and completely. Treatment should be continued for one week after clearing of signs and symptoms of atopic dermatitis. Tacrolimus ointment should not be used with occlusive dressings, because the safety of tacrolimus use under occlusion, which may promote systemic exposure, has not been evaluated.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply a thin layer of tacrolimus ointment to the affected skin areas twice daily and rub in gently and completely. Treatment should be continued for one week after clearing of signs and symptoms of atopic dermatitis. Tacrolimus ointment should not be used with occlusive dressings, because the safety of tacrolimus use under occlusion, which may promote systemic exposure, has not been evaluated.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 553,
    "genericName": "Acitretin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 25mg or 30mg daily for about 2 to 4 weeks. Maintenance dose,in general, 25-50mg daily for a further 6 to 8 weeks; may be increased up to a maximum of 75mg daily, If necessary in some cases. In disorders of keratinization, maintenance therapy is usually needed, and a lowest possible dosage should be given, that may be less than 20mg/day and should not exceed 50mg/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 50
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "alternativeMaintenance",
            "condition": "f necessary in some cases",
            "unit": "mg",
            "amount": {
              "max": 75
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "alternativeMaintenance",
            "condition": "in disorders of keratinization",
            "unit": "mg/day",
            "amount": {
              "min": 20,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "The daily dosage is about 0.5mg/kg; higher doses of up to 1mg/kg/day (maximum 35mg/day) may be necessary some cases for limited periods. The maintenance dose should be kept as low as possible in view of possible long-term side effects.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "alternative",
            "condition": "may be necessary some cases for limited periods.",
            "unit": "mg/kg/day",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "notes": "The maintenance dose should be kept as low as possible in view of possible long-term side effects."
          }
        ]
      }
    ]
  },
  {
    "serial": 554,
    "genericName": "Cyclosporin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially 2.5mg/kg daily in 2 divided doses, increased gradually to maximum 5mg/kg daily if no improvement within 1 month (Discontinue if response still insufficient after 6 weeks); Initial dose of 5mg/kg daily justified if condition requires rapid improvement.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "notes": "Discontinue if response still insufficient after 6 weeks"
          },
          {
            "type": "primaryFollowup",
            "condition": "f no improvement within 1 month",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 16
        },
        "description": "Under 16 years not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 555,
    "genericName": "Clindamycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Clean the face or affected areas gently with warm water or soap as recommended by the physician. After the skin is dried, apply a thin film of clindamycin lotion to the affected areas twice daily, in the morning and in the eveing. Do not wash withing three hours after using lotion. The treatment period is usually 6 weeks or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 6,
              "max": 6
            },
            "notes": "Do not wash withing three hours after using lotion"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Safety and effectiveness in Children under 12 years have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 556,
    "genericName": "Erythromycin",
    "doseList": [
      {
        "description": "The erythromycin topical solution should be rebbed over the affected area twice a day after the skin is thoroughly washed with warm water and soap and patted dry. Acne lesions on the face, neck, shoulders, chest and back may be treated in this manner, additional containers may be used, if needed, Each container should be used once and iscarded.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 557,
    "genericName": "Azelaic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "After the skin is thoroughly washed and patted dry, a thin film of azelaic acid should be gently but thoroughly massaged into the affected areas twice daily, in the morning and evening. The hands shouldbe usahed following Application.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Safety and effectiveness in peadiatric patients under 12 years of age have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 558,
    "genericName": "Benzoyl Peroxide",
    "doseList": [
      {
        "description": "Apply to the affected area once or twice daily. Frequency of use should be adjusted to obtain the desired clinical response. Washing with soap and water prior to application greatly enhances the efficacy of the preparation.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Paediatric use: Safety and effectiveness in paediatric patients under the age of 12 have nog been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 559,
    "genericName": "Treatinoin / Isotretinoin",
    "doseList": [
      {
        "description": "Apply 1 to 2 times daily to the area of skin where acne lesions occur; only apply sufficient to cover the affected area lightly, using a gauze swab, cotton, wool or the tips of clean fingers, Warning: patient should be warned that some redness and skin peeling may occur after application for several days but settles with time.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "Warning: patient should be warned that some redness and skin peeling may occur after application for several days but settles with time."
          }
        ]
      }
    ]
  },
  {
    "serial": 560,
    "genericName": "Adapalene",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adapalene cream is usually used once daily at night-time. A thin film of cream is applied to the skin areas where lesions appear, using enough to cover the entire affected areas lightly. Before application of cream, the area should be cleansed with a mild or soapless cleanser or water.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 12
        },
        "description": "Safety and effectiveness in Children below 12 years of age have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 561,
    "genericName": "Topical urea prepn ",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Urea cream is applied topically. Wash affected aeas well, rinse off all treaces of soap, dry the skin and apply cream sparingly twice daily. Occlusive dressings may be used, but are usually unnecessary because of the self-occlusive nature of the cream.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Can be used in all age groups.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Can be used in all age groups."
          }
        ]
      }
    ]
  },
  {
    "serial": 562,
    "genericName": "Cepalin",
    "doseList": [
      {
        "description": "Mederma gel to be applied generously and massaged gently for 2-3 minutes into the scar 3-4 times a day, while spreading outward from the center. 20gram tube will last approximately 3 months (full course of therapy) on a scar up to 3” in length.",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 563,
    "genericName": "Eldoquin Forte 4%",
    "doseList": [
      {
        "description": "There is no sunblocking or sunscreening agents in Eldoquin forte, so it should be used only at night or on areas of the body covered by protective cloting. After clearing and during maintenance theapy, sun exposure should be avoided on bleached skin by application of a sunscreen, or protective clothing to prevent prpigmentation. If no bleaching or lightening effect is noted after 2 months of treatment, the medication should be discontinued.",
        "subDoseList": [
          {
            "type": "primary",
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "maintenance",
            "notes": "After clearing and during maintenance therapy, sun exposure should be avoided on bleached skin by application of a sunscreen, or protective clothing ot prevent repigmentation. If no bleaching or lightening effect is noted after 2 months of treatment, the medication should be discontinued."
          }
        ]
      }
    ]
  },
  {
    "serial": 564,
    "genericName": "Spotclen",
    "doseList": [
      {
        "description": "There is no sunblcking or sunscreening agents in Spotclen cream so it should be used only at night or on areas of the body covered by protective clothing. It should be applied to the affected area twice daily or as directed by the physician. Do not rub in. After clearing and during maintenance therapy, sun exposure should be avoided on bleached skin by application of a sunscreen, or protective clothing ot prevent repigmentation. If no bleaching or lightening effect is noted after 2 months of treatment, the medication should be discontinued.",
        "subDoseList": [
          {
            "type": "primary",
            "doseTime": {
              "night": true
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "notes": "After clearing and during maintenance therapy, sun exposure should be avoided on bleached skin by application of a sunscreen, or protective clothing ot prevent repigmentation. If no bleaching or lightening effect is noted after 2 months of treatment, the medication should be discontinued."
          }
        ]
      }
    ]
  },
  {
    "serial": 565,
    "genericName": "Methoxsalen",
    "doseList": [
      {
        "description": "This product should be applied to a well-defined area of vitiligo by the physician and the area is then exposed to a suitable source of UVA or sunlight. Initial exposure time should be conservative and not exceed that which is predicted to be on-half the minimal erythma dojse. Treatment intervals should be regulated by the erythema response; generally once a week is recommended or less often depending on the results. The hand and fingers of the person applying the medication should be protected by gloves of finger cots to avoid photosensitization and possible burns. Pigmentation may begin after a few weeks but significant repigmentation may require 6-9 months of treatment. Periodic re-treatment may be necessary to retain all of the new pigment. Idiopathic vitiligo is reversible but not equally reversible in every patient.",
        "subDoseList": [
          {
            "type": "primary",
            "Interval": {
              "unit": "week",
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 6,
              "max": 9
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 566,
    "genericName": "Sunblock19/spectra Ban ultra 28",
    "doseList": [
      {
        "description": "Apply SunBlock 19 or SpectraBanultra 28 carefully and evenly to areas to be exposed or protected only by light clothing. Allow 30 minutes before going out or swimming. A single application may give daylong protection but the product should be re-applied during prolonged period of sunning, swimming or excessive sweaing.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Apply SunBlock 19 or SpectraBanultra 28 carefully and evenly to areas to be exposed or protected only by light clothing. Allow 30 minutes before going out or swimming. A single application may give daylong protection but the product should be re-applied during prolonged period of sunning, swimming or excessive sweaing."
          }
        ]
      }
    ]
  },
  {
    "serial": 567,
    "genericName": "Chlorhexidine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Antiseptic Solution: Repid skin cleansing solution for hand disinfectionprior ot surgery & for routing use in the ward to reduce risk of cross-infection. For detail & other use: See Bterature attached with the preparation. Adult & Children: Apply two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Antiseptic Solution: Repid skin cleansing solution for hand disinfectionprior ot surgery & for routing use in the ward to reduce risk of cross-infection. For detail & other use: See Bterature attached with the preparation. Adult & Children: Apply two or three times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 568,
    "genericName": "Chloroxlenol",
    "doseList": [
      {
        "description": "Wash withone table spoonful of dettol to a tumbler of water (1 in 13) for urgent application, undiluted dettol may be used but not in a sensitive skin.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "water"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 569,
    "genericName": "Povidone-Iodine",
    "doseList": [
      {
        "description": "5% & 10% Solution: Apply full strength as often as needed, as a paint or ewt soak; for minor wounds and infection apply directly to the affected area: The site may be covered with gauze or adhesive bendage.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "5% & 10% Solution: Apply full strength as often as needed, as a paint or ewt soak; for minor wounds and infection apply directly to the affected area: The site may be covered with gauze or adhesive bendage."
          }
        ]
      }
    ]
  },
  {
    "serial": 570,
    "genericName": "Povidone-Iodine Surgical scrub",
    "doseList": [
      {
        "indication": "1. For pre-operative washing by operating personnel",
        "description": "1. For pre-operative washing by operating personnel-Wet hands with water; pour about 5ml of solution onto the palm and spread over both the hands, without adding more water rub the scrub thoroughly over the entire area for about two minutes, use a brush if need, clean toroughly under fingernails, add a little water to develop copious suds, rinse thoroughly under running water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "temName": "water"
            }
          }
        ]
      },
      {
        "indication": "2. For pre-operative use on patients",
        "description": "For pre-operative use on patients- After the sin is shaved, wet it with water, apply the surgical scrub (1ml is sufficient to cover an area of 20-30 square inches) and rub thoroughly for minimum of two minutes.Then develop oa lather and rinse off with the aid of sterile gauze saturated with water.The area may then be painted with povidone-iodine (10%) antiseptic solution and allowed to dry.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "temName": "water"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 571,
    "genericName": "Povidone-Iodine Gargle & Mouthwash",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Use undiluted or dilute with an equal volume of warm water, gargle or rinse for at least 30 seconds; repeat every 2 to 4 hours for as long as required.",
        "subDoseList": [
          {
            "type": "primary",
            "additionalItem": {
              "temName": "warm water"
            },
            "duration": {
              "unit": "seond",
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Use undiluted or dilute with an equal volume of warm water, gargle or rinse for at least 30 seconds; repeat every 2 to 4 hours for as long as required.",
        "subDoseList": [
          {
            "type": "primary",
            "additionalItem": {
              "temName": "warm water"
            },
            "duration": {
              "unit": "seond",
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 572,
    "genericName": "Povidone-Iodine Vagial possaries",
    "doseList": [
      {
        "route": "",
        "ageGroup": "",
        "indication": "",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "pessary",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "night": true,
              "morning": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "notes": "F menstruation occurs during treament, it is important to continue the treatment during those days."
          }
        ]
      }
    ]
  },
  {
    "serial": 573,
    "genericName": "Crystal Violet/ gentian violet",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply once or twice daily on the lesions.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply once or twice daily on the lesions.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 574,
    "genericName": "Hydrogen Peroxide",
    "doseList": [
      {
        "description": "Use during cleansing and deodorizing wounds and ulcers as required.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Use during cleansing and deodorizing wounds and ulcers as required"
          }
        ]
      }
    ]
  },
  {
    "serial": 575,
    "genericName": "Pyralvex Drop",
    "doseList": [
      {
        "description": "Apply 3-4 times daily on the surface lesions by using soft brush.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "using soft brush"
          }
        ]
      }
    ]
  },
  {
    "serial": 576,
    "genericName": "Ferrous Fumarate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Therapeutic",
        "description": "Ferrous iron, 120-180mg in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 180
            },
            "notes": "Ferrous iron"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "60mg iron daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "Therapeutic",
        "description": "Up to 1 year 36mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 36,
              "max": 36
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Therapeutic",
        "description": "1-5 years 72mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 72,
              "max": 72
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Therapeutic",
        "description": "6-12 years 12mg iron daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 577,
    "genericName": "Ferrous Gluconate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Therapeutic",
        "description": "Ferrous iron, 120-180mg in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 180
            },
            "notes": "Ferrous iron"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "60mg iron daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "Therapeutic",
        "description": "Up to 1 year 36mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 36,
              "max": 36
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Therapeutic",
        "description": "1-5 years 72mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 72,
              "max": 72
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Therapeutic",
        "description": "6-12 years 12mg iron daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 578,
    "genericName": "Ferrous Sulphate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Therapeutic",
        "description": "Ferrous iron, 120-180mg in single or divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 120,
              "max": 180
            },
            "notes": "Ferrous iron"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "60mg iron daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "indication": "Therapeutic",
        "description": "Up to 1 year 36mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 36,
              "max": 36
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Therapeutic",
        "description": "1-5 years 72mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 72,
              "max": 72
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "Therapeutic",
        "description": "6-12 years 12mg iron daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 579,
    "genericName": "ron (III) Hydroxide Polymaltose Complex",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5ml to 10ml 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "5ml to 10ml once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "condition": "5-10 kg",
        "description": "nfants (5-10kg)- 2.5ml to 5 ml once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 2.5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "condition": "5-10 kg",
        "description": "Paediatric drop: Infacts (5-10kg)- 0.5ml to 1 ml (or 8 to 15 drops) once daily. Premature infants (less than 1.5kg)-3mg of elemental iron (or 0.06ml)kg body weight daily In 2 to 3 divided doses. All doses to be taken immediately after meal. Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "notes": "Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician."
            }
          },
          {
            "type": "alternative",
            "unit": "drop",
            "amount": {
              "min": 8,
              "max": 15
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "notes": "Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician."
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "condition": "Premature infants (less than 1.5kg)",
        "description": "Paediatric drop: Infacts (5-10kg)- 0.5ml to 1 ml (or 8 to 15 drops) once daily. Premature infants (less than 1.5kg)-3mg of elemental iron (or 0.06ml)kg body weight daily In 2 to 3 divided doses. All doses to be taken immediately after meal. Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "notes": "Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician."
            }
          },
          {
            "type": "alternative",
            "unit": "ml",
            "amount": {
              "min": 0.06,
              "max": 0.06
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "notes": "Duration of therapy depends upon the extent of iron deficiency and should be taken as directed by the physician."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 580,
    "genericName": "ron Dextran",
    "doseList": [
      {
        "route": "Injection",
        "description": "Normal recommended dosage is 100-200mg two or three times a week depending on haemoglobin level. If repid delivery of iron is required, a total dose Infusion of upto 20mg/kg can be given. Administration: By intravenous drip Infusionor slow intravenous injecton. May be given as dosage schedule mentioned above, or the total requirement may be given as a single dose infusin by slow I.drip over 6-8 hours at a rate not exceeding 1m;/min (provided that there is no reaction within 30 minutes of administration of a 0.5ml I.test dose).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            },
            "timesWeekly": {
              "min": 2,
              "max": 3
            },
            "duration": {
              "unit": "hour",
              "min": 6,
              "max": 8
            },
            "nfusionRate": {
              "unit": "ml/min",
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 581,
    "genericName": "Ferrous Fumarate + Folic Acid",
    "doseList": [
      {
        "description": "Dosage and duration of therapy depend upon the extent of iron deficiency and should be taken as directed by the physician. The usual therapeutic dosage of elemental iron for Adults is 50-100mg 2 to 3 times daily. Iron theapy should continue for 3-6 months after restoration of normal hematologic values in order to replenish iron stores.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 582,
    "genericName": "Ferrous Sulphate + Folic Acid",
    "doseList": [
      {
        "description": "Dosage and duration of therapy depend upon the extent of iron deficiency and should be taken as directed by the physician. The usual therapeutic dosage of elemental iron for Adults is 50-100mg 2 to 3 times daily. Iron theapy should continue for 3-6 months after restoration of normal hematologic values in order to replenish iron stores.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 583,
    "genericName": "Carbonyl Iron + Folic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "One capsule daily before food or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before food"
            },
            "notes": "before food or as advised by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 584,
    "genericName": "ron Polymaltose + Folic Acid",
    "doseList": [
      {
        "description": "Dosage and duration of therapy depend upon the extent of iron deficiency and should be taken as directed by the physician. The usual therapeutic dosage of elemental iron for Adults is 50-100mg 2 to 3 times daily. Iron theapy should continue for 3-6 months after restoration of normal hematologic values in order to replenish iron stores. For Speific Preparation: Dosage given below under individual product.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "primary",
            "condition": "For Speific Preparation",
            "notes": "Dosage given below under individual product."
          }
        ]
      }
    ]
  },
  {
    "serial": 585,
    "genericName": "Chewrol",
    "doseList": [
      {
        "description": "Up to 3 Tablets daily in divided doses depending on the severity of the anaemia being treated. The Tablet should be chewed to get flavor and taste. Chewrol chewable Tablets can be taken with meals as appropriate to the patient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "max": 3
            },
            "connectionToMeal": {
              "when": "taken with meals as appropriate to the patient."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 586,
    "genericName": "ron + Folic Acid + B-Vitamins + Vitamin C",
    "doseList": [
      {
        "description": "1 capsule daily, or in more severe cases 2 capsules daily may be given before food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ],
        "notes": "may be given before food or as directed by the physician"
      }
    ]
  },
  {
    "serial": 587,
    "genericName": "Carbonyl Iron + Folic Acid + B-Vitamins + Vitamin C",
    "doseList": [
      {
        "description": "1 capsule daily, or in more severe cases 2 capsules daily may be given before food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ],
        "notes": "may be given before food or as directed by the physician"
      }
    ]
  },
  {
    "serial": 588,
    "genericName": "ron + Folic Acid + Zinc",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Treatment",
        "description": "Adult- 2 capsules a day or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Adult & Elderly- Usually one capsule once daily. In severe cases, 2 capsules a day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Prophylaxis",
        "description": "Adult & Elderly- Usually one capsule once daily. In severe cases, 2 capsules a day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "Child: Age over one year- one cpsule daily, (The capsule may be opened and the pellets may be mixed with soft, cool food but they moust not be chewed).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "The capsule may be opened and the pellets may be mixed with soft, cool food but they moust not be chewed"
          }
        ]
      }
    ]
  },
  {
    "serial": 589,
    "genericName": "Carbonyl Iron + Folic Acid + Zinc prepn",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Treatment",
        "description": "Adult- 2 capsules a day or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Prophylaxis",
        "description": "Adult & Elderly- Usually one capsule once daily. In severe cases, 2 capsules a day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Prophylaxis",
        "description": "Adult & Elderly- Usually one capsule once daily. In severe cases, 2 capsules a day may be required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "condition": "in severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "Child: Age over one year- one cpsule daily, (The capsule may be opened and the pellets may be mixed with soft, cool food but they moust not be chewed).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "The capsule may be opened and the pellets may be mixed with soft, cool food but they moust not be chewed"
          }
        ]
      }
    ]
  },
  {
    "serial": 590,
    "genericName": "ron Polymaltose + Folic Acid + Zinc",
    "doseList": [
      {
        "description": "One Tablet daily. Two Tablets may be required a day in severe cases or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in severe cases or as advised by the physician",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 591,
    "genericName": "ron + Vitamin-B Complex + Zinc",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5-10ml (1 to 2 tsf) 3 times daily or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "5-10ml (1 to 2 tsf)"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "5ml (1 tsf) 3 times daily or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "5ml (1 tsf)"
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "5ml (1 tsf) 3 times daily or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "5ml (1 tsf)"
          }
        ]
      }
    ]
  },
  {
    "serial": 592,
    "genericName": "ron Polymaltose + Folic Acid + Vitamin B-Complex+ Zinc",
    "doseList": [
      {
        "description": "One capsule daily. Two capsules may be required a day in severe cases or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in severe cases or as advised by the physician",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 593,
    "genericName": "ron Folic Acid + Vitamin-B Complex + Vitamin C + Zinc",
    "doseList": [
      {
        "description": "One capsule daily. In more severe cases, 2 capsules a day may be given or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases or as directed by the physician",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 594,
    "genericName": "Carbonyl Iron + Folic Acid + Vitamin-B Complex + Vitamin C + Zinc",
    "doseList": [
      {
        "description": "One capsule daily. In more severe cases, 2 capsules a day may be given or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases or as directed by the physician",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 595,
    "genericName": "Desferrioxamine",
    "doseList": [
      {
        "route": "",
        "ageGroup": "",
        "indication": "Subcutaneous Infusions of desferrioxamine",
        "description": "Subcutaneous Infusions of desferrioxamine (20-40mg/kg over 12 hours) are given on 5 to 7 nights Each week. It may also be given through the Infusion line at the time of blood transfusion (up to 2 gm per unit of blood).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "duration": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "night",
              "min": 5,
              "max": 7
            },
            "doseTime": {
              "night": true
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 596,
    "genericName": "Cyanocobalamin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Adult: 250-1000mcg I.M on alteranate days for 1-2 weeks (or for 10 times), then 250mcg weekly until blood count is normal. Maintenance, 1000mcg every monthly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 1000
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "until blood count is normal",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "repeated": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child: Initially as for Adult, subsequent dosage according to haematological response (For detail see manuf. Literature).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 1000
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "subsequent dosage according to haematological response"
          }
        ]
      }
    ]
  },
  {
    "serial": 597,
    "genericName": "Hydroxocobalamin",
    "doseList": [
      {
        "indication": "Addisonian pernicious anaemia & other macrocytic anaemias without neurological involvement",
        "description": "Addisonian pernicious anaemia & other macrocytic anaemias without neurological involvement: Initially, 250mcg to 1000mcg I.M Injection on alternate days for 1 or 2 weeks then 250mcg weekly until blood count is normal; Maintenance, 1000mcg every 2 or 3 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 1000
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "until blood count is normal",
            "unit": "mcg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "repeated": {
              "unit": "week",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "repeated": {
              "unit": "month",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Addisonian pernicious anaemia and other macrocytic anaemias with neurological involvement",
        "description": "Addisonian pernicious anaemia and other macrocytic anaemias with neurological involvement: Initially, 1000mcg on alternate days as long as improvement continues; Maintenance, 1000mcg every 2 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "treatmentPeriod": {
              "notes": "as long as improvement continues"
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "repeated": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "Tobaceo amblyopia & Leber’s optic atrophy",
        "description": "Tobaceo amblyopia & Leber’s optic atrophy: Intially, 1000mcg daily by I.M Injection for 2 weeks then twice weekly as long as improvement is maintained; Maintenance, 1000mcg every 3 months or as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "timesWeekly": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "notes": "as long as improvement is maintained"
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "repeated": {
              "unit": "month",
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 598,
    "genericName": "Mecobalamin",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult, Usually 500mcg (one Tablet) 3 times a day; the dosage should be adjusted according to the age of patient and the severity of symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Peripheral neuropathies",
        "description": "Peripheral neuropathies, The usual Adult dose is 500mcg (one ampoule) administered I.M or I.3 times a week; the dosage shuld be adjusted according to the age of the patient and severity of symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Magaloblastic anemia",
        "description": "Magaloblastic anemia, The usual Adult dose is 500mcg (one ampoule) administered I.M or I.3 times a week; after about 2 months of administration, dosage should be changed to 500mcg (one ampoule)every one to three months as maintenance therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "notes": ", dosage should be changed to 500mcg (one ampoule)every one to three months as maintenance therapy."
          }
        ]
      }
    ]
  },
  {
    "serial": 599,
    "genericName": "Folic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially, 5mg daily for 4 months or until a haematopoietic response has been obtained; Maintenance, 5mg every 1-7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 4,
              "max": 4
            },
            "notes": "4 months or until a haematopoietic response has been obtained"
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "every 1-7 days"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Initially daily for 2 days, upto 1 year 500mcg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "Initially daily for 2 days, 1-5 years 5mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Initially daily for 2 days, 6-12 years 10mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 600,
    "genericName": "Epoetin Alfa & Beta",
    "doseList": [
      {
        "route": "Injection",
        "description": "By Injection: The treatment is divided into 2 phases: Correction Phase- 50 IU/kg, 3 times per week by the subcutaneous or intravenous route; when a dose adjustment is necessary, it should be done at 4 week intermals & each adjustment in dose shold be equal to 25 IU/kg. Maintenance Phase- The usual dose is between 30 and 100 IU/kg, 3 times per week; the maximum dosage should not exceed 200 IU/kg, 3 times per week. By the subcutaneous route, the mean dose is 20-30% lower than the intravenous dose. If the haemoglobin exceeds 13gm/dl, the dose should be discontinued until the haemoglobin drops to 12gm/dl. The dose should be reduced by 25% when treatment is resumed and then titrated to maintain haemoglobin level. When the treatment is stopped, the haemoglobin concentration falls by around 0.5gm/dl per week.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Correction Phase",
            "unit": "U/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "notes": "when a dose adjustment is necessary, it should be done at 4 week intermals & each adjustment in dose shold be equal to 25 IU/kg."
          },
          {
            "type": "maintenance",
            "condition": "Maintenance Phase",
            "unit": "U/kg",
            "amount": {
              "min": 30,
              "max": 100
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "notes": "the maximum dosage should not exceed 200 IU/kg, 3 times per week."
          }
        ]
      }
    ]
  },
  {
    "serial": 601,
    "genericName": "Recormon inj.",
    "doseList": [
      {
        "indication": "Treatment of anaemia of chronic renal failure",
        "secondaryIndication": "in haemodailysis patients",
        "description": "Treatment of anaemia of chronic renal failure: The recormon pre-filled syringe is ready for use. The solution can be administ-ered subcutaneously or intravenously in case of intravenous administration, the solution should be injected over approximately 2 minutes e.g in haemodailysis patients via the arteriovenous fintula at the end of dailysis. For non-haemodailysed patients s.c administration should always be preferred in order to avoid puncture of peripheral veins. The aim of treatment is to increase the packed cell volume to 30 to 35% whereby the weekly increase should be at least 0.5% a Value of 35% should not be exceeded. In the presence of Hypertension or existing cardiovascular, cerebrovas-cular or peripheral vascular diseases, the weekly increase in the PCV and the target PCV should be determined individually taking into account the clinical picture. In some patients the optimum PCV may be below 30%.",
        "subDoseList": [
          {
            "type": "primary",
            "duration": {
              "unit": "minute",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "indication": "Treatment of anaemia of chronic renal failure",
        "secondaryIndication": "For non-haemodailysed patients",
        "description": "Treatment of anaemia of chronic renal failure: The recormon pre-filled syringe is ready for use. The solution can be administ-ered subcutaneously or intravenously in case of intravenous administration, the solution should be injected over approximately 2 minutes e.g in haemodailysis patients via the arteriovenous fintula at the end of dailysis. For non-haemodailysed patients s.c administration should always be preferred in order to avoid puncture of peripheral veins. The aim of treatment is to increase the packed cell volume to 30 to 35% whereby the weekly increase should be at least 0.5% a Value of 35% should not be exceeded. In the presence of Hypertension or existing cardiovascular, cerebrovas-cular or peripheral vascular diseases, the weekly increase in the PCV and the target PCV should be determined individually taking into account the clinical picture. In some patients the optimum PCV may be below 30%.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "For non-haemodailysed patients s.c administration should always be preferred in order to avoid puncture of peripheral veins."
          }
        ]
      },
      {
        "indication": "Treatment of anaemia of chronic renal failure",
        "secondaryIndication": "in the presence of Hypertension or existing cardiovascular, cerebrovas-cular or peripheral vascular diseases",
        "description": "Treatment of anaemia of chronic renal failure: The recormon pre-filled syringe is ready for use. The solution can be administ-ered subcutaneously or intravenously in case of intravenous administration, the solution should be injected over approximately 2 minutes e.g in haemodailysis patients via the arteriovenous fintula at the end of dailysis. For non-haemodailysed patients s.c administration should always be preferred in order to avoid puncture of peripheral veins. The aim of treatment is to increase the packed cell volume to 30 to 35% whereby the weekly increase should be at least 0.5% a Value of 35% should not be exceeded. In the presence of Hypertension or existing cardiovascular, cerebrovas-cular or peripheral vascular diseases, the weekly increase in the PCV and the target PCV should be determined individually taking into account the clinical picture. In some patients the optimum PCV may be below 30%.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "the weekly increase in the PCV and the target PCV should be determined individually taking into account the clinical picture. In some patients the optimum PCV may be below 30%."
          }
        ]
      },
      {
        "route": "",
        "ageGroup": "",
        "indication": "",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": null,
              "max": null
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 602,
    "genericName": "Vitamin-A",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Prephylaxis",
        "description": "Oral- Prephylaxis, 400 i.u. daily. In deficiency state, 50,00 to 300,000i.u daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "alternative",
            "condition": "in deficiency state",
            "unit": ".u",
            "amount": {
              "min": 50000,
              "max": 300000
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Injection- by deep I.M. inj., 150,000-300,000i.u. Monthly, increased to weekly in acute deficiency states.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 150000,
              "max": 300000
            }
          },
          {
            "type": "alternative",
            "condition": "in deficiency state",
            "notes": "Monthly, increased to weekly in acute deficiency states."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Oral- upto 50,000 i.u. daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "max": 50000
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Injecton- Same as Adult. Injection- by deep I.M. inj., 150,000-300,000i.u. Monthly, increased to weekly in acute deficiency states.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 150000,
              "max": 300000
            }
          },
          {
            "type": "alternative",
            "condition": "in deficiency state",
            "notes": "Monthly, increased to weekly in acute deficiency states."
          }
        ]
      }
    ]
  },
  {
    "serial": 603,
    "genericName": "Ergocalciferol (D2)/ Cholecalciferol (D3)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Simple vita-D deficiency",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Deficiency caused by intestinal malabsorption or chronic liver disease",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "max": 40000
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Renal osteodystrophy",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "max": 200000
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Rickets & Osteomalacia",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1000,
              "max": 5000
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Simple vita-D deficiency",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 400,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Deficiency caused by intestinal malabsorption or chronic liver disease",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "max": 40000
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Renal osteodystrophy",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "max": 200000
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Rickets & Osteomalacia",
        "description": "Simple vita-D deficiency, 400 i.u. (10mcg) daily; Deficiency caused by intestinal malabsorption or chronic liver disease, upto 40,000 i.u. (1mg) daily. Renal osteodystrophy, upto 200,000 i.u. (5mg) daily, Rickets & Osteomalacia, 1000-5000 i.u. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1000,
              "max": 5000
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 604,
    "genericName": "Alfacalcidol",
    "doseList": [
      {
        "route": "mouth or I.V Injection",
        "ageGroup": "Adult",
        "description": "Adult & Child over 20kg- initially 1 mcg daily (elderly 500 nanogram), adjusted in avoid hypercalcaemia; Maintenance, usually 0.25-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "second",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth or I.V Injection",
        "ageGroup": "elderly",
        "description": "Adult & Child over 20kg- initially 1 mcg daily (elderly 500 nanogram), adjusted in avoid hypercalcaemia; Maintenance, usually 0.25-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanogram",
            "amount": {
              "min": 500,
              "max": 500
            },
            "duration": {
              "unit": "second",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth or I.V Injection",
        "ageGroup": "Child",
        "condition": "over 20kg",
        "description": "Adult & Child over 20kg- initially 1 mcg daily (elderly 500 nanogram), adjusted in avoid hypercalcaemia; Maintenance, usually 0.25-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "second",
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "mouth or I.V Injection",
        "ageGroup": "Child",
        "condition": "under 20kg",
        "description": "Child under 20kg- initially 50 nanograms/kg daily; Neonate & premature infant- initially 50-100 nanograms/kg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "duration": {
              "unit": "second",
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "route": "mouth or I.V Injection",
        "ageGroup": "Child",
        "condition": "under 20kg",
        "secondaryCondition": "Neonate & premature infant",
        "description": "Child under 20kg- initially 50 nanograms/kg daily; Neonate & premature infant- initially 50-100 nanograms/kg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 100
            },
            "duration": {
              "unit": "second",
              "min": 30,
              "max": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 605,
    "genericName": "Bon-one Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Child over 20kg- initially 1 mcg daily (elderly 500 manogram), adjusted to avoid hypercalcaemia; maintenance, usually 0.25 1 mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Adult & Child over 20kg- initially 1 mcg daily (elderly 500 nanogram), adjusted in avoid hypercalcaemia; Maintenance, usually 0.25-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanogram",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "over 20kg",
        "description": "Adult and Child over 20kg- initially 1 mcg daily (elderly 500 manogram), adjusted to avoid hypercalcaemia; maintenance, usually 0.25 1 mcg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "under 20kg",
        "description": "Child under 20kg- initially 50 nanograms/kg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "under 20kg",
        "secondaryCondition": "Neonate & premature infant",
        "description": "Neonate & Premature infant- initially 50-100 nanograms/kgdaily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 606,
    "genericName": "One Alpha Cap.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Child over 20kg- initially 1 mcg daily (elderly 500 manogram), adjusted to avoid hypercalcaemia; maintenance, usually 0.25 1 mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Adult & Child over 20kg- initially 1 mcg daily (elderly 500 nanogram), adjusted in avoid hypercalcaemia; Maintenance, usually 0.25-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanogram",
            "amount": {
              "min": 500,
              "max": 500
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "over 20kg",
        "description": "Adult and Child over 20kg- initially 1 mcg daily (elderly 500 manogram), adjusted to avoid hypercalcaemia; maintenance, usually 0.25 1 mcg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "under 20kg",
        "description": "Child under 20kg- initially 50 nanograms/kg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "under 20kg",
        "secondaryCondition": "Neonate & premature infant",
        "description": "Neonate & Premature infant- initially 50-100 nanograms/kgdaily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms/kg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 607,
    "genericName": "Calcitriol",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Renal osteodystrophy",
        "description": "Adult- Initially 0.25mcg daily or on alternate days, increased if necessary in steps of 0.25mcg at intervals of 2-4 weeks; usual dose 0.5-1mcg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "ncrementRate": {
              "unit": "mcg",
              "min": 0.25,
              "max": 0.25
            },
            "Interval": {
              "unit": "week",
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Renal osteodystrophy",
        "description": "Child, not established",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "mouth",
        "indication": "Established postmenopausal osteoporosis",
        "description": "Established postmenopausal osteoporosis: 0.25 mcg twice daily (monitor plasma calcium and creatinine level if possible).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Hypocalcaemia in dailysis patients with chronic renal failure",
        "description": "Established postmenopausal osteoporosis: 0.25 mcg twice daily (monitor plasma calcium and creatinine level if possible).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "nanograms",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": "mcg",
            "amount": {
              "min": 0.5,
              "max": 3
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            },
            "ncrementRate": {
              "unit": "nanogram",
              "min": 250,
              "max": 500
            },
            "Interval": {
              "unit": "week",
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "- Hypocalcaemia in dailysis patients with chronic renal failure",
        "description": "Child, not established",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 608,
    "genericName": "Thiamine (B1)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Daily dietary requirement",
        "description": "Daily dietary requirement, 3 to 6mg; Neuritis, 25 to 100mg daily by inj. Followed by 10-50 mg daily orally. In acute deficiency, 100-200mg daily by I.M or I.inj. Followed by oral therapy. Neuralgias, 50-150mg by inj. Every alternate day. Anorexia, Same as neuritis.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Neuritis",
        "description": "Daily dietary requirement, 3 to 6mg; Neuritis, 25 to 100mg daily by inj. Followed by 10-50 mg daily orally. In acute deficiency, 100-200mg daily by I.M or I.inj. Followed by oral therapy. Neuralgias, 50-150mg by inj. Every alternate day. Anorexia, Same as neuritis.",
        "subDoseList": [
          {
            "type": "primary",
            "route": "Injection",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            }
          },
          {
            "type": "primary",
            "route": "mouth",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in acute deficiency",
        "description": "Daily dietary requirement, 3 to 6mg; Neuritis, 25 to 100mg daily by inj. Followed by 10-50 mg daily orally. In acute deficiency, 100-200mg daily by I.M or I.inj. Followed by oral therapy. Neuralgias, 50-150mg by inj. Every alternate day. Anorexia, Same as neuritis.",
        "subDoseList": [
          {
            "type": "primary",
            "route": "Injection",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          },
          {
            "type": "primary",
            "route": "mouth"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Neuralgias",
        "description": "Daily dietary requirement, 3 to 6mg; Neuritis, 25 to 100mg daily by inj. Followed by 10-50 mg daily orally. In acute deficiency, 100-200mg daily by I.M or I.inj. Followed by oral therapy. Neuralgias, 50-150mg by inj. Every alternate day. Anorexia, Same as neuritis.",
        "subDoseList": [
          {
            "type": "primary",
            "route": "Injection",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 150
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Anorexia",
        "description": "Daily dietary requirement, 3 to 6mg; Neuritis, 25 to 100mg daily by inj. Followed by 10-50 mg daily orally. In acute deficiency, 100-200mg daily by I.M or I.inj. Followed by oral therapy. Neuralgias, 50-150mg by inj. Every alternate day. Anorexia, Same as neuritis.",
        "subDoseList": [
          {
            "type": "primary",
            "route": "Injection",
            "unit": "mg",
            "amount": {
              "min": 25,
              "max": 100
            }
          },
          {
            "type": "primary",
            "route": "mouth",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: 5-20 mg daily orally and parenterally",
        "subDoseList": [
          {
            "type": "primary",
            "route": "Injection",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 609,
    "genericName": "Riboflavine (B2)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "5 to 10 mg 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "5 to 10 mg 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 610,
    "genericName": "Nicotinic Acid (B3)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 Tablet Daily or 100-200 mg. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 611,
    "genericName": "Pyridoxine (B6)",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Neuritis & Dificiency states",
        "description": "Neuritis & Dificiency states, 20-25mg upto 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 25
            },
            "timesDaily": {
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "soniazid neuropathy",
        "description": "soniazid neuropathy, prophylaxis 10mg daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "diopathic sideroblastic anaemia",
        "description": "diopathic sideroblastic anaemia, 100-400 mg daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 400
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Premenstrual Syndrome",
        "description": "Premenstrual Syndrome, 50-100mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Convulsions",
        "description": "Child: Convulsions, 20-100mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 100
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 612,
    "genericName": "VIT. B1+B2+B6",
    "doseList": [
      {
        "description": "nsevere cases, one amp. Daily until all the symptoms disappear. For milder cases, one amp. 2-3 times a week.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "nsevere cases, Daily until all the symptoms disappear",
            "unit": "ampoule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "For milder cases",
            "unit": "ampoule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesWeekly": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 613,
    "genericName": "Vitamin B1+B6+B12",
    "doseList": [
      {
        "route": "mouth",
        "description": "Oral preparation may be administered in a dose of 1-3 Tablets daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "description": "Injectons are preferably to be given by deep intramuscularly (as in intragluteal muscles). In severe cases 1 ampoule daily until the acute symptoms subside. For milder cases and follow up therapy 2 to 3 ampoules per week.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in severe cases until the acute symptoms subside",
            "unit": "ampoule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primary",
            "condition": "For milder cases and follow up therapy",
            "unit": "ampoule",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 614,
    "genericName": "Vitamin B Complex ",
    "doseList": [
      {
        "description": "Capsule & Tablet prepns. 1-2 caps/tabs daily. Other Preparation-see under individual drug.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Capsule prepns",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "Tablet prepns",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "other prepns",
            "notes": "see under individual drug"
          }
        ]
      }
    ]
  },
  {
    "serial": 615,
    "genericName": "Ascorbic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Scurvy",
        "description": "Adult: Scurvy, 500mg-1gm; infections, 1 gm. Both 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 1000
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "nfections",
        "description": "Adult: Scurvy, 500mg-1gm; infections, 1 gm. Both 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "indication": "Scurvy",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "indication": "Scurvy",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12,
          "max": 14
        },
        "indication": "Scurvy",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 375,
              "max": 750
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "indication": "nfections",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 12
        },
        "indication": "nfections",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12,
          "max": 14
        },
        "indication": "nfections",
        "description": "Children: Under 4 years, 1/4 , Adult dose; 4-12 yrs. ½ Adult dose; 12-14 yrs. ¾ Adult dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 750,
              "max": 750
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 616,
    "genericName": "Ceegram 500 Effervescent Tab.",
    "doseList": [
      {
        "description": "1 Tablet daily with a meal or as directed by the physician, dDissolve one effervescent Tablet in half glass (100ml) of water and drink instantly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "ml",
                "min": 100,
                "max": 100
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 617,
    "genericName": "Ceevit Forte Tab.",
    "doseList": [
      {
        "description": "1 Tablet daily with a meal or as directed by the physician, dDissolve one effervescent Tablet in half glass (100ml) of water and drink instantly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "ml",
                "min": 100,
                "max": 100
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 618,
    "genericName": "Cevion Tab.",
    "doseList": [
      {
        "description": "1 Tablet daily with a meal or as directed by the physician, dDissolve one effervescent Tablet in half glass (100ml) of water and drink instantly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with meal"
            },
            "additionalItem": {
              "temName": "water",
              "quantity": {
                "unit": "ml",
                "min": 100,
                "max": 100
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 619,
    "genericName": "Alpha Tocopheryl Acetate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3-15 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 3,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-10mg/kg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 620,
    "genericName": "Becosules Gold Cap.",
    "doseList": [
      {
        "description": "1 or 2 Capsules daily or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 621,
    "genericName": "Multivitamin",
    "doseList": [
      {
        "description": "Usual dosage, 10-15 drops (0.6-1ml)once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.6,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 622,
    "genericName": "Folic Acid + Zinc",
    "doseList": [
      {
        "description": "1 capsule daily throughout the first trimester of pregnancy or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 623,
    "genericName": "Vitamin-B Complex + Zinc",
    "doseList": [
      {
        "ageGroup": "Child",
        "condition": "Children under 10kg",
        "description": "Children under 10kg-1 tsf (5ml) daily after meal or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 5
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children within 10-30kg",
        "description": "Children within 10-30kg-1 tsf (5ml)2 or 3 times daily after meal or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children ovear 30kg",
        "description": "Adults and Children ovear 30kg- 1 or 2 tsf (5 or 10ml)3 times daily after meal or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Adult over 30kg",
        "description": "Adults and Children ovear 30kg- 1 or 2 tsf (5 or 10ml)3 times daily after meal or as recommended by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 5,
              "max": 10
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 624,
    "genericName": "Multvitamin + Multimineral",
    "doseList": [
      {
        "description": "1 Tablet or capsule daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 625,
    "genericName": "Antioxidant Vitamin Prepns",
    "doseList": [
      {
        "description": "1 Tablet or capsule daily, or as prescribed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 626,
    "genericName": "Super Antioxidant Vitamin Multimineral",
    "doseList": [
      {
        "description": "One Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 627,
    "genericName": "Antioxidant vitamin & Minerals for eye health",
    "doseList": [
      {
        "description": "One capsule daily; in more severe cases, 2 capsules a day may be given or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in more severe cases",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "in more severe cases or as advised by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 628,
    "genericName": "Vitamin C + Vitamin D3 + Folic Acid",
    "doseList": [
      {
        "description": "One Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 629,
    "genericName": "Multivitamin-Multimineral High Pothency A-Z Formula",
    "doseList": [
      {
        "description": "One Tablet once daily or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 630,
    "genericName": "Multivitamin & Multimineral A-Z Gold preparation",
    "doseList": [
      {
        "description": "One Tablet daily with food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Not formulated for use in Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 631,
    "genericName": "Multivitamin & Multimineral A-Z Silver preparation",
    "doseList": [
      {
        "description": "One Tablet daily with food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Not formulated for use in Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 632,
    "genericName": "Potassium Salts",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: 10-50 mmol K+ (1 mmol equto 75 mg of KCI) daily or on alternate days in divided doses after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mmol K+",
            "amount": {
              "min": 10,
              "max": 50
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "notes": "(1 mmol equto 75 mg of KCI) daily or on alternate days"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: See manufacturer’s note..",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Child: See manufacturer’s note."
          }
        ]
      }
    ]
  },
  {
    "serial": 633,
    "genericName": "Doxtrose (Glucose) Prepns.",
    "doseList": [
      {
        "indication": "Water replacement",
        "description": "A healthy Adult requires 1.5-2.5 litre daily, so replacement should be to recover loses and maintenance therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "litre",
            "amount": {
              "min": 1.5,
              "max": 2.5
            }
          }
        ]
      },
      {
        "indication": "Energy Source",
        "description": "1-3 litres daily of 20-25% Solution.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "litre",
            "amount": {
              "min": 1,
              "max": 3
            },
            "notes": "of 20-25% Solution"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "According to water and energy requirement.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "According to water and energy requirement."
          }
        ]
      }
    ]
  },
  {
    "serial": 634,
    "genericName": "Baby Saline Prepns",
    "doseList": [
      {
        "description": "According to the requirements or as advised by the physician & see manufactuers note.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "According to the requirements or as advised by the physician & see manufactuers note."
          }
        ]
      }
    ]
  },
  {
    "serial": 635,
    "genericName": "Normal Saline Prepns",
    "doseList": [
      {
        "description": "According to the requirements or as advised by the physician & see manufactuers note.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "According to the requirements or as advised by the physician & see manufactuers note."
          }
        ]
      }
    ]
  },
  {
    "serial": 636,
    "genericName": "Dextrose Saline Prepns",
    "doseList": [
      {
        "description": "According to the requirements or as advised by the physician & see manufactuers note.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "According to the requirements or as advised by the physician & see manufactuers note."
          }
        ]
      }
    ]
  },
  {
    "serial": 637,
    "genericName": "sotonic Dextrose Saline",
    "doseList": [
      {
        "description": "60-120 drops per minute or according to the require ments or directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 60,
              "max": 120
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 638,
    "genericName": "Human Albumin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "Human Albumin (5%)",
        "description": "Human Albumin is administered intravenously. The total dosage will very with the individual. Human Albumin (5%) In Adults, an intital Infusion of 500jml is suggested. Additional amountsw may be administered as clinically indicated. The dosage in Children will vary with the clinical state and body weight. A dose one-quarter to one-half the Adult dose may be administered or dosage may be calculated on the basis of 3-5 ml per kg. of body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (5%)",
        "description": "Human Albumin is administered intravenously. The total dosage will very with the individual. Human Albumin (5%) In Adults, an intital Infusion of 500jml is suggested. Additional amountsw may be administered as clinically indicated. The dosage in Children will vary with the clinical state and body weight. A dose one-quarter to one-half the Adult dose may be administered or dosage may be calculated on the basis of 3-5 ml per kg. of body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 125,
              "max": 250
            }
          },
          {
            "type": "alternative",
            "unit": "ml/kg",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "condition": "Human Albumin (5%)",
        "indication": "in the treatmentof the patient in shock with greatly reduced blood volume",
        "description": "in the treatmentof the patient in shock with greatly reduced blood volume; Albumin Injection may be administered as rapidly as necessary in order to improve the clinical condition and restore norml blood volume. This may be repeated in 15-30 minutes if the initial dose fails to prove adequate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Albumin Injection may be administered as rapidly as necessary in order to improve the clinical condition and restore norml blood volume."
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "minute",
              "min": 15,
              "max": 30
            }
          }
        ]
      },
      {
        "condition": "Human Albumin (5%)",
        "indication": "in the patient with a slightly low or normal blood volume",
        "description": "in the patient with a slightly low or normal blood volume the rate of administration should be 1-2 ml per minute.",
        "subDoseList": [
          {
            "type": "primary",
            "administrationRate": {
              "unit": "ml/minute",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (5%)",
        "indication": "in the treatmentof the patient in shock with greatly reduced blood volume",
        "description": "The usual rate of administration in Children should be one-qurter the Adult rate. In the treatmentof the patient in shock with greatly reduced blood volume; Albumin Injection may be administered as rapidly as necessary in order to improve the clinical condition and restore norml blood volume. This may be repeated in 15-30 minutes if the initial dose fails to prove adequate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "The usual rate of administration in Children should be one-qurter the Adult rate."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (5%)",
        "indication": "in the patient with a slightly low or normal blood volume",
        "description": "The usual rate of administration in Children should be one-qurter the Adult rate. In the patient with a slightly low or normal blood volume the rate of administration should be 1-2 ml per minute.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "The usual rate of administration in Children should be one-qurter the Adult rate."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Human Albumin (20% & 25%)",
        "description": "in Adult an initial Infusion of 100ml is suggested. Additional amounts may be administered as clinically indicated. The dosage In Children will vary with the clinical state and body weight. A dose one-quarter to one-half the Adult dose may be administered or dosage may be calculated on the basic of 1 ml per pound of body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (20% & 25%)",
        "description": "in Adult an initial Infusion of 100ml is suggested. Additional amounts may be administered as clinically indicated. The dosage In Children will vary with the clinical state and body weight. A dose one-quarter to one-half the Adult dose may be administered or dosage may be calculated on the basic of 1 ml per pound of body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 33.33,
              "max": 50
            }
          },
          {
            "type": "alternative",
            "unit": "ml/pound",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (20% & 25%)",
        "indication": "For jaundiced injants suffering from haemolytic disease of the newborn",
        "description": "For jaundiced injants suffering from haemolytic disease of the newborn the appropriate dose for binding of free serum bilirubin is 1 gm. Per kg. of body weight which may be administered during the procedure.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm/kg",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "condition": "Human Albumin (20% & 25%)",
        "indication": "in the treatment of the patient in shock with greatly reduced blood volume",
        "description": "in the treatment of the patient in shock with greatly reduced blood volume. Albumin injectjion may be administered as rapidly as necessary in order tio improve the clinical condition and restore normal blood volume. This may be repeated in 15-30 minutes if the initial dose fails to prove adequate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Albumin injectjion may be administered as rapidly as necessary in order tio improve the clinical condition and restore normal blood volume."
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "minute",
              "min": 15,
              "max": 30
            }
          }
        ]
      },
      {
        "condition": "Human Albumin (20% & 25%)",
        "indication": "in the patient with a slightly low or normal blood volume",
        "description": "in the patient with a slightly low or normal blood volume the rate of administration should be 1 ml per minute. The usual rate of administration in Children should be one- quarter the Adult rate.",
        "subDoseList": [
          {
            "type": "primary",
            "administrationRate": {
              "unit": "ml/minute",
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Human Albumin (20% & 25%)",
        "indication": "in the patient with a slightly low or normal blood volume",
        "description": "in the patient with a slightly low or normal blood volume the rate of administration should be 1 ml per minute. The usual rate of administration in Children should be one- quarter the Adult rate.",
        "subDoseList": [
          {
            "type": "primary",
            "administrationRate": {
              "unit": "ml/minute",
              "min": 0.25,
              "max": 0.25
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 640,
    "genericName": "Aminosyn 5% & 10% inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adults, 200-800ml daily dosage by I.injusion, initially 15-20 drops/minimum Then can be increased to 30-40 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 200,
              "max": 800
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            }
          },
          {
            "nfusionRate": {
              "unit": "drop/min",
              "min": 30,
              "max": 40
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 641,
    "genericName": "Aminoven 5% Inf.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adults, 200-800ml daily dosage by I.injusion, initially 15-20 drops/minimum Then can be increased to 30-40 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 200,
              "max": 800
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            }
          },
          {
            "nfusionRate": {
              "unit": "drop/min",
              "min": 30,
              "max": 40
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 642,
    "genericName": "nfusamin-S 5 inj.",
    "doseList": [
      {
        "description": "Usually 500ml as one dose, is gradually (60-80 drops/min) infused I.one to several times daily. Dosages are adjusted properly depending on djisease conditions, age & body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 500,
              "max": 500
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 60,
              "max": 80
            },
            "timesDaily": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 643,
    "genericName": "VAmin Glucose inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adults, 200-800ml daily dosage by I.injusion, initially 15-20 drops/minimum Then can be increased to 30-40 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 200,
              "max": 800
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            }
          },
          {
            "nfusionRate": {
              "unit": "drop/min",
              "min": 30,
              "max": 40
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "nfants & Children:I.Infusion should be given calculated as 0.2-0.25gm of nitrogen/ kg body weight in 24 hours.15-20 drops/minimum",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.2,
              "max": 0.25
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 15,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 644,
    "genericName": "Nutrisol-S (5%) inj.",
    "doseList": [
      {
        "description": "Usually 500ml as one dose, is gradually (60-80 drops/min) infused I.one to several times daily. Dosages are adjusted properly depending on djisease conditions, age & body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 500,
              "max": 500
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 60,
              "max": 80
            },
            "timesDaily": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 645,
    "genericName": "Proliv 5% inj.",
    "doseList": [
      {
        "description": "Usually 500ml as one dose, is gradually (60-80 drops/min) infused I.one to several times daily. Dosages are adjusted properly depending on djisease conditions, age & body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 500,
              "max": 500
            },
            "nfusionRate": {
              "unit": "drop/min",
              "min": 60,
              "max": 80
            },
            "timesDaily": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 646,
    "genericName": "ntralipid 10% inj./ Intralipos 10% inj./ Liposyn I10% inj.",
    "doseList": [
      {
        "description": "Usually, 500ml of 10% fat emulsion is administered by I.drip Infusion over a time of atleast 3 hours. The dosag is adjusted according to body wt.& condition up to 2 gm of fat per kg body wt/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 500,
              "max": 500
            },
            "duration": {
              "unit": "hour",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 647,
    "genericName": "Calcium Gluconate / Lactate/ Pantothenate",
    "doseList": [
      {
        "route": "mouth",
        "description": "By mouth- Up to mmol ca++ daily  in divided doses as calcium gluconate or lactate or pantothenate.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "By mouth- Up to mmol ca++ daily  in divided doses as calcium gluconate or lactate or pantothenate."
          }
        ]
      },
      {
        "route": "slow I.or deep I.M. Injection",
        "description": "By slow I.or deep I.M. Injection- Calcium gluconate 1-2 gm (2.25-4.5 mmol of ca++).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": {
              "unit": "mmol",
              "min": 2.25,
              "max": 4.5
            }
          }
        ]
      },
      {
        "route": "slow I.or deep I.M. Injection",
        "ageGroup": "Child",
        "description": "Child: Half Adult dose by slow I.routh. By slow I.or deep I.M. Injection- Calcium gluconate 1-2 gm (2.25-4.5 mmol of ca++).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "volume": {
              "unit": "mmol",
              "min": 1.125,
              "max": 2.25
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 648,
    "genericName": "Calcium salt",
    "doseList": [
      {
        "condition": "Adult Preparation (500mg)",
        "description": "Adult Preparation (500mg): 1 Tablet daily or as directed by the physicion.Higher doses should not be tken utess recommended by the physicion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Peadiatric Preparation (250mg)",
        "description": "Peadiatric Preparation (250mg): Children, 1 Tablet daily; adolescent, 1-2 Tablets daily; Adults, 2 Tablets daily or as directec by the physician. Highe dodes should not be taken unless recommended by the physcion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "condition": "Peadiatric Preparation (250mg)",
        "description": "Peadiatric Preparation (250mg): Children, 1 Tablet daily; adolescent, 1-2 Tablets daily; Adults, 2 Tablets daily or as directec by the physician. Highe dodes should not be taken unless recommended by the physcion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Peadiatric Preparation (250mg)",
        "description": "Peadiatric Preparation (250mg): Children, 1 Tablet daily; adolescent, 1-2 Tablets daily; Adults, 2 Tablets daily or as directec by the physician. Highe dodes should not be taken unless recommended by the physcion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 649,
    "genericName": "Calcium + Vitamin C",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Children of school age- 1 Tablet daily; Chidren 3 to 7 years- ½ Tablet daily; Infants- as prescribed by the phycian. It is rapidly soluble and dissolve in half glass (100ml) of water before se; needs on shaking are strring.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children of school age",
        "description": "Adult and Children of school age- 1 Tablet daily; Chidren 3 to 7 years- ½ Tablet daily; Infants- as prescribed by the phycian. It is rapidly soluble and dissolve in half glass (100ml) of water before se; needs on shaking are strring.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "description": "Adult and Children of school age- 1 Tablet daily; Chidren 3 to 7 years- ½ Tablet daily; Infants- as prescribed by the phycian. It is rapidly soluble and dissolve in half glass (100ml) of water before se; needs on shaking are strring.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "Adult and Children of school age- 1 Tablet daily; Chidren 3 to 7 years- ½ Tablet daily; Infants- as prescribed by the phycian. It is rapidly soluble and dissolve in half glass (100ml) of water before se; needs on shaking are strring.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "as prescribed by the phycian"
          }
        ]
      }
    ]
  },
  {
    "serial": 650,
    "genericName": "Calcium + Vitamin D",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Dietary deficiency",
        "description": "Dietary deficiency: 1 Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Dietary deficiency",
        "description": "Dietary deficiency: 1 Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Dietary deficiency",
        "description": "Children: Doses for Children being half of those for adutls. Dietary deficiency: 1 Tablet daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "As phosphate binder",
        "description": "As phosphate binder: Dose required by the individual patient depending  on serum calcium and phosphate levels.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Dose required by the individual patient depending  on serum calcium and phosphate levels."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "As phosphate binder",
        "description": "As phosphate binder: Dose required by the individual patient depending  on serum calcium and phosphate levels.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Dose required by the individual patient depending  on serum calcium and phosphate levels."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "As phosphate binder",
        "description": "Children: Doses for Children being half of those for adutls. As phosphate binder: Dose required by the individual patient depending  on serum calcium and phosphate levels.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Doses for Children being half of those for adutls.Dose required by the individual patient depending  on serum calcium and phosphate levels."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Adjuncct to ostenporosis therapy",
        "description": "Adjuncct to ostenporosis therapy: 2-3 Tablets daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Adjuncct to ostenporosis therapy",
        "description": "Adjuncct to ostenporosis therapy: 2-3 Tablets daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Adjuncct to ostenporosis therapy",
        "description": "Children: Doses for Children being half of those for adutls. Adjuncct to ostenporosis therapy: 2-3 Tablets daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 651,
    "genericName": "Calcium + Vitamin C + Vitamin D",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Dosage of this combined product should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general, the dosage is : Adult, elderly and school going Children- 1 Tablet daily; Children 3-7 years-1/2 Tablet daily; infants- as advised by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Dosage of this combined product should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general, the dosage is : Adult, elderly and school going Children- 1 Tablet daily; Children 3-7 years-1/2 Tablet daily; infants- as advised by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "school going Children",
        "description": "Dosage of this combined product should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general, the dosage is : Adult, elderly and school going Children- 1 Tablet daily; Children 3-7 years-1/2 Tablet daily; infants- as advised by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 7
        },
        "description": "Dosage of this combined product should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general, the dosage is : Adult, elderly and school going Children- 1 Tablet daily; Children 3-7 years-1/2 Tablet daily; infants- as advised by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "Dosage of this combined product should be individualized based on the demands in age, sex and various physiological (pregnancy & lactation) & disease conditions. In general, the dosage is : Adult, elderly and school going Children- 1 Tablet daily; Children 3-7 years-1/2 Tablet daily; infants- as advised by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "nfants- as advised by the physicians."
          }
        ]
      }
    ]
  },
  {
    "serial": 652,
    "genericName": "Calcium + Vitamin D + Minerals",
    "doseList": [
      {
        "description": "2 Tablets per day, preferably 1 Tablet in the morning and 1 table in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 653,
    "genericName": "Nalepsin inj.",
    "doseList": [
      {
        "indication": "Seizure prophylaxis in pre-eclampsia and eclampsia",
        "description": "Seizure prophylaxis in pre-eclampsia and eclampsia: A loading dose of 4 gm or 16mmol (100ml) over upto 20 minutes followed by a maintenance dose of 2 gm or 8mmol (50ml) /hour. Recurrence of seizure may require an additional I.bolus of 2-4 gm or 8-16mmol (50-100ml). For seizure prophylaxis, treatment should continue during labour and for atleast 24 hours after delivery.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 4,
              "max": 4
            },
            "duration": {
              "unit": "minute",
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "maintenance",
            "unit": "gm/hour",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "Recurrence of seizure",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "primary",
            "condition": "For seizure prophylaxis",
            "notes": "For seizure prophylaxis, treatment should continue during labour and for atleast 24 hours after delivery."
          }
        ]
      },
      {
        "indication": "Myocardial infarction",
        "description": "Myocardial infarction: 2 gm or 8mmol (50ml) over 20 maintain, then 16gm  or 64mmol (400ml)over 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            },
            "duration": {
              "unit": "minute",
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "gm",
            "amount": {
              "min": 16,
              "max": 16
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "indication": "Magnesium deficiency",
        "description": "Magnesium deficiency: 0.5-1 mmol/kg/day (200-400ml) on the first day followed by 25mmol (150ml) daily, upto 160 mmol (100ml) over upto 5 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mmol/kg/day",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "volume": {
              "unit": "ml",
              "min": 200,
              "max": 400
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mmol",
            "amount": {
              "min": 25,
              "max": 25
            },
            "volume": {
              "unit": "ml",
              "min": 150,
              "max": 150
            }
          },
          {
            "type": "maintenance",
            "unit": "mmol",
            "amount": {
              "max": 160
            },
            "volume": {
              "unit": "ml",
              "max": 100
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      },
      {
        "indication": "Tetanus",
        "description": "Tetanus: an Infusion of magnesium sulphate sufficient to maintain a blood magnesium concentration of 2.5 to 4 mmol per litre has been recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mmol/litre",
            "amount": {
              "min": 2.5,
              "max": 4
            }
          }
        ]
      },
      {
        "indication": "Arrythmia",
        "description": "Arrythmia: 8mmol (50ml) over 10-15 minutes (repeated once if needed).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mmol",
            "amount": {
              "min": 8,
              "max": 8
            },
            "volume": {
              "unit": "ml",
              "min": 50,
              "max": 50
            },
            "duration": {
              "unit": "minute",
              "min": 10,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 654,
    "genericName": "G-Magsulph Inj.",
    "doseList": [
      {
        "route": "Injection",
        "description": "G-mag sulph Injection, as supplied in ampoule with higher concentration, it can be given by deep intramuscular Injection in doses up to 5 gm (10ml) and by slow intravenous Injection in doses of up to 4 gm or by I.Infusion by dilution as required in glucose or saline in djoses of up to 4 gm /hour. The daily total dose should not exceed 30gm in patients with normal renal function.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "by deep intramuscular Injection",
            "unit": "gm",
            "amount": {
              "min": 5,
              "max": 5
            },
            "volume": {
              "unit": "ml",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "alternative",
            "condition": "by slow intravenous Injection",
            "unit": "gm",
            "amount": {
              "min": 4,
              "max": 4
            }
          },
          {
            "type": "alternative",
            "condition": "by I.Infusion",
            "unit": "gm/hour",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ],
        "notes": "The daily total dose should not exceed 30gm in patients with normal renal function."
      }
    ]
  },
  {
    "serial": 655,
    "genericName": "Zinc Sulphate Monohydrate",
    "doseList": [
      {
        "ageGroup": "Child",
        "condition": "Children range under 10kg",
        "description": "Children range under 10kg: 22.5 mg zinc dail after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 22.5,
              "max": 22.5
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children within 10-30kg",
        "description": "Children within 10-30kg: 22.5 mg zinc 1-3 times daily after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 22.5,
              "max": 22.5
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children over 30 kg",
        "description": "Adults & Children over 30 kg: 45mg zinc 1-3 times daily after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 45,
              "max": 45
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "over 30 kg",
        "description": "Adults & Children over 30 kg: 45mg zinc 1-3 times daily after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 45,
              "max": 45
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children range under 10kg",
        "secondaryCondition": "Dosage of syrup (4.05mg/5ml)",
        "description": "Dosage of syrup (4.05mg/5ml): Adjust as the dosage regimen given above, such as- Children under 10kg, 5-6 tsf daily in divided doses; Children within 10-30kg, 5-6 tsf 1-3 times daily; Adults and Children over 30kg 10 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 5,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children within 10-30kg",
        "secondaryCondition": "Dosage of syrup (4.05mg/5ml)",
        "description": "Dosage of syrup (4.05mg/5ml): Adjust as the dosage regimen given above, such as- Children under 10kg, 5-6 tsf daily in divided doses; Children within 10-30kg, 5-6 tsf 1-3 times daily; Adults and Children over 30kg 10 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 5,
              "max": 6
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children over 30 kg",
        "secondaryCondition": "Dosage of syrup (4.05mg/5ml)",
        "description": "Dosage of syrup (4.05mg/5ml): Adjust as the dosage regimen given above, such as- Children under 10kg, 5-6 tsf daily in divided doses; Children within 10-30kg, 5-6 tsf 1-3 times daily; Adults and Children over 30kg 10 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "over 30 kg",
        "secondaryCondition": "Dosage of syrup (4.05mg/5ml)",
        "description": "Dosage of syrup (4.05mg/5ml): Adjust as the dosage regimen given above, such as- Children under 10kg, 5-6 tsf daily in divided doses; Children within 10-30kg, 5-6 tsf 1-3 times daily; Adults and Children over 30kg 10 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children range under 10kg",
        "secondaryCondition": "Dosage of syrup (20mg/5ml)",
        "description": "Dosage of syrup (20mg/5ml): adjust as the dosage regimen given above, such as- Children under 10kg, 1 tsf daily; Children within 10-30kg, 1 tsf 1-3 times daily; Adults and Childrenover 30kg 2 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children within 10-30kg",
        "secondaryCondition": "Dosage of syrup (20mg/5ml)",
        "description": "Dosage of syrup (20mg/5ml): adjust as the dosage regimen given above, such as- Children under 10kg, 1 tsf daily; Children within 10-30kg, 1 tsf 1-3 times daily; Adults and Childrenover 30kg 2 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children over 30 kg",
        "secondaryCondition": "Dosage of syrup (20mg/5ml)",
        "description": "Dosage of syrup (20mg/5ml): adjust as the dosage regimen given above, such as- Children under 10kg, 1 tsf daily; Children within 10-30kg, 1 tsf 1-3 times daily; Adults and Childrenover 30kg 2 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "over 30 kg",
        "secondaryCondition": "Dosage of syrup (20mg/5ml)",
        "description": "Dosage of syrup (20mg/5ml): adjust as the dosage regimen given above, such as- Children under 10kg, 1 tsf daily; Children within 10-30kg, 1 tsf 1-3 times daily; Adults and Childrenover 30kg 2 tsf 1-3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children range under 10kg",
        "secondaryCondition": "Dosage of Tablet (20mg/Tablet)",
        "description": "Dosage of Tablet (20mg/Tablet): Child under 10kg, 20mg zinc daily after food; Child within 10-30kg, 20mg zinc 1 to 3 times daily; Adult & Child over 30kg 40mg zinc 1 to 3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children within 10-30kg",
        "secondaryCondition": "Dosage of Tablet (20mg/Tablet)",
        "description": "Dosage of Tablet (20mg/Tablet): Child under 10kg, 20mg zinc daily after food; Child within 10-30kg, 20mg zinc 1 to 3 times daily; Adult & Child over 30kg 40mg zinc 1 to 3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Children over 30 kg",
        "secondaryCondition": "Dosage of Tablet (20mg/Tablet)",
        "description": "Dosage of Tablet (20mg/Tablet): Child under 10kg, 20mg zinc daily after food; Child within 10-30kg, 20mg zinc 1 to 3 times daily; Adult & Child over 30kg 40mg zinc 1 to 3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "over 30 kg",
        "secondaryCondition": "Dosage of Tablet (20mg/Tablet)",
        "description": "Dosage of Tablet (20mg/Tablet): Child under 10kg, 20mg zinc daily after food; Child within 10-30kg, 20mg zinc 1 to 3 times daily; Adult & Child over 30kg 40mg zinc 1 to 3 times daily after food or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 656,
    "genericName": "Ensure",
    "doseList": [
      {
        "description": "To prepare a 250ml feeding, put 200ml of cold water in a glass. Gradually add 6 level scoops (enclosed) of powder while stirring and mix until dissolved. When mixed as directed powder provides approx. 1 kcal per ml.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "scoop",
            "amount": {
              "min": 6,
              "max": 6
            },
            "additionalItem": {
              "temName": "cold water",
              "quantity": {
                "unit": "ml",
                "min": 200,
                "max": 200
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 657,
    "genericName": "Formance",
    "doseList": [
      {
        "description": "To prepare a 240ml feeding, put 200ml of cold water in a glass. Gradually add 5 level scoops (enclosed) or 45.4gm of powder while stirring and mix until dissolved.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "scoop",
            "amount": {
              "min": 5,
              "max": 5
            },
            "volume": {
              "unit": "mg",
              "min": 45.4,
              "max": 45.4
            },
            "additionalItem": {
              "temName": "cold water",
              "quantity": {
                "unit": "ml",
                "min": 200,
                "max": 200
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 658,
    "genericName": "Pediasure",
    "doseList": [
      {
        "description": "To prepare a 225ml feeding, put 190ml of cold water in a glass. Gradually add 5 level scoops (enclosed) or 45.4gm of powder while stirring and mix until dissolved. When mixed as directed powder provides approx. 1 kcal per ml. A 400gm Can powder yields approx. nine 225ml servings.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "scoop",
            "amount": {
              "min": 5,
              "max": 5
            },
            "volume": {
              "unit": "mg",
              "min": 45.4,
              "max": 45.4
            },
            "additionalItem": {
              "temName": "cold water",
              "quantity": {
                "unit": "ml",
                "min": 190,
                "max": 190
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 659,
    "genericName": "Salmon Calcitonin",
    "doseList": [
      {
        "route": "Injection",
        "indication": "Osteoporosis",
        "description": "Injection- 50-100 IU/day, s.c or I.M together with calcium and vitamin D supplementation. In some cases, the Injection can be administered on alternate days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 50,
              "max": 100
            },
            "supplementalItem": {
              "temName": "with calcium and vitamin D"
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "supplementalItem": {
              "temName": "with calcium and vitamin D"
            }
          }
        ]
      },
      {
        "route": "ntranasal spray",
        "indication": "Osteoporosis",
        "description": "ntranasal spray- 100-200 IU/day depending on severity of the disease, together with calcium & vitamin D supplementation. In case of giving 200 IU/day, two sprays a day, one in the morning and one in the evening, alternationg nostrils.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 100,
              "max": 200
            },
            "supplementalItem": {
              "temName": "with calcium and vitamin D"
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Paget’s disease",
        "description": "Injection- 50-100 IU/day, s.c or I.M. In some cases, the Injection can be administered on alternate days. If necessary, the djosage can be increased to 200 IU/day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 50,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            }
          }
        ]
      },
      {
        "route": "ntranasal spray",
        "indication": "Paget’s disease",
        "description": "ntranasal spray- 200 IU/day; two sprays a day, one in the morning ad one in the evening, alternating nostrils. Treatment should be at least 3 months irrespective of the route of administration. Dosage may be adjusted to the individual requirements.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Hypercalcemia (following cancers and hyperpatathyroidism)",
        "secondaryIndication": "Hypercalcemic crisis",
        "description": "ndection- 5-10 IU/kg/day over a period of at least 6 hours in I.drip (most preferred & effective method) or by slow I.injectoinin 2-4 divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/kg/day",
            "amount": {
              "min": 5,
              "max": 10
            },
            "duration": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Hypercalcemia (following cancers and hyperpatathyroidism)",
        "secondaryIndication": "Sudecks’s disease",
        "description": "Sudecks’s disease: Injecton- 50-100 IU/day, s.c or I.M in some cases, the Injection can be administered on alternate days. If necessary, the dosage can be increased to 200 IU/day depending on severity of the disease. In case of giving 100 IU/day, one spray a day, alternating nostrils daily. In case of giving 200IU/day, two sprays a day, one in the morning and one in the evening, alternating nostrils.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 50,
              "max": 100
            },
            "notes": "in case of giving 100 IU/day, one spray a day, alternating nostrils daily"
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "notes": "in case of giving 200IU/day, two sprays a day, one in the morning and one in the evening, alternating nostrils."
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Bone pain due to metastatic cancers",
        "description": "Injection- 50-100 IU/day, s.c or I.M",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 50,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "ntranasal spray",
        "indication": "Bone pain due to metastatic cancers",
        "description": "ntranasal spray- 100-200 IU/day depending on severity of the disease. In case of giving 100 IU/day, one spray a day, alternating nostrils daily, in case of giving 200 IU/day, two sprays a day, one in the morning and one in the evening, alternationg nostrils. Irrespective of the froute of administration, dosage should be adjusted to individual requirements.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u/day",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary",
            "unit": ".u/day",
            "amount": {
              "min": 200,
              "max": 200
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 660,
    "genericName": "Alendronate",
    "doseList": [
      {
        "indication": "Post-menopausal osteoporosis",
        "description": "Post-menopausal osteoporosis- 10mg once daily. To permit adequate absorption, alendronate Tablet must be taken in an empty stomach with a full glass of water, at least 30 minutes before the breakfast or first food or drink or medication of the day. Patients should stand or sit upright for at least 30 minutes after taking the alendronate Tablet & do not lie down until after earting breakfast. Patients should not chew or suck on the Tablet & don’t take the Tablet ant bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before the breakfast or first food or drink or medication of the day.",
              "minute": 30
            },
            "notes": "To permit adequate absorption, alendronate Tablet must be taken in an empty stomach with a full glass of water, Patients should stand or sit upright for at least 30 minutes after taking the alendronate Tablet & do not lie down until after earting breakfast. Patients should not chew or suck on the Tablet & don’t take the Tablet ant bed time."
          }
        ]
      },
      {
        "indication": "Paget’s diseast of bone",
        "description": "Paget’s diseast of bone- 40mg once daily for 6 months. To permit adequate absorption, alendronate Tablet must be taken in an empty stomach with a full glass of water, at least 30 minutes before the breakfast or first food or drink or medication of the day. Patients should stand or sit upright for at least 30 minutes after taking the alendronate Tablet & do not lie down until after earting breakfast. Patients should not chew or suck on the Tablet & don’t take the Tablet ant bed time.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 6,
              "max": 6
            },
            "connectionToMeal": {
              "when": "before the breakfast or first food or drink or medication of the day.",
              "minute": 30
            },
            "notes": "To permit adequate absorption, alendronate Tablet must be taken in an empty stomach with a full glass of water, Patients should stand or sit upright for at least 30 minutes after taking the alendronate Tablet & do not lie down until after earting breakfast. Patients should not chew or suck on the Tablet & don’t take the Tablet ant bed time."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 661,
    "genericName": "bandronic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl)",
        "description": "in general patients with osteolytic bone metastases require lower doses than patients with the humoral type of hypercalcaemia. In Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl) 2 mg is an effective dose. In most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl) 4 mg will be an adequate dosage. The highest dose used in clinical trials was 6mg but this dose dose not adds any further benefit in terms of efficacy. Adult & elderly: Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "premedication": {
              "notes": "Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type."
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl)",
        "description": "in general patients with osteolytic bone metastases require lower doses than patients with the humoral type of hypercalcaemia. In Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl) 2 mg is an effective dose. In most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl) 4 mg will be an adequate dosage. The highest dose used in clinical trials was 6mg but this dose dose not adds any further benefit in terms of efficacy. Adult & elderly: Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "premedication": {
              "notes": "Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type."
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "in Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl)",
        "description": "in general patients with osteolytic bone metastases require lower doses than patients with the humoral type of hypercalcaemia. In Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl) 2 mg is an effective dose. In most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl) 4 mg will be an adequate dosage. The highest dose used in clinical trials was 6mg but this dose dose not adds any further benefit in terms of efficacy. Adult & elderly: Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "premedication": {
              "notes": "Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type."
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "in most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl)",
        "description": "in general patients with osteolytic bone metastases require lower doses than patients with the humoral type of hypercalcaemia. In Patients with mild to moderate hypercalcaemia (albumin- corrected serum calcium<3mmol/1 or <12 mg/dl) 2 mg is an effective dose. In most patients with severe hypercalcaemia (albumin-corrected serum calcium> 3mmol/1 or > 12mg/dl) 4 mg will be an adequate dosage. The highest dose used in clinical trials was 6mg but this dose dose not adds any further benefit in terms of efficacy. Adult & elderly: Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "premedication": {
              "notes": "Prior to treatment with ibandronic acid the patient should be adequately rehydrated with 0.9% sodium Childride, Consideration should be given to the severity of the hypercalcaemia as well as the tumour type."
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 662,
    "genericName": "Risedronate",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "Adult: The recommended daily dose is 5 mg (1 Tablet) orally. The absorption of risedronate is affected by foods and drinks, so, this should not be taken with food or drinks other than water. Take the dose (1 Tablet) once daily, either at least 30 minutes before the first food or drink (other than water of the day). Or at least 2 hours from any food or drink at any other time of the day, and at least 30 minutes before going to bed. Supplemental calcium and vitamin D should be considered if the dietary in take is inadequate. In all cases including duration of treatment physician’s prescription and advice must be strictly followed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before the first food or drink (other than water of the day)",
              "minute": 30
            },
            "alternativeConnectionToMeal": {
              "when": "from any food or drink at any other time of the day",
              "hour": {
                "min": 2
              }
            },
            "connectionToBedtime": {
              "when": "before going to bed",
              "minute": 30
            },
            "supplementalItem": {
              "temName": "calcium and vitamin D"
            },
            "notes": "this should not be taken with food or drinks other than water."
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "Children: Safety and efficacy of risedronate have not been established in Children and adolescents.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 663,
    "genericName": "Zoledronic Acid",
    "doseList": [
      {
        "indication": "For prevention of skeletal-related events in patients with advanced malignancies involving bone",
        "description": "For prevention of skeletal-related events in patients with advanced malignancies involving bone, the recommended dose is 4 mg given as a 15- minute I.Infusion every 3 to 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "duration": {
              "unit": "minute",
              "min": 15,
              "max": 15
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "indication": "For treatment of HCM",
        "description": "For treatment of HCM, the recommended dose is 4 mg given as a single 15-minute I.infulsion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "duration": {
              "unit": "minute",
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "indication": "Patients who show complete response and relapse, or who are refractory to initial treatment may be retrealed with zoledronic acid",
        "description": "Patients who show complete response and relapse, or who are refractory to initial treatment may be retrealed with zoledronic acid 8mg given as a single 15-minute I.Infusion. However, at least 1 week must elapse before retreatment ot allows for a full response to the initial dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 8,
              "max": 8
            },
            "duration": {
              "unit": "minute",
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "indication": "pationets with mild to moderate Renal Impairment.",
        "description": "No dose adjustment is necessary in pationets with mild to moderate Renal Impairment.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "No dose adjustment is necessary in pationets with mild to moderate Renal Impairment."
          }
        ]
      }
    ]
  },
  {
    "serial": 664,
    "genericName": "Raloxifene HCI",
    "doseList": [
      {
        "description": "60mg once daily orally, without regard to meal. High fat meal increases the absorption of raloxifene.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "High fat meal increases the absorption of raloxifene."
          }
        ]
      }
    ]
  },
  {
    "serial": 665,
    "genericName": "Glucosamine",
    "doseList": [
      {
        "description": "500mg 3 times daily or as directed by the physician. A single dowe of 1500mg (3 tabs) daily may also be effective. Obese individuals may need higher doses, based on body weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "A single dowe of 1500mg (3 tabs) daily may also be effective. Obese individuals may need higher doses, based on body weight."
          }
        ]
      }
    ]
  },
  {
    "serial": 666,
    "genericName": "Glucosamine + Chondroitin",
    "doseList": [
      {
        "description": "1-2 Tablets, 3 times daily. Dose may be adjusted according to the response of the drug and body weight. Doses can be tapered after 60 days as per requirement of the individual and for cost convenience. Typical dosage recommendation, hased on body weight is as follows: under 54kg-800mg chondroitin sulfate & 1000mg gluconsamine sulfate per day; 54-91kg- 1200mg chondroitin sulfate & 1500mg glucosamine sulfate per day; Over 91kg- 1600mg chondroitin sulfate & 2000mg glucosamine sulfate per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 667,
    "genericName": "C-jointin Cap.",
    "doseList": [
      {
        "description": "1 capsule 2 times daily or as directed by the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 668,
    "genericName": "Busulphan",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "nduction of remission",
        "description": "nduction of remission, 2-4mg daily; Maintenance, 0.5-2 mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 669,
    "genericName": "Chlorambucil",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "used alone 0.2 mg/kg body- wt. daily fo 3-6 week or, 5-10 mg daily for 3-6 week or, 5-10mg daily for 3-6 weeks; maintenance, 2-4mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.2,
              "max": 0.2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "used alone 0.2 mg/kg body- wt. daily fo 3-6 week or, 5-10 mg daily for 3-6 week or, 5-10mg daily for 3-6 weeks; maintenance, 2-4mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.2,
              "max": 0.2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "alternate",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 670,
    "genericName": "Cyclophosphamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Low dose therapy",
        "description": "Low dose therapy:2-6mg/kg body wt. daily as a single I.dose or in divided oral dose for 7 days & maintenance 100-200mg daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Medium dose therapy",
        "description": "Medium dose therapy:10-15mg/kg as a single I.dose weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 15
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Large or high dose therapy",
        "description": "Large or high dose therapy:20-40mg/kg as a single I.dose given at 10-20 days intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 20,
              "max": 40
            },
            "Interval": {
              "unit": "day",
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 671,
    "genericName": "fosfamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult: Usually 8-10gm/m2freactionated equally to single daily doses over 5 days or a 24 hour Infusion of 5-6gm/m2; only use in conjuction with Mensa (Uromitxan). For further information see manufacturers literature.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 8,
              "max": 10
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternative",
            "unit": "gm/m^2",
            "amount": {
              "min": 5,
              "max": 6
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 672,
    "genericName": "Melphalan",
    "doseList": [
      {
        "route": "Adult",
        "ageGroup": "Adult",
        "description": "150-300gm/kg daily for 4-6 days; Repeated after 4-8 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 150,
              "max": 300
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 6
            },
            "repeated": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 673,
    "genericName": "Mesna",
    "doseList": [
      {
        "description": "When given by I.V Injection, dose is calculated according to cyclophosphamide or ifosfamide treatment- for details consult product literature; dose given as calculated, repeated 4 and 8 hours after treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 674,
    "genericName": "Bleomycin inj.",
    "doseList": [
      {
        "route": "Infusion",
        "ageRange": {
          "unit": "year",
          "min": 80
        },
        "indication": "Sq. cell carcinoma",
        "description": "Sq. cell carcinoma: Over 80 years 15mg pr week (in a single or divided doses), total 100mg; 70-79 years 30mg/week, total 150-200mg; 60-69 ears 30-60mg/week, total 200-300mg; under 60 years 30-60 mg/week,total 500mg. all slow I.or in Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/week",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "(in a single or divided doses), total 100mg"
          }
        ]
      },
      {
        "route": "Infusion",
        "ageRange": {
          "unit": "year",
          "min": 70,
          "max": 79
        },
        "indication": "Sq. cell carcinoma",
        "description": "Sq. cell carcinoma: Over 80 years 15mg pr week (in a single or divided doses), total 100mg; 70-79 years 30mg/week, total 150-200mg; 60-69 ears 30-60mg/week, total 200-300mg; under 60 years 30-60 mg/week,total 500mg. all slow I.or in Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/week",
            "amount": {
              "min": 30,
              "max": 30
            },
            "notes": "total 150-200mg"
          }
        ]
      },
      {
        "route": "Infusion",
        "ageRange": {
          "unit": "year",
          "min": 60,
          "max": 69
        },
        "indication": "Sq. cell carcinoma",
        "description": "Sq. cell carcinoma: Over 80 years 15mg pr week (in a single or divided doses), total 100mg; 70-79 years 30mg/week, total 150-200mg; 60-69 ears 30-60mg/week, total 200-300mg; under 60 years 30-60 mg/week,total 500mg. all slow I.or in Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/week",
            "amount": {
              "min": 30,
              "max": 60
            },
            "notes": "total 200-300mg"
          }
        ]
      },
      {
        "route": "Infusion",
        "ageRange": {
          "unit": "year",
          "max": 60
        },
        "indication": "Sq. cell carcinoma",
        "description": "Sq. cell carcinoma: Over 80 years 15mg pr week (in a single or divided doses), total 100mg; 70-79 years 30mg/week, total 150-200mg; 60-69 ears 30-60mg/week, total 200-300mg; under 60 years 30-60 mg/week,total 500mg. all slow I.or in Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/week",
            "amount": {
              "min": 30,
              "max": 60
            },
            "notes": "total 500 mg"
          }
        ]
      },
      {
        "route": "Infusion",
        "indication": "Malignant lymphomas",
        "description": "Malignant lymphomas: 15mg once or twice a week to a total dose of 225mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "timesWeekly": {
              "min": 1,
              "max": 2
            },
            "notes": "total dose of 225mg."
          }
        ]
      }
    ]
  },
  {
    "serial": 675,
    "genericName": "Capecitabine",
    "doseList": [
      {
        "route": "oral",
        "indication": "Intermittent therapy",
        "description": "Capecitabine Tablets are administered orally with water, and are given within 30 minutes after a meal. The total daily dose fo capecitabine is to be given into two divided doses (morning and evening). Intermittent therapy- The recommended dosage for capecitabine monotherapy is 2500mg/m^2/day (maximum tolerated dose as 300mg/m2/day) for 3 two weeks cycle with an interval of one-week rest following each cycle. The patients responding to initial (3 cycle) therapy should continue capecitabine till they maintain tumour response or stable disease.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "Interval": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "water"
            },
            "connectionToMeal": {
              "when": "after a meal",
              "minute": 30
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "The patients responding to initial (3 cycle) therapy should continue capecitabine till they maintain tumour response or stable disease."
          }
        ]
      },
      {
        "route": "oral",
        "indication": "Continuous therapy",
        "description": "Capecitabine Tablets are administered orally with water, and are given within 30 minutes after a meal. The total daily dose fo capecitabine is to be given into two divided doses (morning and evening). Continuous therapy- The maximum tolerated dose for capecitabine monotherapy is 1650mg/m^2/day as continuous schedule. The rest period is avoided in continuous therapy there is no need for prior adjustment of the dose for mild to moderate Hepatic dysfunction due to liver metastases.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day",
            "amount": {
              "min": 1650,
              "max": 1650
            },
            "additionalItem": {
              "temName": "water"
            },
            "connectionToMeal": {
              "when": "after a meal",
              "minute": 30
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "oral",
        "indication": "Combination dose with docetaxel",
        "description": "Capecitabine Tablets are administered orally with water, and are given within 30 minutes after a meal. The total daily dose fo capecitabine is to be given into two divided doses (morning and evening). Combination dose with docetaxel- 2500mg/m^2/day for 1-14 days can be given with 75mg/m2 of docetaxel for once in there weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day",
            "amount": {
              "min": 2500,
              "max": 2500
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 14
            },
            "additionalItem1": {
              "temName": "water"
            },
            "additionalItem2": {
              "genericName": "docetaxel",
              "quantity": {
                "unit": "mg/m^2",
                "min": 75,
                "max": 75
              }
            },
            "connectionToMeal": {
              "when": "after a meal",
              "minute": 30
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      },
      {
        "route": "oral",
        "indication": "Combination dose with paclitaxel",
        "description": "Capecitabine Tablets are administered orally with water, and are given within 30 minutes after a meal. The total daily dose fo capecitabine is to be given into two divided doses (morning and evening). Combination dose with paclitaxel- 1650mg/m^2/day for day 1-14 (using the intermittent schedule) can be safely administered with paclitaxel 175mg/m^2 (every 3 weeks) regardless of the extent of prior therapy.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day",
            "amount": {
              "min": 1650,
              "max": 1650
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 14
            },
            "additionalItem1": {
              "temName": "water"
            },
            "additionalItem2": {
              "genericName": "paclitaxel",
              "condition": "every 3 weeks",
              "quantity": {
                "unit": "mg/m^2",
                "min": 175,
                "max": 175
              }
            },
            "connectionToMeal": {
              "when": "after a meal",
              "minute": 30
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 676,
    "genericName": "Fluracedyl Inj.",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Injection-12mg/kg body-wt. I.daily on 3 conseeutive days, if no signs of toxicity, give 6mg/kg daily I.on the alternate days i.e. 5th, 7th& 9th days. Maintenance, 5-15 mg/kg I.once weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 12,
              "max": 12
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f no signs of toxicity",
            "unit": "mg/kg",
            "amount": {
              "min": 6,
              "max": 6
            },
            "notes": "on the alternate days i.e. 5th, 7th& 9th days."
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 15
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "Infusion",
        "ageGroup": "Adult",
        "description": "nfusion- a dose of 15mg/kg daily (but not more than 1gm per Infusion) is diluted in 500ml of 5% dextrose soln. and infused at a rate of 40 drops/minimum over 4 hours. Some patient may have received a maximum dose of 30gm at a maximum rate of 1 gm daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "duration": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "not more than 1gm per Infusion) is diluted in 500ml of 5% dextrose soln. and infused at a rate of 40 drops/minimum"
          }
        ]
      }
    ]
  },
  {
    "serial": 677,
    "genericName": "Gemcitabine",
    "doseList": [
      {
        "description": "The drug is only administered intravenously and not more than once per week. The recommended dose is 1000mg/m2 given by 30 minute I.Infusion. This dose should be repeated once weekly f there weeks, followed by a one week rest period. This 4 week cycle is then repeated. Gemcitabine can be administered on an outpatient basis. Dosage reduction is based upon the amount of toxicity experienced by the patient.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 1000,
              "max": 1000
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "notes": "followed by a one week rest period. This 4 week cycle is then repeated."
          },
          {
            "type": "primaryFollowup",
            "notes": "Dosage reduction is based upon the amount of toxicity experienced by the patient."
          }
        ]
      }
    ]
  },
  {
    "serial": 678,
    "genericName": "Mercaptopurine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2.5mg/kg body-wt. daily increasing after 4 weeks if necessary to 5mg/kg body-wt. daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "notes": "ncreasing after 4 weeks if necessary to 5mg/kg body-wt. daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 679,
    "genericName": "Methotrexate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Trophoblastic tumour",
        "description": "Trophoblastic tumour: 15-30mg I.M daily for 5 days, rejpat after a period of 1 or more weeks, when all toxic effects have disappeared. In general 3 to 5 courses of therapy will be given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "week",
              "min": 1
            },
            "notes": "in general 3 to 5 courses of therapy will be given."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Leukaemia",
        "description": "Leukaemia: In A.L.L a dosage of 3.3 mg/m^2 (or 0/2mg.kg) may be used in combination with 40-60mg prednisolone/m^2 (or 1.3-2mg/kg) body surface area daily for 4-6 weeks. After a remission a maintenance dosage of 20-30mg (or 0.6-1mg/kg) orally or I.M, twice a week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 3.3,
              "max": 3.3
            },
            "additionalItem": {
              "genericName": "prednisolone",
              "quantity": {
                "unit": "kg/m^2",
                "min": 40,
                "max": 60
              }
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "alternative",
            "unit": "mg.kg",
            "amount": {
              "min": 0,
              "max": 2
            },
            "additionalItem": {
              "genericName": "prednisolone",
              "quantity": {
                "unit": "kg/m^2",
                "min": 1.3,
                "max": 2
              }
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternativeMaintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 0.6,
              "max": 1
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Breast cancer",
        "description": "Breast cancer: Usually used in conjunction withother cytotoxic agents or radiotherapy & / or surgery (in early stage), 10-60mg/m2 (0.3-2mg/kg) typical I.dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 10,
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".Injection or Infusion",
        "ageGroup": "Adult",
        "indication": "Non-Hodgkins lymphoma",
        "description": "in Childhood lymphosarcoma, 90-900mg (or 3-30mg/kg) by I.V Injection or Infusion. Higher doses being followed by recovery with calcium folinate.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 900
            }
          },
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 30
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "Higher doses being followed by recovery with calcium folinate."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Burkitt’s lymphoma",
        "description": "Burkitt’s lymphoma may be treatment at a dose of 15mg (0.5mg/kg)daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "a dose of 15mg (0.5mg/kg)daily."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "to control invasion of the nervous system.",
        "description": "ntrathecal administration of methotrexate at a rate of 15mg/day for 4 days have been used to control invasion of the nervous system.For delil & others- see manufacturers literature.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 15,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Trophoblastic tumour",
        "description": "Trophoblastic tumour: 15-30mg I.M daily for 5 days, rejpat after a period of 1 or more weeks, when all toxic effects have disappeared. In general 3 to 5 courses of therapy will be given.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "repeated": {
              "unit": "week",
              "min": 1
            },
            "notes": "in general 3 to 5 courses of therapy will be given."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Leukaemia",
        "description": "Leukaemia: In A.L.L a dosage of 3.3 mg/m^2 (or 0/2mg.kg) may be used in combination with 40-60mg prednisolone/m^2 (or 1.3-2mg/kg) body surface area daily for 4-6 weeks. After a remission a maintenance dosage of 20-30mg (or 0.6-1mg/kg) orally or I.M, twice a week.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 3.3,
              "max": 3.3
            },
            "additionalItem": {
              "genericName": "prednisolone",
              "quantity": {
                "unit": "kg/m^2",
                "min": 40,
                "max": 60
              }
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "alternative",
            "unit": "mg.kg",
            "amount": {
              "min": 0,
              "max": 2
            },
            "additionalItem": {
              "genericName": "prednisolone",
              "quantity": {
                "unit": "kg/m^2",
                "min": 1.3,
                "max": 2
              }
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 30
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternativeMaintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 0.6,
              "max": 1
            },
            "timesWeekly": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Breast cancer",
        "description": "Breast cancer: Usually used in conjunction withother cytotoxic agents or radiotherapy & / or surgery (in early stage), 10-60mg/m2 (0.3-2mg/kg) typical I.dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 10,
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".Injection or Infusion",
        "ageGroup": "Child",
        "indication": "Non-Hodgkins lymphoma",
        "description": "in Childhood lymphosarcoma, 90-900mg (or 3-30mg/kg) by I.V Injection or Infusion. Higher doses being followed by recovery with calcium folinate.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 90,
              "max": 900
            }
          },
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 30
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "Higher doses being followed by recovery with calcium folinate."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Burkitt’s lymphoma",
        "description": "Burkitt’s lymphoma may be treatment at a dose of 15mg (0.5mg/kg)daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "notes": "a dose of 15mg (0.5mg/kg)daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "to control invasion of the nervous system.",
        "description": "ntrathecal administration of methotrexate at a rate of 15mg/day for 4 days have been used to control invasion of the nervous system.For delil & others- see manufacturers literature.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 15,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 680,
    "genericName": "Methotrax Tab.",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Rheumatoid arthritis",
        "description": "By mouth, 7.5 mg once weekly as a single dose or divided into 3 doses of 2.5mg given at intervals of 12 horus, adjusted according to response; maximum total weekly dose 20mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 7.5,
              "max": 7.5
            },
            "timesWeekly": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "Interval": {
              "unit": "hour",
              "min": 12,
              "max": 12
            },
            "notes": "divided into 3 doses"
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Leukemia in Children",
        "description": "By mouth, 15mg body surface weekly in combination with other drugs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Maintenance therapy of acute lymphoblastic leukemia",
        "description": "Maintenance therapy of acute lymphoblastic leukemia: A common dose of 15-30mg body surface, once or twice weekly by mouth with other drugs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "timesWeekly": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Choriocarcinoma",
        "description": "Maintenance therapy of acute lymphoblastic leukemia: A common dose of 15-30mg body surface, once or twice weekly by mouth with other drugs.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "and for 3-5 courses at intervals of 1-2  weeks after each course."
          },
          {
            "type": "alternate",
            "condition": "employed in the treatment of breast cancer, often in combination with cyclophosphamide & fluorouracil.",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 16
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "Treatment of psoriasis",
        "description": "Treatment of psoriasis: Single weekly doses of 10-25mg ma be given by mouth, adjusted according to response; elderly consider dose reduction with extreme coution; Child not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 25
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Treatment of psoriasis",
        "description": "Treatment of psoriasis: Single weekly doses of 10-25mg ma be given by mouth, adjusted according to response; elderly consider dose reduction with extreme coution; Child not recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "elderly consider dose reduction with extreme coution"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Treatment of psoriasis",
        "description": "Treatment of psoriasis: Single weekly doses of 10-25mg ma be given by mouth, adjusted according to response; elderly consider dose reduction with extreme coution; Child not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 681,
    "genericName": "Folinic acid",
    "doseList": [
      {
        "indication": "Antidote to methotrexate (Folinic acid rescue)",
        "description": "Antidote to methotrexate (Folinic acid rescue): in general, folinic acid shold not be administered simultancously wih systemic methotrexate because the therapeutic effect of te antimetabolite may be nullified. However, when methotrexate is administered by intrathecal Injection, folinic acid may be given I.M, I.or orally Concomitantly to offset systemic methotrexate without abolishing the local activity of the antineoplastic drug. As part of a high-dose methotrexate regimen in cancer chemotherapy, folinic acid rescue therapy should beging 8-24 hours after the beginning of mehotrexate administration. Generally, doses up to 120mg have heen given over 12-24 hours by I.M, or I.V Injection or I.V. Infusion, followed by 12-15mg I.M or 15mg orally, every 6 hours for the next 48 hours. With lower doses of methotrexate, 15mg folinic acid orall every hour for 48-72 hours may e sufficient.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "by I.M, or I.V Injection or I.Infusion",
            "unit": "mg",
            "amount": {
              "max": 120
            },
            "duration": {
              "unit": "hour",
              "min": 12,
              "max": 24
            },
            "notes": "As part of a high-dose methotrexate regimen in cancer chemotherapy, folinic acid rescue therapy should beging 8-24 hours after the beginning of mehotrexate administration."
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 15
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "duration": {
              "unit": "hour",
              "min": 48,
              "max": 48
            }
          },
          {
            "type": "alternativePrimaryFollowup",
            "condition": "orally",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "hour",
              "min": 48,
              "max": 72
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Treatment of overdose of folic acid antagonists",
        "description": "Treatment of overdose of folic acid antagonists: In cases of overdosage of folic acid antagonist, folinic acid may be administered by I.Infusion in doses up to 75mg within 12 hours, followed by 12 mg I.M every 6 hours for 4 doses. In general, where overdosage is suspected, the dose of folinic acid should e equal to or higher than the offending dose of the folic acid antagonist administered, and should be given as soon as possible; preferably within the first hour, after wich it is much less effective.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": null,
              "max": 75
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 12,
              "max": 12
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "indication": "Treatment of megaloblastic anaemia",
        "description": "Treatment of megaloblastic anaemia- 15mg orally daily hoth Adult and Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "indication": "Treatment of megaloblastic anaemia",
        "description": "Treatment of megaloblastic anaemia- 15mg orally daily hoth Adult and Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 682,
    "genericName": "Etoposide",
    "doseList": [
      {
        "description": "Eposin concentrate for Infusion must e diluted pror to use with either 5% dextrose in water, or 0.9% sodium chloride Solution to give a final concentration of 0.2 or 0.4mg/ml. if solution are prepared at concentrations above 0.4mg/ml, Precipitate on may occur. The usual dose of eposin in combination with other approved chemothera-peutic agents, ranges from 100-120mg/m2/day for 3-5 days. Chemotherapy courses are repeated at 3 to 4 week intervals after adequate recovery from any toxicity. In paticents with renal function impairment the dose should be lowered. Eposin in interded for I.administration only. To prevent the occurrence of hypotension, the Infusion should be given over at least 30-60 minutes.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day",
            "amount": {
              "min": 100,
              "max": 200
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "Interval": {
              "condition": "Chemotherapy courses",
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "duration": {
              "condition": "To prevent the occurrence of hypotension",
              "unit": "minute",
              "min": 30,
              "max": 60
            },
            "notes": "Eposin concentrate for Infusion must e diluted pror to use with either 5% dextrose in water, or 0.9% sodium chloride Solution to give a final concentration of 0.2 or 0.4mg/ml."
          }
        ]
      }
    ]
  },
  {
    "serial": 683,
    "genericName": "Vinblastine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.1mg/kg body-wt I.weekly increasing as required by 0.05mg/kg body wt to maximum 0.5mg/kg weekly. Maintenance maximum dose not causing leucopenia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "max": 0.5
            },
            "ncrementRate": {
              "unit": "mg/kg",
              "min": 0.05,
              "max": 0.05
            }
          },
          {
            "type": "maintenance",
            "notes": "Maintenance maximum dose not causing leucopenia."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "0.1mg/kg body-wt I.weekly increasing as required by 0.05mg/kg body wt to maximum 0.5mg/kg weekly. Maintenance maximum dose not causing leucopenia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "max": 0.5
            },
            "ncrementRate": {
              "unit": "mg/kg",
              "min": 0.05,
              "max": 0.05
            }
          },
          {
            "type": "maintenance",
            "notes": "Maintenance maximum dose not causing leucopenia."
          }
        ]
      }
    ]
  },
  {
    "serial": 684,
    "genericName": "Vincristine",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Adult- 0.025 to 0.075mg/kg body wt. to a maximum Recommended Total dose of 2mg intravenously weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.025,
              "max": 0.075
            },
            "notes": "Recommended Total dose of 2mg intravenously weekly."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child: Initially 0.05mg/kg body-wt. Followed by weekly increments of 0.025mg/kg upto a maximum of 0.15mg/kg. After remission, the dosage may be reduced to 0.025mg/kg Weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.05,
              "max": 0.05
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "max": 0.15
            },
            "ncrementRate": {
              "unit": "mg/kg",
              "min": 0.025,
              "max": 0.025
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 0.025,
              "max": 0.025
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 685,
    "genericName": "Bevacizumab ",
    "doseList": [
      {
        "route": "",
        "ageGroup": "",
        "indication": "Platosin",
        "description": "The recommended dose of bevacizumab is 5mg/kg of body weight given once every 14 days asan I.Infusion. Bevacizumab should be prepared by a healthcare professional using aseptic technique. Withdraw the volume of bevacizumab equivalent to a dose of 5mg/kg hody weight and dilute in a total volume of 100ml of sterile, pyrogen-free 0.9% sodium chloride. No incompatibilities between bevacizumab and polyvinyl chloride or polyolefin bags have been observed (error! Reference source not found). Bevacizumab Infusions should not be administered or mixed with dextrose or glucose solutions (error! Reference source not found). Do not administer as an intravenous push or bolus. The initial bevacizumab dose should be delivered over 90 minutes as an I.Infusion. If the first Infusion is well tolerated, the second Infusion may be administered over 60 minutes. If the 60-minute Infusion is well tolerated, all subsequent Infusions may be administered over 30minutes. After resolution of the vial content chemical and physical in-use stability has been demonstrated for 48 hours at 20C-300C in 0.9% sodium chloride solution. However, from a microbiological point of view, the product should be used immediately.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "day",
              "min": 14,
              "max": 14
            },
            "duration": {
              "unit": "minute",
              "min": 90,
              "max": 90
            }
          },
          {
            "type": "primaryFollowup",
            "duration": {
              "unit": "minute",
              "min": 60,
              "max": 60
            }
          },
          {
            "type": "maintenance",
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 687,
    "genericName": "Docetaxel",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "100mg/m^2 adminis-etred as a one-hour I.Infusion every three weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 100,
              "max": 100
            },
            "duration": {
              "unit": "hour",
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly, on special instruction.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Elderly, on special instruction."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- Safety and efficacy no established.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "Hepatic impairment",
        "description": "Hepatic impairment: reduce,dosage, discontinue in severe cases.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Elderly, on special instruction."
          }
        ]
      }
    ],
    "notes": "Admin: Reconstitute the concentrate preparation with accompanying solvent vial and dilute with Infusion solution (0.9% sodium chloride or 5% dextrose for I.V Injection) Before use. The concentration of Decetaxel in Infusion solution should be between 0.3-0.9mg/ml. Apply usual cytotoxic caution when preparing or handling the drug."
  },
  {
    "serial": 688,
    "genericName": "matinib",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "paticnts in chronic phase CML",
        "description": "The recommended dosage of imatinib is 400mg/day for paticnts in chronic phase CML and 600mg/day for patients in accelerated phase or blast crisis. The recommended dosage of imatinib is 400mg/day or 600mg/day for patients with unresectable and metastatic, malignant GIST. In CML, dose increase from 400mg to 600mg in patients with chronic phase disease, or from 600mg to 800mg (given as 400mg twice daily) in paients in accelerated phase or blast crisis may be considered n the absence of severe drug reaction and severe non-leukemia related neutropenia or thrombocytopenia in the following circumstances: disease progression (at any time); failure to achive a satisfactory hematologic response after at least 3 months of treatmet loss of previously achieved hematologic response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 600,
              "max": 600
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "for patients in accelerated phase or blast crisis",
        "description": "The recommended dosage of imatinib is 400mg/day for paticnts in chronic phase CML and 600mg/day for patients in accelerated phase or blast crisis. The recommended dosage of imatinib is 400mg/day or 600mg/day for patients with unresectable and metastatic, malignant GIST. In CML, dose increase from 400mg to 600mg in patients with chronic phase disease, or from 600mg to 800mg (given as 400mg twice daily) in paients in accelerated phase or blast crisis may be considered n the absence of severe drug reaction and severe non-leukemia related neutropenia or thrombocytopenia in the following circumstances: disease progression (at any time); failure to achive a satisfactory hematologic response after at least 3 months of treatmet loss of previously achieved hematologic response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 600,
              "max": 600
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "min": 800,
              "max": 800
            },
            "notes": "given as 400mg twice daily"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "for patients with unresectable and metastatic, malignant GIST",
        "description": "The recommended dosage of imatinib is 400mg/day for paticnts in chronic phase CML and 600mg/day for patients in accelerated phase or blast crisis. The recommended dosage of imatinib is 400mg/day or 600mg/day for patients with unresectable and metastatic, malignant GIST. In CML, dose increase from 400mg to 600mg in patients with chronic phase disease, or from 600mg to 800mg (given as 400mg twice daily) in paients in accelerated phase or blast crisis may be considered n the absence of severe drug reaction and severe non-leukemia related neutropenia or thrombocytopenia in the following circumstances: disease progression (at any time); failure to achive a satisfactory hematologic response after at least 3 months of treatmet loss of previously achieved hematologic response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/day",
            "amount": {
              "min": 400,
              "max": 400
            }
          },
          {
            "type": "alternative",
            "unit": "mg/day",
            "amount": {
              "min": 600,
              "max": 600
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: The safety & efficacy below 18 years of age is not established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 689,
    "genericName": "rinotecan",
    "doseList": [
      {
        "route": ".injusion",
        "description": "Recommended dosage-350mg/m2 administered by I.injusion over a 30 to 90 minute period every 3 weeks as single agent. Dosage adjustments- in patients who experienced asymptomatic severe neutropenia (Neutrophil count<500 cells/mm3), fever or infections associated with nwutropenia (temperature> 380C and neutrophil count < 1,000 cells/mm2) or severe Diarrhoea (requiring an intravenous rehydration), dosage should be reduced from 350mg to 300mg; If the patient again experiences sevre neutropenia, fever or infined above or severe Diarrhoea, the dosage should be decreased from 300mg to 250mg at the next cycle.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2",
            "amount": {
              "min": 350,
              "max": 350
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 90
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "in patients who experienced asymptomatic severe neutropenia (Neutrophil count<500 cells/mm3), fever or infections associated with nwutropenia (temperature> 380C and neutrophil count < 1,000 cells/mm2) or severe Diarrhoea (requiring an intravenous rehydration)",
            "unit": "mg",
            "amount": {
              "min": 300,
              "max": 300
            }
          },
          {
            "type": "maintenance",
            "condition": "f the patient again experiences sevre neutropenia, fever or infined above or severe Diarrhoea",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 690,
    "genericName": "Paclitaxel",
    "doseList": [
      {
        "indication": "for paticent with carcinoma of the overy",
        "secondaryIndication": "1.  For previously untreated patients with carcinoma of the overy",
        "description": "All patients should be premedicated prior to paclitaxel administration in order to prevent severe hypersensitivity reactions. Such premedication may consist of dexamethasone 20mg administered orally approximately 12 nad 6 hours before paclitaxel, diphenhydramine (or its equivalent) 50mg I.V 30 to 60 minutes prior to paclitaxel, and cimetidine (300mg) or ranitidine (50mg) I.V 30 to 60 minutes before paclitaxel. Treatment regimen:for paticent with carcinoma of the overy, the following regimens  are recommended. 1.  For previously untreated patients with carcinoma of the overy, one of the following recommended regiments may be given every 3 weeks. In sclecting the appropriate regimen, differences in toxicities should be considered. a.  Paclitaxel administered I.over 3 hours at a dose of 175mg followed by cisplatin at a dose of 75mg. Or, b.  Paclitaxel administered I.over 24 hours at a dose of 135mg followed by cisplation at a dose of 75mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 175,
              "max": 175
            },
            "duration": {
              "unit": "hour",
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "followupItem": {
              "genericName": "cisplatin",
              "quantity": {
                "unit": "mg",
                "min": 75,
                "max": 75
              }
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 135,
              "max": 135
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          }
        ]
      },
      {
        "indication": "for paticent with carcinoma of the overy",
        "secondaryIndication": "In patients previously treated with chemotherapy for carcinoma of the overy",
        "description": "All patients should be premedicated prior to paclitaxel administration in order to prevent severe hypersensitivity reactions. Such premedication may consist of dexamethasone 20mg administered orally approximately 12 nad 6 hours before paclitaxel, diphenhydramine (or its equivalent) 50mg I.V 30 to 60 minutes prior to paclitaxel, and cimetidine (300mg) or ranitidine (50mg) I.V 30 to 60 minutes before paclitaxel. Treatment regimen:for paticent with carcinoma of the overy, the following regimens  are recommended. 2. After failure of initial chemotherapy for metastatic diseaseor relapse within 6 months of adjuvant chemotherapy, paclitaxel at a dose of 175mg administered intravenously over 3 hours every 3 weeks has been shown to be effective.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 135,
              "max": 135
            },
            "duration": {
              "unit": "hour",
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          },
          {
            "type": "alternative",
            "unit": "mg",
            "amount": {
              "min": 175,
              "max": 175
            },
            "duration": {
              "unit": "hour",
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "followupItem": {
              "genericName": "cisplatin",
              "quantity": {
                "unit": "mg",
                "min": 75,
                "max": 75
              }
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          }
        ]
      },
      {
        "indication": "Patients with AIDS-related Kaposi’s sarcoma",
        "description": "All patients should be premedicated prior to paclitaxel administration in order to prevent severe hypersensitivity reactions. Such premedication may consist of dexamethasone 20mg administered orally approximately 12 nad 6 hours before paclitaxel, diphenhydramine (or its equivalent) 50mg I.V 30 to 60 minutes prior to paclitaxel, and cimetidine (300mg) or ranitidine (50mg) I.V 30 to 60 minutes before paclitaxel. Patients with AIDS-related Kaposi’s sarcoma: Paclitaxel administered at a dose of 135mg given intravenously over 3 hours every 3 weeks or ata dose of 100mg given intravenously over 3 hours every 2 weeks is recommended (dose intensity 45-50mg/week). In the two clinical trials evaluationg these schedules, the former schedule (135mg every 3 weeks)was more toxic than the latter. In addition, all patients with low performance status were treated with the latter schedule (100mg every 2 weeks).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 135,
              "max": 135
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "Interval": {
              "unit": "week",
              "min": 3,
              "max": 3
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          },
          {
            "type": "alternative",
            "condition": "all patients with low performance status were treated with the latter schedule",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            },
            "duration": {
              "unit": "hour",
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "premedication": {
              "tem1": {
                "temName": "dexamethasone",
                "quantity": {
                  "unit": "mg",
                  "min": 20,
                  "max": 20
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "hour": {
                    "min": 6,
                    "max": 12
                  }
                }
              },
              "tem2": {
                "temName": "diphenhydramine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              },
              "tem3": {
                "temName": "cimetidine",
                "quantity": {
                  "unit": "mg",
                  "min": 300,
                  "max": 300
                },
                "alternativeItemName": "ranitidine",
                "quantity": {
                  "unit": "mg",
                  "min": 50,
                  "max": 50
                },
                "doseTime": {
                  "when": "before paclitaxel",
                  "minute": {
                    "min": 30,
                    "max": 60
                  }
                }
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 691,
    "genericName": "Retinoic Acid",
    "doseList": [
      {
        "description": "The recommended dose is 45mg/m^2/day administered as two equally divided doses until complete remission is documented. Therapy should be discontinued 30 days after achievement of complete remission or after 90 days of treatment, whichever occurs first.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/m^2/day ",
            "amount": {
              "min": 45,
              "max": 45
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 30,
              "max": 90
            },
            "notes": "Therapy should be discontinued 30 days after achievement of complete remission or after 90 days of treatment, whichever occurs first."
          }
        ]
      }
    ]
  },
  {
    "serial": 692,
    "genericName": "Trastuzumab",
    "doseList": [
      {
        "description": "HER2 testing is mandatory prior to initiation of trastuzumab therapy. Loading dose: The recommended initial loading dose is 4mg/kg body weight as a 90 minute I.Infusion. Subsequent doses: The recommended weekly dose of trastuzumab is 2mg/kg body weight. If the initial dose does not cause any intolerance, the following dose can be administered as a 30-minute Infusion; should not administer as an intravenous push or bolus. clinical studies, patients were treated with trastuzumab until progression of discase.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 4,
              "max": 4
            },
            "duration": {
              "unit": "minute",
              "min": 90,
              "max": 90
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "duration": {
              "condition": "f the initial dose does not cause any intolerance",
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "notes": "weekly dose"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly: Data sggest that the dispositionof trastuzumab is not altered based on age.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Elderly: Data sggest that the dispositionof trastuzumab is not altered based on age."
          }
        ]
      }
    ]
  },
  {
    "serial": 693,
    "genericName": "Azathioprine",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "1-5 mg/kg body-wt daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 5
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "description": "1-5 mg/kg body-wt daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 5
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 694,
    "genericName": "Mycophenolate Mofetil",
    "doseList": [
      {
        "condition": "Renal Transplantation",
        "indication": "Prophylaxis of rejection",
        "description": "A dose of 1gm administered orally or intravenously (over 2 hours) twice a day (daily dose of 2gm) is recommended for use in renal transplant patients.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "duration": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "for use in renal transplant patients",
            "unit": "gm",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "condition": "Renal Transplantation",
        "indication": "Treatment of refractory rejection",
        "description": "The dose of 1.5gm administered twice daily (daily dose of 3gm) is recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "(daily dose of 3gm) is recommended."
          }
        ]
      },
      {
        "condition": "Cardiac transplantation",
        "description": "A dose of 1.5gm administered intravenously (over no less than 2 hours) twice daily or 1.5gm orally twice daily (daily dose of 3gm) is recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "duration": {
              "unit": "hour",
              "min": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "unit": "gm",
            "amount": {
              "min": 1.5,
              "max": 1.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "orally twice daily (daily dose of 3gm) is recommended."
          }
        ]
      }
    ]
  },
  {
    "serial": 695,
    "genericName": "Cyclosporin",
    "doseList": [
      {
        "route": "mouth",
        "indication": "Organ transplantation",
        "description": "Organ transplantation-used alone, 10-15 mg/kg as a single dose by mouth 4-12 hours before transplantation followed by 10-15mg/kg daily for 1-2 weeks post-operatively then reduced to 2-6mg/kg daily for maintenance (dose should be adjusted by monitoring blood concentrations and renal function); dose lower if given concomitantly with other immunosuppressant therapy (e.g. corticosteroids); If necessary 1/3 oral dose can be given by I.Infusion over 2-6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 15
            },
            "notes": "4-12 hours before transplantation"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 6
            },
            "additionalItem": {
              "notes": "f necessary 1/3 oral dose can be given by I.Infusion over 2-6 hours."
            }
          }
        ]
      },
      {
        "indication": "Bone morrow transplantation, prevention and treatment of graft-versus-host disease",
        "description": "Bone morrow transplantation, prevention and treatment of graft-versus-host disease, 3-5mg/kg daily by I.Infusion over 2-6 hours from day before transplantation to 2 weeks post-operatively (or 12.5-15mg/kg daily by mouth) then 12.5 mg/kg daily by mouth for 3-6 months then tailed off.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 3,
              "max": 5
            },
            "duration": {
              "unit": "hour",
              "min": 2,
              "max": 6
            },
            "notes": "from day before transplantation"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 12.5,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "unit": "mg/kg",
            "amount": {
              "min": 12.5,
              "max": 12.5
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 3,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 696,
    "genericName": "Rituximab",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "Forat Infusion",
        "description": "The recommended initial rate for Infusionis 50mg/hour; after the first 30 minutes, it can be escalated in 50mg/hour increments every 30 minutes to a maximm of 400mg/hour. If hypersensitivity or an Infusion related eve3nt develops, the Infusion should be temporarily slowed or interrupted and can continue at one half the previous rates upon improvement of symptoms. If the same adverse reactions occur severly for second time the decision to stop treatment shold beconsidered. The Infusion rate may be increased upon improvementof symptoms.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/hour",
            "amount": {
              "min": 50,
              "max": 50
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/hour",
            "amount": {
              "max": 400
            },
            "ncrementRate": {
              "unit": "mg/hour",
              "min": 50,
              "max": 50
            },
            "notes": "t can be escalated in 50mg/hour increments every 30 minutes"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Subsequent Infusions",
        "description": "Subsequent Infusions: infuse at initial rate of 100mg/hour and increase by 100mg/hour increments at 30minute intervals, to a maximum of 400mg/hour. Patients who have responded to rituximab have been retreated with comparable response ratesof first treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/hour",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/hour",
            "amount": {
              "max": 400
            },
            "ncrementRate": {
              "unit": "mg/hour",
              "min": 100,
              "max": 100
            },
            "Interval": {
              "unit": "minute",
              "min": 30,
              "max": 30
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children: safety and efficacy of rituximab in Children have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 697,
    "genericName": "Interferon",
    "doseList": [
      {
        "indication": "in chronic mayeloid leukaemia",
        "description": "in chronic mayeloid leukaemia, this is given I.M or s.c 3-9 mega units (m.u) daily. It can induce control & maintain control of this disease in chronic phase in about 70% of patients.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mega unit (m.u)",
            "amount": {
              "min": 3,
              "max": 9
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "Multimle myeloma & renal cell carcinoma",
        "description": "Multimle myeloma & renal cell carcinoma- 3 to 18 million units by I.M Injection once daily according to the clinical judgement of the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million unit",
            "amount": {
              "min": 3,
              "max": 18
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "Malignant melanoma",
        "description": "Malignant melanoma- 12 million units/m^2 of body surface area by I.M Injection 3 times weekly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million unit/m^2",
            "amount": {
              "min": 12,
              "max": 12
            },
            "timesWeekly": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "mprovement of viraemia of chronic hepatitis it",
        "description": "mprovement of viraemia of chronic hepatitis it-0 to 18 milion units daily by I.M Injection. Dosage may be increased to 18 milion units after the initial 3 days of treatment with 9 million units according to the patient’s condition.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million unit",
            "amount": {
              "min": 0,
              "max": 9
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "million unit",
            "amount": {
              "max": 18
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 698,
    "genericName": "Flutamide",
    "doseList": [
      {
        "description": "250mg 3 times daily is recommended dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 699,
    "genericName": "Letrozole",
    "doseList": [
      {
        "description": "2.5mg once daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 700,
    "genericName": "Tamoxifen",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "20mg daily increasing to 40mg daily if necessary (in divided doses).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "primary",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "For anovulatory infertility",
        "description": "For anovulatory infertility 20mg daily on four successive days commencing on 2nd day of menstruation. Increase if necessary to 40mg then 80mg daily for subsequent courses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 20
            },
            "notes": "on four successive days commencing on 2nd day of menstruation."
          },
          {
            "type": "primary",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 40,
              "max": 40
            }
          },
          {
            "type": "primary",
            "condition": "f necessary",
            "unit": "mg",
            "amount": {
              "min": 80,
              "max": 80
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 701,
    "genericName": "Filgrastim",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Cytotoxic-induced neutropenia",
        "description": "0.5 million units (5mcg)/kg/day (first dose started not less than 24 hours after chemotherapy) as a daily s.c Injection or I.Infusion (over 30 minutes). Treatment should be continued until neutrophil count in normal range, usually for up to 14 days (up to 38 days in acute myeloid leukaemia).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "mcg/kg/day",
              "min": 5,
              "max": 5
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 14
            },
            "alternativeTreatmentPeriod": {
              "condition": "in acute myeloid leukaemia",
              "unit": "day",
              "max": 38
            },
            "notes": "first dose started not less than 24 hours after chemotherapy"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Cytotoxic-induced neutropenia",
        "description": "0.5 million units (5mcg)/kg/day (first dose started not less than 24 hours after chemotherapy) as a daily s.c Injection or I.Infusion (over 30 minutes). Treatment should be continued until neutrophil count in normal range, usually for up to 14 days (up to 38 days in acute myeloid leukaemia).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "mcg/kg/day",
              "min": 5,
              "max": 5
            },
            "duration": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 14
            },
            "alternativeTreatmentPeriod": {
              "condition": "in acute myeloid leukaemia",
              "unit": "day",
              "max": 38
            },
            "notes": "first dose started not less than 24 hours after chemotherapy"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "elderly",
        "indication": "Cytotoxic-induced neutropenia",
        "description": "Elderly- no specifie dosage recommendations are made.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "indication": "in patients treated with cytotoxic chemotherapy & outologous bone-marrow transplantation",
        "description": "in patients treated with cytotoxic chemotherapy & outologous bone-marrow transplantation- The recommended starting dose of filgrastim is 1 milllion units (10mcg)kg/day given by continuous s.c Infusion over 24 hours or by continuous s.c Infusion over 24 hors or by continuous I.Infusion over 30 minutes or over 24 hours (first dose started not less than 24 hours after chemothepapy & within 24 hours of bone-marrow Infusion).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mcg/kg/day",
              "min": 10,
              "max": 10
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            },
            "notes": "first dose started not less than 24 hours after chemothepapy & within 24 hours of bone-marrow Infusion"
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "Mobilisotion of peripheral blood progenitor cells",
        "description": "Mobilisotion of peripheral blood progenitor cells- Used alone, by s.c Injection or Infusion over 24 hours, 1 million units/kg/day for 6 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units/kg/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 6,
              "max": 6
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "route": "Injection or Infusion",
        "indication": "Mobilisotion of peripheral blood progenitor cells",
        "description": "Mobilisotion of peripheral blood progenitor cells- Used alone, by s.c Injection or Infusion over 24 hours, 1 million units/kg/day for 6 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units/kg/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 6,
              "max": 6
            },
            "duration": {
              "unit": "hour",
              "min": 24,
              "max": 24
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Severe chronic neutropenia",
        "description": "by s.c Injection, in severe congenital neutropenia, initially 1.2 milllion units/kg/day in single or divided doses, (in idiopathie or cyclic neutropenia, initially 0.5 million units/kg/day) adjusted according to response. Filgrastim may be diluted in 5% glucose I.solution BP. Dilution below 0.2 million units (2mcg)/ml is not recommended. When diluted below this range, add human serum albumin to a final concentration of 2mcg/ml. Diluted filgrastim solution should not be prepared more than 24 hours before use. Filgrastim and diluted filgrastim solutions should be stored at 2- 80C. Filgrastim should not be diluted with saline. Filgrastim is for s.c or I.administration. Sites of s.c Injection should be varied.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in severe congenital neutropenia",
            "unit": "million units/kg/day",
            "amount": {
              "min": 1.2,
              "max": 1.2
            },
            "additionalItem": {
              "notes": "Filgrastim may be diluted in 5% glucose I.solution BP"
            }
          },
          {
            "type": "primary",
            "condition": "in idiopathie or cyclic neutropenia",
            "unit": "million units/kg/day",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "additionalItem": {
              "notes": "Filgrastim may be diluted in 5% glucose I.solution BP"
            },
            "notes": "adjusted according to response"
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Severe chronic neutropenia",
        "description": "by s.c Injection, in severe congenital neutropenia, initially 1.2 milllion units/kg/day in single or divided doses, (in idiopathie or cyclic neutropenia, initially 0.5 million units/kg/day) adjusted according to response. Filgrastim may be diluted in 5% glucose I.solution BP. Dilution below 0.2 million units (2mcg)/ml is not recommended. When diluted below this range, add human serum albumin to a final concentration of 2mcg/ml. Diluted filgrastim solution should not be prepared more than 24 hours before use. Filgrastim and diluted filgrastim solutions should be stored at 2- 80C. Filgrastim should not be diluted with saline. Filgrastim is for s.c or I.administration. Sites of s.c Injection should be varied.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in severe congenital neutropenia",
            "unit": "million units/kg/day",
            "amount": {
              "min": 1.2,
              "max": 1.2
            },
            "additionalItem": {
              "notes": "Filgrastim may be diluted in 5% glucose I.solution BP"
            }
          },
          {
            "type": "primary",
            "condition": "in idiopathie or cyclic neutropenia",
            "unit": "million units/kg/day",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "additionalItem": {
              "notes": "Filgrastim may be diluted in 5% glucose I.solution BP"
            },
            "notes": "adjusted according to response"
          }
        ]
      }
    ]
  },
  {
    "serial": 702,
    "genericName": "Lenograstim",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Bone-marrow transplantation",
        "description": "The recommended dose is 19.2 million units (150mcg)/day, start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution; The treatment should be continued until neutrophil count stable in acceptable range (maximum 28 days).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 19.2,
              "max": 19.2
            },
            "volume": {
              "unit": "mcg/day",
              "min": 150,
              "max": 150
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 28
            },
            "notes": "start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "indication": "Bone-marrow transplantation",
        "description": "The recommended dose is 19.2 million units (150mcg)/day, start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution; The treatment should be continued until neutrophil count stable in acceptable range (maximum 28 days).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 19.2,
              "max": 19.2
            },
            "volume": {
              "unit": "mcg/day",
              "min": 150,
              "max": 150
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 28
            },
            "notes": "start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution"
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "indication": "Bone-marrow transplantation",
        "description": "Elderly: As per Adult dose. The recommended dose is 19.2 million units (150mcg)/day, start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution; The treatment should be continued until neutrophil count stable in acceptable range (maximum 28 days).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "million units",
            "amount": {
              "min": 19.2,
              "max": 19.2
            },
            "volume": {
              "unit": "mcg/day",
              "min": 150,
              "max": 150
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 28
            },
            "notes": "start treatment 24 hours after transplantation by I.Infusion in 30 minutes, diluted in isotonic saline solution"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "Bone-marrow transplantation",
        "description": "Children: As per Adult dose, safety demonas-trated in Children older than 2 years in bone marrow transplantation.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 703,
    "genericName": "Chicken pox",
    "doseList": [
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "description": "0.5ml of reconstituted vaccine contains one immunizing dose. From the age of 12 months up to and including 12 years of age: 1 dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "0.5ml of reconstituted vaccine contains one immunizing dose."
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 13
        },
        "description": "0.5ml of reconstituted vaccine contains one immunizing dose. 13 years & above: 2 doses with an interval of 6 to 10 weeks. The same schedule should be applied for the high-risk patients also. In these patients, periodic measurement of varicella antibodies after vaccination may be indicated in order to identify those who may benefit from revaccination.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 2,
              "max": 2
            },
            "Interval": {
              "unit": "week",
              "min": 6,
              "max": 10
            },
            "notes": "0.5ml of reconstituted vaccine contains one immunizing dose."
          }
        ]
      }
    ]
  },
  {
    "serial": 704,
    "genericName": "Cholera Vaccine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "First dose- 0.5ml s.c. or I.M. 2nd dose- 1ml s.c. or I.M (or 0.2ml intradermally) after 4 weeks (or 7 days if rapid immunization is necessary).",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First dose",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd dose",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "(or 0.2ml intradermally) after 4 weeks (or 7 days if rapid immunization is necessary)"
          },
          {
            "type": "primaryFollowupFollowup",
            "condition": "Booster dose",
            "notes": "Necessary after 6 months; Give the same as 2nd dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "First dose- under 1 years not recommended; 1-5 years 0.1 ml s.c. or I.M; 5-10 yrs. 0.3ml s.c. or I.M. 2nd doses- 1-5 yrs, 0.3ml s.c. or I.M.  (or 0.1ml intradermally); 5-10 yrs, 0.5ml s.c. or I.M. (or 0.1ml intradermally). Interval, same as Adult. Booster dose- Necessary after 6 months; Give the same as 2nd dose.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First dose",
            "notRecommended": true
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "description": "First dose- under 1 years not recommended; 1-5 years 0.1 ml s.c. or I.M; 5-10 yrs. 0.3ml s.c. or I.M. 2nd doses- 1-5 yrs, 0.3ml s.c. or I.M.  (or 0.1ml intradermally); 5-10 yrs, 0.5ml s.c. or I.M. (or 0.1ml intradermally). Interval, same as Adult. Booster dose- Necessary after 6 months; Give the same as 2nd dose.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First dose",
            "unit": "ml",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd dose",
            "unit": "ml",
            "amount": {
              "min": 0.3,
              "max": 0.3
            },
            "notes": "(or 0.1ml intradermally) after 4 weeks (or 7 days if rapid immunization is necessary)"
          },
          {
            "type": "primaryFollowupFollowup",
            "condition": "Booster dose",
            "notes": "Necessary after 6 months; Give the same as 2nd dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 5,
          "max": 10
        },
        "description": "First dose- under 1 years not recommended; 1-5 years 0.1 ml s.c. or I.M; 5-10 yrs. 0.3ml s.c. or I.M. 2nd doses- 1-5 yrs, 0.3ml s.c. or I.M.  (or 0.1ml intradermally); 5-10 yrs, 0.5ml s.c. or I.M. (or 0.1ml intradermally). Interval, same as Adult. Booster dose- Necessary after 6 months; Give the same as 2nd dose.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "First dose",
            "unit": "ml",
            "amount": {
              "min": 0.3,
              "max": 0.3
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd dose",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "notes": "(or 0.1ml intradermally) after 4 weeks (or 7 days if rapid immunization is necessary)"
          },
          {
            "type": "primaryFollowupFollowup",
            "condition": "Booster dose",
            "notes": "Necessary after 6 months; Give the same as 2nd dose."
          }
        ]
      }
    ]
  },
  {
    "serial": 705,
    "genericName": "Diphtheria Vaccine",
    "doseList": [
      {
        "route": "Injection",
        "indication": "Prophylaxis",
        "description": "Prophylaxis- 500-2000 i.u, s.c or I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 500,
              "max": 2000
            }
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "Therapeutic",
        "description": "Therapeutic- 10000 to 30000 i.u.by I.M Injection or 40000 to 100000 i.u. by I.V Injection in 2 divided doses with an interval of ½-2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 10000,
              "max": 30000
            },
            "Interval": {
              "unit": "hour",
              "min": 0.5,
              "max": 2
            }
          },
          {
            "type": "alternative",
            "unit": ".u",
            "amount": {
              "min": 40000,
              "max": 100000
            },
            "Interval": {
              "unit": "hour",
              "min": 0.5,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 706,
    "genericName": "Dpt + HB combined vaccine",
    "doseList": [
      {
        "route": "I.M Injection",
        "description": "The recommended dose (0.5ml) of the vaccine must be administered by deep intramuscular (I.M) Injection, Preferably in the anterolateral part of thigh.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "indication": "in patients with thrombocytopenia or bleeing disorders",
        "description": "in patients with thrombocytopenia or bleeing disorders, the vaccine should be admini-stered subcutaneously. The primary vaceination schedule consists of 3 doses within the first six months of life.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "does",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "within the first six months of life."
          }
        ]
      },
      {
        "condition": "Vaccination schedule & booster dose",
        "indication": "Where hepatitis B, vaccine is not given at birth",
        "description": "Where hepatitis B, vaccine is not given at birth, the cobined vaccine can be administered beginning as early as 8 weeks of age. Where there is a hith endemicity of hepatitis B, the practice to administer hepatitis B vaccine at birth should be continued. In these circums-tances, vaccine-tion with the combined vaccine should star at 6 weeks of age. 3 vaccine doses must be administered at intervals of at least 4 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "does",
            "amount": {
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 4
            }
          }
        ]
      },
      {
        "condition": "Vaccination for infants born to HBs Ag+positive mothers",
        "indication": "in the case of Children born of known hepatitis B carrier mothers the immunoprophylactic",
        "description": "in the case of Children born of known hepatitis B carrier mothers the immunoprophylactic measures for hepatitis B should not be modified. This may require separate vaccination with hepatitis B and DPT vaccines and also include the administration of HBIg at birth. For further information, see below under the text of Hepatitis B vaccine.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "This may require separate vaccination with hepatitis B and DPT vaccines and also include the administration of HBIg at birth."
          }
        ]
      }
    ]
  },
  {
    "serial": 707,
    "genericName": "Haemophilus Influenzae Vaccine",
    "doseList": [
      {
        "indication": "Primary vaccination",
        "description": "For 2 months-3 Injections at 1 or 2 months intervals followed by a booster 12 months after the third dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "followed by a booster 12 months after the third dose"
          }
        ]
      },
      {
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "indication": "Second chance vaccination",
        "condition": "When it has not beenpossible to give the Child a primary vaccination",
        "description": "(i) Between 6 and 12 months: 2 Injections at 1 or 2 months intervals followed by a booster 12 months after the second dose; (ii)  From 12 months and up to 5 years: a single Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 2,
              "max": 2
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "followed by a booster 12 months after the second dose"
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "indication": "Second chance vaccination",
        "condition": "When it has not beenpossible to give the Child a primary vaccination",
        "description": "(i) Between 6 and 12 months: 2 Injections at 1 or 2 months intervals followed by a booster 12 months after the second dose; (ii)  From 12 months and up to 5 years: a single Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 708,
    "genericName": "Hiberix Inj.",
    "doseList": [
      {
        "description": "The primary vaccination schedule consists of three doses in the first 6 months of life and can start from the age of 6 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "doses",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "in the first 6 months of life and can start from the age of 6 weeks."
          }
        ]
      },
      {
        "ageGroup": "infant",
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "condition": "previously unvaccinated",
        "description": "nfants between the ages of 6 and 12 months previously unvaccinated should receive 2 Injections, given with an interval of one month, followed by a booster in the second years of life.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 2,
              "max": 2
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "followed by a booster in the second years of life."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 5
        },
        "condition": "previously unvaccinated",
        "description": "Previously unvaccinated Children aged 1-5 years should be given one dose of vaccine. To ensure a long-term protection, a booster djose is recomme-nded in the second year of life. As vaccination schemes vary from country to country, the schedule for eah country may be used in accordance with the different national recomme-ndations.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "To ensure a long-term protection, a booster djose is recomme-nded in the second year of life."
          }
        ]
      }
    ]
  },
  {
    "serial": 709,
    "genericName": "Avaxim Inj.",
    "doseList": [
      {
        "route": "by I.M Injection",
        "ageGroup": "Adult",
        "description": "a single dose of Avaxim 160 units (0.5ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Avaxim is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 160 units",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "description": "a single dose of Avaxim 160 units (0.5ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Avaxim is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 160 units",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 15
        },
        "description": "a single dose of Avaxim 160 units (0.5ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 160",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 15
        },
        "description": "a single dose of Avaxim 160 units (0.5ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 160",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      }
    ]
  },
  {
    "serial": 710,
    "genericName": "Havrix Inj.",
    "doseList": [
      {
        "route": "by I.M Injection",
        "ageGroup": "Adult",
        "description": "a single dose of Avaxim 1440 Adult (1ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 1440 Adult",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 16
        },
        "description": "a single dose of Avaxim 1440 Adult (1ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Avaxim 1440 Adult",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "adolescent",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 15
        },
        "description": "a single dose of Avaxim 1440 Adult (1ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Havrix 720 Junior",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 15
        },
        "description": "a single dose of Avaxim 1440 Adult (1ml dose) is used for primary immunization. A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection. Havrix is administered by I.M Injection. The site of Injection is the deltoid region in Adults and older Children, and antero-lateral port of the thigh in young Children. The vaccine should not be administered in the gluteal region. The vaccine should not be administered subcutaneously or intradermally since adminisration by these routes may result in a less than optimal anti-HAV antibody response. Avaxim should under on circumstances be administered intravenously.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Havrix 720 Junior",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "A booster dose is recommended at any time between 6 and 12 months after the primary immunization, in order to ensure long term protection."
          }
        ]
      }
    ]
  },
  {
    "serial": 711,
    "genericName": "Engerix-B inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 doses of 1 ml each of the vaccine should be administered s.c or I.M on the outer site of upper arm at an interval of 1 month. A tirid dose of 1 ml should be given 5 to 6 months after the first inoculation. For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 years old, 3 doses of 0.5ml each should be injected in the same mannar (as Adult).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "volume": {
              "unit": "ml",
              "min": 0.5,
              "max": 0.5
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      }
    ]
  },
  {
    "serial": 712,
    "genericName": "Euvax-B inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 doses of 1 ml each of the vaccine should be administered s.c or I.M on the outer site of upper arm at an interval of 1 month. A tirid dose of 1 ml should be given 5 to 6 months after the first inoculation. For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 years old, 3 doses of 0.5ml each should be injected in the same mannar (as Adult).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "volume": {
              "unit": "ml",
              "min": 0.5,
              "max": 0.5
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      }
    ]
  },
  {
    "serial": 713,
    "genericName": "HEpavax-Gene Inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 doses of 1 ml each of the vaccine should be administered s.c or I.M on the outer site of upper arm at an interval of 1 month. A tirid dose of 1 ml should be given 5 to 6 months after the first inoculation. For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 years old, 3 doses of 0.5ml each should be injected in the same mannar (as Adult).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "volume": {
              "unit": "ml",
              "min": 0.5,
              "max": 0.5
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      }
    ]
  },
  {
    "serial": 714,
    "genericName": "Shanvac-B inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 doses of 1 ml each of the vaccine should be administered s.c or I.M on the outer site of upper arm at an interval of 1 month. A tirid dose of 1 ml should be given 5 to 6 months after the first inoculation. For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "description": "Under 10 years old, 3 doses of 0.5ml each should be injected in the same mannar (as Adult).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "volume": {
              "unit": "ml",
              "min": 0.5,
              "max": 0.5
            },
            "Interval": {
              "unit": "month",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "given 5 to 6 months after the first inoculation."
          },
          {
            "type": "primaryFollowupFollowup",
            "notes": "For more repid immunization the 3rd dose can be given 2 months after initial dose with a booster at 12 months."
          }
        ]
      }
    ]
  },
  {
    "serial": 715,
    "genericName": "Hepatitis B Immune Globulin",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "description": "Hepabig should only be administered by intramuscular Injection. Following exposure to hepatitis B Virus (HBV), should be administered within 7 days (preferably within 48 hours) and, if necessary, repeated the same or increased quantity of dose. The recommended dose for Adult is 1,000 to 2,000 I.U.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1000,
              "max": 2000
            },
            "notes": "Following exposure to hepatitis B Virus (HBV), should be administered within 7 days (preferably within 48 hours) and, if necessary, repeated the same or increased quantity of dose."
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "neonate",
        "indication": "in prophylaxis in neonates born to HBsAg positive mothers",
        "description": "Hepabig should only be administered by intramuscular Injection. Following exposure to hepatitis B Virus (HBV), should be administered within 7 days (preferably within 48 hours) and, if necessary, repeated the same or increased quantity of dose. The recommended dose for Adult is 1,000 to 2,000 I.U. Although post-exposure prophylaxis with hepatitis B immune globulin (HBIG), alone was previously recommended for neonates born to HBsAg positive woned, combined possive immunization with HBIG and active immunization with hepatitis B virus vaccine is curren-tly recommended in these neonates.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 100,
              "max": 200
            }
          },
          {
            "type": "primaryFollowup",
            "unit": ".u/kg",
            "amount": {
              "min": 32,
              "max": 48
            }
          }
        ],
        "notes": "in prophylaxis in neonates born to HBsAg positive mothers, should be injected within 5 days after birth (preferably within 48 hours) and repeated after fifteen days or 2/3 months after the first administration."
      }
    ]
  },
  {
    "serial": 716,
    "genericName": "Measles Vaccine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.5ml by I.M or s.c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year. Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "Under 1 year. Not recommended; other same as Adult.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 717,
    "genericName": "Mencevax Acwy Inj",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Child aged over 18 months 0.5ml by deep s.c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 18
        },
        "description": "Adult and Child aged over 18 months 0.5ml by deep s.c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 718,
    "genericName": "Meningococcal (A+C)Inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult and Child aged over 18 months 0.5ml by deep s.c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 18
        },
        "description": "Adult and Child aged over 18 months 0.5ml by deep s.c Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 719,
    "genericName": "Mumps vacine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "nject total volume (0.5 ml) of reconstituted vaccine by s.c. route.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year. Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "over 1 year, same Adult.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 720,
    "genericName": "MMR Vaccine",
    "doseList": [
      {
        "route": "",
        "ageGroup": "",
        "indication": "",
        "description": "The dosage of vaccine is the same (0.5ml) for all age groups. Inject the total volume of the single dose vial (0.5ml) reconstituted vaccine deef subcutaneously or intravenously), preferably into the outer aspect of upper arm. Reconstitute the powder of the vial with the diluents supplied.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 721,
    "genericName": "Poliomyelitis Vaccine",
    "doseList": [
      {
        "route": "mouth",
        "description": "3 doses course, each dose (2-3 drops) given orally at an interval of 6-8 weeks (see immune. Schedule).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 6,
              "max": 8
            },
            "notes": "each dose (2-3 drops)"
          }
        ]
      }
    ]
  },
  {
    "serial": 722,
    "genericName": "Polioral DropChairon",
    "doseList": [
      {
        "route": "mouth",
        "description": "3 doses course, each dose (2-3 drops) given orally at an interval of 6-8 weeks (see immune. Schedule).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose",
            "amount": {
              "min": 3,
              "max": 3
            },
            "Interval": {
              "unit": "week",
              "min": 6,
              "max": 8
            },
            "notes": "each dose (2-3 drops)"
          }
        ]
      }
    ]
  },
  {
    "serial": 723,
    "genericName": "Rabies vaccine",
    "doseList": [
      {
        "indication": "1. Preventive action or pre-exposure prophylaxis",
        "description": "1.  Preventive action or pre-exposure prophylaxis:2 doses of 1ml Injection each should be given s.c or I.M one month apart. Booster-1 year later 1 Injection (1ml). This preventative vaccination is recommended for those living in an endemic area.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "2 doses of 1ml Injection each should be given s.c or I.M one month apart"
          },
          {
            "type": "primaryFollowupFollowup",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "Booster-1 year"
          }
        ]
      },
      {
        "indication": "2. Curative action or treatment of rabies after exposure",
        "secondaryIndication": "a) If the subject has not been vaccinated",
        "description": "Curative action or treatment of rabies after exposure:a) If the subject has not been vaccinated- after being bitten by an animal with rabies or suspected rabies, 6 subcutaneous Injection should be given on days: D-O, D-3, D-14, D-30, D-90.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 6,
              "max": 6
            },
            "notes": "D-O, D-3, D-14, D-30, D-90."
          }
        ]
      },
      {
        "indication": "2. Curative action or treatment of rabies after exposure",
        "secondaryIndication": "b) If the subject has had preventive vaccination those vaccinated less than one year ago",
        "description": "b) If the subject has had preventive vaccination those vaccinated less than one year ago- give a booster on day: D-O; Subjects vaccinated more than one year ago depending on the seriousness of the case give: First booter on day D-O; Second booter on day D-3; Third booter on day D-7",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "D-O"
          }
        ]
      },
      {
        "indication": "2. Curative action or treatment of rabies after exposure",
        "secondaryIndication": "b) Subjects vaccinated more than one year ago",
        "description": "b) If the subject has had preventive vaccination those vaccinated less than one year ago- give a booster on day: D-O; Subjects vaccinated more than one year ago depending on the seriousness of the case give: First booter on day D-O; Second booter on day D-3; Third booter on day D-7",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 3,
              "max": 3
            },
            "notes": "First booter on day D-O, Second booter on day D-3, Third booter on day D-7"
          }
        ]
      },
      {
        "indication": "2. Curative action or treatment of rabies after exposure",
        "secondaryIndication": "in cases of very severe biting",
        "description": "c) Finally, in cases of very severe biting, on day D-O, give additional treatment of 20 i.u per kg of human antirabies immunoglobulin; or 40 i.u per kg of a purified antirabies serum of equine origin.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Injection",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "on day D-O",
            "additionalItem": {
              "temName": "human antirabies immunoglobulin",
              "quantity": {
                "unit": ".u/kg",
                "min": 20,
                "max": 20
              }
            },
            "alternativeAdditionalItem": {
              "temName": "purified antirabies serum of equine origin",
              "quantity": {
                "unit": ".u/kg",
                "min": 40,
                "max": 40
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 724,
    "genericName": "Tetanus toxoid",
    "doseList": [
      {
        "route": "Injection",
        "description": "0.5ml by I.M or deep s.c Injection followed after 4 weeks by a second dose and after 4 weeks bya a third dose (see immunization schedule).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "followed after 4 weeks by a second dose"
          },
          {
            "type": "maintenance",
            "notes": "after 4 weeks bya a third dose"
          }
        ]
      },
      {
        "route": "Injection",
        "condition": "Reinforcing dose",
        "description": "0.5ml at 18 months to 2 years of age; 2nd booster, at 5-6 years (school going age); 3rd booster at 10 years of age.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "at 18 months to 2 years of age",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "2nd booster, at 5-6 years (school going age)"
          },
          {
            "type": "primaryFollowupFollowup",
            "condition": "3rd booster at 10 years of age."
          }
        ]
      },
      {
        "route": "Injection",
        "indication": "in the event of injures which may give rise to tetanus",
        "description": "in the event of injures which may give rise to tetanus, administer a single dose of 0.5ml unless a booster has been given in the preceding year.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "unless a booster has been given in the preceding year.",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 725,
    "genericName": "Tuberculosis Vaccine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.1ml (infants uder 3 months 0.05ml) by intradermal Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          }
        ]
      },
      {
        "ageGroup": "infant",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "0.1ml (infants uder 3 months 0.05ml) by intradermal Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 726,
    "genericName": "Typhoid Fever Vaccine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.5ml single dose vaccine for both Children and Adult by intramuscular Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "0.5ml single dose vaccine for both Children and Adult by intramuscular Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 0.5,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 727,
    "genericName": "Typhim VInj.",
    "doseList": [
      {
        "description": "A single Injection ensures protection, a second Injection is not justified, (but to a limited number of subjects, a second Injection has been given) Protection lasts for at least 3 years. The preferred route of administration is intramuscular although it may also be given subcutaneously.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "A single Injection ensures protection, a second Injection is not justified, (but to a limited number of subjects, a second Injection has been given) Protection lasts for at least 3 years. The preferred route of administration is intramuscular although it may also be given subcutaneously."
          }
        ]
      }
    ]
  },
  {
    "serial": 728,
    "genericName": "Human Normal Immunoglobulin",
    "doseList": [
      {
        "route": "I.M Injection",
        "ageGroup": "Adult",
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Travel proohylaxis for short period (2 months or less abroad)",
        "description": "Travel proohylaxis for short period (2 months or less abroad) Adult 250mg & Child under 10 years 125mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Travel proohylaxis for short period (2 months or less abroad)",
        "description": "Travel proohylaxis for short period (2 months or less abroad) Adult 250mg & Child under 10 years 125mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 125,
              "max": 125
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Adult",
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "For longer travel prophylaxis (3-5 months or more) & to control outbreaks",
        "description": "For longer travel prophylaxis (3-5 months or more) & to control outbreaks, Adult 500mg & Child under 10 years 250mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 10
        },
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "For longer travel prophylaxis (3-5 months or more) & to control outbreaks",
        "description": "For longer travel prophylaxis (3-5 months or more) & to control outbreaks, Adult 500mg & Child under 10 years 250mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Measles Prophylaxis",
        "description": "Measles Prophylaxis- Child under 1 year 250mg, 1-2 years 500mg, 3 years and over 750mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Measles Prophylaxis",
        "description": "Measles Prophylaxis- Child under 1 year 250mg, 1-2 years 500mg, 3 years and over 750mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3
        },
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Measles Prophylaxis",
        "description": "Measles Prophylaxis- Child under 1 year 250mg, 1-2 years 500mg, 3 years and over 750mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "condition": "Normal immunoglo-bulin for I.M use",
        "indication": "Rubella in pregnancy, & Preventionof clinical attack",
        "description": "Rubella in pregnancy, & Preventionof clinical attack- 750mg by deep I.M Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 750,
              "max": 750
            }
          }
        ]
      },
      {
        "route": "I.M Injection",
        "condition": "Normal immunoglobulin for I.use",
        "description": "Normal human immunoglobulin preparations for I.administration are available for replacement therapy as in hypogammaglobulinaemia and other immune deficiency states, following burns etc. The usual dose is 0.2-0.8ml/kg body weight, to be repeated every 4-8 weeks. The administration must be performed at a high dilution (at least 1:20) & very slowly (15 drops/minimum) while the patient is kept under close clinical supervision. For further information- consult product literature.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.2,
              "max": 0.8
            },
            "repeated": {
              "unit": "week",
              "min": 4,
              "max": 8
            },
            "notes": "The administration must be performed at a high dilution (at least 1:20) & very slowly (15 drops/minimum) while the patient is kept under close clinical supervision."
          }
        ]
      }
    ]
  },
  {
    "serial": 729,
    "genericName": "Humaglobin Inj.",
    "doseList": [
      {
        "description": "0.2-0.8ml/kg body weight, by I.admistration, to be repeated every 4-8 weeks. It is advisable to administer in I.Infusion. The administration must be performed at a high dilution (at least 1:20) & very slowly (15 drops/minimum) while the patient is kept under close clinical supervision. For further information-consult product literature.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.2,
              "max": 0.8
            },
            "repeated": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 730,
    "genericName": "Human Gamma Globulin Inj.",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Hepatitis-A Prophylaxis",
        "description": "Hepatitis-A Prophylaxis- Adult and Child 0.02-0.04ml/kg; greater exposure risk, 0.06-0.12ml/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.02,
              "max": 0.04
            }
          },
          {
            "type": "primary",
            "condition": "greater exposure risk",
            "unit": "ml/kg",
            "amount": {
              "min": 0.06,
              "max": 0.12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "indication": "Hepatitis-A Prophylaxis",
        "description": "Hepatitis-A Prophylaxis- Adult and Child 0.02-0.04ml/kg; greater exposure risk, 0.06-0.12ml/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.02,
              "max": 0.04
            }
          },
          {
            "type": "primary",
            "condition": "greater exposure risk",
            "unit": "ml/kg",
            "amount": {
              "min": 0.06,
              "max": 0.12
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Measles prophylaxis",
        "description": "Measles prophylaxis-0.2ml/kg; to allow attenuated attack- 0.04ml/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.2,
              "max": 0.2
            }
          },
          {
            "type": "primary",
            "condition": "to allow attenuated attack",
            "unit": "ml/kg",
            "amount": {
              "min": 0.04,
              "max": 0.04
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Rubella in Pregnancy, & prevention of clinical attack",
        "description": "Rubella in Pregnancy, & prevention of clinical attack- 20ml to be injected.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 20,
              "max": 20
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Antibody deficiency Syndromes",
        "description": "Antibody deficiency Syndromes- consult product literature.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Antibody deficiency Syndromes- consult product literature."
          }
        ]
      }
    ]
  },
  {
    "serial": 731,
    "genericName": "ntraglobin F Inj.",
    "doseList": [
      {
        "indication": "Substitution therapy in primary and secondary immunodeficiencies",
        "description": "The dosage regimen and intervals depend on the interded use (substitution or prophylaxis), and one the disease and age of the patient.Therefore, on recommendation can be given for a standard dosage.The following dosage suggestions may be used as reference: Substitution therapy in primary and secondary immunodeficiencies: 2-8ml (100-400mg)/kg b.w or be more frequent if the IgG level achieved in blood is not sufficient or if the decrease in particulary rapid. For immunosuppressed transplantation patients Intraglobin F is generally used prior to and following surgery. Dosage is individually tailored and begins normally with 10ml (500mg)/kg b.w/week being followed for maintenance with 10ml (500mg/kg b.w/month).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 2,
              "max": 8
            }
          }
        ]
      },
      {
        "indication": "Substitution therapy in primary and secondary immunodeficiencies",
        "secondaryIndication": "For immunosuppressed transplantation patients",
        "description": "The dosage regimen and intervals depend on the interded use (substitution or prophylaxis), and one the disease and age of the patient.Therefore, on recommendation can be given for a standard dosage.The following dosage suggestions may be used as reference: Substitution therapy in primary and secondary immunodeficiencies: 2-8ml (100-400mg)/kg b.w or be more frequent if the IgG level achieved in blood is not sufficient or if the decrease in particulary rapid. For immunosuppressed transplantation patients Intraglobin F is generally used prior to and following surgery. Dosage is individually tailored and begins normally with 10ml (500mg)/kg b.w/week being followed for maintenance with 10ml (500mg/kg b.w/month).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "maintenance",
            "unit": "ml",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ]
      },
      {
        "indication": "diopathic thrombocytopenic purpara (ITP)",
        "description": "The dosage regimen and intervals depend on the interded use (substitution or prophylaxis), and one the disease and age of the patient.Therefore, on recommendation can be given for a standard dosage.The following dosage suggestions may be used as reference: Idiopathic thrombocytopenic purpara (ITP): 8ml  (400mg)/kg b.w on 5 consecutive days, or 20ml (1gm)/kg b.w on 2 consecutive days. Maintenance doses may be administered intermittently where increases in platelet counts are clinically indicated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 8,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternative",
            "unit": "ml",
            "amount": {
              "min": 20,
              "max": 20
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "notes": "Maintenance doses may be administered intermittently where increases in platelet counts are clinically indicated."
          }
        ]
      },
      {
        "indication": "Kawasaksymdrome",
        "description": "The dosage regimen and intervals depend on the interded use (substitution or prophylaxis), and one the disease and age of the patient.Therefore, on recommendation can be given for a standard dosage.The following dosage suggestions may be used as reference: 20-40ml(1-2gm)/kg b.w as a single dose in association with acetylsalicylic acid. Intraglobin F should be infused intravenously at an initial rate of 30 drops per minute for 10 minutes. If well tolerated, the rate of administration may gradually be increased to a maximum of 40 drops per minute for the remainder of the Infusion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 20,
              "max": 40
            },
            "additionalItem": {
              "genericName": "acetylsalicylic acid"
            },
            "nfusionRate": {
              "unit": "drop per minute",
              "min": 30,
              "max": 30
            },
            "duration": {
              "unit": "minute",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f well tolerated",
            "nfusionRate": {
              "unit": "drop per minute",
              "min": 40,
              "max": 40
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 732,
    "genericName": "Octagam Inj.",
    "doseList": [
      {
        "description": "The usual dose is 0.2-0.8ml/kg body weitht, to be repeated every 4-8 weeks. The administration must be performed at a high dilution (at least 1:20) & very slowly (15 drops/minimum) while the patient is kept under close clinical supervision.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 0.2,
              "max": 0.8
            },
            "repeated": {
              "unit": "week",
              "min": 4,
              "max": 8
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 733,
    "genericName": "Pentaglobin Inj.",
    "doseList": [
      {
        "ageGroup": "neonate",
        "description": "5ml/kg body weight daily on 3 consecutive days. Further Infusions may be required depending on the clinical course. Pentaglobin should be infused I.at the following rates- in neonates and infants, 1.7ml/kg/hour by Infusion pump; in Children and Adults, 0.4ml/kg/hour or alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "nfusionRate": {
              "unit": "ml/kg/hour",
              "min": 1.7,
              "max": 1.7
            },
            "notes": "alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours."
          }
        ]
      },
      {
        "ageGroup": "infant",
        "description": "5ml/kg body weight daily on 3 consecutive days. Further Infusions may be required depending on the clinical course. Pentaglobin should be infused I.at the following rates- in neonates and infants, 1.7ml/kg/hour by Infusion pump; in Children and Adults, 0.4ml/kg/hour or alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "nfusionRate": {
              "unit": "ml/kg/hour",
              "min": 1.7,
              "max": 1.7
            },
            "notes": "alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "5ml/kg body weight daily on 3 consecutive days. Further Infusions may be required depending on the clinical course. Pentaglobin should be infused I.at the following rates- in neonates and infants, 1.7ml/kg/hour by Infusion pump; in Children and Adults, 0.4ml/kg/hour or alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "nfusionRate": {
              "unit": "ml/kg/hour",
              "min": 0.4,
              "max": 0.4
            },
            "notes": "alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "5ml/kg body weight daily on 3 consecutive days. Further Infusions may be required depending on the clinical course. Pentaglobin should be infused I.at the following rates- in neonates and infants, 1.7ml/kg/hour by Infusion pump; in Children and Adults, 0.4ml/kg/hour or alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            },
            "nfusionRate": {
              "unit": "ml/kg/hour",
              "min": 0.4,
              "max": 0.4
            },
            "notes": "alternatively, first 100ml at 0.4ml/kg/hour then 0.2ml/kg/hour continuously until 15ml/kg is reached within 72 hours."
          }
        ]
      },
      {
        "indication": "mmunoglobulin substitution in immunocompro-mised patients",
        "description": "mmunoglobulin substitution in immunocompro-mised patients- 3-5ml/kg body weight, repetition at weekly intervals if necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml/kg",
            "amount": {
              "min": 3,
              "max": 5
            },
            "notes": "repetition at weekly intervals if necessary."
          }
        ]
      }
    ]
  },
  {
    "serial": 734,
    "genericName": "Human anti-tetanus Immunoglobulin",
    "doseList": [
      {
        "indication": "Prophylaxis",
        "description": "Prophylaxis- in case of injury, thorough debridement and cleansing if the wound should be performed. Prompt I.M administration of 250 i.u. (1ml) of TIG is usually adequate. (Child- 4 units/kg body weight).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 250,
              "max": 250
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Prophylaxis",
        "description": "Prophylaxis- in case of injury, thorough debridement and cleansing if the wound should be performed. Prompt I.M administration of 250 i.u. (1ml) of TIG is usually adequate. (Child- 4 units/kg body weight).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "unit/kg",
            "amount": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "in severe multiple injuries or of a highly potential tetanus infectivity",
        "description": "in severe multiple injuries or of a highly potential tetanus infectivity the dow should be doubled. Passive immunization with immunoglobulin should be accompanied by simultaneous active immunization with adsorbed thetanus vaccine with separate syringe & into saperate site. TIG usually provides a protective level of tetanus antitoxin over 0.01 i.u per ml serum for a period of 4 wks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 500,
              "max": 500
            },
            "notes": "TIG usually provides a protective level of tetanus antitoxin over 0.01 i.u per ml serum for a period of 4 wks."
          }
        ]
      },
      {
        "indication": "declared tetanus in conjunction with other therapeutic measures",
        "description": "Treatment: TIG could be used for the treatment of declared tetanus in conjunction with other therapeutic measures. The dose would range between 3,000 i.u. and 6,000 i.u.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 3000,
              "max": 6000
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 735,
    "genericName": "Partobulin SDF Inj.",
    "doseList": [
      {
        "description": "One dose 1250 i.u (250mcg) shold be given I.M immediately or as soon as possible after delivery, or abortion of a Rh positive Child, preferably within 48 hours, but not later than 72 hours post partum. Following any potentially sensitizing episode (e.g stillbirth, amniocentesis) up to 20 weeks of gestation 650 i.u (125mcg) per episode (after 20 weeks of gestation, 1250 i.u) immediately or withing 72 hours. For Injection must only be given deep intramuscularly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": ".u",
            "amount": {
              "min": 1250,
              "max": 1250
            },
            "notes": "shold be given I.M immediately or as soon as possible after delivery, or abortion of a Rh positive Child, preferably within 48 hours, but not later than 72 hours post partum."
          },
          {
            "type": "primaryFollowup",
            "unit": ".u",
            "amount": {
              "min": 650,
              "max": 650
            },
            "notes": "mmediately or withing 72 hours.."
          }
        ]
      }
    ]
  },
  {
    "serial": 736,
    "genericName": "Ketamine",
    "doseList": [
      {
        "condition": ".dose",
        "description": "nitial I.dose varies between 1-4.5mg/kg. the average dose, 2mg/kg resulting in anaesthesia of 5-10 minimum duration.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 4.5
            }
          },
          {
            "type": "primary",
            "condition": "in anaesthesia of 5-10 minimum duration",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "condition": "I.M dose",
        "description": "nitial I.dose varies between 1-4.5mg/kg. the average dose, 2mg/kg resulting in anaesthesia of 5-10 minimum duration.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 6.5,
              "max": 13
            }
          },
          {
            "type": "primary",
            "condition": "anaesthesia of about 12-25 minimum duration",
            "unit": "mg/kg",
            "amount": {
              "min": 10,
              "max": 10
            }
          }
        ],
        "notes": "Anaesthesia can be maintained by the initial or by the half of the initial dose."
      }
    ]
  },
  {
    "serial": 737,
    "genericName": "Thiopentone sodium",
    "doseList": [
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "in fit premedica-ted Adults",
        "description": "Adult- in fit premedica-ted Adults, initially 100-150 mg (4-6ml of 2.5% solution) over 10-15 seconds, followed by further quantity if necessary according to response after 30-60 sconds; or up to 4 mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 150
            },
            "duration": {
              "unit": "second",
              "min": 10,
              "max": 15
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "f necessary according to response after 30-60 sconds",
            "unit": "mg/kg",
            "amount": {
              "max": 4
            }
          }
        ]
      },
      {
        "route": "Injection",
        "ageGroup": "Child",
        "description": "Child, Induction 2-7mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 738,
    "genericName": "Diethyl Ether",
    "doseList": [
      {
        "description": "From an open make or a sutible vaporiser. Induction up to 20%, maintenance 3-10%.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 20,
              "max": 20
            }
          },
          {
            "type": "maintenance",
            "unit": "%",
            "amount": {
              "min": 3,
              "max": 10
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 741,
    "genericName": "Ketorolac",
    "doseList": [
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "10mg every 4-6 hourly (elderly 6-8 hourly); max 40mg daily; maximum duration of treatment 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "elderly",
        "description": "10mg every 4-6 hourly (elderly 6-8 hourly); max 40mg daily; maximum duration of treatment 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 8
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "max": 40
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 16
        },
        "description": "under 16 years, not recommended.",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Short-term management of post-operative pain",
        "description": "Short-term management of post-operative pain,initially 10mg I.M or I.followed by 10-30mg 4-6 hourly (2 hourly in initial post-operative period); maximum 90mg daily (elderly & patients weighing less than 50kg maximum 60mg daily); mximum durationof treatment 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 10
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          },
          {
            "type": "maintenance",
            "unit": "mg",
            "amount": {
              "max": 90
            },
            "notes": "elderly & patients weighing less than 50kg maximum 60mg daily"
          }
        ],
        "notes": "maximum duration of treatment 2 days."
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Short-term management of pain on a regular schedule",
        "description": "Short-term management of pain on a regular schedule- 30-60mg I.M as a loading dose followed by 15-30 6 hourly; maximum 150mg for 1st day & 120mg/day thereafter.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ],
        "notes": "maximum 150mg for 1st day & 120mg/day thereafter."
      },
      {
        "route": "Injection",
        "ageGroup": "Adult",
        "indication": "Pain associated with surgical procedures",
        "description": "Pain associated with surgical procedures- 30mg I.M followed by 10-30mg 4-6 hourly. Perenteral use of ketorolac is not recommended for longer period (not more than 5 days.)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 10,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ],
        "notes": "Perenteral use of ketorolac is not recommended for longer period (not more than 5 days.)"
      }
    ]
  },
  {
    "serial": 742,
    "genericName": "Fentanyl",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Spontan-eous Respire-tion",
        "description": "Fentanyl Injection can be administered intravenously either as a bolus or by Infusion & by intramuscular route also. The dose of fentanyl should be individualized according to age, bddy weight, physical status, underlying pathological condition, use of other drugs and type of surgery and anaeshesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 200
            }
          },
          {
            "type": "supplementary",
            "unit": "mcg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Assisted ventila-tion",
        "description": "Fentanyl Injection can be administered intravenously either as a bolus or by Infusion & by intramuscular route also. The dose of fentanyl should be individualized according to age, bddy weight, physical status, underlying pathological condition, use of other drugs and type of surgery and anaeshesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 300,
              "max": 3500
            }
          },
          {
            "type": "supplementary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Spontan-eous Respire-tion",
        "description": "Fentanyl Injection can be administered intravenously either as a bolus or by Infusion & by intramuscular route also. The dose of fentanyl should be individualized according to age, bddy weight, physical status, underlying pathological condition, use of other drugs and type of surgery and anaeshesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 3,
              "max": 5
            }
          },
          {
            "type": "supplementary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "Assisted ventila-tion",
        "description": "Fentanyl Injection can be administered intravenously either as a bolus or by Infusion & by intramuscular route also. The dose of fentanyl should be individualized according to age, bddy weight, physical status, underlying pathological condition, use of other drugs and type of surgery and anaeshesia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 15,
              "max": 15
            }
          },
          {
            "type": "supplementary",
            "unit": "mcg",
            "amount": {
              "min": 1,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "for use in anaesthesia",
        "description": "Doses in excess of 200mcg are for use in anaesthesia only. As a premedicant, 1-2ml fentanyl may be gien intramuscularly 45 minutes before induction of anaesthesia.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Doses in excess of 200mcg",
            "unit": "ml",
            "amount": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "before induction of anaesthesia": true,
              "minute": 45
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in unpremedi-cated Adult patients",
        "description": "After I.administration in unpremedi-cated Adult patients, 2ml fentanyl may be expected to provide sufficient analgesia for 10-20 minutes in surgical procedures involving low pain intersity. 10ml fentanyl injected asa bolus gives analgesia lasting about one hour. The analgesia produced is sufficient for surgery involving moderately painful procedures. Giving a dose of 50mcg/kg fentanyl will provide interse analgesia for some four to six hours, for intersely stimulationg surgery. Giving a dose of 50mcg/kg fentanyl will provide interse analgesia for some four to six hours, for intersely stimulationg surgery.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "in surgical procedures involving low pain intersity",
            "unit": "ml",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primary",
            "condition": "sufficient for surgery involving moderately painful procedures",
            "unit": "ml",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primary",
            "condition": "for intersely stimulationg surgery.",
            "unit": "mcg/kg",
            "amount": {
              "min": 50,
              "max": 50
            }
          }
        ]
      },
      {
        "indication": "in ventilated patients",
        "description": "Fentanyl may also be given as an Infusion. In ventilated patients, a loading dose of fentanyl may be given as a fast Infusionof approximately 1mcg/kg/min for the first 10 minutes followed by an Infusion of approximately 0.1mcg/kg/minimum alternatively the loading dose of fentanyl may be given as a bolus. Infusion rates should be titrated to individual patient pesponse; lower Infusion rates may be adequate. Unless it is planned to ventilate post-operatively, the Infusion should be terminated at about 40 minutes before the end of surgery. Lower Infusion rates, e.g 0.05-0.08 mcg/kg/minimum are necessary if spontaneous ventilation is to be maintained. Higher Infusion rates (up to 3mcg/kg/min) have been used in cardiac surgery.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/minute",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "minute",
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mcg/kg/minute",
            "amount": {
              "min": 0.1,
              "max": 0.1
            }
          },
          {
            "type": "alternate",
            "notes": "alternatively the loading dose of fentanyl may be given as a bolus. Infusion rates should be titrated to individual patient pesponse; lower Infusion rates may be adequate. Unless it is planned to ventilate post-operatively, the Infusion should be terminated at about 40 minutes before the end of surgery.",
            "condition": "Lower Infusion rates if spontaneous ventilation is to be maintained",
            "unit": "mcg/kg/min",
            "amount": {
              "min": 0.05,
              "max": 0.08
            }
          },
          {
            "type": "alternate",
            "notes": "alternatively the loading dose of fentanyl may be given as a bolus. Infusion rates should be titrated to individual patient pesponse; lower Infusion rates may be adequate. Unless it is planned to ventilate post-operatively, the Infusion should be terminated at about 40 minutes before the end of surgery.",
            "condition": "Higher Infusion rates in cardiac surgery",
            "unit": "mcg/kg/min",
            "amount": {
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 744,
    "genericName": "Atracurium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "0.3-0.6mg/kg I.Full block can be prolonged with supplementary doses of 0.1-0.2mg/kg as required. Endotracheal intubation can usually be accomplished within 90 seconds of I.V Injection of 0.5-0.6mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 0.6
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 0.1,
              "max": 0.2
            }
          }
        ],
        "notes": "Endotracheal intubation can usually be accomplished within 90 seconds of I.V Injection of 0.5-0.6mg/kg."
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Under 1 year, not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1
        },
        "description": "Over 1 year, same as Adult in proportion to body-wt.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Over 1 year, same as Adult in proportion to body-wt."
          }
        ]
      },
      {
        "indication": "Continuous Infusion",
        "description": "Suitiable for adminimum By continuous Infusion at a rate of 0.005-0.01mg/kg/minimum (0.3-0.6 mg/kg/hour) to maintain neuromuscular bloc during long surgical procedures.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/min",
            "amount": {
              "min": 0.005,
              "max": 0.01
            }
          },
          {
            "type": "alternate",
            "condition": "to maintain neuromuscular bloc during long surgical procedures",
            "unit": "mg/kg",
            "amount": {
              "min": 0.3,
              "max": 0.6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 745,
    "genericName": "Pancuronium",
    "doseList": [
      {
        "route": ".Injection",
        "ageGroup": "Adult",
        "description": "Initially 50-100mcg/kg for intubation, then 10-20mcg/kg according to the patients response. All by I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 50,
              "max": 100
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "according to the patients response",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "ageGroup": "neonate",
        "description": "Child: Neonates, 30-40mcg/kg initially, then 100mcg/kg. Then 10-20mcg/kg. All by I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 30,
              "max": 40
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mcg/kg",
            "amount": {
              "min": 100,
              "max": 100
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 20
            }
          }
        ]
      },
      {
        "route": ".Injection",
        "ageGroup": "Child",
        "indication": "Intersive care",
        "description": "Intersive care, by I.inj. 60mcg/kg every 1 to 1 & half an hour; by I.M inj. 30-60mcg/kg every 1-2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 1.5
            }
          }
        ]
      },
      {
        "route": "I.M. Injection",
        "ageGroup": "Child",
        "indication": "Intersive care",
        "description": "Intersive care, by I.M inj. 30-60mcg/kg every 1-2 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 30,
              "max": 60
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 746,
    "genericName": "Popecuromium Bromide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "ntubation and subsequent surgery",
        "description": "The usual initial dose for intubation and subsequent surgery is 0.07-0.08 mg/kg body-weight initavanously. This dose produces relaxation suitable for intubation within 90-120 sec lasting for 50-70minimum In patients intubated by succinylcholine the useal initial dose after intubation is 0.04-0.05mg/kg body-weight. Duration of action is of 15-25 min depending on individual response. Higher doses produce prolonged action.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 0.07,
              "max": 0.08
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 0.04,
              "max": 0.05
            },
            "notes": "Duration of action is of 15-25 min depending on individual response. Higher doses produce prolonged action."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "patients with renal failure",
        "description": "To patients with renal failure not higher dose than 0.04mg/kg body-weight are suggested (prolongation of effect may occur). Repeated dose is usually 25% of the initial dose, i.e 0.010-0.015mg/kg body-weight.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "max": 0.04
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg",
            "amount": {
              "min": 0.010,
              "max": 0.015
            },
            "notes": "Repeated dose is usually 25% of the initial dose"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "in case of diazepam- ketamine-fentanyl-nitrous oxide is applied in Children",
        "description": "in case of diazepam- ketamine-fentanyl-nitrous oxide is applied in Children, larger than the Adult doses, i.e 80-90mcg/kg is suggested. In neonates, lower thanthe Children doses, i.e. 50-60 mcg/kg are suggested. These doses produce relaxation for surgical intervantions of 25-35 min duration. IF necessary, muscle relaxation can be prolonged for further 25-35 min by the supplemental administration of the one third of the initial dose. Residual relaxation can be reversed rapidly and safely by the administration of neostigmine and atropine. Due to the great variety of individual response, monitoring of drug effect by a peripheral nerve stimulitor  is highly recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 80,
              "max": 90
            },
            "notes": "These doses produce relaxation for surgical intervantions of 25-35 min duration."
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "indication": "in case of diazepam- ketamine-fentanyl-nitrous oxide is applied in Children",
        "description": "in case of diazepam- ketamine-fentanyl-nitrous oxide is applied in Children, larger than the Adult doses, i.e 80-90mcg/kg is suggested. In neonates, lower thanthe Children doses, i.e. 50-60 mcg/kg are suggested. These doses produce relaxation for surgical intervantions of 25-35 min duration. IF necessary, muscle relaxation can be prolonged for further 25-35 min by the supplemental administration of the one third of the initial dose. Residual relaxation can be reversed rapidly and safely by the administration of neostigmine and atropine. Due to the great variety of individual response, monitoring of drug effect by a peripheral nerve stimulitor  is highly recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 80,
              "max": 90
            },
            "notes": "These doses produce relaxation for surgical intervantions of 25-35 min duration."
          }
        ]
      }
    ]
  },
  {
    "serial": 747,
    "genericName": "Rocuronium",
    "doseList": [
      {
        "route": "By I.V Injection",
        "description": "ntubation, 600mcg/kg; Maintenance 150mcg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 600,
              "max": 600
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "route": "By I.Infusion",
        "description": "300-600mcg/kg/hour (after initial I.V Injection of 600mcg/kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/hour",
            "amount": {
              "min": 300,
              "max": 600
            },
            "notes": "after initial I.V Injection of 600mcg/kg"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "route": "By I.V Injection",
        "description": "ntubation, 600mcg/kg; Maintenance 150mcg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 600,
              "max": 600
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 150,
              "max": 150
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "route": "By I.Infusion",
        "description": "300-600mcg/kg/hour (after initial I.V Injection of 600mcg/kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/hour",
            "amount": {
              "min": 300,
              "max": 600
            },
            "notes": "after initial I.V Injection of 600mcg/kg"
          }
        ]
      },
      {
        "ageGroup": "neonate",
        "description": "Neonate- Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 748,
    "genericName": "Vecuronium",
    "doseList": [
      {
        "route": ".injecton",
        "description": "ntubation, 80-100mcg/kg; maintenance 20-30mcg/kg according to response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 80,
              "max": 100
            }
          },
          {
            "type": "maintenance",
            "unit": "mcg/kg",
            "amount": {
              "min": 20,
              "max": 30
            }
          }
        ]
      },
      {
        "route": ".injecton",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 4
        },
        "description": "Neonate and Infant up to 4 months, initially 10-20mcg/kg then incremental doses to achieve response",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 10,
              "max": 20
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "then incremental doses to achieve response"
          }
        ]
      },
      {
        "route": ".injecton",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 5
        },
        "description": "Children over 5 months, as Adult dose (up to 1 year onset more rapid and high intubation dose may not be required).",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "as Adult dose (up to 1 year onset more rapid and high intubation dose may not be required)."
          }
        ]
      },
      {
        "route": ".Infusion",
        "description": "50-80mcg/kg/hour (afte initial I.V Injection of 40-100mcg/kg).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg/hour",
            "amount": {
              "min": 50,
              "max": 80
            },
            "notes": "afte initial I.V Injection of 40-100mcg/kg."
          }
        ]
      }
    ]
  },
  {
    "serial": 749,
    "genericName": "Suxamethonium",
    "doseList": [
      {
        "route": ".inection",
        "ageGroup": "Adult",
        "description": "600mcg/kg (rengs 0.3-1.1 mg/kg depending on egree of relaxation required); usual range 20-100mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg/kg",
            "amount": {
              "min": 600,
              "max": 600
            },
            "notes": "rengs 0.3-1.1 mg/kg depending on egree of relaxation required"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 20,
              "max": 100
            }
          }
        ]
      },
      {
        "route": ".inection",
        "ageGroup": "infant",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "nfant, under 1 year, 2mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".inection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 12
        },
        "description": "Child, 1-12 years, 1-2mg/kg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "description": "As a 0.1% solution, 2-5mg/minute (or 2-5ml/minute).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.1,
              "max": 0.1
            },
            "notes": "2-5mg/minute (or 2-5ml/minute)."
          }
        ]
      }
    ]
  },
  {
    "serial": 750,
    "genericName": "Tolperisone",
    "doseList": [
      {
        "route": "Injection",
        "description": "Daily 200mg given intramuscularly or daily 100mg with slow intravenous administration.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ntramuscularly",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          },
          {
            "type": "alternate",
            "condition": "with slow intravenous administration.",
            "unit": "mg",
            "amount": {
              "min": 100,
              "max": 100
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Adult",
        "description": "150-450mg 3 times daily according to the individual requirements and tolerance of the patient.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ntramuscularly",
            "unit": "mg",
            "amount": {
              "min": 150,
              "max": 450
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3,
          "max": 72
        },
        "description": "For 3 mon to 6 yrs- 5-10mg/kg/day divided into 3 doses (1-3 tabs, daily)",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ntramuscularly",
            "unit": "mg/kg/day",
            "amount": {
              "min": 5,
              "max": 10
            },
            "notes": "divided into 3 doses (1-3 tabs, daily)"
          }
        ]
      },
      {
        "route": "mouth",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 14
        },
        "description": "6-14 yrs. 4-2mg/kg/day, divided into 3 doses.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ntramuscularly",
            "unit": "mg/kg/day",
            "amount": {
              "min": 4,
              "max": 2
            },
            "notes": "divided into 3 doses"
          }
        ]
      }
    ]
  },
  {
    "serial": 750,
    "genericName": "Neostigmine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-5 mg I.with 0.4-1.25mg atropine given some minutes before.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 5
            },
            "additionalItem": {
              "genericName": "atropine",
              "quantity": {
                "unit": "mg",
                "amount": {
                  "min": 0.4,
                  "max": 1.25
                }
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-5 mg I.with 0.4-1.25mg atropine given some minutes before.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.125,
              "max": 1
            },
            "additionalItem": {
              "genericName": "atropine",
              "quantity": {
                "unit": "mg/kg",
                "amount": {
                  "min": 0.02,
                  "max": 0.03
                }
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 751,
    "genericName": "Cardioplegia Soln",
    "doseList": [
      {
        "description": "20ml Cardioplegia solution is added to 1 litre Ringer’s solution. The solutionis cooled (2-80C) prior to use. The solution is then administered by rapid Infusion into the aortic root at a rate of about 300ml/m2/min for 3 minutes initially. ReInfusion is usually done every 30 minutes or sooner if the my ocardial temperature reaches 180C or returning cardiac activity is observed. Discard any unused portion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 20,
              "max": 20
            },
            "additionalItem": {
              "genericName": "Ringer’s solution",
              "quantity": {
                "unit": "litre",
                "amount": {
                  "min": 1,
                  "max": 1
                }
              }
            },
            "notes": "The solutionis cooled (2-80C) prior to use"
          },
          {
            "type": "primaryFollowup",
            "notes": "The solution is then administered by rapid Infusion into the aortic root at a rate of about 300ml/m2/min for 3 minutes initially."
          },
          {
            "type": "maintenance",
            "notes": "ReInfusion is usually done every 30 minutes or sooner if the my ocardial temperature reaches 180C or returning cardiac activity is observed."
          }
        ]
      }
    ]
  },
  {
    "serial": 752,
    "genericName": "Ethyl Chloride Spray tube",
    "doseList": [
      {
        "description": "Spray locally over the area to be operated.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "Spray locally over the area to be operated."
          }
        ]
      }
    ]
  },
  {
    "serial": 753,
    "genericName": "Lignocaine HCI",
    "doseList": [
      {
        "route": "Injection",
        "description": "maximum Dose 200mg without adrenaline, 500mg with adrenaline. (Maximum dose of adrenaline 500mcg.).",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "without adrenaline",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 200
            }
          },
          {
            "type": "primary",
            "condition": "with adrenaline",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            }
          }
        ]
      },
      {
        "indication": "nfiltration anaes",
        "description": "0.25 to 0.5%, with adrenaline 1 in 200000, using 2-50ml of a 0.5% solution in minor surgery & upto 60ml in more extensive surgery.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "notes": "with adrenaline 1 in 200000, using 2-50ml of a 0.5% solution in minor surgery & upto 60ml in more extensive surgery."
          }
        ]
      },
      {
        "indication": "Nerve blocks",
        "description": "With adrenaline 1 in 200000, 1% to a maximum of 50ml, 2% to a maximum of 25ml.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "With adrenaline 1 in 200000, 1% to a maximum of 50ml, 2% to a maximum of 25ml."
          }
        ]
      },
      {
        "indication": "Epidural & Caudal block",
        "description": "with adrenaline 1 in 200000, 1% to a maximum of 50ml, 2% to a maximum of 25 ml.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "with adrenaline 1 in 200000, 1% to a maximum of 50ml, 2% to a maximum of 25 ml."
          }
        ]
      },
      {
        "indication": "Surface anaesthesia",
        "description": "usual strengths 2-4% Mouth, throat and upper gastro-intestinal tract maximum 200mg.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "max": 200
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "in proportion to dose for 70 kgAdult.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "in proportion to dose for 70 kgAdult."
          }
        ]
      }
    ]
  },
  {
    "serial": 754,
    "genericName": "Xylocaine Gel Asta",
    "doseList": [
      {
        "ageGroup": "women",
        "description": "Women-3 to 5ml.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "men",
        "description": "Initially 10ml, then 3-5ml.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 10,
              "max": 10
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "ml",
            "amount": {
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 755,
    "genericName": "Bupivacaine HCI",
    "doseList": [
      {
        "indication": "Local infiltration",
        "description": "Adjust according to site of operation and response of patient. Local infiltration- 0.25% (up to 60ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "volume": {
              "unit": "ml",
              "max": 60
            }
          }
        ]
      },
      {
        "indication": "Peripheral nerve block",
        "description": "Adjust according to site of operation and response of patient. Peripheral nerve block- 0.25% (maximum 60ml), 0.5% (maximum 30ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "volume": {
              "unit": "ml",
              "max": 60
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "%",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "max": 30
            }
          }
        ]
      },
      {
        "indication": "Epidural block",
        "secondaryIndication": "Surgery",
        "tertiaryIndication": "Lumbar",
        "description": "Lumbar – 0.5-0.7%(maximum 20ml of either).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.5,
              "max": 0.7
            },
            "volume": {
              "unit": "ml",
              "max": 20
            }
          }
        ]
      },
      {
        "indication": "Epidural block",
        "secondaryIndication": "Surgery",
        "tertiaryIndication": "Lumbar",
        "description": "Caudal – 0.5% (maximum 30ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "max": 30
            }
          }
        ]
      },
      {
        "indication": "Epidural block",
        "secondaryIndication": "Labour",
        "tertiaryIndication": "Lumbar",
        "description": "Lumbar – 0.25-0.5% (maximum 12 ml of either)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "max": 12
            }
          }
        ]
      },
      {
        "indication": "Epidural block",
        "secondaryIndication": "Labour",
        "tertiaryIndication": "Caudal",
        "description": "Caudal – 0.25% (maximum 30ml) or 0.5% (maximum 20ml).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "%",
            "amount": {
              "min": 0.25,
              "max": 0.25
            },
            "volume": {
              "unit": "ml",
              "max": 30
            }
          },
          {
            "type": "alternate",
            "unit": "%",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "volume": {
              "unit": "ml",
              "max": 20
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 756,
    "genericName": "Ultracaine Heavy Inj.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Spinal anaesthesia for sugery",
        "description": "The doses recommende below should be regarded as a guide for use in the average Adult. Spinal anaesthesia for sugery- 2-4ml (10-20mg). The spread of anaesthesia obtained with Ultracaine Heavy depends on several factors including the volume of solution and te position of the patient during and following the Injection. When injected in the L3-L4intervertebral space with the patient in the sitting position, 3ml of Ultracaine Heavy spreads of to the T7-T10 spinal segments. With the patient receiving the Injection in the horizontal position and then turned supine, the blockade spreads to T4-T7 spinal segments, it should be understood that the level of spinal anaesthesia achieved with any local anaesthetic can be unpredictable in a given patient. The effects of Utracaine Heavy exceeding 5ml have not yet been studied and such volumes can therefore not be recommended.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "ml",
            "amount": {
              "min": 2,
              "max": 4
            },
            "notes": "The effects of Utracaine Heavy exceeding 5ml have not yet been studied and such volumes can therefore not be recommended."
          }
        ]
      }
    ]
  },
  {
    "serial": 757,
    "genericName": "Ephedrine",
    "doseList": [
      {
        "route": ".Injection",
        "indication": "nduction",
        "description": "2-2.5 mg/kg (less in elderly)at a rate of  20-40 mg every 10 seconds.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 2.5
            },
            "rate": {
              "unit": "mg/10 seconds",
              "min": 20,
              "max": 40
            },
            "notes": "less in elderly"
          }
        ]
      },
      {
        "route": ".Injection",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3
        },
        "indication": "nduction",
        "description": "Child over 3 yrs. 2-5 mg/kg adjusted as necessary.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 2,
              "max": 5
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "indication": "Maintenane",
        "description": "4-12mg/kg/hour",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/hour",
            "amount": {
              "min": 4,
              "max": 12
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3
        },
        "indication": "Maintenane",
        "description": "Child, over 3 yrs. 9-15 mg/kg/hour Sedation during intensive care (with assisted ventilation), by I.V. Infusion, 1-4 mg/kg/hour for upto 3 days",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg/hour",
            "amount": {
              "min": 9,
              "max": 15
            },
            "notes": "Sedation during intensive care (with assisted ventilation)"
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/kg/hour",
            "amount": {
              "min": 1,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 3
            }
          }
        ]
      },
      {
        "route": ".Infusion",
        "ageGroup": "Child",
        "description": "Child, Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 758,
    "genericName": "Nalidixic Acid",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "Acute infections",
        "description": "1 gm every 6 hours daily for minimum 7 days, reducing to 500 mg every 6 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "gm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "Chronic infections",
        "description": "500mg every 6 hours daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 500,
              "max": 500
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "max": 3
        },
        "description": "Child: Under 3 months not recommended",
        "subDoseList": [],
        "notRecommended": true
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "month",
          "min": 3,
          "max": 144
        },
        "description": "3 months-12 yrs. Up to 50mg/kg body-wt. daily in divided doses (6 hourly)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg/kg",
            "amount": {
              "min": 50,
              "max": 50
            },
            "repeated": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 759,
    "genericName": "Glycine Irrigation Soln",
    "doseList": [
      {
        "description": "rrigatin solution is administered as drip through the bi-luminal catheter and can be continued as required.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "rrigatin solution is administered as drip through the bi-luminal catheter and can be continued as required."
          }
        ]
      }
    ]
  },
  {
    "serial": 760,
    "genericName": "Finasteride",
    "doseList": [
      {
        "description": "5mg daily, review treatment after 6 months (may require several months treatment before benefit is obtained).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "notes": "review treatment after 6 months "
          }
        ]
      }
    ]
  },
  {
    "serial": 761,
    "genericName": "Oxybutynin Chloride",
    "doseList": [
      {
        "description": "Oxybutynin chloride may be administered with or without food. The recommended starting dose is 5mg once daily. Dosage may be adjusted in 5 mg increments to achieve a balance of efficacy and tolerability (up to a maximum of 30mg/day). In general, dosage adjustment may proceed at approximately weekly intervals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 5,
              "max": 5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "with or without food"
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "mg/day",
            "amount": {
              "max": 30
            },
            "notes": "Dosage may be adjusted in 5 mg increments to achieve a balance of efficacy and tolerability (up to a maximum of 30mg/day). In general, dosage adjustment may proceed at approximately weekly intervals."
          }
        ]
      }
    ]
  },
  {
    "serial": 762,
    "genericName": "Tamsulosin",
    "doseList": [
      {
        "indication": "for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)",
        "description": ".",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.4,
              "max": 0.4
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "after",
              "hour": 1.5
            },
            "notes": "t should be administered approximately one and half hour following the same meal each day."
          },
          {
            "type": "primaryFollowup",
            "condition": "For those patients who fail to respond to the 0.4mg dose after 2 to 4 weeks of treatment",
            "unit": "mg",
            "amount": {
              "min": 0.8,
              "max": 0.8
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 763,
    "genericName": "Tolterodine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose for tolterodine is 2mg twice daily. In case of troublesome side-effects the dose may be reduced from 2 mg to 1 mg twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "in case of troublesome side-effects",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "for patients with impaired renal function, impaired liver function, or receiving concomitant medication with potent CYP3A inhibitors, such as macrolide antibiotics (e.g erythromycin and clarithromycin) or azole antifungal anents (e.g ketoconazole, itraconazole and miconazole)",
        "description": "The recommended total daily dose of tolterodine is 2mg (1mg twice daily) for patients with impaired renal function, impaired liver function, or receiving concomitant medication with potent CYP3A inhibitors, such as macrolide antibiotics (e.g erythromycin and clarithromycin) or azole antifungal anents (e.g ketoconazole, itraconazole and miconazole). After 6 months the need for further treatment should be considered.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "notes": "After 6 months the need for further treatment should be considered."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Safety and effectiveness of tolterodin ein Children have yet not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 764,
    "genericName": "Ergometrine Maleate",
    "doseList": [
      {
        "route": "mouth",
        "description": "0.5-1 mg (onset of action about 8 mins; duration about 1 hour) daily in divided doses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "duration": {
              "unit": "hour",
              "min": 1,
              "max": 1
            },
            "notes": "onset of action about 8 mins"
          }
        ]
      },
      {
        "route": "I.M. Injection",
        "description": "200-500mcg (onset about 2 mins).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 200,
              "max": 500
            },
            "notes": "onset about 2 mins"
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "For emergency control of haemorrhage",
        "description": "For emergency control of haemorrhage, 100-500mcg. (onset about 1 min).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 100,
              "max": 500
            },
            "notes": "onset about 1 min"
          }
        ]
      },
      {
        "route": ".Injection",
        "indication": "Atonic post partum haemorrhage",
        "description": "Atonic post partum haemorrhage can be controlled by 125-250mcg. By I.V Injection.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 125,
              "max": 250
            }
          }
        ]
      },
      {
        "route": "mouth",
        "indication": "in menorrhagia",
        "description": "in menorrhagia, 0.125-0.250mg orally 3-4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 0.125,
              "max": 0.250
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 765,
    "genericName": "Oxytocin",
    "doseList": [
      {
        "route": "slow I.Infusion",
        "ageGroup": "Adult",
        "indication": "nduction andaugmentation of labour",
        "description": "nduction andaugmentation of labour, as I.fluid containing 1 unit per litre, 1-3 milliunits (1-3 ml of fluid or 15-45 drops) per miute, adjusted according to response.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 15,
              "max": 45
            },
            "volume": {
              "unit": "ml",
              "min": 1,
              "max": 3
            },
            "notes": "as I.fluid containing 1 unit per litre, 1-3 milliunits"
          }
        ]
      },
      {
        "route": "slow I.Infusion",
        "ageGroup": "Adult",
        "indication": "Missed abortion",
        "description": "Missed abortion, as a fluid containing 10-20 units/500ml given at a rate of 10-30 drops/minute, increased in strength by 10-20 units/500ml every hour to a max strength of 100 units/500ml.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "as a fluid containing 10-20 units/500ml given at a rate of 10-30 drops/minute, increased in strength by 10-20 units/500ml every hour to a max strength of 100 units/500ml."
          }
        ]
      },
      {
        "route": "slow I.Infusion",
        "ageGroup": "Adult",
        "indication": "Pospartum haemorrhage",
        "description": "Pospartum haemorrhage, 5-10 units/500ml given at a rate of 15 drops/minimum adjusted according to response.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "5-10 units/500ml given at a rate of 15 drops/minimum adjusted according to response."
          }
        ]
      },
      {
        "route": "nasal spray",
        "ageGroup": "Adult",
        "indication": "facilitation of lactation",
        "description": "1 squeeze (about 2 units) into one or both nostrils 2-5 inutes before feeding infant.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "squeeze ",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "(about 2 units) into one or both nostrils 2-5 inutes before feeding infant."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not applicable",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 766,
    "genericName": "Clotrimazole",
    "doseList": [
      {
        "indication": "First infection",
        "secondaryIndication": "candida vaginitis",
        "description": "in general a 3 day treatment is sufficient for candida vaginitis- insert 2 Tablets (100mgx 2) high into the vagina with applicator at night, on 3 consecutive days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "volume": {
              "unit": "mg/Tablet",
              "min": 100,
              "max": 100
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "indication": "Reinfectiions",
        "description": "in general a 6 day treatment is sufficient- insert 1 Tablet (100mg) high into the vagina with applicator at night, on 6 consecutive days. If necessary, 2 Tablets daily – 1 in the morning and 1 in the evening-can be used for 6-12 days without any hesitation. Treatment should be timed so as to avoid the menstrual period.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg/Tablet",
              "min": 100,
              "max": 100
            },
            "additionalItem": {
              "temName": "applicator"
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 6,
              "max": 12
            },
            "notes": "Treatment should be timed so as to avoid the menstrual period."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not applicable",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 767,
    "genericName": "Econate-G Cream Incepta",
    "doseList": [
      {
        "description": "Apply twice daily in the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 768,
    "genericName": "Econate-vt tab",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 tab. Inserted high into the vagina for 3 consecutive nights regardless of any intervening menses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "for 3 consecutive nights regardless of any intervening menses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, Not applicable",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 769,
    "genericName": "Ecozole-vt tab",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 tab. Inserted high into the vagina for 3 consecutive nights regardless of any intervening menses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "for 3 consecutive nights regardless of any intervening menses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, Not applicable",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 770,
    "genericName": "Gyno pevaryl-V Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 tab. Inserted high into the vagina for 3 consecutive nights regardless of any intervening menses.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "for 3 consecutive nights regardless of any intervening menses"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child, Not applicable",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 771,
    "genericName": "Gyno pevaryl-V Cream",
    "doseList": [
      {
        "description": "Apply twice daily in the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 772,
    "genericName": "Metronidazole + Miconazole",
    "doseList": [
      {
        "indication": "in trichomoniasis, oncurrently with oral metronidazole treatment",
        "description": "in trichomoniasis, oncurrently with oral metronidazole treatment 1 vaginal Tablet should be inserted high up into the vagina once a day (preparably before going to bed at night) for 10 days. Long-trem recovery may be expected only is reponse to the simultaneous oral treatment of both partners.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet ",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "notes": "Long-trem recovery may be expected only is reponse to the simultaneous oral treatment of both partners."
          }
        ]
      },
      {
        "indication": "in candidiasis or other fungal infections",
        "description": "in candidiasis or other fungal infections, 1 vaginal Tablet has to be inserted high up into the vagina for 10 days. The vagina Tablet should be slightly moistened before application.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet ",
            "amount": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 10,
              "max": 10
            },
            "notes": "The vagina Tablet should be slightly moistened before application."
          }
        ]
      }
    ]
  },
  {
    "serial": 773,
    "genericName": "Nystatin",
    "doseList": [
      {
        "description": "1 or 2 Nystat V.T. should be inserted daily at night. This should be continued for 2 weeks and even it should be continued during menstrual period.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Nystat V.T.",
            "amount": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 2
            },
            "notes": "even it should be continued during menstrual period."
          }
        ]
      }
    ]
  },
  {
    "serial": 774,
    "genericName": "Tioconazole",
    "doseList": [
      {
        "description": "One 300mg suppository to be used intravaginally as single dose, preferably at bedtime for one night only; for patients who are improved but not completelyycured a second application may be effective if administred one week later.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "suppository",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": {
              "unit": "mg",
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "notes": "for patients who are improved but not completelyycured a second application may be effective if administred one week later."
          }
        ]
      },
      {
        "indication": "Vaginal candidiasis",
        "description": "Vaginal candidiasis may be accompanied byvulval infection. Therefore, concomitant local treatment with the tioconazole cream should be applied to the vulva and as far as the anal region once or twice daily for up to 7 days (as need) is advisable.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      },
      {
        "indication": "To treat the male partner",
        "description": "To treat the male partner, a small amount of cream should be applied onto the glans penis once or twice daily for up to 7 days as needed or to help prevent reinfection by the partner.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 775,
    "genericName": "Gynomix Saft cap.",
    "doseList": [
      {
        "description": "Use in vagina 1 capsule at night (bed time) for 12 days or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 776,
    "genericName": "Gynoril Suppos.",
    "doseList": [
      {
        "description": "1 suppository to be introduced into the vagina at night (bed time) for 12 days or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "suppository",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 12,
              "max": 12
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 777,
    "genericName": "Albothyl Ovule Altana Pharma",
    "doseList": [
      {
        "description": "One ovule should be inserted deeply into the vagina before going to bed every other day for a period of 1-2 weeks. They maybe used as a sole medication or adjunctive treatment during intervals between cauterization by albothyl conc. It is recommended to stop treatment during menstruation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Ovule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 2
            },
            "notes": "They maybe used as a sole medication or adjunctive treatment during intervals between cauterization by albothyl conc. It is recommended to stop treatment during menstruation."
          }
        ]
      }
    ]
  },
  {
    "serial": 778,
    "genericName": "Hexitane Obstetric Cream ACI",
    "doseList": [
      {
        "description": "To be applied liberally to the skin on and around vulva, to hand, prior to vaginal application.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "To be applied liberally to the skin on and around vulva, to hand, prior to vaginal application."
          }
        ]
      }
    ]
  },
  {
    "serial": 779,
    "genericName": "Chloramphenicol",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 drops or 1 application of oint. 3 hourly or more frequently if requd.Adminimum Should be continued 48 hours after symptoms hav disappeared.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 3
            },
            "notes": "Adminimum Should be continued 48 hours after symptoms hav disappeared."
          },
          {
            "type": "alternate",
            "unit": "application of oint.",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 3
            },
            "notes": "Adminimum Should be continued 48 hours after symptoms hav disappeared."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 drops or 1 application of oint. 3 hourly or more frequently if requd.Adminimum Should be continued 48 hours after symptoms hav disappeared.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 3
            },
            "notes": "Adminimum Should be continued 48 hours after symptoms hav disappeared."
          },
          {
            "type": "alternate",
            "unit": "application of oint.",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 3
            },
            "notes": "Adminimum Should be continued 48 hours after symptoms hav disappeared."
          }
        ]
      }
    ]
  },
  {
    "serial": 780,
    "genericName": "Ciprofloxacin",
    "doseList": [
      {
        "indication": "Bacterial corneal ulcer",
        "description": "Ciprofloxacin 2 drops to be instilled into the affected eye every 15 minutes for the first six hoursl and then every 30 minutes for the rest of the day while patient awake. One the second day 2 drops every hour, from the third day every 4 hours. Treatment may be continued more than two weeks if corneal re-epithelialization has not occurred.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "minute",
              "min": 15,
              "max": 15
            },
            "treatmentPeriod": {
              "unit": "hour",
              "min": 6,
              "max": 6
            }
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "minute",
              "min": 30,
              "max": 30
            },
            "notes": "for the rest of the day while patient awake."
          },
          {
            "type": "maintenance",
            "condition": "One the second day",
            "unit": "drop/hour",
            "amount": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "maintenance",
            "condition": "from the third day",
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "Treatment may be continued more than two weeks if corneal re-epithelialization has not occurred."
          }
        ]
      },
      {
        "indication": "Bacterial conjunctivitis",
        "description": "Ciprofloxacin 1 to 2 drops to be instilled to the affected eye every two hours for 2 days, then every 4 hours for the next five days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 781,
    "genericName": "Gentamicin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-3 drops 3-6 times daily or 4 hourly. Oint. Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "alternate",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "1-3 drops 3-6 times daily or 4 hourly. Oint. Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye ointment",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-3 drops 3-6 times daily or 4 hourly. Oint. Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 6
            }
          },
          {
            "type": "alternate",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-3 drops 3-6 times daily or 4 hourly. Oint. Apply 3 or 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye ointment",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 782,
    "genericName": "Levofloxacin",
    "doseList": [
      {
        "description": "Days 1 & 2: Instill 1-2 drops in the affected eye(s) every 2 hours while awake, up to 8 times per day. Days 3 to 7: Instill 1-2 drops in the affected eye(s) every 4 hours while awake, up to 4 times per day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "condition": "while awake",
              "unit": "hour",
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 2,
              "max": 2
            },
            "notes": "days 1 and 2"
          },
          {
            "type": "primaryFollowup",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "condition": "while awake",
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 5,
              "max": 5
            },
            "notes": "days 3 to 7"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 1
        },
        "description": "Children: Safety and efficacy in infants below the age of 1 year have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 783,
    "genericName": "Lomefloxacin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop 2-3 times daily. At the beginning of the treatment application should be more frequent, apply 5 drops within 20 minutes or 1 drop every hour during 6 to 10 hours. Duration of treatment- 7 to 9 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 9
            },
            "notes": "At the beginning of the treatment application should be more frequent, apply 5 drops within 20 minutes or 1 drop every hour during 6 to 10 hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 784,
    "genericName": "Moxifloxacin eye drop",
    "doseList": [
      {
        "description": "1 drop in the affected eye(s) 3 times a day for 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 785,
    "genericName": "Natamycin eye drop",
    "doseList": [
      {
        "indication": "Fungal keratitis",
        "description": "1 drop instilled in the conjunctival sac at hourly or two hourly intervals; the frequency of application can be reduced to 1 drop 6 to 8 times daily after the first 3 to 4 days. Therapy should generally be continued for 14-21 days or until there is resolution of active fungal infection. In many cases it may be helpful to reduce the dosage gradually 4 to 7 days interval to assure that the replicating organism has been eliminated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "Interval": {
              "unit": "hour",
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "min": 6,
              "max": 8
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 4
            }
          }
        ],
        "notes": "Therapy should generally be continued for 14-21 days or until there is resolution of active fungal infection. In many cases it may be helpful to reduce the dosage gradually 4 to 7 days interval to assure that the replicating organism has been eliminated"
      },
      {
        "indication": "Fungal conjunctivitis",
        "description": "Fungal conjunctivitis-less freueent initial dosage (1 drop 4 to 6 times daily) may be sufficient in fungal conjunctivitis.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 786,
    "genericName": "Sulphacetamide eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Eye drops-2 to 4 drops 2-6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Eye ointment- apply 2.5% or 6% inside eye lid at night; 10% on eyelid 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye ointment inside eye lid",
            "unit": "%",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "notes": "2.5% or 6% inside eye lid at night"
          },
          {
            "type": "alternate",
            "condition": "eye ointment inside eye lid",
            "unit": "%",
            "amount": {
              "min": 6,
              "max": 6
            },
            "doseTime": {
              "night": true
            },
            "notes": "2.5% or 6% inside eye lid at night"
          },
          {
            "type": "primary",
            "condition": "eye ointment on eye lid",
            "unit": "%",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Eye drops-2 to 4 drops 2-6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Eye ointment- apply 2.5% or 6% inside eye lid at night; 10% on eyelid 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye ointment inside eye lid",
            "unit": "%",
            "amount": {
              "min": 2.5,
              "max": 2.5
            },
            "notes": "2.5% or 6% inside eye lid at night"
          },
          {
            "type": "alternate",
            "condition": "eye ointment inside eye lid",
            "unit": "%",
            "amount": {
              "min": 6,
              "max": 6
            },
            "doseTime": {
              "night": true
            },
            "notes": "2.5% or 6% inside eye lid at night"
          },
          {
            "type": "primary",
            "condition": "eye ointment on eye lid",
            "unit": "%",
            "amount": {
              "min": 10,
              "max": 10
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 787,
    "genericName": "Tetracycline/ Oxytetacycline eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "in acute infection",
        "description": "Eye ointment- apply 2 hourly (in acute infection).",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Eye ointment",
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Eye drops-1 or 2 drops 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Eye drops",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "indication": "in acute infection",
        "description": "Eye ointment- apply 2 hourly (in acute infection).",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Eye ointment",
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Eye drops-1 or 2 drops 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Eye drops",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 788,
    "genericName": "Tobramycin eye drop",
    "doseList": [
      {
        "condition": "drop",
        "indication": "in mild to moderate infections",
        "description": "Drop- IN mild to moderate infections instill 1 or 2 drops into the affected eye(s) every 4 hours; in severe infection, 2 drops into the eye (s) hourly until improvement, following which treatment should be reduced prior to discontinuation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "condition": "drop",
        "indication": "in severe infection",
        "description": "Drop- in mild to moderate infections instill 1 or 2 drops into the affected eye(s) every 4 hours; in severe infection, 2 drops into the eye (s) hourly until improvement, following which treatment should be reduced prior to discontinuation.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "notes": "hourly until improvement"
          },
          {
            "type": "primaryFollowup",
            "notes": "following which treatment should be reduced prior to discontinuation."
          }
        ]
      },
      {
        "condition": "ointment",
        "indication": "in mild to moderate infections",
        "description": "in mild to moderate infections apply 2 or 3 times dily into the affected eye(s)",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "condition": "ointment",
        "indication": "in severe infection",
        "description": "in severe infection, apply every 3 to 4 hours until improvement, following which treatment should be reduced prior to discontinuation.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            },
            "notes": "until improvement"
          },
          {
            "type": "primaryFollowup",
            "notes": "following which treatment should be reduced prior to discontinuation."
          }
        ]
      }
    ]
  },
  {
    "serial": 789,
    "genericName": "Neomycin + Bacitracin eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply at 3 to 4 hours interval or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply at 3 to 4 hours interval or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 790,
    "genericName": "Neomycin + Polymyxin-B + Bacitracin/gramicidin eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 or 2 drops 3 to 4 times daily or more frequently if requird.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Apply 2 or more times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "indication": "eye ointment",
            "timesDaily": {
              "min": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or 2 drops 3 to 4 times daily or more frequently if requird.",
        "subDoseList": [
          {
            "type": "primary",
            "indication": "eye drop",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Apply 2 or more times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "indication": "eye ointment",
            "timesDaily": {
              "min": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 791,
    "genericName": "Fucidic acid 1% eye drop",
    "doseList": [
      {
        "description": "1 drop 2 times for the period up to 2 days after the eye appears to be normal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "day",
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 792,
    "genericName": "Idoxuridine 1% Eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop hourly during the day & 2 hourly at night until the lesion dose not stain, then 2 hourly by day & 4 hourly at night for an additional 3-5 days; maximum treatment period 21 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "1 drop hourly during the day & 2 hourly at night until the lesion dose not stain"
          },
          {
            "type": "primaryFollowup",
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "notes": "then 2 hourly by day & 4 hourly at night"
          },
          {
            "type": "maintenance",
            "treatmentPeriod": {
              "unit": "day",
              "max": 21
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop hourly during the day & 2 hourly at night until the lesion dose not stain, then 2 hourly by day & 4 hourly at night for an additional 3-5 days; maximum treatment period 21 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "notes": "1 drop hourly during the day & 2 hourly at night until the lesion dose not stain"
          },
          {
            "type": "primaryFollowup",
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "notes": "then 2 hourly by day & 4 hourly at night"
          },
          {
            "type": "maintenance",
            "treatmentPeriod": {
              "unit": "day",
              "max": 21
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 793,
    "genericName": "Clotrimazole eye drop",
    "doseList": [
      {
        "description": "1 to 2 drops to be instilled every 4 hours in the conjuncti- val sae or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 794,
    "genericName": "Clotrimazole eye ointment",
    "doseList": [
      {
        "description": "s should be applied thinly and evenly to the conjunctival sac every 4 hours daily or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 795,
    "genericName": "Fluconazole eye drop",
    "doseList": [
      {
        "description": "1-2 drops to be instilled into the affected eyes 5 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 796,
    "genericName": "Acyclovir eye ointment",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Insert 1 cm ointment into  lower conjunctival sac, 5 tims daily at 4 hourly intervals. Continue use for minimum 3 days after healing.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "cm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "Continue use for minimum 3 days after healing."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Insert 1 cm. ointment into  lower conjunctival sac, 5 tims daily at 4 hourly intervals. Continue use for minimum 3 days after healing.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "cm",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 4,
              "max": 4
            },
            "notes": "Continue use for minimum 3 days after healing."
          }
        ]
      }
    ]
  },
  {
    "serial": 797,
    "genericName": "Betamethasone eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 1 or 2 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 1 or 2 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 798,
    "genericName": "Betamethasone + Neomycin eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Drops: 3 or 4 times daily. Ointment: Apply 3-6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "drops",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "description": "Drops: 3 or 4 times daily. Ointment: Apply 3-6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ointment",
            "timesDaily": {
              "min": 3,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Drops: 3 or 4 times daily. Ointment: Apply 3-6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "drops",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Drops: 3 or 4 times daily. Ointment: Apply 3-6 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "ointment",
            "timesDaily": {
              "min": 3,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 799,
    "genericName": "Dexamethasone eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops every 1 to 4 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops every 1 to 4 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 800,
    "genericName": "Dexamethasone + Chloramphenicol eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 or 4  times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 or 4  times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 801,
    "genericName": "Dexamethasone + Ciprofloxacin eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops every 4 to 6 hours. During initial 1 to 2 days the dosage may be increased to 1 to 2 drops every 2 Hours. Frequency should be decreased gradually or warranted in clinical signs. Care should be taking not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "During initial 1 to 2 days the dosage may be increased to 1 to 2 drops every 2 Hours."
          }
        ]
      }
    ]
  },
  {
    "serial": 802,
    "genericName": "Dexamethasone+ Neomycin+ Polymyxin B eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 803,
    "genericName": "Dexamethasone + Tobramycin eye suspension",
    "doseList": [
      {
        "condition": "Suspension",
        "description": "1 or 2 drops instilled into the conjunctival sac(s) every 4 to 6 hours. During the initial 24 to 48 hurs, the dosage may be increased to 1-2 drops every two hours. Frequency should be decreased gradually as warranted by improvement in clinical signs; Care should be taen not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "During the initial 24 to 48 hurs, the dosage may be increased to 1-2 drops every two hours. Frequency should be decreased gradually as warranted by improvement in clinical signs; Care should be taen not to discontinue therapy prematurely."
          }
        ]
      },
      {
        "condition": "Ointment",
        "description": "1 or 2 drops instilled into the conjunctival sac(s) every 4 to 6 hours. During the initial 24 to 48 hurs, the dosage may be increased to 1-2 drops every two hours. Frequency should be decreased gradually as warranted by improvement in clinical signs; Care should be taen not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "doseTime": {
              "bedtime": true
            },
            "notes": "After applying ointment, look downward before closing th eye. Ointment may be used at bedtime in conjunction with suspension used during the day."
          }
        ]
      }
    ]
  },
  {
    "serial": 804,
    "genericName": "Fluorometholone eye drops",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop 2-3 times daily into the conjunctival sac; in the first 24-48 hours, the dose may be increased to 1 drop hourly for Adults; caution should be exercised in the case of reactive hyperaemia.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "in the first 24-48 hours, the dose may be increased to 1 drop hourly for Adults; caution should be exercised in the case of reactive hyperaemia."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2
        },
        "description": "(above 2 years)- as, no specific studies have been performed & due to possible systemic adverse effects, efemoline should be used with caution in Children.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "as, no specific studies have been performed & due to possible systemic adverse effects, efemoline should be used with caution in Children."
          }
        ]
      }
    ]
  },
  {
    "serial": 805,
    "genericName": "Fluorometholone + Gentamicin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "condition": "Eye drop",
        "description": "1-2 drops 5 times daily in the affected eye(s); in severe cases may be given 1 drop /hour for 1 to 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternate",
            "condition": "in severe cases",
            "unit": "drop/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Eye drop",
        "indication": "in ocular post-operative treatment",
        "description": "1 drop 4 times daily for 1 week, then reduced application frequency for the remaining part of the treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "then reduced application frequency for the remaining part of the treatment."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Eye drop",
        "description": "1-2 drops 5 times daily in the affected eye(s); in severe cases may be given 1 drop /hour for 1 to 2 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            }
          },
          {
            "type": "alternate",
            "condition": "in severe cases",
            "unit": "drop/day",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 5,
              "max": 5
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 1,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Eye drop",
        "indication": "in ocular post-operative treatment",
        "description": "1 drop 4 times daily for 1 week, then reduced application frequency for the remaining part of the treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 1
            },
            "notes": "then reduced application frequency for the remaining part of the treatment."
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Eye ointment",
        "description": "Apply 3-4 times daily into the affected eye(s).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "condition": "Eye ointment",
        "indication": "Ocular post-operative treatment",
        "description": "Ocular post-operative treatment- to support the therapy with eye drop during the night apply the ointment before going to bed.",
        "subDoseList": [
          {
            "type": "primary",
            "doseTime": {
              "night": true
            },
            "notes": "to support the therapy with eye drop during the night apply the ointment before going to bed."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Eye ointment",
        "description": "Apply 3-4 times daily into the affected eye(s).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "condition": "Eye ointment",
        "indication": "Ocular post-operative treatment",
        "description": "Ocular post-operative treatment- to support the therapy with eye drop during the night apply the ointment before going to bed.",
        "subDoseList": [
          {
            "type": "primary",
            "doseTime": {
              "night": true
            },
            "notes": "to support the therapy with eye drop during the night apply the ointment before going to bed."
          }
        ]
      }
    ]
  },
  {
    "serial": 806,
    "genericName": "Hydrocortisone acetate( 1%), neomycin sulphate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 807,
    "genericName": "PREDNISOLONE + NEOMYCIN Eye/Ear drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 808,
    "genericName": "sulfacetamide and prednisolone  eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 809,
    "genericName": "Diclofenac Sodium drop",
    "doseList": [
      {
        "description": "1 drop 3-5 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 810,
    "genericName": "Emedastine Difumarate",
    "doseList": [
      {
        "description": "1 drop should be applied to the affected eye(s) twice daily. Emedastine has not been studied in clinical trials beyond 6 weeks. Emedastine should not be used for longer than 4 weeks after first opening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "max": 4
            },
            "notes": "Emedastine has not been studied in clinical trials beyond 6 weeks.Emedastine should not be used for longer than 4 weeks after first opening."
          }
        ]
      }
    ]
  },
  {
    "serial": 811,
    "genericName": "Ketorolac drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drops 4 times a day or as advised by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- Not recommended as safety and efficacy in peadiatric patients have not been established.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 812,
    "genericName": "Ketotifen drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "The recommended dose is one drop in the affected eye(s) 8 to 12 hourly or as directed by the physician. If a dose is  missed, apply as soon as possible; do not apply if almost time for the next dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "notes": "or as directed by the physician. If a dose is  missed, apply as soon as possible; do not apply if almost time for the next dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3
        },
        "description": "The recommended dose is one drop in the affected eye(s) 8 to 12 hourly or as directed by the physician. If a dose is  missed, apply as soon as possible; do not apply if almost time for the next dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 8,
              "max": 12
            },
            "notes": "or as directed by the physician. If a dose is  missed, apply as soon as possible; do not apply if almost time for the next dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 3
        },
        "description": "Children below 3 years of ago: Not recommended.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 813,
    "genericName": "Lodoxamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Adult & older Children- 1 or 2 drops in each eye 4 times a day at regula intervals. Once symptomatic improvemet has been established, therapy should be continued for as long as needed to sustain improvement. If required, corticosteroids may be used concomitantly with lodoxamide. Clinical studies on use in Childen below the age of four years have not been performed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Once symptomatic improvemet has been established, therapy should be continued for as long as needed to sustainimprovement. If required, corticosteroids may be used concomitantly with lodoxamide."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Adult & older Children- 1 or 2 drops in each eye 4 times a day at regula intervals. Once symptomatic improvemet has been established, therapy should be continued for as long as needed to sustain improvement. If required, corticosteroids may be used concomitantly with lodoxamide. Clinical studies on use in Childen below the age of four years have not been performed.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Once symptomatic improvemet has been established, therapy should be continued for as long as needed to sustain improvement. If required, corticosteroids may be used concomitantly with lodoxamide."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 4
        },
        "description": "Clinical studies on use in Childen below the age of four years have not been performed.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 814,
    "genericName": "Sodium Cromoglycate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 or 2 drops in each eye, 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or 2 drops in each eye, 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 815,
    "genericName": "NAPHAZOLINE + PHENIRAMINE eye drop",
    "doseList": [
      {
        "description": "1 or 2 drops instilled in each eye every 3 to 4 hours or less frequently, as required to relieve symptoms, or as advised by the physician.To prevent contamination of the dropper tip and solution, care should be taken not to touch the eyelids or surrounding area with the dropper tip of the bottle.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 4
            },
            "notes": "To prevent contamination of the dropper tip and solution, care should be taken not to touch the eyelids or surrounding area with the dropper tip of the bottle."
          }
        ]
      }
    ]
  },
  {
    "serial": 816,
    "genericName": "Antazoline hydrochloride O.5mg & tetryzoline hydrochloride O.4mg/ml eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Apply 1 drop every 3 hours during the acete phase; Maintenance, 1 drop 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "maintenance",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops per day are sufficient for Children.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 817,
    "genericName": "ZINCSULPHATE+ BORIC ACID Drop",
    "doseList": [
      {
        "description": "1-2 drops 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 818,
    "genericName": "Antazoline Phosphate, Naphazoline Hydrochloride, Zinc Sulfate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 819,
    "genericName": "Atropine eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 820,
    "genericName": "Homatropine hydrobromide 2%",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop or more as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop or more as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 821,
    "genericName": "Oxyphenonium",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 822,
    "genericName": "Tropicamide",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops at 1-5 minimum intervals. If patient not examined within 30 minimum an additional drop should be used.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "Interval": {
              "unit": "minute",
              "min": 1,
              "max": 5
            },
            "notes": "If patient not examined within 30 minimum an additional drop should be used."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops at 1-5 minimum intervals. If patient not examined within 30 minimum an additional drop should be used.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "Interval": {
              "unit": "minute",
              "min": 1,
              "max": 5
            },
            "notes": "If patient not examined within 30 minimum an additional drop should be used."
          }
        ]
      }
    ]
  },
  {
    "serial": 823,
    "genericName": "Tropicamide + Phenylephrine",
    "doseList": [
      {
        "description": "Instil 1-2 drops in the eye(s) 15-20 minutes before examination. If examination is not conducted within 20-30 minutes, an additional drop may be placed in the eye(s) to prolong the effect.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "notes": "15-20 minutes before examination.If examination is not conducted within 20-30 minutes, an additional drop may be placed in the eye(s) to prolong the effect."
          }
        ]
      }
    ]
  },
  {
    "serial": 824,
    "genericName": "Pilocarpine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop 4 to 6 daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop 4 to 6 daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "indication": "For Miosis",
        "description": "1 drop of 1% soln.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": "1% soln."
          }
        ]
      }
    ]
  },
  {
    "serial": 825,
    "genericName": "Timolol drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Initially one drop of 0.25% solution twice daily changing to 0.5% solution twice daily frequird.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": "0.25% solution",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "primaryFollowup",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": "0.5% solution",
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 827,
    "genericName": "Latanoprost",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop into the affected eye(s) once daily in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "1 drop into the affected eye(s) once daily in the evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "evening": true
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child: Not recommended",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 831,
    "genericName": "Hypromellose 0.3% eye drop.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 drops 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 drops 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 832,
    "genericName": "VITAMIN A PALMITATE + CARBOMER: Eye gel",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3-4 times per day 1 drop or as required, depending on the severity of he case. Hold the tube vertically and apply 1 drop into the conjuctival sac.Close he tube immediately after use. Do not use for longer than one month after opening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "Hold the tube vertically and apply 1 drop into the conjuctival sac.Close he tube immediately after use. Do not use for longer than one month after opening."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "3-4 times per day 1 drop or as required, depending on the severity of he case. Hold the tube vertically and apply 1 drop into the conjuctival sac.Close he tube immediately after use. Do not use for longer than one month after opening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "notes": "Hold the tube vertically and apply 1 drop into the conjuctival sac.Close he tube immediately after use. Do not use for longer than one month after opening."
          }
        ]
      }
    ]
  },
  {
    "serial": 833,
    "genericName": "POVIDONE 5%: Eye Drop",
    "doseList": [
      {
        "description": "1 drop 4 times daily or as required, depending upon tohe severity of the disease to be instilled into the conjunctival sac.Close the bottle immediately after use. Do not use for longer than one month after first opening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            },
            "notes": "Close the bottle immediately after use. Do not use for longer than one month after first opening."
          }
        ]
      }
    ]
  },
  {
    "serial": 834,
    "genericName": "Tears Naturale Eye drop",
    "doseList": [
      {
        "description": "Instill 1 or 2 drops as frequently as required to relieve eye irritation symptoms or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 835,
    "genericName": "Fluorescein sodium 2% eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 or more drops as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or more drops as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 836,
    "genericName": "Oxybuprocaline hydrochloride 0.4% eye drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 or more drops as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 or more drops as required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 838,
    "genericName": "Chloramphenicol drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 drops 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 to 4 drops 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 839,
    "genericName": "Ciprofloxacin drop",
    "doseList": [
      {
        "description": "Initially 2 to 3 drops every 2 or 3 hours; reducing the frequency of instillation gradually as infection is controlled.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            },
            "notes": "reducing the frequency of instillation gradually as infection is controlled."
          }
        ]
      }
    ]
  },
  {
    "serial": 840,
    "genericName": "Gentamicin drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 drops 3 or 4 times daily and at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "additionalDose": {
              "doseTime": {
                "night": true
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2-4 drops 3 or 4 times daily and at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "additionalDose": {
              "doseTime": {
                "night": true
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 841,
    "genericName": "Lomefloxacin drop",
    "doseList": [
      {
        "description": "Initially 2 to 3 drops every 2 to 3 hours; reducing the frequency of instillation gradually as infection is controlled.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            },
            "notes": "reducing the frequency of instillation gradually as infection is controlled."
          }
        ]
      }
    ]
  },
  {
    "serial": 842,
    "genericName": "Oxytertracycline drop",
    "doseList": [
      {
        "description": "Pour a small amount of ointment in the external auditory meatus 2 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "Ointment",
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Pour a small amount of ointment in the external auditory meatus."
          }
        ]
      },
      {
        "description": "First reconstituted solution, then 3-5 drops are instilled to the infected ear at an interval of 2 to 3 hors; after each instillation maintain the ear turned upward for few minutes to provide maximum contact of the drug with the affected area.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "drop",
            "unit": "drop",
            "amount": {
              "min": 3,
              "max": 5
            },
            "Interval": {
              "unit": "hour",
              "min": 2,
              "max": 3
            },
            "notes": "after each instillation maintain the ear turned upward for few minutes to provide maximum contact of the drug with the affected area."
          }
        ]
      }
    ]
  },
  {
    "serial": 843,
    "genericName": "Betamethasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 drops 2 or 3 hourly; Reduce frequency of application when relief is obtained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            },
            "notes": "Reduce frequency of application when relief is obtained."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 to 3 drops 2 or 3 hourly; Reduce frequency of application when relief is obtained.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            },
            "notes": "Reduce frequency of application when relief is obtained."
          }
        ]
      }
    ]
  },
  {
    "serial": 844,
    "genericName": "Betamethasone + Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 drops 2 or 3 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 to 3 drops 2 or 3 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "repeated": {
              "unit": "hour",
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 845,
    "genericName": "Dexamethasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 to 2 drops every 1-4 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 drops every 1-4 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 1,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 846,
    "genericName": "Dexamethasone + Ciprofloxacin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Instil 2-4 drops 2-4 times daily.Care should be taken not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Care should be taken not to discontinue therapy prematurely"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Instil 2-4 drops 2-4 times daily.Care should be taken not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Care should be taken not to discontinue therapy prematurely"
          }
        ]
      }
    ]
  },
  {
    "serial": 847,
    "genericName": "Hydrocortisone + Ciprofloxacin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Instil 2-4 drops 2-4 times daily.Care should be taken not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Care should be taken not to discontinue therapy prematurely"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Instil 2-4 drops 2-4 times daily.Care should be taken not to discontinue therapy prematurely.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            },
            "notes": "Care should be taken not to discontinue therapy prematurely"
          }
        ]
      }
    ]
  },
  {
    "serial": 848,
    "genericName": "Hydrocortisone + Gentamicin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 drops 3 or 4 times daily and at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "additionalDose": {
              "doseTime": {
                "bedtime": true
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 to 4 drops 3 or 4 times daily and at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            },
            "additionalDose": {
              "doseTime": {
                "bedtime": true
              }
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 849,
    "genericName": "Hydrocortisone + Neomycin + Polymyxin-B",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Instil 3 drops 3 or 4 times daily or insert soaked wick, keeping it saturated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "notes": "sert soaked wick, keeping it saturated."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Install 3 drops 3 or 4 times daily or insert soaked wick, keeping it saturated.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 3,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          },
          {
            "type": "alternate",
            "notes": "sert soaked wick, keeping it saturated."
          }
        ]
      }
    ]
  },
  {
    "serial": 850,
    "genericName": "Prednisolone + Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 drops 3 to 4 times daily or more frequently if required",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 851,
    "genericName": "Ephedrine hydrochloride",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Instil 1-2 drops into each nostril upto 3 or 4 times daily when required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Instil 1-2 drops into each nostril upto 3 or 4 times daily when required.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 852,
    "genericName": "Pseudoephedrine Tab",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "As a decongestant and symptomatic treatment for upper respiratory tract infection",
        "description": "60mg every 4-6 hours, up to maximum of 240mg in 24 hours.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 60,
              "max": 60
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            },
            "notes": "up to maximum of 240mg in 24 hours."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "indication": "As a decongestant and symptomatic treatment for upper respiratory tract infection",
        "description": "6-12 years of age, 30mg evry 4-6 hours daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 30,
              "max": 30
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "indication": "As a decongestant and symptomatic treatment for upper respiratory tract infection",
        "description": "2-5 years of age, 15mg every 4-6 hours daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 15,
              "max": 15
            },
            "repeated": {
              "unit": "hour",
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 2
        },
        "indication": "As a decongestant and symptomatic treatment for upper respiratory tract infection",
        "description": "For Children less than 2 years of age, the drug is not admised unless specifically recommended by a physician.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 853,
    "genericName": "Xylometazoline HCI drop",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 drops of 0.1% soln. in each nostril 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "volume": "0.1% soln.",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "Nasal spray- Doasage & Administration see below under the Antazol nasal spray."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 drops of 0.05% soln. in each nostril once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 2
            },
            "volume": "0.05% soln.",
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "notes": "Nasal spray- Doasage & Administration see below under the Antazol nasal spray."
          }
        ]
      }
    ]
  },
  {
    "serial": 854,
    "genericName": "Xylometazoline hydrochloride 0.1% nasal Spray",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Single application of 0.1% spray in each nostril, 2 or 3 times daily or as directed by the physician.To spray properly, squeeze the bottle quickly and firmly. Do not tilt the head backward while spraying.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": "0.1% soln.",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "To spray properly, squeeze the bottle quickly and firmly. Do not tilt the head backward while spraying."
          },
          {
            "type": "alternate",
            "notes": "as directed by the physician."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- This preparation is not recommended for Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 854,
    "genericName": "Xylometazoline hydrochloride 0.05% nasal drop Spray",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Single application of 0.05% spray in each nostril, 2 or 3 times daily or as directed by the physician.To spray properly, squeeze the bottle quickly and firmly. Do not tilt the head backward while spraying.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 1,
              "max": 1
            },
            "volume": "0.1% soln.",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "notes": "To spray properly, squeeze the bottle quickly and firmly. Do not tilt the head backward while spraying."
          },
          {
            "type": "alternate",
            "notes": "as directed by the physician."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Child- This preparation is not recommended for Children.",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 855,
    "genericName": "Oxymetazoline HCI",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "Over 6 years, instill 2-3 drops of 0.05% solution, & under 6 years, 2-3 drops of 0.025% solution into each nostril, 2 to 3 times daily.Duration of treatment 3-5 days; maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "volume": "0.05% solution",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "notes": "maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "Over 6 years, instill 2-3 drops of 0.05% solution, & under 6 years, 2-3 drops of 0.025% solution into each nostril, 2 to 3 times daily.Duration of treatment 3-5 days; maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "volume": "0.05% solution",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "notes": "maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "Over 6 years, instill 2-3 drops of 0.05% solution & under 6 years, 2-3 drops of 0.025% solution into each nostril, 2 to 3 times daily.Duration of treatment 3-5 days; maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "volume": "0.025% solution",
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 3,
              "max": 5
            },
            "notes": "maximum duration 2 weeks. Spray- Instill 2-3 sprays into each nostril 2 times daily."
          }
        ]
      }
    ]
  },
  {
    "serial": 856,
    "genericName": "Sodium Cromoglycate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 drop to each nostril 4 to 6 times daily.Therapy should be continous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 drop to each nostril 4 to 6 times daily.Therapy should be continous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 6
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 857,
    "genericName": "Xylometazoline HCL+ Sodium Cromoglicate",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "one spray to each nostril 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "one spray to each nostril 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "one spray to each nostril 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 859,
    "genericName": "Beclomethasone nasal spray",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 applications in each nostril twice daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "2 applications in each nostril twice daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "under 6 years, not recommended;",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 860,
    "genericName": "Beclomethasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 applications in each nostril twice daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "2 applications in each nostril twice daily.Therapy should be continuous.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "application",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "max": 6
        },
        "description": "under 6 years, not recommended;",
        "subDoseList": [],
        "notRecommended": true
      }
    ]
  },
  {
    "serial": 861,
    "genericName": "Betamethasone & Betamethasone + Neomycin",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 drops in each nostril 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 to 3 drops in each nostril 2 or 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "drop",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 862,
    "genericName": "Fluticasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "two sprays into each nostril once a day, preferably in the morning; in some cases two sprays into each nostril twice daily may be required; the maximum daily dose should not exceed four sprays into each nostril.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          },
          {
            "type": "alternate",
            "condition": "in some cases",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          }
        ]
      },
      {
        "ageGroup": "elderly",
        "description": "Elderly- The normal Adult dosage is applicable. two sprays into each nostril once a day, preferably in the morning; in some cases two sprays into each nostril twice daily may be required; the maximum daily dose should not exceed four sprays into each nostril.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          },
          {
            "type": "alternate",
            "condition": "in some cases",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "two sprays into each nostril once a day, preferably in the morning; in some cases two sprays into each nostril twice daily may be required; the maximum daily dose should not exceed four sprays into each nostril.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          },
          {
            "type": "alternate",
            "condition": "in some cases",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 11
        },
        "description": "4 to 11 years, one spray into each nostril once a day, preferably in the morning; in some cases one spray into ech nostril twice daily may be equired; the maximum daily dose should not exceed two sprays into each nostril.For full thearapeutic benefit regular usage is essential. The absence of an immediate effect should be explained  of an immediate effect should be explained to the patient as maximum relief may not be obtained until after 3 to 4 days of treatment.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed four sprays into each nostril."
          },
          {
            "type": "alternate",
            "condition": "in some cases",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            },
            "notes": "the maximum daily dose should not exceed two sprays into each nostril. The absence of an immediate effect should be explained to the patient as maximum relief may not be obtained until after 3 to 4 days of treatment."
          }
        ]
      }
    ]
  },
  {
    "serial": 863,
    "genericName": "Mometasone",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "prophylaxis and treatment",
        "description": "The usual recommended dose for prophylaxis and treatment is two sprays (50mcg/spray) in each nostril once daily (total dose 200mcg). Once symptoms are controlled, dose reduction to  one spray in each nostril (total dose 100mcg) may be effective for matintenance.If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four sprays in each nostril once daily (total dose 400mcg). Dose reduction is recommednded following control of symptoms.Clinically significant onset of action occurs as early as 12 hours after the first dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "condition": "Once symptoms are controlled",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "If symptoms are inadequately controlled",
            "unit": "spray",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Dose reduction is recommednded following control of symptoms. Clinically significant onset of action occurs as early as 12 hours after the first dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "indication": "prophylaxis and treatment",
        "description": "The usual recommended dose for prophylaxis and treatment is two sprays (50mcg/spray) in each nostril once daily (total dose 200mcg). Once symptoms are controlled, dose reduction to  one spray in each nostril (total dose 100mcg) may be effective for matintenance.If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four sprays in each nostril once daily (total dose 400mcg). Dose reduction is recommednded following control of symptoms.Clinically significant onset of action occurs as early as 12 hours after the first dose.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "maintenance",
            "condition": "Once symptoms are controlled",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "primaryFollowup",
            "condition": "If symptoms are inadequately controlled",
            "unit": "spray",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Dose reduction is recommednded following control of symptoms. Clinically significant onset of action occurs as early as 12 hours after the first dose."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 3,
          "max": 11
        },
        "description": "The usual recommended dose is one spray (50mcg/spray) in each nostril once daily (total dose 100mcg).In Patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with mometasone is recommended two to four weeks prior to the anticipated start of the pollen season.Shake container well before each use.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "spray",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          },
          {
            "type": "alternate",
            "condition": "in Patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis",
            "notes": "prophylactic treatment with mometasone is recommended two to four weeks prior to the anticipated start of the pollen season.Shake container well before each use."
          }
        ]
      }
    ]
  },
  {
    "serial": 864,
    "genericName": "Triamcinolone inhaler",
    "doseList": [
      {
        "description": "4 actuations (220mcg) once a day & the effect be assessed in 4 to 7 days. If greater effct is desired an increase of dose to 440mcg (8 actuations) once a day can be tried. Although the preparations may be used at 220mcg/day or 440mcg/day divided into 2 or 4 times a day, the degree of relief dose not seen to be significantly different compared to oncea-da dosing.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mcg",
            "amount": {
              "min": 220,
              "max": 220
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "assessmentPeriod": {
              "unit": "day",
              "min": 4,
              "max": 7
            }
          },
          {
            "type": "alternate",
            "condition": "If greater effct is desired",
            "unit": "mcg",
            "amount": {
              "min": 440,
              "max": 440
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "notes": "Although the preparations may be used at 220mcg/day or 440mcg/day divided into 2 or 4 times a day, the degree of relief dose not seen to be significantly different compared to oncea-da dosing."
          }
        ]
      }
    ]
  },
  {
    "serial": 865,
    "genericName": "Carmina Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablet 2-3 time daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 tab. Twice daily aftr meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 866,
    "genericName": "Carmina spy.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 tsf 2-3 times daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 tsf twice daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 867,
    "genericName": "Carmolin Spy.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 tsf 2-3 times daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 tsf twice daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 868,
    "genericName": "Elzyne Spy.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs 1-2 tsf thrice daily. Duration of use 1 to 3 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 1,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 869,
    "genericName": "GAsto-4 Spy.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3 to 4 tsf thrice daily, half an hour after food.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food",
              "minute": 60
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 teaspoonful thrice daily half an hour after food. This syrup to be used for 2-4 weeks. It can be taken as it is, or slightly diluted with a little water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food",
              "minute": 30
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 4
            },
            "notes": "t can be taken as it is, or slightly diluted with a little water."
          }
        ]
      }
    ]
  },
  {
    "serial": 870,
    "genericName": "Hazmotab Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 Tablets 2-3 times daily chewable or with water before/after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before/after meal"
            },
            "notes": "chewable or with water"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "½-1 Tablet daily chewable or with water before/after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before/after meal"
            },
            "notes": "hewable or with water."
          }
        ]
      }
    ]
  },
  {
    "serial": 871,
    "genericName": "HD-Zainarq Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 tsf thrice daily, after measl.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 tsf thrice daily after meals.Dosage may be adjusted in case of acute dyspepsia up to a maximum 3 to 4 tsf trice daily before meals and after meals.The duration is 7 to 14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "primary",
            "indication": "acute dyspepsia",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "before meals and after meals"
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 872,
    "genericName": "Anisol Syp.",
    "doseList": [
      {
        "ageRange": {
          "unit": "month",
          "min": 0,
          "max": 6
        },
        "description": "0-6month: ½ tsf 3 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "description": "6-12month: 1 tsf 3 to 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "description": "1 to 2 tsf 3 to 4 times daily. Or as directed by the physicin.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 873,
    "genericName": "Babica Syp.",
    "doseList": [
      {
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Up to 6 months, ½ tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "description": "6 month-1 years, 1 tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "description": "1-2 years, 2 tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 874,
    "genericName": "Naunehal Syp.",
    "doseList": [
      {
        "ageRange": {
          "unit": "month",
          "max": 6
        },
        "description": "Up to 6 months, ½ tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "month",
          "min": 6,
          "max": 12
        },
        "description": "6 month-1 years, 1 tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      },
      {
        "ageRange": {
          "unit": "year",
          "min": 1,
          "max": 2
        },
        "description": "1-2 years, 2 tsf; All are thrice or four times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 875,
    "genericName": "Dyroma Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "4 tsf 3 times daily with water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalItem": {
              "temName": "water"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 3 times daily 7-14 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 14
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 876,
    "genericName": "Dyrotab tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 Tablets 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 Tablets 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 877,
    "genericName": "Paichish Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablets twice or thrice a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Children (6-12 years), 1 Tablet twice or thrice a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 878,
    "genericName": "Saffodin Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 Tablets twice or thrice a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Children (6-12 years), 1 Tablet twice or thrice a day",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 879,
    "genericName": "Dawa-Ul-Misk Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "indication": "For cardiac weakness",
        "description": "1 tsf once daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "For Gastric and liver weakess",
        "description": "1 tsf given with 4 tsf arq. Moullaham.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "genericName": "arq. Moullaham",
              "unit": "t.s.f",
              "amount": {
                "min": 4,
                "max": 4
              }
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 4,
          "max": 6
        },
        "description": "4-6 years, ¼-1/2tsf once daily for 1-2 months or as advised by the physician.If needed for longer use, give 1 week interval after evey 2-3 weeks medication",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "timesDaily": {
              "min": 1,
              "max": 1
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 1,
              "max": 2
            },
            "notes": "f needed for longer use, give 1 week interval after evey 2-3 weeks medication."
          }
        ]
      }
    ]
  },
  {
    "serial": 880,
    "genericName": "Dinar Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "½ -1 tsf twice daily after meal",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 881,
    "genericName": "Hepa-10 Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 tsf twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "6-12 yrs 1-2 tsf twice daily. To given for 3-5 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 5
        },
        "description": "2-5 yrs ½-1 tsf twice daily. To given for 3-5 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 5
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 2,
          "max": 2
        },
        "description": "0-2 yrs ¼- ½ tsf twice daily. To given for 3-5 weeks.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.25,
              "max": 0.5
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 882,
    "genericName": "Hepatolin Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 tsf 2-3 times daily after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 2-3 times daily after meal Or, as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 883,
    "genericName": "Hepazin Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf thrice daily,",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "½-1 tsf thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 1
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 884,
    "genericName": "Jigarine Stiop",
    "doseList": [
      {
        "description": "One or two single dose strip be swallowed, immediately followed by hot water drink, daily at night or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "dose strip",
            "amount": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "notes": "mmediately followed by hot water drink"
          }
        ]
      }
    ]
  },
  {
    "serial": 885,
    "genericName": "HD-Rashala Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf 3 times daily after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 3 times daily after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 886,
    "genericName": "Garlic Tab.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 Tablet aftr meals every day safeguards against diseases which are caused by bacteria or other microorganisms. 1 garlic Tablet at breakfast and 1 after each meal builds up the strength and vitality. 2 garlic Tablets twice a day with each meal is effective in cold and chest congestion.For gastro-intestinal ailments one garlic Tablet, one hour before meals.",
        "subDoseList": [
          {
            "type": "primary",
            "benefit": "safeguards against diseases which are caused by bacteria or other microorganisms",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          },
          {
            "type": "primary",
            "benefit": "builds up the strength and vitality.",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "breakfast": true
            },
            "connectionToMeal": {
              "when": "after meals"
            },
            "notes": "1 garlic Tablet at breakfast and 1 after each meal"
          },
          {
            "type": "primary",
            "benefit": "effective in cold and chest congestion.",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "with each meal"
            }
          },
          {
            "type": "primary",
            "condition": "For gastro-intestinal ailments",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 1
            },
            "connectionToMeal": {
              "when": "before meals",
              "hour": 1
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 887,
    "genericName": "Garlicon Syp.",
    "doseList": [
      {
        "description": "3 to 4 tsf 3 times daily with a cap of water before or after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "additionalItem": {
              "temName": "with a cap of water"
            },
            "connectionToMeal": {
              "when": "before or after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 888,
    "genericName": "Coflex Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 tsf thrice daily; in severe cases 2 tsf 6 hourly.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          },
          {
            "type": "alternate",
            "condition": "in severe cases",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "repeated": {
              "unit": "hour",
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "½ to ¼ tsf as per direction of the physicians.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.25,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 889,
    "genericName": "Joshanda (J-1)",
    "doseList": [
      {
        "description": "Boil well with a cupful of water the contents of the pack, strain and take it while hot, sweetened to taste. To be taken twice a day, first time in the morning and at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "bedtime": true
            },
            "notes": "Boil well with a cupful of water the contents of the pack, strain and take it while hot, sweetened to taste"
          }
        ]
      }
    ]
  },
  {
    "serial": 890,
    "genericName": "Pectoral Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 3 tsf 2 to 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 tsf 2 to 3 times daily. To be used 7 days.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 7,
              "max": 7
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 891,
    "genericName": "Sadur Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 tsf at morning and evening; in severe cases take one dose more at bedtime. If severity persists, 1 tsf can be repeated every four bours, but total intake msut not exceed 6 tsf in a day.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "additionalDose": {
              "unit": "t.s.f",
              "amount": {
                "min": 1,
                "max": 1
              },
              "doseTime": {
                "bedtime": true
              }
            },
            "notes": "f severity persists, 1 tsf can be repeated every four bours, but total intake msut not exceed 6 tsf in a day."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "¼ to ½ tsf as per directions.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.25,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 892,
    "genericName": "Sualin Tab.",
    "doseList": [
      {
        "description": "2 Tablets be chewed three times a day or more as directed by the physician.It is very effective when taken dissolvd in boiled water. It may be taken along with joshanda.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "notes": "t is very effective when taken dissolvd in boiled water. It may be taken along with joshanda."
          }
        ]
      }
    ]
  },
  {
    "serial": 893,
    "genericName": "Arecona Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 tsf 4 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 4,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "Children- as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "as directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 894,
    "genericName": "Aphrodin Cap.",
    "doseList": [
      {
        "description": "Usually one capsule in the morning and one capsule at bed time or two capsules before bed time, preferably be taken with milk, or honey daily or as directed by the physician.Apphrodin should be continued at least 3-4 weeks for optimum result.For better result, patients are advised following mode of administration: daily 2+0+2 capsules for 5 days, then daily 2+0+2 capsules for 10 days, followed by 1+0+1 capsule as maintenance dose.Continuous use of aphrodin may serve as a good general restorative tonic. For complete functional impotence it is ecessary to increase the above dosage of aphrodin to increase the above dosage of aphrodin to 2 capsules t.i.d. This should be given under constant supervision.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true,
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "notes": "preferably be taken with milk, or honey daily or as directed by the physician."
          },
          {
            "type": "alternate",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "bedtime": true
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "notes": "preferably be taken with milk, or honey daily or as directed by the physician."
          }
        ]
      }
    ]
  },
  {
    "serial": 895,
    "genericName": "Castorin Cap.",
    "doseList": [
      {
        "description": "2 capsules to be taken with milk two hours before coitus. Dinner should be taken 2-3 hours earlier and very hight too.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 896,
    "genericName": "Durex Cap.",
    "doseList": [
      {
        "description": "2 casules to be taken 1-2 times daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 897,
    "genericName": "Endurex Cap.",
    "doseList": [
      {
        "description": "2 capsules 1-2 times daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 898,
    "genericName": "Femolin Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 tsf daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in irregular menstruation, dysmenorrhoea and amenorrhoea",
        "description": "in irregular menstruation, dysmenorrhoea and amenorrhoea, from the lat day of the period till the first day of the next menstruation, 2-4 tsf every night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "doseTime": {
              "night": true
            },
            "notes": "from the lat day of the period till the first day of the next menstruation"
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "in leucorrhoea",
        "description": "in leucorrhoea, 2-3 tsf to be taken at night.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "ageGroup": "Adult",
        "indication": "For weakness & inflammationin the uterus",
        "description": "For weakness & inflammationin the uterus, 2 tsf maxed with lukewarm water to be taken at night. To be used for a period.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "additionalItem": {
              "temName": "lukewarm water"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 899,
    "genericName": "Frodex Tab.",
    "doseList": [
      {
        "description": "1 Tablet to be taken with milk in the morning and 1 at bedtime.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "bedtime": true
            },
            "additionalItem": {
              "temName": "milk"
            },
            "notes": "1 Tablet to be taken with milk in the morning and 1 at bedtime."
          }
        ]
      }
    ]
  },
  {
    "serial": 900,
    "genericName": "Libidex Cap.",
    "doseList": [
      {
        "description": "1-2 capsule daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 901,
    "genericName": "Nishat Tab.",
    "doseList": [
      {
        "description": "2 Tablets to be taken with milk two hours before coitus. Dinner should be taken 2-3 hours earlier and very light too.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "additionalItem": {
              "temName": "milk"
            },
            "notes": "to be taken with milk two hours before coitus. Dinner should be taken 2-3 hours earlier and very hight too."
          }
        ]
      }
    ]
  },
  {
    "serial": 902,
    "genericName": "Vigo-fort Cap.",
    "doseList": [
      {
        "description": "1-2 capsules before bed time. Or, As directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            },
            "doseTime": {
              "when": "before bed time"
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 903,
    "genericName": "Vitolex Cap.",
    "doseList": [
      {
        "description": "1-2 capsule daily or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "As directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 904,
    "genericName": "Alkul(Buzuri)Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 tsf twice to four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 tsf as pr direction.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 905,
    "genericName": "Renaton (Buzuri) Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 tsf twice to four times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 4
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 tsf as pr direction.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 906,
    "genericName": "Reumac Cap.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 capsules 2 times daily after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6
        },
        "description": "Children over 6 years- 1 to 2 capsules 2 times daily after meal, or as directed by the physicion.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physicion"
          }
        ]
      }
    ]
  },
  {
    "serial": 907,
    "genericName": "Rheumacon Tab.",
    "doseList": [
      {
        "description": "One to two Tablets twice a day after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 908,
    "genericName": "Suranjan Tab.",
    "doseList": [
      {
        "description": "One to two Tablets twice a day after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 909,
    "genericName": "Hamdaard Balm Oint.",
    "doseList": [
      {
        "description": "t should be rebbed well on the chest, forehead, throat, and on the affected and painful parts of the body.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "t should be rebbed well on the chest, forehead, throat, and on the affected and painful parts of the body."
          }
        ]
      }
    ]
  },
  {
    "serial": 910,
    "genericName": "Medix",
    "doseList": [
      {
        "description": "Apply to the affected part 3-4 times a day.",
        "subDoseList": [
          {
            "type": "primary",
            "timesDaily": {
              "min": 3,
              "max": 4
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 911,
    "genericName": "Purin Syp.",
    "doseList": [
      {
        "description": "2 tsf in the evening with plain water or a cup of milk.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "evening": true
            },
            "additionalItem": {
              "temName": "plain water or a cup of milk"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "For Children dose very according to age 1/3 to1/2 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "according to age",
            "unit": "t.s.f",
            "amount": {
              "min": 0.33,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 912,
    "genericName": "Safex Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 tsf thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1 to 2 tsf 1 or 2 times daily. Safex should be continued at least 4-6 week for optimum result.Sediment is the part of medicine. Shake well before use.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 4,
              "max": 6
            },
            "notes": "Sediment is the part of medicine. Shake well before use."
          }
        ]
      }
    ]
  },
  {
    "serial": 913,
    "genericName": "SafSyp.",
    "doseList": [
      {
        "description": "2 tsf in the evening with plain water or a cup of milk.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "evening": true
            },
            "additionalItem": {
              "temName": "plain water or a cup of milk"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "For Children dose very according to age 1/3 to 1/2 tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "condition": "according to age",
            "unit": "t.s.f",
            "amount": {
              "min": 0.33,
              "max": 0.5
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 914,
    "genericName": "Faulad Syp.",
    "doseList": [
      {
        "description": "2 tsf twice or thrice daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 915,
    "genericName": "Ferodin Cap.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1-2 capsules 2 times daily after meal. Or, as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physicion"
          }
        ]
      }
    ]
  },
  {
    "serial": 916,
    "genericName": "Feroma Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf 3 times daily after meal.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 3 times daily after meal. The duration is 3-6 weeks. Shake well before use.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 6
            },
            "notes": "Shake well before use."
          }
        ]
      }
    ]
  },
  {
    "serial": 917,
    "genericName": "Amlac Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-4 tsf 3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 3 times daily. Duration: 15-30 days. Shake well before use",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "day",
              "min": 15,
              "max": 30
            },
            "notes": "Shake well before use; (floating substances are the part of medicine)"
          }
        ]
      }
    ]
  },
  {
    "serial": 918,
    "genericName": "Carotone Plus Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf 2-3 times daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf 2-3 times daily after meal.Duration: 2-3 weeks or a directed by the physician. Shake well before use, (Floating substances are the part of medicinal plants).",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meal"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 2,
              "max": 3
            },
            "alternateTreatmentPeriod": "as directed by the physician",
            "notes": "Shake well before use, (Floating substances are the part of medicinal plants)."
          }
        ]
      }
    ]
  },
  {
    "serial": 919,
    "genericName": "Cinkara Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "6 tsf twice daily",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 6,
              "max": 6
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 tsf twice daily, or as prescribed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physicion"
          }
        ]
      }
    ]
  },
  {
    "serial": 920,
    "genericName": "Ginseng Gold Cap.",
    "doseList": [
      {
        "description": "1-2 capsule daily 20-30 minutes before or aftr meal unless otherwish prescribed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "capsule",
            "amount": {
              "min": 1,
              "max": 2
            },
            "connectionToMeal": {
              "when": "before or after meals",
              "minutes": {
                "min": 20,
                "max": 30
              }
            },
            "notes": "unless otherwish prescribed by the physician."
          }
        ]
      }
    ]
  },
  {
    "serial": 921,
    "genericName": "Josha Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "3-4 tsf 2 or 3 times daily after meals.Josha may be taken directly as it is, or may be mixed with sharbeat to make delicious drink.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 3,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            },
            "notes": "Josha may be taken directly as it is, or may be mixed with sharbeat to make delicious drink."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2-3 tsf 2 or 3 times daily after meals. Josha may be taken directly as it is, or may be mixed with sharbeat to make delicious drink.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            },
            "notes": "Josha may be taken directly as it is, or may be mixed with sharbeat to make delicious drink."
          }
        ]
      }
    ]
  },
  {
    "serial": 922,
    "genericName": "Khamira Gaozaban AmberJawhardar",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "1 tsf in empty stomach in the morning or evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "notes": "in empty stomach"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 12
        },
        "description": "1 tsf in empty stomach in the morning or evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "notes": "in empty stomach"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "ageRange": {
          "unit": "year",
          "min": 6,
          "max": 12
        },
        "description": "Children between 6-12 yrs. Half tsf.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 0.5,
              "max": 0.5
            },
            "doseTime": {
              "morning": true,
              "evening": true
            },
            "notes": "in empty stomach"
          }
        ]
      }
    ]
  },
  {
    "serial": 923,
    "genericName": "Maullaham Syp.",
    "doseList": [
      {
        "description": "4 tsf to be taken with milk in the morning and evening.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 4
            },
            "additionalItem": {
              "temName": "milk"
            },
            "doseTime": {
              "morning": true,
              "evening": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 924,
    "genericName": "Neoba Tab.",
    "doseList": [
      {
        "description": "Usually 3-4 Tablets daily in divided doses, preferably after meals or as directed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 3,
              "max": 4
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 925,
    "genericName": "Reovit Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2-3 tsf thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 3
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "1-2 tsf thrice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 926,
    "genericName": "Vitolin Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "6 tsf twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 6,
              "max": 6
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 tsf twice daily, or as prescribed by the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            }
          },
          {
            "type": "alternate",
            "notes": "as directed by the physician"
          }
        ]
      }
    ]
  },
  {
    "serial": 927,
    "genericName": "HD-Chyabanprash Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "4 tsf thrice daily.Treatment may need to be given for 1-2 month. Shake well before use.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 4,
              "max": 4
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 1,
              "max": 2
            },
            "notes": "Shake well before use."
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "2 tsf thrice daily.Treatment may need to be given for 1-2 month. Shake well before use.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 3,
              "max": 3
            },
            "treatmentPeriod": {
              "unit": "month",
              "min": 1,
              "max": 2
            },
            "notes": "Shake well before use."
          }
        ]
      }
    ]
  },
  {
    "serial": 928,
    "genericName": "DolabTab.",
    "doseList": [
      {
        "description": "2 Tablets once or twice daily.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "Tablet",
            "amount": {
              "min": 2,
              "max": 2
            },
            "timesDaily": {
              "min": 1,
              "max": 2
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 929,
    "genericName": "HD-Santara Syp.",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "2 to 4 tsf 2 or 3 times daily after food with water.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 4
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after food"
            },
            "additionalItem": {
              "temName": "water"
            },
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "benefits": "After 2 to 3 hours"
          }
        ]
      },
      {
        "ageGroup": "Child",
        "description": "According to the advice of the physician.",
        "subDoseList": [
          {
            "type": "primary",
            "notes": "According to the advice of the physician.Shake well before use, because, floating substances are the part of medicine.",
            "treatmentPeriod": {
              "unit": "week",
              "min": 3,
              "max": 4
            },
            "benefits": "After 2 to 3 hours"
          }
        ]
      }
    ]
  },
  {
    "serial": 930,
    "genericName": "Leucomin Syp.",
    "doseList": [
      {
        "indication": "for menstrual irregularity and dysmenorrhoea",
        "description": "After menstruation till the starting of next period, 2 tsf to be taken at night for menstrual irregularity and dysmenorrhoea.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "notes": "After menstruation till the starting of next period"
          }
        ]
      },
      {
        "indication": "for leucorrhoea",
        "description": "2 tsf to be taken at night for leucorrhoea.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "indication": "for metritis",
        "description": "2 tsf mixed with lukewarm water be taken at night for metritis.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "additionalItem": {
              "temName": "mixed with lukewarm water"
            }
          }
        ]
      },
      {
        "indication": "in chronic cases",
        "description": "in chronic cases one dose of 2 tsf to be taken in the morning as well.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 931,
    "genericName": "Masturin Syp.",
    "doseList": [
      {
        "indication": "for menstrual irregularity and dysmenorrhoea",
        "description": "After menstruation till the starting of next period, 2 tsf to be taken at night for menstrual irregularity and dysmenorrhoea.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "notes": "After menstruation till the starting of next period"
          }
        ]
      },
      {
        "indication": "for leucorrhoea",
        "description": "2 tsf to be taken at night for leucorrhoea.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            }
          }
        ]
      },
      {
        "indication": "for metritis",
        "description": "2 tsf mixed with lukewarm water be taken at night for metritis.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "night": true
            },
            "additionalItem": {
              "temName": "mixed with lukewarm water"
            }
          }
        ]
      },
      {
        "indication": "in chronic cases",
        "description": "in chronic cases one dose of 2 tsf to be taken in the morning as well.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 932,
    "genericName": "Jernide Syp.",
    "doseList": [
      {
        "description": "1 tsf twice or thice daily after meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "timesDaily": {
              "min": 2,
              "max": 3
            },
            "connectionToMeal": {
              "when": "after meals"
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 933,
    "genericName": "Suparipak Syp.",
    "doseList": [
      {
        "description": "1-2 tsf of suparipak powder with a lttle milk in the morning or 1 tsf with a little milk twice a day- morning and before retiring.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 2
            },
            "additionalItem": {
              "temName": "with a lttle milk"
            },
            "doseTime": {
              "morning": true
            }
          },
          {
            "type": "alternate",
            "unit": "t.s.f",
            "amount": {
              "min": 1,
              "max": 1
            },
            "additionalItem": {
              "temName": "with a lttle milk"
            },
            "timesDaily": {
              "min": 2,
              "max": 2
            },
            "doseTime": {
              "morning": true,
              "beforeRetiring": true
            }
          }
        ]
      }
    ]
  },
  {
    "serial": 583,
    "genericName": "Pyrimethamine",
    "doseList": [
      {
        "ageGroup": "Adult",
        "description": "200-400mg once daily with meals.",
        "subDoseList": [
          {
            "type": "primary",
            "unit": "mg",
            "amount": {
              "min": 200,
              "max": 400
            },
            "connectionToMeal": {
              "when": "with meals"
            }
          }
        ]
      }
    ]
  }
]